<SEC-DOCUMENT>0001193125-23-066281.txt : 20230309
<SEC-HEADER>0001193125-23-066281.hdr.sgml : 20230309
<ACCEPTANCE-DATETIME>20230309171732
ACCESSION NUMBER:		0001193125-23-066281
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		21
CONFORMED PERIOD OF REPORT:	20230309
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230309
DATE AS OF CHANGE:		20230309

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TEVA PHARMACEUTICAL INDUSTRIES LTD
		CENTRAL INDEX KEY:			0000818686
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-16174
		FILM NUMBER:		23720706

	BUSINESS ADDRESS:	
		STREET 1:		5 BAZEL ST
		STREET 2:		P O B 3190
		CITY:			PETACH TIKVA
		STATE:			L3
		ZIP:			49131
		BUSINESS PHONE:		9729267267

	MAIL ADDRESS:	
		STREET 1:		TEVA PHARMACEUTICAL INDUSTRIES LIMITED
		STREET 2:		5 BAZEL ST PO B 3190
		CITY:			PETACH TIKVA
		STATE:			L3
		ZIP:			49131
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d475718d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:teva="http://www.tevapharm.com/20230309" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityRegistrantName" name="dei:EntityRegistrantName" contextRef="duration_2023-03-09_to_2023-03-09">TEVA PHARMACEUTICAL INDUSTRIES LTD</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2023-03-09_to_2023-03-09">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2023-03-09_to_2023-03-09">0000818686</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="teva-20230309.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2023-03-09_to_2023-03-09"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000818686</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-03-09</xbrli:startDate> <xbrli:endDate>2023-03-09</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2023-03-09_to_2023-03-09">8-K</ix:nonNumeric></span></p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 OR 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported) <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2023-03-09_to_2023-03-09" format="ixt:datemonthdayyearen">March&#160;9, 2023</ix:nonNumeric></p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <span style=" -sec-ix-hidden:Hidden_dei_EntityRegistrantName">TEVA PHARMACEUTICAL INDUSTRIES LIMITED</span> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2023-03-09_to_2023-03-09" format="ixt-sec:edgarprovcountryen">Israel</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2023-03-09_to_2023-03-09">001-16174</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2023-03-09_to_2023-03-09">00-0000000</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other Jurisdiction of</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Incorporation Or Organization)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(I.R.S. Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification Number)</p></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2023-03-09_to_2023-03-09">124 Dvora Hanevi&#8217;a Street</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2023-03-09_to_2023-03-09">Tel Aviv</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2023-03-09_to_2023-03-09">6944020</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCountry" contextRef="duration_2023-03-09_to_2023-03-09" format="ixt-sec:countrynameen">Israel</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Address of Principal Executive Offices, including Zip Code)</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">+<ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2023-03-09_to_2023-03-09">972</ix:nonNumeric><span style="white-space:nowrap">-</span> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2023-03-09_to_2023-03-09">3-914-8213</ix:nonNumeric></span></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Registrant&#8217;s Telephone Number, including Area Code)</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not Applicable</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name, former address and former fiscal year, if changed since last report)</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2023-03-09_to_2023-03-09" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2023-03-09_to_2023-03-09" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2023-03-09_to_2023-03-09" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2023-03-09_to_2023-03-09" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2023-03-09_to_2023-03-09">American Depositary Shares, each representing one Ordinary Share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2023-03-09_to_2023-03-09">TEVA</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2023-03-09_to_2023-03-09" format="ixt-sec:exchnameen">New York Stock Exchange</ix:nonNumeric></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">((&#167;240.12b-2</span> of this chapter).</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">Emerging Growth Company&#160;&#160;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2023-03-09_to_2023-03-09" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;&#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;1.01.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Entry into a Material Definitive Agreement. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March 9, 2023, (i) Teva Pharmaceutical Finance Netherlands II B.V. (&#8220;<span style="text-decoration:underline">Teva Finance II</span>&#8221;), a wholly owned subsidiary of Teva Pharmaceutical Industries Limited (the &#8220;<span style="text-decoration:underline">Company</span>&#8221;), issued &#8364;800,000,000 aggregate principal amount of 7.375% Sustainability-Linked Senior Notes due 2029 (the &#8220;<span style="text-decoration:underline">2029 Euro Notes</span>&#8221;) and &#8364;500,000,000 aggregate principal amount of 7.875% Sustainability-Linked Senior Notes due 2031 (the &#8220;<span style="text-decoration:underline">2031 Euro Notes</span>&#8221; and, together with the 2029 Euro Notes, the &#8220;<span style="text-decoration:underline">Euro Notes</span>&#8221;); and (ii)&#160;Teva Pharmaceutical Finance Netherlands III B.V. (&#8220;<span style="text-decoration:underline">Teva Finance III</span>&#8221; and, together with Teva Finance II, the &#8220;<span style="text-decoration:underline">Issuers</span>&#8221;), a wholly owned subsidiary of the Company, issued $600,000,0000 aggregate principal amount of 7.875% Sustainability-Linked Senior Notes due 2029 (the &#8220;<span style="text-decoration:underline">2029 USD Notes</span>&#8221;) and $500,000,000 aggregate principal amount of 8.125% Sustainability-Linked Senior Notes due 2031 (the &#8220;<span style="text-decoration:underline">2031 USD Notes</span>&#8221; and, together with 2029 USD Notes, the &#8220;<span style="text-decoration:underline">USD Notes</span>&#8221; and together with the Euro Notes, the &#8220;<span style="text-decoration:underline">Notes</span>&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Teva intends to use the net proceeds from the Notes (i)&#160;to fund the announced tender offer for a maximum combined aggregate purchase price (exclusive of accrued and unpaid interest) of up to $2,500,000,000 (equivalent) (upsized from a previously announced cap of $2,250,000,000), (ii) to pay fees and expenses in connection therewith, and (iii)&#160;to the extent of any remaining proceeds, for the repayment of outstanding debt upon maturity, tender offer or earlier redemption. Net proceeds may be temporarily invested pending application for their stated purpose. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Euro Notes were issued pursuant to a Senior Indenture, dated as of March&#160;14, 2018 (the &#8220;<span style="text-decoration:underline">Euro Notes Base Indenture</span>&#8221;), by and among Teva Finance II, the Company, as guarantor, and The Bank of New York Mellon, as trustee, as supplemented by the Fourth Supplemental Indenture, dated as of March&#160;9, 2023 (the &#8220;<span style="text-decoration:underline">Euro Notes Supplemental Indenture</span>&#8221; and, together with the Euro Notes Base Indenture, the &#8220;<span style="text-decoration:underline">Euro Notes Indenture</span>&#8221;), by and among Teva Finance II, the Company, as guarantor, The Bank of New York Mellon, as trustee, and The Bank of New York Mellon, London Branch, as paying agent. The USD Notes were issued pursuant to a Senior Indenture, dated as of March&#160;14, 2018 (the &#8220;<span style="text-decoration:underline">USD Notes Base Indenture</span>&#8221;), as supplemented by the Fourth Supplemental Indenture, dated as of March&#160;9, 2023 (the &#8220;<span style="text-decoration:underline">USD Notes Supplemental Indenture</span>&#8221; and, together with the USD Notes Base Indenture, the &#8220;<span style="text-decoration:underline">USD Notes Indenture</span>&#8221; and, together with the Euro Notes Indenture, the &#8220;<span style="text-decoration:underline">Indentures</span>&#8221;), in each case, by and among Teva Finance III, the Company, as guarantor, and The Bank of New York Mellon, as trustee. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interest will be payable on the Notes semi-annually in arrears on March&#160;15 and September&#160;15 of each year, beginning on September&#160;15, 2023, until their maturity dates of September&#160;15, 2029 for the 2029 Euro Notes and the 2029 USD Notes and September&#160;15, 2031 for the 2031 USD Notes and the 2031 Euro Notes. The Euro Notes and the USD Notes are senior unsecured obligations of Teva Finance II and Teva Finance III, respectively, and the Notes are guaranteed on a senior unsecured basis by the Company. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">From and including September&#160;15, 2026 (the&#160;&#8220;<span style="text-decoration:underline"><span style="white-space:nowrap">Step-up</span></span><span style="text-decoration:underline"></span><span style="text-decoration:underline">&#160;Date</span>&#8221;), the interest rate payable on the Notes shall increase by: </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(a) 0.100% per annum unless Teva has achieved the Regulatory Submissions Target as of the Testing Date (each as defined in the Euro Notes Supplemental Indenture and the&#160;USD Notes Supplemental Indenture); </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(b) 0.100% per annum unless Teva has achieved the Product Volume Target as of the Testing Date (each as defined in the Euro Notes Supplemental Indenture and the USD Notes Supplemental Indenture); and </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(c) 0.100% per annum unless Teva has achieved the Emission Reduction Target as of the Testing Date (each as defined in the Euro Notes Supplemental Indenture and the USD Notes Supplemental Indenture); </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Teva Finance II may redeem the Euro Notes of any series, in whole or in part, at any time or from time to time, upon at least 10 days&#8217;, but not more than 60 days&#8217;, prior notice delivered to the registered address of each holder of the Euro Notes to be redeemed with a copy of such notice delivered to the trustee and the paying agent. The Euro Notes will be redeemable at a redemption price equal to the greater of (1) 100% of the principal amount of the Euro Notes of such series to be redeemed or (2)&#160;the sum of the present values of the Remaining Scheduled Payments (as defined in the Euro Notes Indenture) of the Euro Notes of such series being redeemed discounted, on a semi-annual basis (assuming a <span style="white-space:nowrap">360-day</span> year consisting of twelve <span style="white-space:nowrap">30-day</span> months), at the applicable Reinvestment </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Rate (as defined in the Euro Notes Indenture), plus accrued and unpaid interest thereon, if any to, but not including, the redemption date; provided that if Teva Finance II elects to redeem the 2029 Euro Notes at any time on or after June&#160;15, 2029 (three months prior to the maturity date of the 2029 Euro Notes) or to redeem the 2031 Euro Notes at any time on or after June&#160;15, 2031 (three months prior to the maturity date of the 2031 Euro Notes), Teva Finance II may redeem the such Euro Notes, in whole or in part, at a redemption price equal to 100% of the principal amount of such series of Euro Notes then outstanding to be redeemed, plus accrued and unpaid interest thereon, if any, to, but not including, the redemption date. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Teva Finance III may redeem the USD Notes, of any series, in whole or in part, at any time or from time to time, upon at least 10 days&#8217;, but not more than 60 days&#8217;, prior notice. The USD Notes will be redeemable at a redemption price equal to the greater of (1) 100% of the principal amount of the USD Notes to be redeemed or (2)&#160;the sum of the present values of the Remaining Scheduled Payments (as defined in the USD Notes Indenture) of the USD Notes of such series being redeemed discounted, on a semi-annual basis (assuming a <span style="white-space:nowrap">360-day</span> year consisting of twelve <span style="white-space:nowrap">30-day</span> months), using a discount rate equal to the sum of the Treasury Rate (as defined in the USD Notes Indenture) plus 50 basis points, plus in each case accrued and unpaid interest thereon, if any, to, but not including, the redemption date; provided that if Teva Finance III elects to redeem the 2029 USD Notes at any time on or after June&#160;15, 2029 (three months prior to the maturity date of the 2029 USD Notes) or to redeem the 2031 USD Notes at any time on or after June&#160;15, 2031 (three months prior to the maturity date of the 2031 USD Notes), Teva Finance III may redeem the USD Notes, in whole or in part, at a redemption price equal to 100% of the principal amount of such series of USD Notes then outstanding to be redeemed, plus accrued and unpaid interest thereon, if any, to, but not including, the redemption date. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The terms of the Indentures, among other things and subject to specified exceptions, limit the ability of (a)&#160;the Company and its subsidiaries to (i)&#160;create liens upon certain of their property and (ii)&#160;enter into sale-leaseback transactions; and (b)&#160;the applicable Issuer and the Company to merge, consolidate or sell, lease or convey all or substantially all of their assets. The Indentures provide for customary events of default, which include (subject in certain cases to customary grace and cure periods), among others, nonpayment of principal or interest; breach of other covenants or agreements in the Indentures; acceleration of certain other indebtedness; failure of the Company&#8217;s guarantee to be enforceable; and certain events of bankruptcy or insolvency. The offering of the Notes was registered under the Securities Act of 1933, as amended (the &#8220;<span style="text-decoration:underline">Securities Act</span>&#8221;), and is being made pursuant to the Company&#8217;s Registration Statement on Form <span style="white-space:nowrap">S-3ASR</span> (File <span style="white-space:nowrap">No.&#160;333-260519)</span> and the prospectus included therein (the &#8220;<span style="text-decoration:underline">Registration Statement</span>&#8221;), filed by the Company with the Commission on October&#160;27, 2021, the preliminary prospectus supplement relating thereto, dated February&#160;27, 2023, and filed with the Commission on February&#160;27, 2023 pursuant to Rule 424(b)(3) promulgated under the Securities Act and the free writing prospectus related thereto, dated March&#160;1, 2023, and filed with the Commission on March&#160;1, 2023 pursuant to Rule 433 under the Securities Act. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing summary descriptions of the Euro Notes Base Indenture, Euro Notes Supplemental Indenture, USD Notes Base Indenture, USD Notes Supplemental Indenture and each series of Notes are not complete and are qualified in their entirety by reference to the Euro Notes Base Indenture, the Euro Notes Supplemental Indenture, the form of 2029 Euro Notes, the form of 2031 Euro Notes, the USD Notes Base Indenture, the USD Notes Supplemental Indenture, the form of 2029 USD Notes and the form of 2031 USD Notes, which are filed as Exhibits 4.1, 4.2, 4.3, 4.4, 4.5, 4.6, 4.7 and 4.8, respectively, to this Current Report on Form <span style="white-space:nowrap">8-K</span> and are incorporated herein by reference. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;2.03</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Creation of a Direct Financial Obligation or an Obligation under an Off Balance Sheet Arrangement of a Registrant. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information set forth in Item 1.01 is incorporated by reference into this Item 2.03. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">3 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;9.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Exhibits </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:4%"></td>
<td style="width:93%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;4.1*</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/818686/000119312518082582/d550834dex45.htm">Senior Indenture, dated as of March&#160;14, 2018, among Teva Pharmaceutical Finance Netherlands II B.V., Teva Pharmaceutical Industries Limited and The Bank of New York Mellon, as trustee (incorporated by reference to Exhibit&#160;4.30 to the Company&#8217;s Annual Report on Form <span style="white-space:nowrap">10-K</span> for the year ended December&#160;31, 2018 filed by the registrant on February&#160;19, 2019). </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;4.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d475718dex42.htm">Fourth Supplemental Senior Indenture, dated as of March&#160;9, 2023, among Teva Pharmaceutical Finance Netherlands II B.V., Teva Pharmaceutical Industries Limited, The Bank of New York Mellon, as trustee, and The Bank of New York Mellon, London Branch, as paying agent. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;4.3</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d475718dex42.htm">Form of 2029 Euro Notes (included in Exhibit&#160;4.2). </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;4.4</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d475718dex42.htm">Form of 2031 Euro Notes (included in Exhibit&#160;4.2). </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;4.5*</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/818686/000119312518082582/d550834dex41.htm">Senior Indenture, dated as of March&#160;14, 2018, among Teva Pharmaceutical Finance Netherlands III B.V., Teva Pharmaceutical Industries Limited and The Bank of New York Mellon, as trustee (incorporated by reference to Exhibit&#160;4.27 to the Company&#8217;s Annual Report on Form <span style="white-space:nowrap">10-K</span> for the year ended December&#160;31, 2018 filed by the registrant on February&#160;19, 2019). </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;4.6</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d475718dex46.htm">Fourth Supplemental Senior Indenture, dated as of March&#160;9, 2023, among Teva Pharmaceutical Finance Netherlands III B.V., Teva Pharmaceutical Industries Limited and The Bank of New York Mellon, as trustee. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;4.7</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d475718dex46.htm">Form of 2029 USD Notes (included in Exhibit&#160;4.6). </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;4.8</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d475718dex46.htm">Form of 2031 USD Notes (included in Exhibit&#160;4.6). </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;5.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d475718dex51.htm">Opinion of Tulchinsky Marciano Cohen Levitski&#160;&amp; Co. (Israeli law) </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;5.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d475718dex52.htm">Opinion of Kirkland&#160;&amp; Ellis LLP (New York law) </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;5.3</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d475718dex53.htm">Opinion of Van Doorne N.V. (Dutch law) </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">23.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d475718dex51.htm">Consent of Tulchinsky Marciano Cohen Levitski&#160;&amp; Co. (included in Exhibit&#160;5.1) </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">23.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d475718dex52.htm">Consent of Kirkland&#160;&amp; Ellis LLP (included in Exhibit&#160;5.2) </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">23.3</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d475718dex53.htm">Consent of Van Doorne, N.V. (included in Exhibit&#160;5.3) </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (included within the Inline XBRL document).</td></tr>
</table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top" align="left">*</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Previously Filed </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">4 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURE </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: March&#160;9, 2023 </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p><div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:40%;border:0;margin-left:auto">


<tr>

<td style="width:12%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:87%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top" colspan="3"><span style="font-weight:bold">TEVA PHARMACEUTICAL INDUSTRIES LIMITED</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Eli Kalif</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Name:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Eli Kalif</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Title:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Executive Vice President, Chief Financial Officer</td></tr>
</table></div>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">5 </p>

</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>2
<FILENAME>d475718dex42.htm
<DESCRIPTION>EX-4.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-4.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 4.2 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:2.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:2.00pt solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">TEVA PHARMACEUTICAL FINANCE NETHERLANDS II B.V., </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">as Issuer, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">TEVA PHARMACEUTICAL
INDUSTRIES LIMITED, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">as Guarantor, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">THE BANK OF NEW YORK MELLON, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">as
Trustee </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">THE BANK OF NEW
YORK MELLON, LONDON BRANCH, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">as Paying Agent </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">FOURTH
SUPPLEMENTAL SENIOR INDENTURE </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Dated as of March&nbsp;9, 2023 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">to the Senior Indenture dated as of March&nbsp;14, 2018 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Creating the
series of Securities (as defined herein) designated </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7.375% Sustainability-Linked Senior Notes due 2029 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7.875% Sustainability-Linked
Senior Notes due 2031 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:2.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:2.00pt solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="83%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD COLSPAN="3" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ARTICLE 1 DEFINITIONS AND INCORPORATION BY REFERENCE</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Definitions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Incorporation by Reference of Trust Indenture Act</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Rules of Construction</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ARTICLE 2 THE NOTES AND THE GUARANTEES</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>11</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Title and Terms</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Forms of Notes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Legends</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Form of Guarantees</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Book-Entry Provisions for the Global Notes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>[Reserved]</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Defaulted Interest</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Execution of Guarantees</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Add On Notes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>ISIN Numbers and Common Codes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ARTICLE 3 ADDITIONAL COVENANTS</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>18</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Payment of Additional Tax Amounts</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Stamp Tax</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Corporate Existence</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Certificates of the Issuer and the Guarantor</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Guarantor To Be the Sole Equityholder of the Issuer</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Limitation on Liens</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Limitation on Sales and Leasebacks</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ARTICLE 4 REDEMPTION OF NOTES</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>21</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Optional Redemption</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Notice of Redemption</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Deposit of Redemption Price</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Tax Redemption</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ARTICLE 5 SATISFACTION AND DISCHARGE</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>22</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Satisfaction and Discharge</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ARTICLE 6 PAYING AGENT</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>22</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Paying Agent</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Electronic Means</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>CSDR Regulation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ARTICLE 7 MISCELLANEOUS PROVISIONS</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>24</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Scope of Supplemental Indenture</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Provisions of Supplemental Indenture for the Sole Benefit of Parties and Holders of Notes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Successors and Assigns of Issuer and Guarantor Bound by Supplemental Indenture</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Notices and Demands on Issuer, Trustee, Paying Agent and Holders of Notes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Officer&#146;s Certificates and Opinions of Counsel; Statements to be Contained Therein</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Payments Due on Saturdays, Sundays and Holidays</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Conflict of any Provisions of Supplemental Indenture with Trust Indenture Act of 1939</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>New York Law to Govern</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Counterparts</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Effect of Headings</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.11</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Submission to Jurisdiction</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.12</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Not Responsible for Recitals or Issuance of Securities</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ARTICLE 8 SUPPLEMENTAL INDENTURES</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>28</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Without Consent of Holders</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>With Consent of Each Affected Holder</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">EXHIBIT A - FORM OF 2029 NOTE</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">EXHIBIT B - FORM OF 2031 NOTE</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">FOURTH SUPPLEMENTAL SENIOR INDENTURE, dated as of March&nbsp;9, 2023, by and among Teva
Pharmaceutical Finance Netherlands II B.V., a private company with limited liability (<I>besloten vennootschap met beperkte aansprakelijkheid</I>), incorporated under Dutch law (the &#147;<U>Issuer</U>&#148;), Teva Pharmaceutical Industries Limited,
a corporation incorporated under the laws of Israel (the &#147;<U>Guarantor</U>&#148;), The Bank of New York Mellon, a New York banking corporation, as trustee (the &#147;<U>Trustee</U>&#148;) and The Bank of New York Mellon, London Branch, as
paying agent (the &#147;<U>Paying Agent</U>&#148;). </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>W I T N E S S E T H: </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Issuer has heretofore executed and delivered to the Trustee and the Paying Agent a Senior Indenture, dated as of March&nbsp;14,
2018 (the &#147;<U>Base Indenture</U>&#148;), providing for the issuance from time to time of one or more series of its senior unsecured debentures, notes or other evidences of indebtedness (the &#147;<U>Securities</U>&#148;); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Issuer has heretofore executed and delivered to the Trustee and the Paying Agent a first supplemental senior indenture, dated as
of March&nbsp;14, 2018, providing for the issuance of the 3.250% Senior Notes due 2022 and the 4.500% Senior Notes due 2025; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the
Issuer has heretofore executed and delivered to the Trustee and the Paying Agent a second supplemental senior indenture, dated as of November&nbsp;25, 2019, providing for the issuance of the 6.000% Senior Notes due 2025; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Issuer has heretofore executed and delivered to the Trustee and the Paying Agent a third supplemental senior indenture, dated as
of November&nbsp;9, 2021, providing for the issuance of the 3.750% Sustainability-Linked Senior Notes due 2027 and the 4.375% Sustainability-Linked Senior Notes due 2030; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, Section&nbsp;7.01(h) of the Base Indenture provides that the Issuer, the Guarantor and the Trustee may from time to time enter into
one or more indentures supplemental thereto to establish the form or terms of Securities of a new series; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Issuer, pursuant
to the foregoing authority, proposes in and by this fourth supplemental senior indenture (this &#147;<U>Supplemental Indenture</U>&#148; and, together with the Base Indenture, the &#147;<U>Indenture</U>&#148;) to amend and supplement the Base
Indenture insofar as it will apply only to the 7.375% Sustainability-Linked Senior Notes due 2029 (the &#147;<U>2029 Notes</U>&#148;) and the 7.875% Sustainability-Linked Senior Notes due 2031 (the &#147;<U>2031 Notes</U>&#148;) issued hereunder
(and not to any other series of Securities). Unless the context otherwise suggests, the 2029 Notes and the 2031 Notes are collectively referred to as the &#147;<U>Notes</U>&#148;; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, all things necessary have been done to make the Notes, when executed by the Issuer and authenticated and delivered hereunder and duly
issued by the Issuer, the valid obligations of the Issuer, and to make this Supplemental Indenture a valid and legally binding agreement of the Issuer, in accordance with their and its terms; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, THIS SUPPLEMENTAL INDENTURE WITNESSETH: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For and in consideration of the premises and the purchases of the Notes by the holders thereof, the Issuer, the Guarantor and the Trustee
mutually covenant and agree for the equal and proportionate benefit of the respective Holders from time to time of the Notes as follows: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DEFINITIONS AND INCORPORATION BY REFERENCE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.1 <U>Definitions.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Capitalized terms used herein but not defined shall have the meanings assigned to them in the Base Indenture unless otherwise indicated. For
all purposes of this Supplemental Indenture and the Notes, the following terms are defined as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Add On Notes</U>&#148;
means any notes originally issued after the date hereof pursuant to Section&nbsp;2.9, including any replacement notes as specified in the relevant Add On Note Board Resolutions, Officer&#146;s Certificate or supplemental indenture issued therefor in
accordance with the Base Indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Additional Tax Amounts</U>&#148; has the meaning specified in Section&nbsp;3.1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Affiliate</U>&#148; means, with respect to a specified Person, another Person that directly, or indirectly through one or more
intermediaries, Controls or is Controlled by or is under common Control with the Person specified. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Agent Members</U>&#148; has
the meaning specified in Section&nbsp;2.5. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Assurance Letter</U>&#148; means one or more assurance letters from an External
Reviewer confirming whether one or more of the Sustainability Performance Targets have been met. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Authorized Agent</U>&#148; has
the meaning specified in Section&nbsp;7.11. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Authorized Officers</U>&#148; has the meaning specified in Section&nbsp;6.2. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Business Day</U>&#148; means any day on which commercial banks and foreign exchange markets are open for business in New York and
London; <I>provided that</I>, for purposes of payments on the Notes, a &#147;Business Day&#148; must be a day on which the Trans-European Automated Real-Time Gross Settlement Express Transfer System (TARGET) is operating. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Capital Stock</U>&#148; means: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in the case of a corporation, corporate stock; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in the case of an association or business entity, any and all shares, interests, participations, rights or
other equivalents (however designated) of corporate stock; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in the case of a partnership or limited liability company, partnership or membership interests (whether general
or limited); and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any other interest or participation that confers on a Person the right to receive a share of the profits and
losses of, or distributions of assets of, the issuing Person. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Certification Date</U>&#148; means June&nbsp;30,
2026. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Clearstream</U>&#148; means Clearstream Banking, S.A. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Common Depositary</U>&#148; means The Bank of New York Mellon, London Branch, at 160 Queen Victoria Street, London EC4V 4LA, United
Kingdom, as common depositary for Euroclear and/or Clearstream, or any successor Person thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Consolidated Net
Worth</U>&#148; means the stockholders&#146; equity of the Guarantor and its consolidated subsidiaries, as shown on the audited consolidated balance sheet of the Guarantor&#146;s latest annual report to stockholders, prepared in accordance with
GAAP. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Control</U>&#148; means the possession, directly or indirectly, of the power to direct or cause the direction of the
management or policies of a Person, whether through the ability to exercise voting power, by contract or otherwise. &#147;<U>Controlling</U>&#148; and &#147;<U>Controlled</U>&#148; have meanings correlative thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>corporation</U>&#148; means corporations, associations, limited liability companies, companies and business trusts or any other
similar entity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Credit Cash Penalties</U>&#148; means any amounts received by the Trustee or Paying Agent from any Depository or
Subcustodian in respect of cash penalty charges payable under CSDR. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>CSDR</U>&#148; means the Central Securities Depositaries Regulation (EU) 909/2014.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Debit Cash Penalties</U>&#148; means any costs or charges incurred by the Trustee or Paying Agent in carrying out instructions
to clear and/or settle transfers of securities under this Supplemental Agreement (including cash penalty charges that may be incurred under CSDR if a settlement fail occurs). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Default</U>&#148; means an event which is, or after notice or lapse of time or both would be, an Event of Default. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Defaulted Interest</U>&#148; has the meaning specified in Section&nbsp;2.7. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Electronic Means</U>&#148; has the meaning specified in Section&nbsp;6.2. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Emission Reduction Target</U>&#148; means the Guarantor&#146;s target to reduce the Scope 1 and 2 greenhouse gas (GHG) emissions by
no less than 25% as of the Testing Date (measured on a calendar year basis and compared to the 2019 baseline); <I>provided</I>, <I>however</I>, that for purposes of determining if the Emission Reduction Target has been attained, the Guarantor and
its consolidated subsidiaries may calculate greenhouse gas emissions attributable to any single or related series of acquisitions or divestitures completed since the issue date of the Notes as contemplated by The Greenhouse Gas Protocol or other
generally accepted protocol or standard for calculating such emissions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Euro</U>&#148; means the lawful single currency of the
participating states of the European Union as at the time of payment is legal tender for the payment of public and private debts. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Euroclear</U>&#148; means Euroclear Bank S.A./N.V. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Event of Default</U>&#148; with respect to the Notes of each series shall not have the meaning assigned to such term by
Section&nbsp;4.01 of the Base Indenture. An Event of Default with respect to the Notes of each series means each one of the following events which shall have occurred and be continuing (whatever the reason for such Event of Default and whether it
shall be voluntary or involuntary or be effected by operation of law or pursuant to any judgment, decree or order of any court or any order, rule or regulation of any administrative or governmental body): </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) the Issuer defaults in the payment of the principal and premium, if any, of any of the Notes of such series when it becomes due and
payable at Maturity or upon redemption; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) the Issuer defaults in the payment of interest (including Additional Tax Amounts, if any) on
any of the Notes of such series when it becomes due and payable and such default continues for a period of 30 days after the date when due; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) the Guarantor fails to perform its obligations under the Guarantees relating to the Notes of such series; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) except as permitted by the Indenture, the Guarantees with respect to such series of Notes is held in any final, <FONT
STYLE="white-space:nowrap">non-appealable</FONT> judicial proceeding to be unenforceable or invalid or shall cease for any reason to be in full force and effect or the Guarantor, or any Person acting on behalf of the Guarantor, shall deny or
disaffirm its obligations under the Guarantees; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) either the Issuer or the Guarantor fails to perform or observe any other term,
covenant or agreement contained in the relevant Notes of such series or this Supplemental Indenture or the Base Indenture and the default continues for a period of 60 days after written notice of such failure, requiring the Issuer or the Guarantor,
as the case may be, to remedy the same, shall have been given to the Issuer or the Guarantor, as the case may be, by the Trustee or to the Issuer or the Guarantor, as the case may be, and the Trustee by the Holders of at least 25% in aggregate
principal amount of the Outstanding Notes of such series (provided that such notice may not be given with respect to any action taken, and reported publicly or to holders of such series of the Notes, more than two years prior to such notice;
provided further that the trustee shall have no obligation to determine when or if any holders have been notified of any such action or to track when such <FONT STYLE="white-space:nowrap">two-year</FONT> period starts or concludes); </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) (i) the Issuer or the Guarantor fails to make by the end of the applicable grace period,
if any, any payment of principal or interest due in respect of any Indebtedness for borrowed money, the aggregate outstanding principal amount of which is an amount in excess of $250,000,000; or (ii)&nbsp;there is an acceleration of any Indebtedness
for borrowed money in an amount in excess of $250,000,000 because of a default with respect to such Indebtedness, without, in the case of either (i)&nbsp;or (ii) above, such Indebtedness having been discharged or such
<FONT STYLE="white-space:nowrap">non-payment</FONT> or acceleration having been cured, waived, rescinded or annulled, for a period of 30 days after written notice to the Issuer by the Trustee or to the Issuer and the Trustee by the Holders of at
least 25% in aggregate principal amount of the Outstanding Notes of such series; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) the entry by a court having jurisdiction in the
premises of (i)&nbsp;a decree or order for relief in respect of the Issuer or the Guarantor in an involuntary case or proceeding under any applicable U.S. federal or state bankruptcy, insolvency, reorganization or other similar law or (ii)&nbsp;a
decree or order adjudging the Issuer or the Guarantor as bankrupt or insolvent, or approving as properly filed a petition seeking reorganization, arrangement, adjustment or composition of or in respect of the Issuer or the Guarantor under any
applicable U.S. federal or state law, or appointing a custodian, receiver, liquidator, assignee, trustee, sequestrator or other similar official of the Issuer or the Guarantor or of any substantial part of its property, or ordering the winding up or
liquidation of its affairs, and the continuance of any such decree or order for relief or any such other decree or order unstayed and in effect for a period of 60 consecutive days; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) the commencement by the Issuer or the Guarantor of a voluntary case or proceeding under any applicable U.S. federal or state bankruptcy,
insolvency, reorganization or other similar law or of any other case or proceeding to be adjudicated as bankrupt or insolvent, or the consent by the Issuer to the entry of a decree or order for relief in respect of the Issuer or the Guarantor in an
involuntary case or proceeding under any applicable U.S. federal or state bankruptcy, insolvency, reorganization or other similar law or to the commencement of any bankruptcy or insolvency case or proceeding against the Issuer or the Guarantor, or
the filing by the Issuer or the Guarantor of a petition or answer or consent seeking reorganization or relief under any applicable U.S. federal or state law, or the consent by the Issuer or the Guarantor to the filing of such petition or to the
appointment of or the taking possession by a custodian, receiver, liquidator, assignee, trustee, sequestrator or other similar official of the Issuer or the Guarantor or of any substantial part of its property, or the making by the Issuer or the
Guarantor of an assignment for the benefit of creditors, or the admission by the Issuer or the Guarantor in writing of its inability to pay its debts generally as they become due, or the taking of corporate action by the Issuer or the Guarantor
expressly in furtherance of any such action. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as otherwise provided herein, with respect to the Notes, the references in
Section&nbsp;4.01 of the Base Indenture to &#147;clauses 4.01(a), 4.01(b), 4.01(c) or 4.01(f) above&#148; shall be construed as references to clauses (a), (b), (c), (d), (e) or (f)&nbsp;of this definition and references to Sections 4.01(d) and
(e)&nbsp;in the Base Indenture shall be construed as references to clauses (g)&nbsp;and (h) of this definition. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any time period in this
Supplemental Indenture, the Base Indenture or the Notes to cure any actual or alleged default or event of default may be extended or stayed by a court of competent jurisdiction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the avoidance of doubt, failure to achieve one or more Sustainability Performance Targets shall not constitute a Default or an Event of
Default with respect to the Notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>External Reviewer</U>&#148; means a qualified provider of third-party assurance or
attestation services appointed by the Issuer, the Guarantor or one of the Guarantor&#146;s other subsidiaries to review the Guarantor&#146;s performance in connection with achieving the Sustainability Performance Targets. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>GAAP</U>&#148; has the meaning given to &#147;generally accepted accounting principles&#148; in the Base Indenture; <I>provided</I>,
<I>however</I>, that any change in GAAP that would cause the Guarantor to record an existing item as a liability upon that entity&#146;s balance sheet, which item was not previously required by GAAP to be so recorded, shall not constitute an
incurrence of Indebtedness for purposes of this Supplemental Indenture. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Global Note</U>&#148; has the meaning specified in Section&nbsp;2.2(b). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>guarantee</U>&#148; means any obligation, contingent or otherwise, of any Person, directly or indirectly guaranteeing any
Indebtedness of any other Person and any obligation, direct or indirect, contingent or otherwise, of such Person: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to purchase or pay (or advance or supply funds for the purchase or payment of) such Indebtedness of such other
Person (whether arising by virtue of partnership arrangements, or by agreement to keep-well, to purchase assets, goods, securities or services, to <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">take-or-pay,</FONT></FONT> or
maintain financial statement conditions or otherwise); or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">entered into for purposes of assuring in any other manner the obligee of such Indebtedness of the payment
thereof or to protect such obligee against loss in respect thereof (in whole or in part); <I>provided</I>, <I>however</I>, that the term &#147;guarantee&#148; will not include endorsements for collection or deposit in the ordinary course of
business. The term &#147;guarantee&#148; used as a verb has a corresponding meaning. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Guarantees</U>&#148;
means the guarantees of the Guarantor in respect of the Notes in the form provided in Section&nbsp;2.4. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Guarantor</U>&#148;
means Teva Pharmaceutical Industries Limited, a corporation incorporated under the laws of Israel, until a successor Person shall have become such pursuant to the applicable provisions of the Indenture, and thereafter &#147;Guarantor&#148; shall
mean such successor Person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Holder</U>,&#148; &#147;<U>Holder of Notes</U>&#148; or other similar terms means the registered
holder of any Note. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Indebtedness</U>&#148; means, with respect to any Person any liability for borrowed money which, in
accordance with GAAP, would be reflected on the balance sheet of such Person as a liability on the date as of which Indebtedness is to be determined, other than accounts payable or any other indebtedness to trade creditors created or assumed by such
Person in the ordinary course of business in connection with the obtaining of materials or services. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Independent Investment
Banker</U>&#148; means a bank appointed by the Issuer which is a primary European government security dealer, and any of its successors, or a market maker in pricing corporate bond issues. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Instructions</U>&#148; has the meaning specified in Section&nbsp;6.2. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Interest Payment Date</U>&#148; means each of March&nbsp;15 and September&nbsp;15 of each year, beginning September&nbsp;15, 2023;
provided, however, in each case, that if any such date is not a Business Day, the payment shall be made on the next succeeding Business Day with the same force and effect as if made on such Interest Payment Date and no interest shall accrue thereon
on account of such delay. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Interest Rate</U>&#148; means 7.375% per annum for the 2029 Notes and 7.875% per annum for the 2031
Notes; <I>provided</I> that, the interest rate on the Notes shall be subject to adjustment as described in Section&nbsp;2.1(c)(1). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Issuer</U>&#148; means Teva Pharmaceutical Finance Netherlands II B.V., a private company with limited liability (<I>besloten
vennootschap met beperkte aansprakelijkheid</I>), incorporated under Dutch law, until a successor Person shall have become such pursuant to the applicable provisions of the Indenture, and thereafter &#147;Issuer&#148; shall mean such successor
Person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Issuer Order</U>&#148; means a written order signed in the name of the Issuer by any Officer of the Issuer or a duly
authorized <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Attorney-in-Fact</FONT></FONT> of the Issuer, and delivered to the Trustee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Lien</U>&#148; means, with respect to any asset, any mortgage, lien, pledge, charge, security interest or encumbrance of any kind in
respect of such asset, whether or not filed, recorded or otherwise perfected under applicable law, including any conditional sale or other title retention agreement, any lease in the nature thereof, any option or other agreement to give a security
interest in and any filing of or agreement to give any financing statement under the Uniform Commercial Code (or equivalent statutes) of any jurisdiction. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Maturity</U>&#148; means the date on which the principal of the Notes of a given
series becomes due and payable as therein or herein provided, whether at the Stated Maturity or by acceleration, call for redemption or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Note</U>&#148; or &#147;<U>Notes</U>&#148; has the meaning specified to it in the sixth recital paragraph of this Supplemental
Indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Officer</U>&#148; has the meaning given to &#147;Officer&#148; in the Base Indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Par Call Date</U>&#148; means (i)&nbsp;with respect to the 2029 Notes June&nbsp;15, 2029 (the date that is three months prior to the
Stated Maturity of such Notes) and (ii)&nbsp;with respect to the 2031 Notes June&nbsp;15, 2031 (the date that is three<B> </B>months prior to the Stated Maturity of such Notes). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Paying Agent</U>&#148; means an office or agency where Notes may be presented for payment, including The Bank of New York Mellon,
London Branch. The term &#147;Paying Agent&#148; includes any additional paying agent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Permitted Liens</U>&#148; means: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Liens existing as of the date when the Issuer first issues such series of Notes pursuant to this Supplemental
Indenture; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Liens on property created, incurred or assumed prior to, at the time of or within one year after the date of
acquisition, completion of construction or completion of improvement of such property to secure all or part of the cost of acquiring, constructing or improving all or any part of such property; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">landlord&#146;s, warehousemen&#146;s, material men&#146;s, carriers&#146;, workmen&#146;s, repairmen&#146;s and
other like Liens arising in the ordinary course of business in respect of obligations which are not overdue or which are being contested in good faith in appropriate proceedings; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">deposits or Liens to secure the performance of bids, trade contracts, leases, statutory obligations, surety and
appeal bonds, performance bonds and other obligations of a like nature, in each case in the ordinary course of business; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Liens existing on any property of any Person at the time such Person became or becomes a subsidiary of the
Guarantor (provided that the Lien has not been created or assumed in contemplation of such Person becoming a subsidiary of the Guarantor); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Liens securing debt owing by a subsidiary to the Guarantor or to one or more of its subsidiaries;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">purchase money Liens upon or in any real property or equipment acquired by the Guarantor or any of its
subsidiaries in the ordinary course of business to secure the purchase price of such property or equipment, or Liens existing on such property or equipment at the time of its acquisition (other than any such Liens created in contemplation of such
acquisition that were not incurred to finance the acquisition of such property), provided, however, that no such Liens shall extend to or cover any properties of any character other than the real property or equipment being acquired;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Liens securing capital lease obligations in respect of property acquired; provided that no such Lien shall
extend to or cover any assets other than the assets subject to such capitalized leases; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Liens in favor of any governmental authority of any jurisdiction securing the obligation of the Guarantor or
any of its subsidiaries pursuant to any contract or payment owed to that entity pursuant to applicable laws, regulations or statutes; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(10)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Liens over any Receivable Assets subject to a Qualified Securitization Transaction; provided that the aggregate
fair market value of all Receivable Assets secured in accordance with this subclause (10)&nbsp;shall not exceed US $2,500,000,000 (or its equivalent in another currency or currencies) at any one time outstanding; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(11)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any extension, renewal, substitution or replacement (or successive extensions, renewals, substitutions or
replacements), as a whole or in part, of any Lien referred to in the foregoing clauses (1)&nbsp;to (10), inclusive, or the Indebtedness secured thereby; <U>provided</U>, <U>however</U>, that (i)&nbsp;the principal amount of Indebtedness secured
thereby and not otherwise authorized by said clauses (1)&nbsp;to (10), inclusive, shall not exceed the principal amount of Indebtedness so secured at the time of such extension, renewal, substitution or replacement; and (ii)&nbsp;any such extension,
renewal, substitution or replacement Lien shall be limited to the property covered by the Lien extended, renewed, substituted or replaced (other than improvements thereon or replacements thereof). </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Person</U>&#148; means any individual, corporation, partnership, joint venture, association, joint-stock company, trust,
unincorporated organization, limited liability company or government or political subdivision thereof or any other entity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Physical Notes</U>&#148; means Notes issued in definitive, fully registered form without interest coupons, substantially in the form
of Exhibits <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">A-1-A-6</FONT></FONT> hereto (&#147;<U>Exhibit A</U>&#148;) and Exhibits <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">B-1-B-6</FONT></FONT> hereto
(&#147;<U>Exhibit B</U>&#148;), as applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Product Volume Target</U>&#148; means the Guarantor&#146;s target to increase
access to medicine program product volume by 150% in the year ending December&nbsp;31, 2025 compared to the year ending December&nbsp;31, 2020 through four access to medicine programs, including donations and social business in <FONT
STYLE="white-space:nowrap">low-</FONT> and middle-income countries (LMICs) on the World Health Organization&#146;s essential medicines list (WHO EML) across six key TAs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Qualified Securitization Transaction</U>&#148; means any transaction or series of transactions entered into by the Guarantor or any
of its subsidiaries pursuant to which the Guarantor or such subsidiary sells, conveys or otherwise transfers to a Securitization Entity, or grants a security interest in for the benefit of a Securitization Entity, any Receivable Assets (whether now
existing or arising or acquired in the future), or otherwise contributes to the capital of such Securitization Entity, in a transaction in which such Securitization Entity finances its acquisition of or interest in such Receivable Assets by selling
or borrowing against such Receivable Assets; provided that such transaction is <FONT STYLE="white-space:nowrap">non-recourse</FONT> to the Guarantor and its subsidiaries (except for Standard Securitization Undertakings). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Receivable Assets</U>&#148; means ordinary course of business accounts receivable of the Guarantor or any of its subsidiaries, and
any assets related thereto, including, without limitation, all collateral securing such accounts receivable, all contracts and contract rights and all guarantees or other obligations in respect of such accounts receivable, proceeds of such accounts
receivable and other assets (including contract rights) which are customarily transferred or in respect of which security interests are customarily granted in connection with asset securitization transactions involving accounts receivable and/or
receivables discount without recourse schemes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Record Date</U>&#148; means either a Regular Record Date or a Special Record
Date, as the case may be. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Redemption Date</U>,&#148; when used with respect to any Notes of any series to be redeemed, means the
date fixed for such redemption. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Redemption Price</U>&#148; when used (a)&nbsp;with respect to any Notes of any series to be
redeemed pursuant to Section&nbsp;4.1 of this Supplemental Indenture, means an amount that is equal to the greater of (i) 100% of the principal amount of the Notes of such series to be redeemed or (ii)&nbsp;the sum of the present values of the
Remaining Scheduled Payments of the Notes of such series being redeemed discounted, on a semi-annual basis (assuming a <FONT STYLE="white-space:nowrap">360-day</FONT> year consisting of twelve <FONT STYLE="white-space:nowrap">30-day</FONT> months),
at the applicable Reinvestment Rate, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
plus accrued and unpaid interest thereon, if any, to, but not including, the Redemption Date, provided that if the Redemption Date is on or after the applicable Par Call Date with respect to any
series of Notes, the Redemption Price for such Notes will be equal to 100% of the aggregate principal amount of such Notes being redeemed, plus accrued and unpaid interest thereon, if any, to, but not including, the Redemption Date; and
(b)&nbsp;with respect to any Notes of such series to be redeemed pursuant to Section&nbsp;4.4 of this Supplemental Indenture, means an amount that is equal to 100% of the principal amount thereof, plus accrued and unpaid interest thereon, if any,
to, but not including, the Redemption Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Reference Bund</U>&#148; means, with respect to the 2029 Notes, the 0.000% Federal
Government Bond of Bundesrepublik Deutschland due August&nbsp;15, 2029, with ISIN DE0001102473 and, with respect to the 2031 Notes, the 0.000% Federal Government Bond of Bundesrepublik Deutschland due August&nbsp;15, 2031, with ISIN DE0001102564.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Reference Dealers</U>&#148; means the Independent Investment Banker and each of the three other banks selected by the Issuer
which are primary European government security dealers, and their respective successors, or market makers in pricing corporate bond issues. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Registrar</U>&#148; means the office or agency where Notes may be presented for registration of transfer or for exchange. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Regulatory Submissions Target</U>&#148; means the Guarantor&#146;s target to increase the cumulative number of new regulatory
submissions made by the Guarantor and its subsidiaries in <FONT STYLE="white-space:nowrap">low-</FONT> and middle-income countries (LMIC) as designated by the World Bank as of June 2020 and on the World Health Organization&#146;s essential medicines
list (WHO EML) as of September 2021 within the therapeutic areas of cardiovascular diseases, pediatric oncology, respiratory diseases, diabetes, mental health and pain/palliative care by 150% in the four-year period ending December&nbsp;31, 2025
compared to the four-year period ended December&nbsp;31, 2020. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Regular Record Date</U>&#148; means the close of business on the
Business Day immediately preceding the related Interest Payment Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Reinvestment Rate</U>&#148; means 0.50%, plus the greater
of (i)&nbsp;the average of the four quotations given by the Reference Dealers of the <FONT STYLE="white-space:nowrap">mid-market</FONT> semi-annual yield to maturity of the applicable Reference Bund at 11:00 a.m. (Central European time
(&#147;CET&#148;)) on the fourth Business Day preceding the applicable Redemption Date and if the applicable Reference Bund is no longer outstanding, a Similar Security will be chosen by the Independent Investment Banker at 11:00 a.m. (CET) on the
third Business Day in London preceding such Redemption Date, quoted in writing by the Independent Investment Banker to the Issuer and (ii)&nbsp;zero. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Remaining Scheduled Payments</U>&#148; means, with respect to each Note to be redeemed, the remaining scheduled payments of principal
of and interest on such Note as if redeemed on the applicable Par Call Date, determined at the interest rate to be applicable on such redemption date. If the applicable Redemption Date is not an Interest Payment Date with respect to such Note, the
amount of the next succeeding scheduled interest payment on such Note will be reduced by the amount of interest accrued on such Note to such Redemption Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Sale-Leaseback Transaction</U>&#148; means the sale or transfer by the Guarantor or any subsidiary of any property to a Person and
the taking back by the Guarantor or any subsidiary, as the case may be, of a lease of such property. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Securities Act</U>&#148;
means the Securities Act of 1933, as amended. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Securitization Entity</U>&#148; means a Person (which may include a special purpose
vehicle and/or a financial institution) to which the Guarantor or any subsidiary transfers Receivable Assets for purposes of a securitization financing, and with respect to which: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">no portion of the Indebtedness or any other obligations (contingent or otherwise) of such entity (i)&nbsp;is
guaranteed by the Guarantor or any subsidiary of the Guarantor (other than the Securitization Entity) (excluding guarantees of obligations (other than the principal of, and interest on, Indebtedness) pursuant to Standard Securitization
Undertakings), (ii) is recourse to or obligates the Guarantor or any subsidiary of the Guarantor (other than the Securitization Entity) in any way other than pursuant to Standard Securitization Undertakings or (iii)&nbsp;subjects any asset of the
Guarantor or any subsidiary of the Guarantor (other than the Securitization Entity), directly or indirectly, contingently or otherwise, to the satisfaction thereof, other than pursuant to Standard Securitization Undertakings and other than any
interest in the Receivable Assets (whether in the form of an equity interest in such assets or subordinated indebtedness payable primarily from such financed assets) retained or acquired by the Guarantor or any subsidiary of the Guarantor;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">neither the Guarantor nor any subsidiary of the Guarantor has any material contract, agreement, arrangement or
understanding other than on terms no less favorable to the Guarantor or such subsidiary than those that might be obtained at the time from Persons that are not Affiliates of the Guarantor, other than fees payable in the ordinary course of business
in connection with servicing receivables of such entity; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">neither the Guarantor nor any subsidiary of the Guarantor has any obligation to maintain or preserve such
entity&#146;s financial condition or cause such entity to achieve certain levels of operating results (it being understood that (i)&nbsp;obligations of the Guarantor or other subsidiaries to transfer Receivable Assets to the Securitization Entity,
(ii)&nbsp;obligations of the Guarantor or any other subsidiary to procure such transfers of Receivable Assets to the Securitization Entity, and (iii)&nbsp;Receivable Asset performance measures or credit enhancement measures shall not constitute an
obligation to preserve the Securitization Entity&#146;s financial condition or to cause it to achieve certain levels of operating results). </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Similar Security</U>&#148; means a reference bond or reference bonds issued by the German Federal Government having an actual or
interpolated maturity comparable with the applicable Par Call Date of the Notes of such series to be redeemed that would be utilized, at the time of selection and in accordance with customary financial practice, in pricing new issues of corporate
debt securities of comparable maturity to the applicable Par Call Date of Notes of such series. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Special Record Date</U>&#148;
for the payment of any Defaulted Interest means a date fixed by the Trustee pursuant to Section&nbsp;2.7. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Standard
Securitization Undertakings</U>&#148; means representations, warranties, covenants and indemnities reasonably customary (as determined by the Guarantor acting in good faith) in accounts receivable securitization transactions and/or receivables
discount without recourse schemes in the applicable jurisdictions, including, to the extent applicable, in a manner consistent with the delivery of a &#147;true sale&#148;/&#147;absolute transfer&#148; opinion with respect to any transfer by the
Guarantor or any Subsidiary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Stated Maturity</U>&#148; means the date specified in any Note as the fixed date for the payment of
principal on such Note. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>subsidiary</U>&#148; means, with respect to any Person, a corporation more than 50% of the outstanding
voting stock of which is owned, directly or indirectly, by such Person or by one or more other subsidiaries, or by such Person and one or more other subsidiaries. For the purposes of this definition only, &#147;voting stock&#148; means stock which
ordinarily has voting power for the election of directors, whether at all times or only so long as no senior class of stock has such voting power by reason of any contingency. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Sustainability Performance Targets</U>&#148; means, collectively, the Product Volume Target, the Regulatory Submissions Target and
the Emissions Reduction Target; <I>provided</I>, <I>however</I>, that for purposes of determining if any Sustainability Performance Target has been achieved, the Guarantor and its consolidated subsidiaries may exclude the impact of (i)&nbsp;any
amendment to, or change in, any applicable laws, regulations, rules, guidelines, standards and policies applicable or relating to the business, operations or properties of the Guarantor and its consolidated subsidiaries following the issue date of
the Notes, including with respect to the measurement or calculation of any of the Sustainability Performance Targets or (ii)&nbsp;any <I>force majeure</I>, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
extraordinary or exceptional events or circumstances, including the occurrence of such events or circumstances with respect to any governmental,
<FONT STYLE="white-space:nowrap">non-governmental</FONT> or healthcare organization whose participation, involvement or functioning is necessary, appropriate or, as of the date of this offering, anticipated, for the achievement of the Sustainability
Performance Targets (including but not limited to <FONT STYLE="white-space:nowrap">geo-political</FONT> instability, poor governance practices or the failure of local infrastructure (including physical or social infrastructure or supranational,
national, state, provincial or local governance)). If a Sustainability Performance Target is not achieved as a result of the occurrence of any of the foregoing described in the proviso to the immediately preceding sentence, as determined by the
Guarantor in its reasonable judgment, such Sustainability Performance Target will be deemed to have been achieved for purposes of this Supplemental Indenture and no interest rate adjustment shall result from the failure to achieve such
Sustainability Performance Target. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Taxing Jurisdiction</U>&#148; means, with respect to the Notes, The Netherlands, Israel or
any jurisdiction where a successor to the Issuer or the Guarantor is incorporated or organized or considered to be a resident, if other than The Netherlands or Israel, respectively, or any jurisdiction through which payments will be made. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Testing Date</U>&#148; means December&nbsp;31, 2025. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>TIA</U>&#148; means the Trust Indenture Act of 1939, as amended, as in effect on the date of this Supplemental Indenture; provided,
however, that in the event the TIA is amended after such date, &#147;TIA&#148; means, to the extent such amendment is applicable to this Supplemental Indenture and the Base Indenture, the Trust Indenture Act of 1939, as so amended, or any successor
statute. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Trustee</U>&#148; means The Bank of New York Mellon, a New York banking corporation, until a successor Trustee shall
have become such pursuant to the applicable provisions of this Supplemental Indenture, and thereafter &#147;Trustee&#148; shall mean such successor Trustee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Underwriting Agreement</U>&#148; means the Underwriting Agreement, dated March&nbsp;1, 2023, among the Issuer, Teva Pharmaceutical
Finance Netherlands III B.V., the Guarantor and the underwriters named in Schedule I thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.2 <U>Incorporation by
Reference of Trust Indenture Act</U><U>.</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Whenever the Indenture refers to a provision of the TIA, the provision is incorporated by
reference in and made a part of this Supplemental Indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following TIA terms used in the Indenture have the following meanings:
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>indenture securities</U>&#148; means the Notes of each series and the Guarantees; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>obligor</U>&#148; on the Notes of each series means the Issuer and on the Guarantees means the Guarantor and any other obligor on the
indenture securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All other TIA terms used in this Supplemental Indenture that are defined by the TIA, defined by TIA reference to
another statute or defined by SEC rule have the meanings assigned to them by such definitions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.3 <U>Rules of
Construction</U><U>.</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For all purposes of this Supplemental Indenture, except as otherwise expressly provided or unless the context
otherwise requires: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) the terms defined in this Article have the meanings assigned to them in this Article and include
the plural as well as the singular; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) all accounting terms not otherwise defined herein have the meanings assigned to
them under GAAP; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) the words &#147;herein,&#148; &#147;hereof&#148; and
&#147;hereunder&#148; and other words of similar import refer to this Supplemental Indenture as a whole and not to any particular Article, Section or other subdivision. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 2 </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE NOTES
AND THE GUARANTEES </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.1 <U>Title and Terms</U><U>.</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The 2029 Notes and 2031 Notes shall be known and designated as the &#147;7.375% Sustainability-Linked Senior Notes due 2029&#148; and the
&#147;7.875% Sustainability-Linked Senior Notes due 2031&#148; of the Issuer, respectively. The aggregate principal amount that may be authenticated and delivered under this Supplemental Indenture of (i)&nbsp;the 2029 Notes is limited to
&#128;800,000,000 and (ii)&nbsp;the 2031 Notes is limited to &#128;500,000,000; except, in each case, for Add On Notes of the applicable series issued in accordance with Section&nbsp;2.9 and Notes of any series authenticated and delivered upon
registration of, transfer of, or in exchange for, or in lieu of, other Notes of the same series pursuant to Section&nbsp;2.5. The Notes of each series shall be issuable in minimum denominations of &#128;100,000 principal amount and integral
multiples of &#128;1,000 in excess of &#128;100,000. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The 2029 Notes shall mature on September&nbsp;15, 2029 and the 2031 Notes shall
mature on September&nbsp;15, 2031, in each case unless earlier redeemed by the Issuer. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Interest on the Notes shall accrue from
March&nbsp;9, 2023, applicable to Notes of such series at the Interest Rate until the principal thereof is paid or made available for payment. Interest shall be payable semi-annually in arrears on each Interest Payment Date. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) From and including September&nbsp;15, 2026 (the &#147;<U><FONT STYLE="white-space:nowrap">Step-up</FONT> Date</U>&#148;)
the Interest Rate payable on the Notes shall increase by: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">0.100% per annum unless the Guarantor has achieved the Regulatory Submissions Target as of the Testing Date;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">0.100% per annum unless the Guarantor has achieved the Product Volume Target as of the Testing Date; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">0.100% per annum unless the Guarantor has achieved the Emission Reduction Target as of the Testing Date;
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">in each case, as certified by the Issuer or the Guarantor to the Trustee in an Officer&#146;s certificate (which shall
include the Assurance Letter as an exhibit thereto) on or prior to the Certification Date (subject to any clerical or administrative errors (including any delays resulting therefrom)); <I>provided</I> that, for the avoidance of doubt: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(A)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Interest Rate on the Notes shall not increase on the <FONT STYLE="white-space:nowrap">Step-up</FONT> Date
if the Guarantor has achieved the three Sustainability Performance Targets as of the Testing Date and certified to such on or prior to the Certification Date; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(B)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the increase in the Interest Rate on the Notes on the <FONT STYLE="white-space:nowrap">Step-up</FONT> Date
shall not exceed a total of 0.100% if the Guarantor has achieved two of the three Sustainability Performance Targets as of the Testing Date and certified to such on or prior to the Certification Date; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(C)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the increase in the Interest Rate on the Notes on the <FONT STYLE="white-space:nowrap">Step-up</FONT> Date
shall not exceed a total of 0.200% if the Guarantor has met one of the three Sustainability Performance Targets as of the Testing Date and certified to such on or prior to the Certification Date; and </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(D)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in no event shall the total increase in the Interest Rate on the Notes on the
<FONT STYLE="white-space:nowrap">Step-up</FONT> Date exceed 0.300% (this being the consequence of the Guarantor failing to achieve any of the three Sustainability Performance Targets on the Testing Date and failing to certify to achievement on or
prior to the Certification Date). </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Interest on the Notes shall be computed on the basis of a <FONT
STYLE="white-space:nowrap">360-day</FONT> year of twelve <FONT STYLE="white-space:nowrap">30-day</FONT> months. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) A Holder of any Note
at the close of business on a Regular Record Date shall be entitled to receive interest on such Note on the corresponding Interest Payment Date. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Payments on the Global Notes will be made through the Paying Agent. Payments on the Notes will be made in Euros at the specified office or
agency of the Paying Agent; <I>provided that </I>all such payments with respect to Notes represented by one or more Global Notes deposited with and registered in the name of the Common Depositary or its nominee for the accounts of Euroclear and
Clearstream, will be by wire transfer of immediately available funds to the account specified in writing by the holder or holders thereof to the Common Depositary. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Payments on Physical Notes shall be payable at the office or agency of the Issuer maintained for such purpose, initially the specified
office or agency of the Paying Agent and, at the option of the Issuer, may be made by wire transfer to the account specified by the Holder or Holders thereof as notified to the Paying Agent in writing at least 15 days prior to the relevant payment
date. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) The Notes shall be redeemable at the option of the Issuer as provided in Article 4. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.2 <U>Forms of Notes</U><U>.</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Except as otherwise provided pursuant to this Section&nbsp;2.2, the Notes are issuable in fully registered form without coupons in
substantially the form of Exhibit A and Exhibit B hereto with such applicable legends as are provided for in Section&nbsp;2.3. The Notes are not issuable in bearer form. The terms and provisions contained in the form of Notes shall constitute, and
are hereby expressly made, a part of this Supplemental Indenture and to the extent applicable, the Issuer, the Guarantor and the Trustee, by their execution and delivery of this Supplemental Indenture, expressly agree to such terms and provisions
and to be bound thereby. Any of the Notes may have such letters, numbers or other marks of identification and such notations, legends and endorsements as the Officers executing the same may approve (execution thereof to be conclusive evidence of
such approval) and as are not inconsistent with the provisions of this Supplemental Indenture and the Base Indenture, or as may be required to comply with any law or with any rule or regulation made pursuant thereto or with any rule or regulation of
any securities exchange or automated quotation system on which the Notes of any series may be listed or designated for issuance, or to conform to usage. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Notes and the Guarantees are being (i)&nbsp;initially offered and sold by the Issuer to the underwriters thereof pursuant to the
Underwriting Agreement. The Notes shall be issued initially in the form of one or more permanent global Notes in fully registered form without interest coupons, substantially in the form of Exhibit A and Exhibit B hereto (the &#147;<U>Global
Notes</U>&#148;), each with the applicable legends as provided in Section&nbsp;2.3. Each Global Note shall be duly executed by the Issuer and authenticated and delivered by the Trustee, shall have endorsed thereon the applicable Guarantees executed
by the Guarantor and shall be deposited with and registered in the name of the Common Depositary or its nominee for the accounts of Euroclear and Clearstream. The aggregate principal amount of each Global Note may from time to time be increased or
decreased by adjustments made on the records of the Registrar or the Paying Agent, at the direction of the Trustee, as hereinafter provided. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) At such time as all beneficial interests in a Global Note have either been exchanged for
Physical Notes, redeemed, repurchased or cancelled, such Global Note shall be returned by the Common Depositary to the Trustee for cancellation or retained and cancelled by the Trustee at the written direction of the Issuer. At any time prior to
such cancellation, if any beneficial interest in a Global Note is exchanged for Physical Notes, redeemed, repurchased or cancelled, the principal amount of Notes of the relevant series represented by such Global Note shall be reduced and an
adjustment shall be made on the books and records of the Trustee with respect to such Global Note, by the Trustee, to reflect such reduction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.3 <U>Legends</U><U>.</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Each Global Note shall bear a legend on the face thereof substantially in the following form (each defined term in the legend being defined
as such for purposes of the legend only) (the &#147;<U>Global Notes Legend</U>&#148;): </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">THIS IS A GLOBAL NOTE WITHIN THE MEANING OF THE
INDENTURE REFERRED TO HEREINAFTER. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE COMMON DEPOSITARY (AS
DEFINED IN THE INDENTURE), TO THE ISSUER OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF THE COMMON DEPOSITARY OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED
REPRESENTATIVE OF THE COMMON DEPOSITARY (AND ANY PAYMENT IS MADE TO THE COMMON DEPOSITARY OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF THE COMMON DEPOSITARY), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR
OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, THE COMMON DEPOSITARY HAS AN INTEREST HEREIN. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">TRANSFERS OF THIS GLOBAL NOTE SHALL BE LIMITED TO TRANSFERS IN WHOLE, BUT NOT IN PART, TO NOMINEES OF THE COMMON DEPOSITARY OR TO A SUCCESSOR
THEREOF OR SUCH SUCCESSOR&#146;S NOMINEE AND TRANSFERS OF PORTIONS OF THIS GLOBAL NOTE SHALL BE LIMITED TO TRANSFERS MADE IN ACCORDANCE WITH THE RESTRICTIONS SET FORTH IN THE INDENTURE REFERRED TO ON THE REVERSE HEREOF. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Each Physical Note shall bear a legend on the face thereof substantially in the following form (the &#147;<U>Physical Notes
Legend</U>&#148;): </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">IN CONNECTION WITH ANY TRANSFER, THE HOLDER WILL DELIVER TO THE REGISTRAR AND TRANSFER AGENT SUCH CERTIFICATES AND
OTHER INFORMATION AS SUCH REGISTRAR AND TRANSFER AGENT MAY REASONABLY REQUIRE TO CONFIRM THAT THE TRANSFER COMPLIES WITH THE FOREGOING RESTRICTIONS. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.4 <U>Form of Guarantees</U><U>.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A Guarantee substantially in the following form shall be endorsed on the reverse of each Note: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Teva Pharmaceutical Industries Limited (the &#147;<U>Guarantor</U>&#148;) hereby unconditionally and irrevocably guarantees to the Holder of
this Note (the &#147;<U>Guarantee</U>&#148;) the due and punctual payment of the principal of and interest (including Additional Tax Amounts, if any), on this Note, when and as the same shall become due and payable, whether at Maturity or upon
redemption or upon declaration of acceleration or otherwise, according to the terms of this Note and of the Indenture. The Guarantor agrees that in the case of default by the Issuer in the payment of any such principal or interest (including
Additional Tax Amounts, if any), the Guarantor shall duly and punctually pay the same. The Guarantor hereby agrees that its obligations hereunder shall be absolute and unconditional irrespective of any extension of the time for payment of this Note,
any modification of this Note, any invalidity, irregularity or unenforceability of this Note or the Indenture, any failure to enforce the same or any waiver, modification, consent or indulgence granted to the Issuer with respect thereto by the
Holder of this Note or the Trustee, or any other circumstances which may otherwise constitute a legal or equitable discharge of a surety or guarantor. The Guarantor hereby waives diligence, presentment, demand of payment, filing of claims with a
court in the event of merger or bankruptcy of the Issuer, any right to require a demand or proceeding first against the Issuer, protest or notice with respect to this Note or the indebtedness evidenced hereby and all demands whatsoever, and
covenants that this Guarantee will not be discharged as to this Note except by payment in full of the principal of and interest (including Additional Tax Amounts, if any) on this Note. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Guarantor shall be subrogated to all rights of the Holders against the Issuer in respect of any amounts paid by the Guarantor pursuant to
the provisions of the Guarantees or the Indenture; <I>provided</I>, <I>however</I>, that the Guarantor hereby waives any and all rights to which it may be entitled, by operation of law or otherwise, upon making any payment hereunder (i)&nbsp;to be
subrogated to the rights of a Holder against the Issuer with respect to such payment or otherwise to be reimbursed, indemnified or exonerated by the Issuer in respect thereof or (ii)&nbsp;to receive any payment in the nature of contribution or for
any other reason, from any other obligor with respect to such payment, in each case, until the principal of and interest (including Additional Tax Amounts, if any) on this Note shall have been paid in full. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Guarantee shall not be valid or become obligatory for any purpose with respect to this Note until the certificate of authentication on
this Note shall have been signed by the Trustee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Guarantee shall be governed by and construed in accordance with the laws of the
State of New York. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, Teva Pharmaceutical Industries Limited has caused the Guarantee to be signed manually or by
facsimile by its duly authorized Officer. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="94%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">TEVA PHARMACEUTICAL INDUSTRIES LIMITED</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.5 <U>Book-Entry Provisions for the Global Notes</U><U>.</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Global Notes initially shall be deposited with and registered in the name of the Common Depositary or its nominee for the accounts of
Euroclear and Clearstream. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Members of, or participants in, Euroclear or Clearstream (&#147;<U>Agent Members</U>&#148;) shall have no
rights under this Supplemental Indenture with respect to any Global Note held on their behalf by Euroclear or Clearstream, or the Common Depositary, or under such Global Note, and the Common Depositary may be treated by the Issuer, the Guarantor,
the Trustee, the Paying Agent and any of their respective agents as the absolute owner of such Global Note for all purposes whatsoever. Notwithstanding the foregoing, nothing contained herein shall prevent the Issuer, the Guarantor, the Trustee, the
Paying Agent or any of their respective agents from giving effect to any written certification, proxy or other authorization furnished by Euroclear or Clearstream or impair, as between Euroclear or Clearstream and the Agent Members, the operation of
customary practices of Euroclear or Clearstream governing the exercise of the rights of a Holder of any Note. With respect to any Global Note deposited on behalf of the subscribers for the Notes represented thereby with the Common Depositary for
credit to their respective accounts (or to such other accounts as they may direct) at Euroclear or Clearstream, the provisions of the &#147;Operating Procedures of the Euroclear System&#148; and the &#147;Terms and Conditions Governing Use of
Euroclear&#148; and the &#147;Management Regulations&#148; and &#147;Instructions to Participants&#148; of Clearstream, respectively, shall be applicable to the Global Notes. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Holder of a Global Note may grant proxies and otherwise authorize any Person, including Euroclear or Clearstream or its nominee, Agent
Members and Persons that may hold interests through Agent Members, to take any action that a Holder is entitled to take under this Supplemental Indenture, the Base Indenture or the Notes of any series. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) A Global Note may not be transferred, in whole or in part, to any Person other than the Common Depositary (or its nominee by a nominee of
the Common Depositary to the Common Depositary or to another nominee of the Common Depositary, or by the Common Depositary or any such nominee to a successor Common Depositary or a nominee of such successor Common Depositary), and no such transfer
to any such other Person may be registered. Beneficial interests in a Global Note may be transferred in accordance with the rules and procedures of Euroclear or Clearstream. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Except as provided in Section&nbsp;2.5(f), owners of beneficial interests in Global Notes shall not be entitled to receive physical
delivery of Physical Notes. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) If at any time: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) either Euroclear or Clearstream notifies the Issuer in writing that it is no longer willing or able to continue to act as
depositary for the Global Notes of any series and a successor depositary for the Global Notes of such series is not appointed by the Issuer within 120 days of such notice; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) an Event of Default has occurred and is continuing and enforcement action is being taken in respect thereof under their
Indenture and the Registrar has received a request from Euroclear or Clearstream on behalf of their Agent Members for the issuance of Physical Notes in exchange for such Global Note or Global Notes; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) the Issuer, at its option, notifies the Trustee in writing that it elects to exchange in whole, but not in part, the Global
Note for Physical Notes; such Global Note or Global Notes shall be deemed to be surrendered to the Trustee for cancellation and the Issuer shall execute, and the Trustee, upon receipt of an Officer&#146;s Certificate and Issuer Order for the
authentication and delivery of Notes, shall authenticate and deliver, in exchange for such Global Note or Global Notes, Physical Notes of the applicable series in an aggregate principal amount equal to the aggregate principal amount of such Global
Note or Global Notes. Such Physical Notes shall be registered in such names as Euroclear or Clearstream shall identify in writing as the beneficial owners of the Notes represented by such Global Note or Global Notes (or any nominee thereof). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Notwithstanding the foregoing, in connection with any transfer of beneficial interests
in a Global Note to the beneficial owners thereof pursuant to Section&nbsp;2.5(f), the Registrar shall reflect on its books and records the date and a decrease in the principal amount of such Global Note in an amount equal to the principal amount of
the beneficial interests in such Global Note to be transferred. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.6 <U>[Reserved]</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.7 <U>Defaulted Interest</U><U>.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the Issuer fails to make a payment of interest on any Note when due and payable (&#147;<U>Defaulted Interest</U>&#148;), it shall pay such
Defaulted Interest plus (to the extent lawful) any interest payable on the Defaulted Interest, in any lawful manner. It may elect to pay such Defaulted Interest, plus any such interest payable on it, to the Persons who are Holders of such Notes on
which the interest is due on a subsequent Special Record Date. The Issuer shall notify the Trustee and the Paying Agent in writing of the amount of Defaulted Interest proposed to be paid on each such Note. The Issuer shall fix any such Special
Record Date and payment date for such payment. At least 15 days before any such Special Record Date, the Issuer shall deliver to Holders affected thereby, with a copy to the Trustee and the Paying Agent, a notice that states the Special Record Date,
the Interest Payment Date and amount of such interest to be paid. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.8 <U>Execution of Guarantees</U><U>.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Guarantor hereby agrees to execute the Guarantees in substantially the form above recited to be endorsed on each Note. If the Issuer shall
execute Physical Notes in accordance with Section&nbsp;2.5, the Guarantor shall execute the Guarantees in substantially the form above recited to be endorsed on each such Note. The Guarantees shall be executed on behalf of the Guarantor by an
Officer of the Guarantor. The signature of any Officer on the Guarantees may be manual or facsimile. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In case any Officer of the Guarantor
who shall have signed the Guarantees endorsed on a Note shall cease to be such Officer before the Note so signed shall be authenticated and delivered by the Trustee, such Note nevertheless may be authenticated and delivered or disposed of as though
the person who signed such Guarantees had not ceased to be such Officer of the Guarantor; and any Guarantees endorsed on a Note may be signed on behalf of the Guarantor by such persons as, at the actual date of the execution of such Guarantee, shall
be the proper Officers of the Guarantor, although at the date of the execution and delivery of this Supplemental Indenture any such person was not such an Officer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.9 <U>Add On Notes</U><U>.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Issuer may, from time to time, subject to compliance with any other applicable provisions of this Supplemental Indenture and the Base
Indenture, without the consent of the Holders, create and issue pursuant to this Supplemental Indenture and the Base Indenture Add On Notes having terms identical to those of the Outstanding Notes of any series, except that Add On Notes: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) may have a different issue date from other Outstanding Notes; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) may have a different first Interest Payment Date after issuance than other Outstanding Notes of such series; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) may have a different amount of interest payable on the first Interest Payment Date after issuance than is payable on other Outstanding
Notes of such series; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) may have a different issue price; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) may have a different CUSIP or ISIN number if such Add On Notes are not fungible with the
Notes of such series then outstanding for United States federal income tax purposes; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) may have terms specified in Add On Note Board
Resolutions, an Officer&#146;s Certificate or a supplemental indenture for such Add On Notes making appropriate adjustments to this Article 2, Exhibit A and Exhibit B (and related definitions), as the case may be, applicable to such Add On Notes in
order to conform to and ensure compliance with the Securities Act (or other applicable securities laws) and any registration rights or similar agreement applicable to such Add On Notes, which are not adverse in any material respect to the Holder of
any Outstanding Notes of such series (other than such Add On Notes) and which shall not affect the rights, benefits, immunities or duties of the Trustee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In authenticating any Add On Notes, and accepting the additional responsibilities under the Indenture in relation to such Add On Notes, the
Trustee shall be entitled to receive, and shall be fully protected in relying upon: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) the Add On Note Board Resolutions, Officer&#146;s
Certificate or supplemental indenture relating thereto, setting forth the form and terms of the Add On Notes; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) an Officer&#146;s
Certificate complying with Section&nbsp;7.5; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) an Opinion of Counsel complying with Section&nbsp;7.5 stating, </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) that the forms of such Notes have been established by or pursuant to Add On Note Board Resolutions, an Officer&#146;s
Certificate or a supplemental indenture, as permitted by this Section&nbsp;2.9 and in conformity with the provisions of this Supplemental Indenture and the Base Indenture; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) that the terms of such Notes have been established by or pursuant to Add On Note Board Resolutions, an Officer&#146;s
Certificate or a supplemental indenture, as permitted by this Section&nbsp;2.9 and in conformity with the provisions of this Supplemental Indenture and the Base Indenture; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) that such Notes and the related Guarantees, when authenticated and delivered by the Trustee and issued by the Issuer and
the Guarantor in the manner provided for herein and in the Base Indenture and the Guarantees, respectively, subject to any customary conditions specified in such Opinion of Counsel, will constitute valid and legally binding obligations of the Issuer
and the Guarantor, respectively, entitled to the benefits provided in this Supplemental Indenture and the Base Indenture, enforceable in accordance with their respective terms, except to the extent that the enforcement of such obligations may be
subject to bankruptcy laws or insolvency laws or other similar laws, general principles of equity and such other qualifications as such counsel shall conclude are customary or do not materially affect the rights of the Holders of such Notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If such forms or terms have been so established by or pursuant to Add On Note Board Resolutions, an Officer&#146;s Certificate or a
supplemental indenture, the Trustee shall have the right to decline to authenticate and deliver any Notes: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) if the
Trustee, being advised by counsel, determines that such action may not lawfully be taken; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) if the Trustee in good faith
determines that such action would expose the Trustee to personal liability to Holders of any Outstanding Notes; or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) if the issue of such Add On Notes pursuant to this Supplemental
Indenture and the Base Indenture will affect the Trustee&#146;s own rights, duties, benefits and immunities under the Notes, this Supplemental Indenture and the Indenture or otherwise in a manner which is not reasonably acceptable to the Trustee.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding anything in this Section&nbsp;2.9, the Issuer may not issue Add On Notes if an Event of Default shall have occurred and
be continuing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.10 <U>ISIN Numbers and Common Codes</U><U>.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Issuer in issuing the Notes may use &#147;ISIN&#148; Numbers (if then generally in use) and common codes, and, if so, the Trustee and the
Paying Agent shall use &#147;ISIN&#148; numbers and common codes in notices of redemption and other notices to the Holders as a convenience to Holders; <I>provided that </I>any such notice may state that no representation is made as to the
correctness of such numbers either as printed on the Notes of a given series or as contained in any notice of a redemption and that reliance may be placed only on the other identification numbers printed on the Notes of a given series, and any such
redemption shall not be affected by any defect in or omission of such numbers. The Issuer will promptly notify the Trustee and the Paying Agent of any change in the &#147;ISIN&#148; numbers or common codes. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 3 </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ADDITIONAL
COVENANTS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to the covenants set forth in Article 3 of the Base Indenture, the Notes shall be subject to the additional
covenants set forth in this Article 3. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.1 <U>Payment of Additional Tax Amounts</U><U>.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">With respect to the Notes, Section&nbsp;12.02 of the Base Indenture is not applicable. All payments of interest and principal by the Issuer
under the Notes of any series and by the Guarantor under the Guarantees shall be made without withholding or deduction for, or on account of, any present or future Taxes unless such withholding or deduction is required by law. In the event that the
Issuer or the Guarantor is required to withhold or deduct on account of any such Taxes from any payment made under or with respect to the Notes, the Issuer or the Guarantor, as the case may be, will (a)&nbsp;withhold or deduct such amounts,
(b)&nbsp;pay such additional Tax amounts so that the net amounts received by each Holder or beneficial owner of the relevant Notes, including those additional Tax amounts, will equal the amount such Holder or beneficial owner would have received if
such Taxes had not been required to be withheld or deducted (&#147;Additional Tax Amounts&#148;) and (c)&nbsp;pay the full amount withheld or deducted to the relevant tax or other authority in accordance with applicable law, except that no such
Additional Tax Amounts shall be payable in respect of any Note: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) to the extent that such Taxes are imposed or levied by
reason of such Holder (or the beneficial owner) having some present or former connection with the Taxing Jurisdiction other than the mere holding (or beneficial ownership) of such Note or receiving principal or interest payments on the Notes
(including but not limited to citizenship, nationality, residence, domicile, or the existence of a business, permanent establishment, a dependent agent, a place of business or a place of management present or deemed present in the Taxing
Jurisdiction); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) in respect of any Taxes that would not have been so withheld or deducted but for the failure by the
Holder or the beneficial owner of the Notes to make a declaration of <FONT STYLE="white-space:nowrap">non-residence,</FONT> or any other claim or filing for exemption to which it is entitled or otherwise comply with any reasonable certification,
identification, information, documentation or other reporting requirement concerning nationality, residence, identity or connection with the Taxing Jurisdiction if (a)&nbsp;compliance is required by applicable law, regulation, administrative
practice or treaty as a precondition to exemption from all or part of the Taxes, (b)&nbsp;the Holder (or beneficial owner) is able to comply with these requirements without undue hardship and (c)&nbsp;the Issuer has given the Holders (or beneficial
owners) at least 30 calendar days prior notice that they will be required to comply with such requirement; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) to the extent that such Taxes are imposed by reason of any estate,
inheritance, gift, sales, transfer or personal property taxes imposed with respect to the Notes, except as otherwise provided in the Indenture; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) to the extent that any such Taxes would not have been imposed but for the presentation of the Notes, where presentation is
required, for payment on a date more than 30 days after the date on which such payment became due and payable or the date on which payment thereof is duly provided for, whichever is later, except to the extent that the Holder would have been
entitled to Additional Tax Amounts had the Notes been presented for payment on any date during such <FONT STYLE="white-space:nowrap">30-day</FONT> period; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) in respect of any Taxes imposed under Sections 1471-1474 of the Internal Revenue Code of 1986, as amended, any applicable
U.S. Treasury Regulations promulgated thereunder, or any judicial or administrative interpretations of any of the foregoing; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6) any combination of items 1 through 5 above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of this Section&nbsp;3.1, &#147;Taxes&#148; means, with respect to payments on the Notes, all taxes, withholdings, duties,
assessments or governmental charges of whatever nature imposed or levied by or on behalf of any Taxing Jurisdiction or any political subdivision thereof or any authority or agency therein or thereof having power to tax. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.2 <U>Stamp Tax</U><U>.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Issuer and the Guarantor will pay any present or future stamp, court or documentary taxes or any other excise or property taxes, charges
or similar levies that arise from the execution, delivery, enforcement or registration of the Notes of any series or any other document or instrument in relation thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.3 <U>Corporate Existence</U><U>.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to Article 8 of the Base Indenture and subject to the ability of the Issuer or the Guarantor to convert (or similar action) to another
form of legal entity under the laws of the jurisdiction under which the Issuer or the Guarantor then exists, each of the Guarantor and the Issuer will do or cause to be done all things necessary to preserve and keep in full force and effect its
corporate existence, rights (charter and statutory) and franchises; provided, however, that the Issuer and the Guarantor shall not be required to preserve any such existence, right or franchise if the Issuer and the Guarantor determine that the
preservation thereof is no longer desirable in the conduct of the business of the Issuer or the Guarantor and that the loss thereof is not disadvantageous in any material respect to the Holders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.4 <U>Certificates of the Issuer and the Guarantor</U><U>.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Issuer will furnish to the Trustee within 120 days after the end of each fiscal year of the Issuer an Officer&#146;s Certificate of the
Issuer as to the signer&#146;s knowledge of the Issuer&#146;s and the Guarantor&#146;s compliance with all conditions and covenants under this Supplemental Indenture and the Base Indenture (such compliance to be determined without regard to any
period of grace or requirement of notice provided under this Supplemental Indenture or the Base Indenture). In the event the Issuer comes to have actual knowledge of an Event of Default or an event which, with notice or the lapse of time or both,
would constitute an Event of Default, regardless of the date, the Issuer shall deliver an Officer&#146;s Certificate to the Trustee specifying such Default and the nature and status thereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.5 <U>Guarantor To Be the Sole Equityholder of the Issuer</U><U>.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">So long as any Notes are outstanding, the Guarantor or its successor will directly or indirectly own all of the outstanding Capital Stock of
the Issuer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.6 <U>Limitation on Liens</U><U>.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Guarantor shall not, and shall not permit any subsidiary to, directly or indirectly, create, incur, or assume any Lien, other than a
Permitted Lien, upon any of its property (including any shares of Capital Stock or Indebtedness of any subsidiary) to secure any other Indebtedness incurred by the Guarantor or any subsidiary, without in any such case making effective provision
whereby all of the Notes outstanding (together with, if the Guarantor so determines, any other Indebtedness by the Guarantor or any subsidiary ranking equally with the Notes or the Guarantees) shall be secured equally and ratably with, or prior to,
such Indebtedness for so long as such other Indebtedness shall be so secured unless, after giving effect to such Lien, the aggregate amount of secured Indebtedness then outstanding (excluding Indebtedness secured solely by Permitted Liens) plus the
value (as defined in Section&nbsp;3.7) of all Sale-Leaseback Transactions (other than those described in clause (a)&nbsp;or clause (b)&nbsp;of Section&nbsp;3.7) then outstanding would not exceed the greater of (i) 10% of the Guarantor&#146;s
Consolidated Net Worth and (ii)&nbsp;US $2,000,000,000 (or its equivalent in another currency or currencies). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.7
<U>Limitation on Sales and Leasebacks</U><U>.</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Guarantor will not, and will not permit any subsidiary to, enter into any
Sale-Leaseback Transaction after the date of this Supplemental Indenture unless: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) the Sale-Leaseback Transaction: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) involves a lease for a period, including renewals, of not more than five years; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) occurs within one year after the date of acquisition, completion of construction or completion of improvement of such
property; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) is with the Guarantor or one of its subsidiaries; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) the Guarantor or any subsidiary, within one year after the Sale-Leaseback Transaction shall have occurred, applies or causes to be applied
an amount equal to the value of the property so sold and leased back at the time of entering into such arrangement to the prepayment, repayment, redemption, reduction or retirement of any Indebtedness of the Guarantor or any subsidiary that is not
subordinated to the Notes and that has a Stated Maturity of more than twelve months; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) the Guarantor or such subsidiary would be
entitled pursuant to Section&nbsp;3.6 to create, incur, issue or assume Indebtedness secured by a Lien on the property without equally and ratably securing the Notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As used in this Section&nbsp;3.7, the term &#147;value&#148; shall mean, with respect to a Sale-Leaseback Transaction, as of any particular
time an amount equal to the greater of (i)&nbsp;the net proceeds of sale of the property leased pursuant to such Sale-Leaseback Transaction, or (ii)&nbsp;the fair value of such property at the time of entering into such Sale-Leaseback Transaction as
determined by the Board of Directors of the Guarantor, in each case multiplied by a fraction of which the numerator is the number of full years of remaining term of the lease (without regard to renewal options) and the denominator is the full years
of the full term of the lease (without regard to renewal options). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 4 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REDEMPTION OF NOTES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.1 <U>Optional Redemption</U><U>.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Issuer may at its option redeem the Notes of any series, in whole or in part, at any time or from time to time, on any date prior to the
Stated Maturity, upon notice as set forth in Section&nbsp;4.2, at the Redemption Price. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.2 <U>Notice of
Redemption</U><U>.</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notice of redemption to the Holders of the Notes of any series to be redeemed shall be given by delivering notice
of such redemption, on at least 10 days&#146;, but not more than 60 days&#146;, prior notice delivered by electronic transmission, first-class mail, postage prepaid, at their respective addresses as they appear on the registration books of the
Registrar, with a copy of such notice delivered to the Trustee. The notice of redemption of the Notes of any series to be redeemed at the option of the Issuer shall be given by the Issuer or, at the Issuer&#146;s request, delivered to the Trustee at
least five Business Days before the date such notice is to be given to Holders (unless a shorter period shall be acceptable to the Trustee), by the Trustee in the name and at the expense of the Issuer. For so long as such Notes are listed on
Euronext Dublin and the rules of Euronext Dublin so require, the Issuer shall publish a notice of redemption in a daily newspaper with general circulation in Ireland (which is expected to be the Irish Times). Such notice of redemption may instead be
published on the website of the Euronext Dublin. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notice of any redemption of any series of Notes in connection with a corporate
transaction (including an equity offering, an incurrence of indebtedness or a change of control) may, at the Issuer&#146;s discretion, be given prior to the completion thereof and any such redemption or notice may, at the Issuer&#146;s discretion,
be subject to one or more conditions precedent, including, but not limited to, completion of the related transaction. If such redemption or purchase is so subject to satisfaction of one or more conditions precedent, such notice shall describe each
such condition, and such notice may be rescinded or the Redemption Date delayed in the event that any or all such conditions shall not have been satisfied by the Redemption Date. In addition, the Issuer may provide in such notice that payment of the
Redemption Price and performance of its obligations with respect to such redemption may be performed by another Person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If any Note of
any series is to be redeemed in part only, the notice of redemption that relates to such Note shall state the portion of the principal amount thereof to be redeemed, in which case a portion of the original Note of such series will be issued in the
name of the holder thereof upon cancellation of the original Note of such series. In the case of a Global Note of any series, an appropriate notation will be made on such Note of such series to decrease the principal amount thereof to an amount
equal to the unredeemed portion thereof. Subject to the terms of the redemption notice (including any conditions contained therein), Notes of any series called for redemption become due on the date fixed for redemption. On and after the Redemption
Date, interest ceases to accrue on such Notes or portions of them called for redemption, unless the redemption price is not paid on the Redemption Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.3 <U>Deposit of Redemption Price</U><U>.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On or prior to the Redemption Date, the Issuer shall deposit with the Paying Agent an amount of money sufficient to pay the Redemption Price
in respect of all the Notes to be redeemed on that Redemption Date. If less than all of the Notes (or any series thereof) are to be redeemed, the Notes to be redeemed shall be selected by the Trustee on a <I>pro rata </I>basis, by lot or by such
method as the Trustee shall deem fair and appropriate and subject to the rules of the applicable depositary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.4 <U>Tax
Redemption</U><U>.</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) If, as a result of any change in or amendment to the laws (or any regulations or rulings promulgated
thereunder) of any Taxing Jurisdiction or any political subdivision or taxing authority thereof or in any Taxing Jurisdiction affecting taxation or any change in official position regarding the application or interpretation of such laws, regulations
or rulings, which change or amendment becomes effective or, in the case of a change in official position, is announced on or after the date of this Supplemental Indenture, the Issuer or the Guarantor (or any of their respective successors), as the
case may be, is or will be obligated to pay any Additional Tax Amounts with respect to the Notes (or any series thereof), and if the Issuer or the Guarantor (or any of their respective successors), as the case may be,
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
determines that such obligation cannot be avoided by the Issuer or the Guarantor (or any of their respective successors), as the case may be, after taking reasonable measures available to it,
then at the option of the Issuer or the Guarantor (or any of their respective successors), as the case may be, the Notes (or any series thereof) may be redeemed in whole, but not in part, at any time, upon the giving not less than 10 days&#146; nor
more than 60 days&#146; notice to the Trustee and the Holders of such Notes, at the Redemption Price; provided, however, that (1)&nbsp;no notice of such tax redemption may be given earlier than 90 days prior to the earliest date on which the Issuer
or the Guarantor (or their respective successors), as the case may be, would, but for such redemption, be obligated to pay such Additional Tax Amounts were a payment on such Notes then due, and (2)&nbsp;at the time such notice is given, such
obligation to pay such Additional Tax Amounts remains in effect. The notice of tax redemption shall be given by the Issuer or, at the Issuer&#146;s request delivered to the Trustee at least five Business Days before the date such notice is to be
given to Holders (unless a shorter period shall be acceptable to the Trustee), by the Trustee in the name and at the expense of the Issuer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Not less than five Business Days (unless a shorter period shall be acceptable to the Trustee) before any notice of tax redemption pursuant
to Section&nbsp;4.4(a) is given to the Trustee or the Holders of the Notes (or any series thereof), the Issuer or the Guarantor (or their respective successors), as the case may be, shall deliver to the Trustee (i)&nbsp;an Officer&#146;s Certificate
stating that the Issuer or the Guarantor (or their respective successors), as the case may be, is entitled to effect such redemption and setting forth a statement of facts showing that the conditions precedent to the right of the Issuer or the
Guarantor (or their respective successors), as the case may be, to so redeem have occurred or have been satisfied and (ii)&nbsp;an opinion of independent legal counsel of recognized standing to that effect based on the statement of facts. Such
notice, once given to the Trustee, shall be irrevocable. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 5 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SATISFACTION AND DISCHARGE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.1 <U>Satisfaction and Discharge</U><U>.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) With respect to the Notes, Section&nbsp;9.01 of the Base Indenture is not applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Issuer and the Guarantor may satisfy and discharge their obligations under this Supplemental Indenture with respect to any series of
Notes while such Notes remain outstanding, if (a)&nbsp;all Outstanding Notes of such series have become due and payable at their scheduled Maturity, or (b)&nbsp;all Outstanding Notes of such series have been called for redemption, and in either
case, the Issuer has deposited with the Trustee an amount sufficient to pay and discharge all Outstanding Notes of such series on the date of their scheduled Maturity or the scheduled Redemption Date, as the case may be. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 6 </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PAYING AGENT
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.1 <U>Paying Agent</U><U>.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Issuer hereby appoints The Bank of New York Mellon, London Branch, to act as principal Paying Agent. In connection with its appointment
and acting hereunder, the principal Paying Agent is entitled to all the rights, privileges, protections, immunities, benefits and indemnities provided to the Trustee under the Indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.2 <U>Electronic Means</U><U>.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Trustee and Paying Agent shall have the right to accept and act upon instructions, including funds transfer instructions
(&#147;Instructions&#148;) given pursuant to the Indenture and delivered using Electronic Means (as defined below); provided, however, that the Company shall provide to the Trustee and Paying Agent an incumbency certificate listing officers with the
authority to provide such Instructions (&#147;Authorized Officers&#148;) </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and containing specimen signatures of such Authorized Officers, which incumbency certificate shall be amended by the Company whenever a person is to be added or deleted from the listing. If the
Company elects to give the Trustee and Paying Agent Instructions using Electronic Means and the Trustee and Paying Agent, each in their discretion elect to act upon such Instructions, their understanding of such Instructions shall be deemed
controlling. The Company understands and agrees that the Trustee and Paying Agent cannot determine the identity of the actual sender of such Instructions and that the Trustee and Paying Agent shall conclusively presume that directions that purport
to have been sent by an Authorized Officer listed on the incumbency certificate provided to the Trustee and Paying Agent have been sent by such Authorized Officer. The Company shall be responsible for ensuring that only Authorized Officers transmit
such Instructions to the Trustee and Paying Agent and that the Company and all Authorized Officers are solely responsible to safeguard the use and confidentiality of applicable user and authorization codes, passwords and/or authentication keys upon
receipt by the Company. The Trustee and Paying Agent shall not be liable for any losses, costs or expenses arising directly or indirectly from their reliance upon and compliance with such Instructions notwithstanding such directions conflict or are
inconsistent with a subsequent written instruction. The Company agrees: (i)&nbsp;to assume all risks arising out of the use of Electronic Means to submit Instructions to the Trustee and Paying Agent, including without limitation the risk of the
Trustee and Paying Agent acting on unauthorized Instructions, and the risk of interception and misuse by third parties; (ii)&nbsp;that it is fully informed of the protections and risks associated with the various methods of transmitting Instructions
to the Trustee and Paying Agent and that there may be more secure methods of transmitting Instructions than the method(s) selected by the Company; (iii)&nbsp;that the security procedures (if any) to be followed in connection with its transmission of
Instructions provide to it a commercially reasonable degree of protection in light of its particular needs and circumstances; and (iv)&nbsp;to notify the Trustee and Paying Agent immediately upon learning of any compromise or unauthorized use of the
security procedures. &#147;Electronic Means&#148; shall mean the following communications methods: <FONT STYLE="white-space:nowrap">e-mail,</FONT> facsimile transmission, secure electronic transmission containing applicable authorization codes,
passwords and/or authentication keys issued by the Trustee and Paying Agent, or another method or system specified by the Trustee and Paying Agent as available for use in connection with its services hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.3 <U>CSDR Regulation</U><U>.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Trustee or Paying Agent may, in respect of any irrevocable commitment in carrying out Instructions to clear and/or settle transactions for
the Company under this Supplemental Indenture, incur Debit Cash Penalties or receive Credit Cash Penalties from the relevant Subcustodians or Depositories through which Securities are held. The Trustee or Paying Agent may, at any time, demand that
the Company reimburse the Trustee or Paying Agent in respect of such Debit Cash Penalties and may, for such purposes, convert the amount of such Debit Cash Penalties into another currency agreed between the Company and the Trustee or Paying Agent to
be used for invoicing purposes at such rate or rates as separately disclosed by the Trustee or Paying Agent to the Company. The Company agrees that its reimbursement obligation arises when the irrevocable commitment is incurred by the Trustee or
Paying Agent despite the actual settlement or maturity date and whether or not the Trustee or Paying Agent has demanded reimbursement. After the Trustee or Paying Agent has made a demand for reimbursement by the Company, the Company shall pay cash
equal to that demand. In any event, the Trustee or Paying Agent may and is hereby authorized to, at any time, debit a Cash Account for the amount the Trustee or Paying Agent will be obligated to pay in respect of any Debit Cash Penalties, whether or
not that debit creates or increases any overdraft by the Company. The Trustee or Paying Agent may also, without notice to the Company, credit a Cash Account with Cash equal to the amount of any Credit Cash Penalties received by the Trustee or Paying
Agent. If any Credit Cash Penalties received by the Trustee or Paying Agent are denominated in a currency other than a currency in which a Cash Account is already opened pursuant to this Supplemental Indenture, the Trustee or Paying Agent shall, and
is hereby authorized and instructed to, open a new Cash Account for the Company in such currency for the purposes of distributing such Credit Cash Penalties received by the Trustee or Paying Agent to the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 7 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MISCELLANEOUS PROVISIONS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.1 <U>Scope of Supplemental Indenture</U><U>.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The changes, modifications and supplements to the Base Indenture effected by this Supplemental Indenture shall only be applicable with
respect to, and govern the terms of, the Notes and shall not apply to any other Securities that may be issued by the Issuer under the Base Indenture. Other than such, changes, modifications and supplements, the Base Indenture is incorporated by
reference herein and affirmed in all respects. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.2 <U>Provisions of Supplemental Indenture for the Sole Benefit of Parties
and</U><U> </U><U>Holders of Notes</U><U>.</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Nothing in this Supplemental Indenture, the Base Indenture or in the Notes or the
Guarantees, expressed or implied, shall give or be construed to give to any person, firm or corporation, other than the parties hereto and their successors and the Holders of the Notes, any legal or equitable right, remedy or claim under this
Supplemental Indenture or under any covenant or provision herein contained, all such covenants and provisions being for the sole benefit of the parties hereto and their successors and of the Holders of the Notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.3 <U>Successors and Assigns of Issuer and Guarantor Bound by Supplemental</U><U> </U><U>Indenture</U><U>.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All the covenants, stipulations, promises and agreements in this Supplemental Indenture contained by or on behalf of the Issuer shall bind its
successors and assigns, whether so expressed or not. All the covenants, stipulations, promises and agreements in this Supplemental Indenture contained by or on behalf of the Guarantor shall bind its successors and assigns, whether so expressed or
not. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.4 <U>Notices and Demands on Issuer, Trustee, Paying Agent and Holders of Notes</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any notice or demand which by any provision of this Supplemental Indenture is required or permitted to be given or delivered to or by the
Trustee, the Paying Agent or by the Holders of Notes to the Issuer or the Guarantor shall be in writing in the English language and may be given or served by being deposited postage prepaid, first-class mail (except as otherwise specifically
provided herein) addressed (until another address is filed with the Trustee and the Paying Agent) as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If to the Issuer: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Teva Pharmaceutical Finance Netherlands II B.V. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Piet Heinkade 107, 1019 GM </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Amsterdam, Netherlands </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Attention: Managing Director </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Fax: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">+972-39-062501</FONT></FONT> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">with a copy (which shall not constitute notice) to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Teva Pharmaceuticals USA, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">400 Interpace Parkway, Building A, </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Parsippany, NJ 07054 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Attention:
David M. Stark </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Fax: +1 (215) <FONT STYLE="white-space:nowrap">293-6499</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">with a copy (which shall not constitute notice)to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Kirkland&nbsp;&amp; Ellis LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">601 Lexington Avenue New York, NY 10022 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Attention: Ross M. Leff, P.C. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Christie W.S. Mok </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Fax: +1 (212) <FONT STYLE="white-space:nowrap">446-4900</FONT> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If to the Guarantor: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Teva
Pharmaceutical Industries Limited </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">124 Dvora Hanevi&#146;a Street </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Tel Aviv, 6944020, Israel </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Attention: Corporate Treasurer </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Facsimile:
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">+972-3-914-8678</FONT></FONT></FONT> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">with copies (which shall not constitute notice) to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Teva Pharmaceuticals USA, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">400 Interpace Parkway, Building A, </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Parsippany, NJ 07054 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Attention:
David M. Stark </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Fax: +1 (215) <FONT STYLE="white-space:nowrap">293-6499</FONT> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Kirkland&nbsp;&amp; Ellis LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">601 Lexington Avenue </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">New York,
NY 10022 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Attention: Ross M. Leff, P.C. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Christie W.S. Mok </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Fax: +1 (212) <FONT STYLE="white-space:nowrap">446-4900</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any notice, direction, request or demand by the Issuer, the Guarantor or any Holder of Notes to or upon the Trustee or the Paying Agent shall
be deemed to have been sufficiently given or made, for all purposes, if delivered in person or mailed by first-class mail as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If
to the Trustee: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">The Bank of New York Mellon </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">240 Greenwich Street, Floor 7E </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">New York, NY 10286 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Attention:
Corporate Trust &#150; Global Finance Unit </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Fax: (212) <FONT STYLE="white-space:nowrap">815-2830</FONT> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If to the Paying Agent: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">The Bank
of New York Mellon, London Branch </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">160 Queen Victoria Street </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">London EC4V 4LA </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">United Kingdom
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Attn: Manager Corporate Trust Services </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Fax: +44 207 964 2536 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">with a
copy (which shall not constitute notice) to the Trustee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Trustee also agrees to accept and act upon instructions or directions
pursuant to the Indenture sent by unsecured <FONT STYLE="white-space:nowrap">e-mail,</FONT> facsimile transmission or other similar unsecured electronic methods. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Issuer, the Guarantor or the Trustee by written notice to each other may designate additional or different addresses for subsequent
notices or communications. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any notice or communication to the Issuer or the Guarantor shall be deemed to have been
given or made as of the date so delivered if personally delivered or if delivered electronically, in pdf format or if telecopied; and seven calendar days after mailing if sent by registered or certified mail, postage prepaid (except that a notice of
change of address shall not be deemed to have been given until actually received by the addressee). Any notice or communication to the Trustee or the Paying Agent shall be deemed delivered upon receipt. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Where this Supplemental Indenture provides for notice to Holders, such notice shall be sufficiently given (unless otherwise herein expressly
provided) if in writing, in the English language, and delivered to each Holder entitled thereto, at his last address as it appears in the register of the Notes of the applicable series. In any case where notice to Holders is given by mail, personal
delivery, telecopy or electronic delivery, neither the failure to mail such notice, nor any defect in any notice so mailed or delivered, to any particular Holder shall affect the sufficiency of such notice with respect to other Holders. Where this
Supplemental Indenture provides for notice in any manner, such notice may be waived in writing by the person entitled to receive such notice, either before or after the event, and such waiver shall be the equivalent of such notice. Waivers of notice
by Holders shall be filed with the Trustee, but such filing shall not be a condition precedent to the validity of any action taken in reliance upon such waiver. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In case, by reason of the suspension of or irregularities in regular mail service, it shall be impracticable to mail notice to the Issuer, the
Guarantor or Holders of Notes when such notice is required to be given pursuant to any provision of this Supplemental Indenture, then any manner of giving such notice as shall be satisfactory to the Trustee shall be deemed to be a sufficient giving
of such notice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding anything to the contrary contained herein, in the Base Indenture or in the Notes, where this Supplemental
Indenture, the Base Indenture or any Note provides for notice of any event (including any notice of redemption or purchase) to a Holder of a Global Note (whether by mail or otherwise), such notice shall be sufficiently given if given to Euroclear or
Clearstream electronically or by other method in accordance with the procedures thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.5 <U>Officer</U><U>&#146;</U><U>s
Certificates and Opinions of Counsel; Statements to be</U><U> </U><U>Contained Therein</U><U>.</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon any application or demand by the
Issuer or the Guarantor to the Trustee to take any action under any of the provisions of this Supplemental Indenture, the Issuer or the Guarantor, as the case may be, shall furnish to the Trustee an Officer&#146;s Certificate or Guarantor&#146;s
Officer&#146;s Certificate, as the case may be, stating that all conditions precedent provided for in this Supplemental Indenture relating to the proposed action have been complied with and an Opinion of Counsel stating that in the opinion of such
counsel all such conditions precedent have been complied with. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each certificate or opinion provided for in this Supplemental Indenture
and delivered to the Trustee with respect to compliance with a condition or covenant provided for in this Supplemental Indenture shall include (a)&nbsp;a statement that the person making such certificate or opinion has read such covenant or
condition, (b)&nbsp;a brief statement as to the nature and scope of the examination or investigation upon which the statements or opinions contained in such certificate or opinion are based, (c)&nbsp;a statement that, in the opinion of such person,
he has made such examination or investigation as is necessary to enable him to express an informed opinion as to whether or not such covenant or condition has been complied with and (d)&nbsp;a statement as to whether or not, in the opinion of such
person, such condition or covenant has been complied with. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any certificate, statement or opinion of an Officer of the Issuer or the
Guarantor may be based, insofar as it relates to legal matters, upon a certificate or opinion of or representations by counsel, unless such Officer knows that the certificate or opinion or representations with respect to the matters upon which his
certificate, statement or opinion may be based as aforesaid are erroneous, or in the exercise of reasonable care should know that the same are erroneous. Any certificate, statement or opinion of counsel may be based, insofar as it relates to factual
matters, information with respect to which is in the possession of the Issuer or the Guarantor, as the case may be, upon the certificate, statement or opinion of or representations by an Officer of Officers of the Issuer or the Guarantor, as the
case may be, unless such counsel knows that the certificate, statement or opinion or representations with respect to the matters upon which his certificate, statement or opinion may be based as aforesaid are erroneous, or in the exercise of
reasonable care should know that the same are erroneous. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any certificate, statement or opinion of an Officer of the Issuer or the Guarantor or of
counsel may be based, insofar as it relates to accounting matters, upon a certificate or opinion of or representations by an accountant or firm of accountants in the employ of the Issuer, unless such Officer or counsel, as the case may be, knows
that the certificate or opinion or representations with respect to the accounting matters upon which his certificate, statement or opinion may be based as aforesaid are erroneous, or in the exercise of reasonable care should know that the same are
erroneous. Any certificate or opinion of any independent firm of public accountants filed with the Trustee shall contain a statement that such firm is independent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Trustee and the principal Paying Agent shall be entitled to conclusively rely on an Officer&#146;s certificate from the Issuer or the
Guarantor, shall have no duty to inquire as to or investigate the accuracy of any such Officer&#146;s certificate (or related Assurance Letter), verify the attainment of the Sustainability Performance Targets, or make calculations, investigations or
determinations with respect to the attainment of the Sustainability Performance Targets. The Trustee and the principal Paying Agent shall have no liability to the Issuer, any Holder or any other Person in acting in good faith on any such
Officer&#146;s certificate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.6 <U>Payments Due on Saturdays, Sundays and Holidays</U><U>.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the date of maturity of interest on or principal of the Notes of any series or the date fixed for redemption or repayment of any such Note
shall not be a Business Day, then payment of interest or principal need not be made on such date, but may be made on the next succeeding Business Day with the same force and effect as if made on the date of maturity or the date fixed for redemption,
and no interest shall accrue for the period after such date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.7 <U>Conflict of any Provisions of Supplemental Indenture
with Trust Indentur</U><U>e</U><U> </U><U>Act</U><U> </U><U>of 1939.</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If and to the extent that any provision of this Supplemental
Indenture limits, qualifies or conflicts with another provision included in this Supplemental Indenture by operation of Sections 310 to 317, inclusive, of the TIA (an &#147;incorporated provision&#148;), such incorporated provision shall control.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.8 <U>New York Law to Govern</U><U>.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Supplemental Indenture, each 2029 Note and each 2031 Note shall be deemed to be a contract under the laws of the State of New York, and
for all purposes shall be construed in accordance with the laws of such State. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.9 <U>Counterparts</U><U>.</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Supplemental Indenture may be executed in any number of counterparts, each of which shall be an original; but such
counterparts shall together constitute but one and the same instrument. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.10 <U>Effect of Headings</U><U>.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Article and Section headings herein and the Table of Contents are for convenience only and shall not affect the construction hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.11 <U>Submission to Jurisdiction</U><U>.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each of the Issuer, the Guarantor, the Paying Agent and the Trustee agrees that any legal suit, action or proceeding arising out of or based
upon this Supplemental Indenture may be instituted in any federal or state court sitting in the Borough of Manhattan in New York City, and, to the fullest extent permitted by law, waives any objection which it may now or hereafter have to the laying
of venue of any such proceeding, and irrevocably submits to the <FONT STYLE="white-space:nowrap">non-exclusive</FONT> jurisdiction of such court in any law suit, action or proceeding. Each </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of the Issuer and the Guarantor, as long as any of the Notes remain Outstanding or the parties hereto have any obligation under this Supplemental Indenture, shall have an authorized agent (the
&#147;<U>Authorized Agent</U>&#148;) in the United States upon whom process may be served in any such legal action or proceeding. Service of process upon such agent and written notice of such service mailed or delivered to it shall to the extent
permitted by law be deemed in every respect effective service of process upon it in any such legal action or proceeding. The Issuer and the Guarantor each hereby appoints Teva Pharmaceuticals USA, Inc. (400 Interpace Parkway, Building A, Parsippany,
NJ 07054) as its agent for such purposes, and covenants and agrees that service of process in any legal action or proceeding may be made upon it at such office of such agent. The Issuer will provide written notice to the Trustee of any change in the
Authorized Agent. In the event that any Authorized Agent resigns, is removed or becomes incapable of so acting, the Issuer shall promptly appoint a successor Authorized Agent and shall notify the Trustee in writing of such change in Authorized
Agent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.12 <U>Not Responsible for Recitals or Issuance of Securities</U><U>.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The recitals contained herein and in the Notes, except the Trustee&#146;s certificates of authentication, shall be taken as the statements of
the Issuer and the Guarantor, and the Trustee assumes no responsibility for their correctness. The Trustee makes no representations as to the validity or sufficiency of this Supplemental Indenture or of the Notes. The Trustee shall not be
accountable for the use or application by the Issuer of Notes or the proceeds thereof. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 8 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SUPPLEMENTAL INDENTURES </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.1 <U>Without Consent of Holders</U><U>.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Sections 7.01(d), (e), (f), (g), (h), (k), (l), (m), (n), (q) and (r)&nbsp;of the Base Indenture are not applicable with respect to the
Notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) In addition to the provisions set forth in Section&nbsp;7.01 of the Base Indenture as amended by Section&nbsp;7.1(a) above,
the Issuer, the Guarantor and the Trustee may amend, modify or supplement the Base Indenture, this Supplemental Indenture or the Notes of any series without the consent of any Holder for one or more of the following purposes: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) to cure any ambiguity, supply any omission or correct or supplement any provision contained herein, in the Base Indenture,
in any supplemental indenture or in the Notes of any series which may be defective or inconsistent with any other provision contained herein or in any supplemental indenture; <U>provided </U>that such amendment, modification or supplement shall not,
in the good faith opinion of the Issuer&#146;s managing and supervisory directors, adversely affect the interests of the Holders of the Notes in any material respect; <U>provided</U>, <U>further</U>, that any amendment made solely to conform the
provisions of this Supplemental Indenture to the description of the Notes contained in the Issuer&#146;s Prospectus Supplement dated March&nbsp;1, 2023 will not be deemed to adversely affect the interests of the Holders of the Notes; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) to surrender any right or power conferred upon the Issuer or the Guarantor hereunder; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) to comply with the requirements of the Commission in order to effect or maintain the qualification of the Indenture under
the TIA; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) to authorize the issuance of Add On Notes of either series of Notes pursuant to Section&nbsp;2.9; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) to add or modify any other provision of the Indenture which the Issuer or the Guarantor, as the case may be, and the
Trustee may deem necessary or desirable and which will not adversely affect the interests of the Holders of the Notes of such series in any material respect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.2 <U>With Consent of Each Affected Holder</U><U>.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to the provisions set forth in Section&nbsp;7.02 of the Base Indenture, the Issuer, the Guarantor and the Trustee may not amend,
modify or supplement the Base Indenture, this Supplemental Indenture or the Notes of any series for one or more of the following purposes without the consent of each Holder so affected: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) to modify the Guarantor&#146;s obligation to own, directly or indirectly, all of the outstanding Capital Stock or membership interests, as
applicable, of the Issuer pursuant to Section&nbsp;3.5 of this Supplemental Indenture; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) to modify any provision of Article 4 relating
to redemption of such series of Notes; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) to modify the Guarantees in a manner that would adversely affect the interests of the Holders
of such series of Notes; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) to reduce the percentage in aggregate principal amount of the Notes such series of then Outstanding
necessary (i)&nbsp;to modify, amend or supplement the Base Indenture or this Supplemental Indenture or (ii)&nbsp;to waive any past default or Event of Default pursuant to Section&nbsp;4.10 of the Base Indenture. </P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly executed as of the
day and year first above written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">TEVA PHARMACEUTICAL FINANCE NETHERLANDS II B.V., as Issuer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ David Vrhovec</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: David Vrhovec</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Authorized Representative</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Stephen David Harper</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Stephen David Harper</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Authorized Representative</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">TEVA PHARMACEUTICAL INDUSTRIES LIMITED, as Guarantor</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Amir Weiss</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Amir Weiss</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Senior Vice President and Chief Accounting Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Eli Kalif</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Eli Kalif</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Executive Vice President and Chief Financial Officer</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(<I>Signature Page Supplemental Indenture (EUR)</I>) </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">THE BANK OF NEW YORK MELLON, as Trustee</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Stacey B. Poindexter</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Stacey B. Poindexter</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Vice President</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">THE BANK OF NEW YORK MELLON LONDON BRANCH, as Paying Agent</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Marco Thuo</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Marco Thuo</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Director</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(<I>Signature Page Supplemental Indenture (EUR)</I>) </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">EXHIBIT A </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[FORM OF FACE OF 2029 GLOBAL NOTE] </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[Insert
Global Notes Legend or Physical Notes Legend, as applicable] </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="41%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="58%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">No.&nbsp;1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&#128;800,000,000 as revised by the Schedule of Increases or Decreases in the Global Note attached hereto</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ISIN: XS2592804434 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Common Code: 259280443 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>GLOBAL NOTE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TEVA PHARMACEUTICAL FINANCE NETHERLANDS II B.V. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>7.375% Sustainability-Linked Senior Notes due 2029 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Payment of Principal, Interest and Additional Tax Amounts, if any, Unconditionally </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Guaranteed By </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TEVA
PHARMACEUTICAL INDUSTRIES LIMITED </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Global Note is in respect of an issue of 7.375% Sustainability-Linked Senior Notes due 2029
(the &#147;<U>Notes</U>&#148;) of Teva Pharmaceutical Finance Netherlands II B.V., a private company with limited liability (<I>besloten vennootschap met beperkte aansprakelijkheid</I>), incorporated under Dutch law (the &#147;<U>Issuer</U>&#148;,
which term includes any successor corporation under the Senior Indenture hereinafter referred to), and issued pursuant to a base indenture (the &#147;<U>Base Indenture</U>&#148;), dated as of March&nbsp;14, 2018, by and among the Issuer, Teva
Pharmaceutical Industries Limited, as guarantor (the &#147;<U>Guarantor</U>&#148;), and The Bank of New York Mellon, a New York banking corporation, as trustee (the &#147;<U>Trustee</U>&#148;), as supplemented by a first supplemental senior
indenture, dated as of March&nbsp;14, 2018, by and among the Issuer, the Guarantor, the Trustee and The Bank of New York Mellon, London Branch, as paying agent (the &#147;<U>Paying Agent</U>&#148;), a second supplemental senior indenture, dated as
of November&nbsp;25, 2019, by and among the Issuer, the Guarantor, the Trustee and the Paying Agent, a third supplemental senior indenture, dated as of November&nbsp;9, 2021, by and among the Issuer, the Guarantor, the Trustee and the Paying Agent
and as further supplemented by a fourth supplemental senior indenture (the &#147;<U>Supplemental Indenture</U>&#148; and, together with the Base Indenture, the &#147;<U>Indenture</U>&#148;), dated as of March&nbsp;9, 2023, by and among the Issuer,
the Guarantor, the Trustee and the Paying Agent. Unless the context otherwise requires, the capitalized terms used herein shall have the meanings specified in the Supplemental Indenture and the Base Indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Issuer, for value received, hereby promises to pay to The Bank of New York Depository (Nominees) Limited, or its registered assigns, the
principal amount of EIGHT HUNDRED MILLION Euros (&#128;800,000,000) on September&nbsp;15, 2029, and to pay interest on such principal amount in Euros at the rate of 7.375% per annum, subject to the paragraph immediately below, computed on a basis of
a 360 day year consisting of twelve 30 day months, from the date hereof until payment of such principal amount has been made or duly provided for, such interest to be paid semi-annually in arrears on March&nbsp;15 and September&nbsp;15 of each year,
commencing September&nbsp;15, 2023. The interest so payable on March&nbsp;15 and September&nbsp;15 (each an &#147;<U>Interest Payment Date</U>&#148;) will, subject to certain exceptions provided in the Supplemental Indenture, be paid to the person
in whose name this Note is registered at the close of business on the Business Day immediately preceding the related Interest Payment Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">From and
including September&nbsp;15, 2026 (the <FONT STYLE="white-space:nowrap">&#147;Step-up</FONT> Date&#148;) the Interest Rate payable on the Notes shall increase by: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">0.100% per annum unless the Guarantor has achieved the Regulatory Submissions Target as of the Testing Date;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">0.100% per annum unless the Guarantor has achieved the Product Volume Target as of the Testing Date; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">0.100% per annum unless the Guarantor has achieved the Emission Reduction Target as of the Testing Date;
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">in each case, as certified by the Issuer or the Guarantor to the Trustee in an Officer&#146;s certificate (which shall include the
Assurance Letter as an exhibit thereto) on or prior to the Certification Date (subject to any clerical or administrative errors (including any delays resulting therefrom)); <I>provided</I> that, for the avoidance of doubt: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(A) the Interest Rate on the Notes shall not increase on the
<FONT STYLE="white-space:nowrap">Step-up</FONT> Date if the Guarantor has achieved the three Sustainability Performance Targets as of the Testing Date and certified to such on or prior to the Certification Date; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(B) the increase in the Interest Rate on the Notes on the <FONT STYLE="white-space:nowrap">Step-up</FONT> Date shall not exceed a total of
0.100% if the Guarantor has achieved two of the three Sustainability Performance Targets as of the Testing Date and certified to such on or prior to the Certification Date; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(C) the increase in the Interest Rate on the Notes on the <FONT STYLE="white-space:nowrap">Step-up</FONT> Date shall not exceed a total of
0.200% if the Guarantor has met one of the three Sustainability Performance Targets as of the Testing Date and certified to such on or prior to the Certification Date; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(D) in no event shall the total increase in the Interest Rate on the Notes on the <FONT STYLE="white-space:nowrap">Step-up</FONT> Date exceed
0.300% (this being the consequence of the Guarantor failing to achieve any of the three Sustainability Performance Targets on the Testing Date and failing to certify to achievement on or prior to the Certification Date). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Reference is hereby made to the further provisions of this Note set forth on the reverse hereof, which further provisions shall for all
purposes have the same effect as if set forth at this place. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Note shall not be valid or become obligatory for any purpose until the
certificate of authentication hereon shall have been signed by the Trustee. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Issuer has caused this Note to be duly executed manually or by
facsimile by its duly authorized officers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">TEVA PHARMACEUTICAL FINANCE NETHERLANDS II B.V.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Trustee&#146;s Certificate of Authentication</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">This is one of the 7.375% Sustainability-Linked Senior Notes due 2029 described in the within-named Indenture.</TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THE BANK OF NEW YORK MELLON,</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">as
Trustee</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Authorized Signatory</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Teva Pharmaceutical Industries Limited (the &#147;Guarantor&#148;) hereby unconditionally
and irrevocably guarantees to the Holder of this Note (the &#147;Guarantee&#148;) the due and punctual payment of the principal of and interest (including Additional Tax Amounts, if any), on this Note, when and as the same shall become due and
payable, whether at Maturity or upon redemption or upon declaration of acceleration or otherwise, according to the terms of this Note and of the Indenture. The Guarantor agrees that in the case of default by the Issuer in the payment of any such
principal or interest (including Additional Tax Amounts, if any), the Guarantor shall duly and punctually pay the same. The Guarantor hereby agrees that its obligations hereunder shall be absolute and unconditional irrespective of any extension of
the time for payment of this Note, any modification of this Note, any invalidity, irregularity or unenforceability of this Note or the Indenture, any failure to enforce the same or any waiver, modification, consent or indulgence granted to the
Issuer with respect thereto by the Holder of this Note or the Trustee, or any other circumstances which may otherwise constitute a legal or equitable discharge of a surety or guarantor. The Guarantor hereby waives diligence, presentment, demand of
payment, filing of claims with a court in the event of merger or bankruptcy of the Issuer, any right to require a demand or proceeding first against the Issuer, protest or notice with respect to this Note or the indebtedness evidenced hereby and all
demands whatsoever, and covenants that this Guarantee will not be discharged as to this Note except by payment in full of the principal of and interest (including Additional Tax Amounts, if any) on this Note. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Guarantor shall be subrogated to all rights of the Holders against the Issuer in respect of any amounts paid by the Guarantor pursuant to
the provisions of the Guarantees or the Indenture; provided, however, that the Guarantor hereby waives any and all rights to which it may be entitled, by operation of law or otherwise, upon making any payment hereunder (i)&nbsp;to be subrogated to
the rights of a Holder against the Issuer with respect to such payment or otherwise to be reimbursed, indemnified or exonerated by the Issuer in respect thereof or (ii)&nbsp;to receive any payment in the nature of contribution or for any other
reason, from any other obligor with respect to such payment, in each case, until the principal of and interest (including Additional Tax Amounts, if any) on this Note shall have been paid in full. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Guarantee shall not be valid or become obligatory for any purpose with respect to this Note until the certificate of authentication on
this Note shall have been signed by the Trustee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Guarantee shall be governed by and construed in accordance with the laws of the
State of New York. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, Teva Pharmaceutical Industries Limited has caused the Guarantee to be
signed manually or by facsimile by its duly authorized officers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">TEVA PHARMACEUTICAL INDUSTRIES LIMITED</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-bottom:1pt; margin-top:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-bottom:1pt; margin-top:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[FORM OF REVERSE OF NOTE] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TEVA PHARMACEUTICAL FINANCE NETHERLANDS II B.V. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>7.375% Sustainability-Linked Senior Note due 2029 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Payment of Principal, Interest and Additional Tax Amounts, if any, Unconditionally </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Guaranteed By </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TEVA
PHARMACEUTICAL INDUSTRIES LIMITED </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Capitalized terms used herein but not defined shall have the meanings assigned to them in the
Indenture referred to below unless otherwise indicated. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Principal and Interest.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Teva Pharmaceutical Finance Netherlands II B.V., a private company with limited liability <I>(besloten vennootschap met beperkte
aansprakelijkheid)</I>, incorporated under Dutch law (the &#147;<U>Issuer</U>&#148;), promises to pay interest on the principal amount of this Note at 7.375% per annum, subject to adjustment as described in the paragraph below, from March&nbsp;9,
2023 until the principal thereof is paid or made available for payment. Interest shall be payable semi-annually in arrears on each March&nbsp;15 and September&nbsp;15 of each year (each an &#147;<U>Interest Payment Date</U>&#148;), commencing
September&nbsp;15, 2023. If an Interest Payment Date falls on a day that is not a Business Day, interest will be payable on the next succeeding Business Day with the same force and effect as if made on such Interest Payment Date and no interest
shall accrue thereon on account of such delay. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interest on the Notes shall be computed on the basis of a
<FONT STYLE="white-space:nowrap">360-day</FONT> year of twelve <FONT STYLE="white-space:nowrap">30-day</FONT> months. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A Holder of any
Note at the close of business on a Regular Record Date shall be entitled to receive interest on such Note on the corresponding Interest Payment Date. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Interest Rate Adjustment Upon Failure to Achieve Sustainability Performance Targets.</U>
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">From and including September&nbsp;15, 2026 (the <FONT STYLE="white-space:nowrap">&#147;Step-up</FONT> Date&#148;) the
Interest Rate payable on the Notes shall increase by: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">0.100% per annum unless the Guarantor has achieved the Regulatory Submissions Target as of the Testing Date;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">0.100% per annum unless the Guarantor has achieved the Product Volume Target as of the Testing Date; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">0.100% per annum unless the Guarantor has achieved the Emission Reduction Target as of the Testing Date;
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">in each case, as certified by the Issuer or the Guarantor to the Trustee in an Officer&#146;s certificate (which shall include the
Assurance Letter as an exhibit thereto) on or prior to the Certification Date (subject to any clerical or administrative errors (including any delays resulting therefrom)); <I>provided</I> that, for the avoidance of doubt: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(A)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Interest Rate on the Notes shall not increase on the <FONT STYLE="white-space:nowrap">Step-up</FONT> Date
if the Guarantor has achieved the three Sustainability Performance Targets as of the Testing Date and certified to such on or prior to the Certification Date; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(B)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the increase in the Interest Rate on the Notes on the <FONT STYLE="white-space:nowrap">Step-up</FONT> Date
shall not exceed a total of 0.100% if the Guarantor has achieved two of the three Sustainability Performance Targets as of the Testing Date and certified to such on or prior to the Certification Date; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(C)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the increase in the Interest Rate on the Notes on the <FONT STYLE="white-space:nowrap">Step-up</FONT> Date
shall not exceed a total of 0.200% if the Guarantor has met one of the three Sustainability Performance Targets as of the Testing Date and certified to such on or prior to the Certification Date; and </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(D)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in no event shall the total increase in the Interest Rate on the Notes on the
<FONT STYLE="white-space:nowrap">Step-up</FONT> Date exceed 0.300% (this being the consequence of the Guarantor failing to achieve any of the three Sustainability Performance Targets on the Testing Date and failing to certify to achievement on or
prior to the Certification Date). </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Method of Payment.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interest on any Note which is payable, and is punctually paid or duly provided for, on any Interest Payment Date shall be paid to the person in
whose name that Note (or one or more Predecessor Notes) is registered at the close of business on the relevant Regular Record Date for such interest. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Payments on the Global Notes will be made through the Paying Agent. Payments on the Notes of this series will be made in Euros at the
specified office or agency of the Paying Agent; <I>provided that </I>all such payments with respect to Notes represented by one or more Global Notes deposited with and registered in the name of the Common Depositary or its nominee for the accounts
of Euroclear and Clearstream, will be by wire transfer of immediately available funds to the account specified in writing by the holder or holders thereof to the Common Depositary. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Paying Agent and Registrar.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Initially, The Bank of New York Mellon, the Trustee under the Supplemental Indenture, will act as Paying Agent and Registrar. The Issuer may
change the Paying Agent or Registrar without notice to any Holder. The Issuer has appointed The Bank of New York Mellon, London Branch, at 160 Queen Victoria Street, London EC4V 4LA, United Kingdom, as Paying Agent. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Supplemental Indentures and Indenture.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Issuer issued this Note under a Base Indenture (the &#147;<U>Base Indenture</U>&#148;), dated as of March&nbsp;14, 2018, by and among the
Issuer, the Guarantor and The Bank of New York Mellon, as trustee (the &#147;<U>Trustee</U>&#148;), as supplemented by a first supplemental senior indenture, dated as of March&nbsp;14, 2018, by and among the Issuer, the Guarantor, the Trustee and
The Bank of New York Mellon, London Branch, as paying agent (the &#147;<U>Paying Agent</U>&#148;), a second supplemental senior indenture, dated as of November&nbsp;25, 2019, by and among the Issuer, the Guarantor, the Trustee and the Paying Agent,
a third supplemental senior indenture, dated as of November&nbsp;9, 2021, by and among the Issuer, the Guarantor, the Trustee and the Paying Agent and as further supplemented by a fourth supplemental senior indenture (the &#147;<U>Supplemental
Indenture</U>&#148; and, together with the Base Indenture, the &#147;<U>Indenture</U>&#148;), dated as of March&nbsp;9, 2023, by and among the Issuer, the Guarantor, the Trustee and the Paying Agent. The terms of the Note include those stated in the
Indenture, and those made part of the Indenture by reference to the Trust Indenture Act of 1939, as amended (&#147;<U>TIA</U>&#148;). This Note is subject to all such terms, and Holders are referred to the Indenture and the TIA for a statement of
all such terms. To the extent permitted by applicable law, in the event of any inconsistency between the terms of this Note and the terms of the Indenture, the terms of the Indenture shall control. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Optional Redemption.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Issuer may at its option redeem this Note, in whole or in part, at any time or from time to time, on any date prior to the Stated
Maturity, upon notice as set forth in Section&nbsp;4.2 of the Supplemental Indenture, at a Redemption Price equal to the greater of (1) 100% of the principal amount of the Notes to be redeemed or (2)&nbsp;the sum of the present values of the
Remaining Scheduled Payments of the Notes being redeemed discounted, on a semi-annual basis (assuming a <FONT STYLE="white-space:nowrap">360-day</FONT> year consisting of twelve <FONT STYLE="white-space:nowrap">30-day</FONT> months), at the
applicable Reinvestment Rate, plus in each case accrued and unpaid interest thereon, if any, to, but not including, the Redemption Date; provided that if the Issuer redeems the Notes on or after the applicable Par Call Date, the Redemption Price for
such Notes will be equal to 100% of the aggregate principal amount of the Notes being redeemed, plus accrued and unpaid interest thereon, if any, to, but not including, the Redemption Date. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On and after the Redemption Date, interest shall cease to accrue on Notes or portions of
Notes called for redemption, unless the Issuer defaults in the payment of the Redemption Price. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notice of redemption will be given by the
Issuer to the Holders as provided in the Supplemental Indenture. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">7.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Tax Redemption.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If, as a result of any change in or amendment to the laws (or any regulations or rulings promulgated thereunder) of any Taxing Jurisdiction or
any political subdivision or taxing authority thereof or in any Taxing Jurisdiction affecting taxation or any change in official position regarding the application or interpretation of such laws, regulations or rulings, which change or amendment
becomes effective or, in the case of a change in official position, is announced on or after the issuance of the Notes, the Issuer or the Guarantor (or any of their respective successors), as the case may be, is or will be obligated to pay any
Additional Tax Amount with respect to the Notes (of any series thereof), and if the Issuer or the Guarantor (or any of their respective successors), as the case may be, determines that such obligation cannot be avoided by the Issuer or the Guarantor
(or any of their respective successors), as the case may be, after taking reasonable measures available to it, then at the option of the Issuer or the Guarantor (or any of their respective successors), as the case may be, the Notes (of any series
thereof) may be redeemed in whole, but not in part, at any time, upon the giving not less than 10 days&#146; nor more than 60 days&#146; notice to the Trustee and the Holders of such Notes, at the Redemption Price; provided, however, that
(1)&nbsp;no notice of such tax redemption may be given earlier than 90 days prior to the earliest date on which the Issuer or the Guarantor (or their respective successors), as the case may be, would, but for such redemption, be obligated to pay
such Additional Tax Amounts were a payment on such Notes then due, and (2)&nbsp;at the time such notice is given, such obligation to pay such Additional Tax Amounts remains in effect. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">8.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Denominations; Transfer; Exchange.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes are issuable in registered form, without coupons, in minimum denominations of &#128;100,000 principal amount and integral multiples
of &#128;1,000 in excess of &#128;100,000. A Holder may register the transfer or exchange of Notes in accordance with the Indenture. The Issuer or the Trustee may require a Holder, among other things, to furnish appropriate endorsements and transfer
documents, and the Issuer may require a Holder to pay any taxes or other governmental charges that may be imposed in connection with any exchange or registration of transfer of Notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Issuer shall not be required to exchange or register a transfer of (a)&nbsp;any Note for a period of 15 days next preceding the first
delivery of notice of redemption of Notes to be redeemed, (b)&nbsp;any Notes selected, called or being called for redemption except, in the case of any Note where notice has been given that such Note is to be redeemed in part, the portion thereof
not so to be redeemed or (c)&nbsp;any Notes between a record date and the next succeeding payment date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event of redemption of the
Notes in part only, in the case of a Global Note, the aggregate principal amount of such Global Notes may be increased or decreased by adjustments made on the records of the Depositary or, if necessary, a new Note or Notes for the unredeemed portion
thereof will be issued in the name of the Holder hereof. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">9.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Holders to be Treated as Owners.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The registered Holder of this Note shall be treated as its owner for all purposes. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">10.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Unclaimed Money.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any moneys deposited with or paid to the Trustee or any Paying Agent for the payment of the principal of or interest on any Note and not
applied but remaining unclaimed for two years after the date upon which such principal or interest shall have become due and payable, shall, upon the written request of the Issuer and unless otherwise required by mandatory provisions of applicable
escheat or abandoned or unclaimed property law, be repaid to the Issuer by the Trustee or such Paying Agent, and the Holder of such Note shall, unless otherwise required by mandatory provisions of applicable escheat or abandoned or unclaimed
property laws, thereafter look only to the Issuer for any payment which such Holder may be entitled to collect, and all liability of the Trustee or any Paying Agent with respect to such moneys shall thereupon cease. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">11.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Satisfaction and Discharge.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Issuer and the Guarantor may satisfy and discharge their obligations under the Indenture while the Notes remain outstanding, if
(a)&nbsp;all Outstanding Notes have become due and payable at their scheduled Maturity, or (b)&nbsp;all Outstanding Notes have been called for redemption, and in either case, the Issuer has deposited with the Trustee an amount sufficient to pay and
discharge all Outstanding Notes on the date of their scheduled Maturity or the scheduled Redemption Date, as the case may be. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">12.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Supplement; Waiver.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Without notice to or the consent of the Holders of the Notes, the Indenture and the Notes may be amended, supplemented or otherwise modified
by the Issuer, the Guarantor and the Trustee as provided in the Indenture. The Indenture permits, with certain exceptions as therein provided, the amendment thereof and the modification of the rights and obligations of the Issuer and the rights of
the Holders of the Notes under the Indenture at any time by the Issuer and the Trustee with the consent of the Holders of a majority in aggregate principal amount of the Outstanding Notes (or such lesser amount as shall have acted at a meeting
pursuant to the provisions of the Indenture). The Indenture also contains provisions permitting the Holders of specified percentages in principal amount of the Notes at the time Outstanding, on behalf of the Holders of all the Notes, to waive
compliance by the Issuer with certain provisions of the Indenture and certain past defaults under the Indenture and their consequences. Any such consent or waiver by the Holder of this Note shall be conclusive and binding upon such Holder and upon
all future Holders of this Note and of any Note issued upon registration of transfer hereof or in exchange herefor or in lieu hereof, whether or not notation of such consent or waiver is made upon this Note or such other Note. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No reference herein to the Indenture and no provision of this Note or of the Indenture shall alter or impair the obligation of the Issuer,
which is absolute and unconditional, to pay the principal of and interest on this Note at the times, places and rate, and in the coin or currency, herein prescribed. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">13.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Defaults and Remedies.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Indenture provides that an Event of Default with respect to the Notes occurs when any of the following occurs: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) the Issuer defaults in the payment of the principal and premium, if any, of any of the Notes when it becomes due and payable at Maturity
or upon redemption; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) the Issuer defaults in the payment of interest (including Additional Tax Amounts, if any) on any of the Notes
when it becomes due and payable and such default continues for a period of 30 days, after the date when due; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) the Guarantor fails to
perform its obligations under the Guarantees; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) except as permitted by the Indenture, the Guarantees is held in any final, <FONT
STYLE="white-space:nowrap">non-appealable</FONT> judicial proceeding to be unenforceable or invalid or shall cease for any reason to be in full force and effect or the Guarantor, or any person acting on behalf of the Guarantor, shall deny or
disaffirm its obligations under the Guarantees; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) either the Issuer or the Guarantor fails to perform or observe any other term, covenant
or agreement contained in the Notes or the Indenture and the default continues for a period of 60 days after written notice of such failure, requiring the Issuer or the Guarantor, as the case may be, to remedy the same, shall have been given to the
Issuer or the Guarantor, as the case may be, by the Trustee or to the Issuer or the Guarantor, as the case may be, and the Trustee by the Holders of at least 25% in aggregate principal amount of the Outstanding Notes (provided that such notice may
not be given with respect to any action taken, and reported publicly or to holders of such series of the Notes, more than two years prior to such notice; provided further that the trustee shall have no obligation to determine when or if any holders
have been notified of any such action or to track when such <FONT STYLE="white-space:nowrap">two-year</FONT> period starts or concludes); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) (i) the Issuer or the Guarantor fails to make by the end of the applicable grace period, if any, any payment of principal or interest due
in respect of any Indebtedness for borrowed money, the aggregate outstanding principal amount of which is an amount in excess of $250,000,000; or (ii)&nbsp;there is an acceleration of any Indebtedness for borrowed money in an amount in excess of
$250,000,000 because of a default with respect to such Indebtedness, without, in the case of either (i)&nbsp;or (ii) above, such Indebtedness having been discharged or such <FONT STYLE="white-space:nowrap">non-payment</FONT> or acceleration having
been cured, waived, rescinded or annulled for a period of 30 days after written notice to the Issuer by the Trustee or to the Issuer and the Trustee by the Holders of at least 25% in aggregate principal amount of the Outstanding Notes of such
series; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) the occurrence of certain events of bankruptcy, insolvency or reorganization of the Issuer or Guarantor as specified in
the Supplemental Indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If an Event of Default shall occur and be continuing, the principal of all the Notes may be declared due and
payable in the manner and with the effect provided in the Supplemental Indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any time period in this Supplemental Indenture, the
Base Indenture or the Notes to cure any actual or alleged default or event of default may be extended or stayed by a court of competent jurisdiction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the avoidance of doubt, failure to achieve one or more Sustainability Performance Targets shall not constitute a Default or an Event of
Default with respect to the Notes. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">14.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Authentication.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Note shall not be valid until the Trustee (or authenticating agent) executes the certificate of authentication on the other side of this
Note. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">15.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>ISIN Numbers and Common Codes.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Issuer has caused ISIN numbers and Common Codes to be printed on this Note and, therefore, the Trustee shall use ISIN numbers and Common
Codes in notices of redemption as a convenience to Holders. Any such notice may state that no representation is made as to the correctness of such numbers either as printed on the Notes or as contained in any notice of a redemption and that reliance
may be placed only on the other identification numbers printed on the Notes, and any such redemption shall not be affected by any defect in or omission of such numbers. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">16.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Governing Law.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Supplemental Indenture, the Base Indenture and this Note shall be governed by, and construed in accordance with, the laws of the State of
New York. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">17.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Successor Corporation.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event a successor corporation legal entity assumes all the obligations of the Issuer or the Guarantor under this Note, pursuant to the
terms hereof and of the Indenture, the Issuer or Guarantor, as the case may be, will be released from all such obligations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ASSIGNMENT FORM </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To assign this Note, fill in the form below and have your signature guaranteed: (I)&nbsp;or (we) assign and transfer this Note to: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="80%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Insert
assignee&#146;s soc. sec. or tax I.D. no.)</P> <P STYLE="margin-top:0pt;margin-bottom:1pt;border-bottom:1px solid #000000" align="left">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">(Print or type assignee&#146;s name, address and zip code)</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">and irrevocably appoint <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> <U></U>to transfer
this Note on the books of the Issuer. The agent may substitute another to act for him. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Dated:<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Your&nbsp;Name:&nbsp;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">(Print your name exactly as it appears on the face of this Note)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Your&nbsp;Signature:&nbsp;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">(Sign exactly as your name appears on the face of this Note)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Signature Guarantee<SUP STYLE="font-size:75%; vertical-align:top">*</SUP>:</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:75%; vertical-align:top">*</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Participant in a recognized Signature Guarantee Medallion Program (or other signature guarantor acceptable
to the Trustee).</I> </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SCHEDULE OF INCREASES OR DECREASES IN THE GLOBAL NOTE </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The initial outstanding principal amount of this Global Note is &#128;800,000,000. The following exchanges of a part of this Global Note for
an interest in another Global Note or for a Physical Note, or exchanges of a part of another Global Note or Physical Note for an interest in this Global Note, have been made: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="18%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="19%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="20%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="20%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="19%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Date of</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Exchange</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Amount of</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">decrease in</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Principal Amount</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">of this Global</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Note</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Amount of</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">increase in</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Principal Amount</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">of this Global</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Note</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Principal&nbsp;Amount</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">of this Global</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Note following</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">such decrease or</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">increase</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Signature of</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">authorized</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">signatory of</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Trustee</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[FORM OF FACE OF 2031 GLOBAL NOTE] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[Insert Global Notes Legend or Physical Notes Legend, as applicable] </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">No.&nbsp;1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&#128;500,000,000 as revised by the Schedule of Increases or Decreases in the Global Note attached hereto</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ISIN: XS2592804194 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Common Code: 259280419 </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>GLOBAL NOTE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TEVA PHARMACEUTICAL FINANCE NETHERLANDS II B.V. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>7.875% Sustainability-Linked Senior Notes due 2031 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Payment of Principal, Interest and Additional Tax Amounts, if any, Unconditionally </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Guaranteed By </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TEVA
PHARMACEUTICAL INDUSTRIES LIMITED </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Global Note is in respect of an issue of 7.875% Sustainability-Linked Senior Notes due 2031
(the &#147;<U>Notes</U>&#148;) of Teva Pharmaceutical Finance Netherlands II B.V., a private company with limited liability (<I>besloten vennootschap met beperkte aansprakelijkheid</I>), incorporated under Dutch law (the &#147;<U>Issuer</U>&#148;,
which term includes any successor corporation under the Senior Indenture hereinafter referred to), and issued pursuant to a base indenture (the &#147;<U>Base Indenture</U>&#148;), dated as of March&nbsp;14, 2018, by and among the Issuer, Teva
Pharmaceutical Industries Limited, as guarantor (the &#147;<U>Guarantor</U>&#148;), and The Bank of New York Mellon, a New York banking corporation, as trustee (the &#147;<U>Trustee</U>&#148;), as supplemented by a first supplemental senior
indenture, dated as of March&nbsp;14, 2018, by and among the Issuer, the Guarantor, the Trustee and The Bank of New York Mellon, London Branch, as paying agent (the &#147;<U>Paying Agent</U>&#148;), a second supplemental senior indenture, dated as
of November&nbsp;25, 2019, by and among the Issuer, the Guarantor, the Trustee and the Paying Agent, a third supplemental senior indenture, dated as of November&nbsp;9, 2021, by and among the Issuer, the Guarantor, the Trustee and the Paying Agent
and as further supplemented by a fourth supplemental senior indenture (the &#147;<U>Supplemental Indenture</U>&#148; and, together with the Base Indenture, the &#147;<U>Indenture</U>&#148;), dated as of March&nbsp;9, 2023, by and among the Issuer,
the Guarantor, the Trustee and the Paying Agent. Unless the context otherwise requires, the capitalized terms used herein shall have the meanings specified in the Supplemental Indenture and the Base Indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Issuer, for value received, hereby promises to pay to The Bank of New York Depository (Nominees) Limited, or its registered assigns, the
principal amount of FIVE HUNDRED MILLION Euros (&#128;500,000,000) on September&nbsp;15, 2031, and to pay interest on such principal amount in Euros at the rate of 7.875% per annum, subject to the paragraph immediately below, computed on a basis of
a 360 day year consisting of twelve 30 day months, from the date hereof until payment of such principal amount has been made or duly provided for, such interest to be paid semi-annually in arrears on March&nbsp;15 and September&nbsp;15 of each year,
commencing September&nbsp;15, 2023. The interest so payable on March&nbsp;15 and September&nbsp;15 (each an &#147;<U>Interest Payment Date</U>&#148;) will, subject to certain exceptions provided in the Supplemental Indenture, be paid to the person
in whose name this Note is registered at the close of business on the Business Day immediately preceding the related Interest Payment Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">From and
including September&nbsp;15, 2026 (the <FONT STYLE="white-space:nowrap">&#147;Step-up</FONT> Date&#148;) the Interest Rate payable on the Notes shall increase by: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">0.100% per annum unless the Guarantor has achieved the Regulatory Submissions Target as of the Testing Date;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">0.100% per annum unless the Guarantor has achieved the Product Volume Target as of the Testing Date; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">0.100% per annum unless the Guarantor has achieved the Emission Reduction Target as of the Testing Date;
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">in each case, as certified by the Issuer or the Guarantor to the Trustee in an Officer&#146;s certificate
(which shall include the Assurance Letter as an exhibit thereto) on or prior to the Certification Date (subject to any clerical or administrative errors (including any delays resulting therefrom)); <I>provided</I> that, for the avoidance of doubt:
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(A) the Interest Rate on the Notes shall not increase on the <FONT STYLE="white-space:nowrap">Step-up</FONT> Date if the Guarantor has
achieved the three Sustainability Performance Targets as of the Testing Date and certified to such on or prior to the Certification Date; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(B) the increase in the Interest Rate on the Notes on the <FONT STYLE="white-space:nowrap">Step-up</FONT> Date shall not exceed a total of
0.100% if the Guarantor has achieved two of the three Sustainability Performance Targets as of the Testing Date and certified to such on or prior to the Certification Date; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(C) the increase in the Interest Rate on the Notes on the <FONT STYLE="white-space:nowrap">Step-up</FONT> Date shall not exceed a total of
0.200% if the Guarantor has met one of the three Sustainability Performance Targets as of the Testing Date and certified to such on or prior to the Certification Date; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(D) in no event shall the total increase in the Interest Rate on the Notes on the <FONT STYLE="white-space:nowrap">Step-up</FONT> Date exceed
0.300% (this being the consequence of the Guarantor failing to achieve any of the three Sustainability Performance Targets on the Testing Date and failing to certify to achievement on or prior to the Certification Date). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Reference is hereby made to the further provisions of this Note set forth on the reverse hereof, which further provisions shall for all
purposes have the same effect as if set forth at this place. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Note shall not be valid or become obligatory for any purpose until the
certificate of authentication hereon shall have been signed by the Trustee. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Issuer has caused this Note to be duly executed manually or by
facsimile by its duly authorized officers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">TEVA PHARMACEUTICAL FINANCE NETHERLANDS II B.V.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Trustee&#146;s Certificate of Authentication </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This is one of the 7.875% Sustainability-Linked Senior Notes due 2031 described in the within-named Indenture. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THE BANK OF NEW YORK MELLON,</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">as
Trustee</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center">Authorized Signatory</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Teva Pharmaceutical Industries Limited (the &#147;Guarantor&#148;) hereby unconditionally
and irrevocably guarantees to the Holder of this Note (the &#147;Guarantee&#148;) the due and punctual payment of the principal of and interest (including Additional Tax Amounts, if any), on this Note, when and as the same shall become due and
payable, whether at Maturity or upon redemption or upon declaration of acceleration or otherwise, according to the terms of this Note and of the Indenture. The Guarantor agrees that in the case of default by the Issuer in the payment of any such
principal or interest (including Additional Tax Amounts, if any), the Guarantor shall duly and punctually pay the same. The Guarantor hereby agrees that its obligations hereunder shall be absolute and unconditional irrespective of any extension of
the time for payment of this Note, any modification of this Note, any invalidity, irregularity or unenforceability of this Note or the Indenture, any failure to enforce the same or any waiver, modification, consent or indulgence granted to the
Issuer with respect thereto by the Holder of this Note or the Trustee, or any other circumstances which may otherwise constitute a legal or equitable discharge of a surety or guarantor. The Guarantor hereby waives diligence, presentment, demand of
payment, filing of claims with a court in the event of merger or bankruptcy of the Issuer, any right to require a demand or proceeding first against the Issuer, protest or notice with respect to this Note or the indebtedness evidenced hereby and all
demands whatsoever, and covenants that this Guarantee will not be discharged as to this Note except by payment in full of the principal of and interest (including Additional Tax Amounts, if any) on this Note. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Guarantor shall be subrogated to all rights of the Holders against the Issuer in respect of any amounts paid by the Guarantor pursuant to
the provisions of the Guarantees or the Indenture; provided, however, that the Guarantor hereby waives any and all rights to which it may be entitled, by operation of law or otherwise, upon making any payment hereunder (i)&nbsp;to be subrogated to
the rights of a Holder against the Issuer with respect to such payment or otherwise to be reimbursed, indemnified or exonerated by the Issuer in respect thereof or (ii)&nbsp;to receive any payment in the nature of contribution or for any other
reason, from any other obligor with respect to such payment, in each case, until the principal of and interest (including Additional Tax Amounts, if any) on this Note shall have been paid in full. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Guarantee shall not be valid or become obligatory for any purpose with respect to this Note until the certificate of authentication on
this Note shall have been signed by the Trustee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Guarantee shall be governed by and construed in accordance with the laws of the
State of New York. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, Teva Pharmaceutical Industries Limited has caused the Guarantee to be
signed manually or by facsimile by its duly authorized officers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">TEVA PHARMACEUTICAL INDUSTRIES LIMITED</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[FORM OF REVERSE OF NOTE] </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TEVA PHARMACEUTICAL FINANCE NETHERLANDS II B.V. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>7.875% Sustainability-Linked Senior Note due 2031 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Payment of Principal, Interest and Additional Tax Amounts, if any, Unconditionally </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Guaranteed By </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TEVA
PHARMACEUTICAL INDUSTRIES LIMITED </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Capitalized terms used herein but not defined shall have the meanings assigned to them in the
Indenture referred to below unless otherwise indicated. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Principal and Interest.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Teva Pharmaceutical Finance Netherlands II B.V., a private company with limited liability <I>(besloten vennootschap met beperkte
aansprakelijkheid)</I>, incorporated under Dutch law (the &#147;<U>Issuer</U>&#148;), promises to pay interest on the principal amount of this Note at 7.875% per annum, subject to adjustment as described in the paragraph below, from March&nbsp;9,
2023 until the principal thereof is paid or made available for payment. Interest shall be payable semi-annually in arrears on each March&nbsp;15 and September&nbsp;15 of each year (each an &#147;<U>Interest Payment Date</U>&#148;), commencing
September&nbsp;15, 2023. If an Interest Payment Date falls on a day that is not a Business Day, interest will be payable on the next succeeding Business Day with the same force and effect as if made on such Interest Payment Date and no interest
shall accrue thereon on account of such delay. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interest on the Notes shall be computed on the basis of a
<FONT STYLE="white-space:nowrap">360-day</FONT> year of twelve <FONT STYLE="white-space:nowrap">30-day</FONT> months. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A Holder of any
Note at the close of business on a Regular Record Date shall be entitled to receive interest on such Note on the corresponding Interest Payment Date. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Interest Rate Adjustment Upon Failure to Achieve Sustainability Performance Targets.</U>
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">From and including September&nbsp;15, 2026 (the <FONT STYLE="white-space:nowrap">&#147;Step-up</FONT> Date&#148;) the
Interest Rate payable on the Notes shall increase by: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(i) 0.100% per annum unless the Guarantor has achieved the Regulatory Submissions
Target as of the Testing Date; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(ii) 0.100% per annum unless the Guarantor has achieved the Product Volume Target as of the Testing Date;
and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(iii) 0.100% per annum unless the Guarantor has achieved the Emission Reduction Target as of the Testing Date; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">in each case, as certified by the Issuer or the Guarantor to the Trustee in an Officer&#146;s certificate (which shall include the Assurance Letter as an
exhibit thereto) on or prior to the Certification Date (subject to any clerical or administrative errors (including any delays resulting therefrom)); <I>provided</I> that, for the avoidance of doubt: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(A)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Interest Rate on the Notes shall not increase on the <FONT STYLE="white-space:nowrap">Step-up</FONT> Date
if the Guarantor has achieved the three Sustainability Performance Targets as of the Testing Date and certified to such on or prior to the Certification Date; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(B)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the increase in the Interest Rate on the Notes on the <FONT STYLE="white-space:nowrap">Step-up</FONT> Date
shall not exceed a total of 0.100% if the Guarantor has achieved two of the three Sustainability Performance Targets as of the Testing Date and certified to such on or prior to the Certification Date; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(C)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the increase in the Interest Rate on the Notes on the <FONT STYLE="white-space:nowrap">Step-up</FONT> Date
shall not exceed a total of 0.200% if the Guarantor has met one of the three Sustainability Performance Targets as of the Testing Date and certified to such on or prior to the Certification Date; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(D)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in no event shall the total increase in the Interest Rate on the Notes on the
<FONT STYLE="white-space:nowrap">Step-up</FONT> Date exceed 0.300% (this being the consequence of the Guarantor failing to achieve any of the three Sustainability Performance Targets on the Testing Date and failing to certify to achievement on or
prior to the Certification Date). </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Method of Payment.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interest on any Note which is payable, and is punctually paid or duly provided for, on any Interest Payment Date shall be paid to the person
in whose name that Note (or one or more Predecessor Notes) is registered at the close of business on the relevant Regular Record Date for such interest. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Payments on the Global Notes will be made through the Paying Agent. Payments on the Notes of this series will be made in Euros at the
specified office or agency of the Paying Agent; <I>provided that </I>all such payments with respect to Notes represented by one or more Global Notes deposited with and registered in the name of the Common Depositary or its nominee for the accounts
of Euroclear and Clearstream, will be by wire transfer of immediately available funds to the account specified in writing by the holder or holders thereof to the Common Depositary. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Paying Agent and Registrar.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Initially, The Bank of New York Mellon, the Trustee under the Supplemental Indenture, will act as Paying Agent and Registrar. The Issuer may
change the Paying Agent or Registrar without notice to any Holder. The Issuer has appointed The Bank of New York Mellon, London Branch, at 160 Queen Victoria Street, London EC4V 4LA, United Kingdom, as Paying Agent. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Supplemental Indentures and Indenture.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Issuer issued this Note under a Base Indenture (the &#147;<U>Base Indenture</U>&#148;), dated as of March&nbsp;14, 2018, by and among the
Issuer, the Guarantor and The Bank of New York Mellon, as trustee (the &#147;<U>Trustee</U>&#148;), as supplemented by a first supplemental senior indenture, dated as of March&nbsp;14, 2018, by and among the Issuer, the Guarantor, the Trustee and
The Bank of New York Mellon, London Branch, as paying agent (the &#147;<U>Paying Agent</U>&#148;), a second supplemental senior indenture, dated as of November&nbsp;25, 2019, by and among the Issuer, the Guarantor, the Trustee and the Paying Agent,
a third supplemental senior indenture, dated as of November&nbsp;9, 2021, by and among the Issuer, the Guarantor, the Trustee and the Paying Agent and as further supplemented by a fourth supplemental senior indenture (the &#147;<U>Supplemental
Indenture</U>&#148; and, together with the Base Indenture, the &#147;<U>Indenture</U>&#148;), dated as of March&nbsp;9, 2023, by and among the Issuer, the Guarantor, the Trustee and the Paying Agent. The terms of the Note include those stated in the
Indenture, and those made part of the Indenture by reference to the Trust Indenture Act of 1939, as amended (&#147;<U>TIA</U>&#148;). This Note is subject to all such terms, and Holders are referred to the Indenture and the TIA for a statement of
all such terms. To the extent permitted by applicable law, in the event of any inconsistency between the terms of this Note and the terms of the Indenture, the terms of the Indenture shall control. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Optional Redemption.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Issuer may at its option redeem this Note, in whole or in part, at any time or from time to time, on any date prior to the Stated
Maturity, upon notice as set forth in Section&nbsp;4.2 of the Supplemental Indenture, at a Redemption Price equal to the greater of (1) 100% of the principal amount of the Notes to be redeemed or (2)&nbsp;the sum of the present values of the
Remaining Scheduled Payments of the Notes being redeemed discounted, on a semi-annual basis (assuming a <FONT STYLE="white-space:nowrap">360-day</FONT> year consisting of twelve <FONT STYLE="white-space:nowrap">30-day</FONT> months), at the
applicable Reinvestment Rate, plus in each case accrued and unpaid interest thereon, if any, to, but not including, the Redemption Date; provided that if the Issuer redeems the Notes on or after the applicable Par Call Date, the Redemption Price for
such Notes will be equal to 100% of the aggregate principal amount of the Notes being redeemed, plus accrued and unpaid interest thereon, if any, to, but not including, the Redemption Date. On and after the Redemption Date, interest shall cease to
accrue on Notes or portions of Notes called for redemption, unless the Issuer defaults in the payment of the Redemption Price. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notice of redemption will be given by the Issuer to the Holders as provided in the
Supplemental Indenture. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">7.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Tax Redemption.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If, as a result of any change in or amendment to the laws (or any regulations or rulings promulgated thereunder) of any Taxing Jurisdiction or
any political subdivision or taxing authority thereof or in any Taxing Jurisdiction affecting taxation or any change in official position regarding the application or interpretation of such laws, regulations or rulings, which change or amendment
becomes effective or, in the case of a change in official position, is announced on or after the issuance of the Notes, the Issuer or the Guarantor (or any of their respective successors), as the case may be, is or will be obligated to pay any
Additional Tax Amount with respect to the Notes (of any series thereof), and if the Issuer or the Guarantor (or any of their respective successors), as the case may be, determines that such obligation cannot be avoided by the Issuer or the Guarantor
(or any of their respective successors), as the case may be, after taking reasonable measures available to it, then at the option of the Issuer or the Guarantor (or any of their respective successors), as the case may be, the Notes (of any series
thereof) may be redeemed in whole, but not in part, at any time, upon the giving not less than 10 days&#146; nor more than 60 days&#146; notice to the Trustee and the Holders of such Notes, at the Redemption Price; provided, however, that
(1)&nbsp;no notice of such tax redemption may be given earlier than 90 days prior to the earliest date on which the Issuer or the Guarantor (or their respective successors), as the case may be, would, but for such redemption, be obligated to pay
such Additional Tax Amounts were a payment on such Notes then due, and (2)&nbsp;at the time such notice is given, such obligation to pay such Additional Tax Amounts remains in effect. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">8.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Denominations; Transfer; Exchange.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes are issuable in registered form, without coupons, in minimum denominations of &#128;100,000 principal amount and integral multiples
of &#128;1,000 in excess of &#128;100,000. A Holder may register the transfer or exchange of Notes in accordance with the Indenture. The Issuer or the Trustee may require a Holder, among other things, to furnish appropriate endorsements and transfer
documents, and the Issuer may require a Holder to pay any taxes or other governmental charges that may be imposed in connection with any exchange or registration of transfer of Notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Issuer shall not be required to exchange or register a transfer of (a)&nbsp;any Note for a period of 15 days next preceding the first
delivery of notice of redemption of Notes to be redeemed, (b)&nbsp;any Notes selected, called or being called for redemption except, in the case of any Note where notice has been given that such Note is to be redeemed in part, the portion thereof
not so to be redeemed or (c)&nbsp;any Notes between a record date and the next succeeding payment date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event of redemption of the
Notes in part only, in the case of a Global Note, the aggregate principal amount of such Global Notes may be increased or decreased by adjustments made on the records of the Depositary or, if necessary, a new Note or Notes for the unredeemed portion
thereof will be issued in the name of the Holder hereof. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">9.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Holders to be Treated as Owners.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The registered Holder of this Note shall be treated as its owner for all purposes. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">10.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Unclaimed Money.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any moneys deposited with or paid to the Trustee or any Paying Agent for the payment of the principal of or interest on any Note and not
applied but remaining unclaimed for two years after the date upon which such principal or interest shall have become due and payable, shall, upon the written request of the Issuer and unless otherwise required by mandatory provisions of applicable
escheat or abandoned or unclaimed property law, be repaid to the Issuer by the Trustee or such Paying Agent, and the Holder of such Note shall, unless otherwise required by mandatory provisions of applicable escheat or abandoned or unclaimed
property laws, thereafter look only to the Issuer for any payment which such Holder may be entitled to collect, and all liability of the Trustee or any Paying Agent with respect to such moneys shall thereupon cease. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">11.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Satisfaction and Discharge.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Issuer and the Guarantor may satisfy and discharge their obligations under the Indenture while the Notes remain outstanding, if
(a)&nbsp;all Outstanding Notes have become due and payable at their scheduled Maturity, or (b)&nbsp;all Outstanding Notes have been called for redemption, and in either case, the Issuer has deposited with the Trustee an amount sufficient to pay and
discharge all Outstanding Notes on the date of their scheduled Maturity or the scheduled Redemption Date, as the case may be. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">12.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Supplement; Waiver.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Without notice to or the consent of the Holders of the Notes, the Indenture and the Notes may be amended, supplemented or otherwise modified
by the Issuer, the Guarantor and the Trustee as provided in the Indenture. The Indenture permits, with certain exceptions as therein provided, the amendment thereof and the modification of the rights and obligations of the Issuer and the rights of
the Holders of the Notes under the Indenture at any time by the Issuer and the Trustee with the consent of the Holders of a majority in aggregate principal amount of the Outstanding Notes (or such lesser amount as shall have acted at a meeting
pursuant to the provisions of the Indenture). The Indenture also contains provisions permitting the Holders of specified percentages in principal amount of the Notes at the time Outstanding, on behalf of the Holders of all the Notes, to waive
compliance by the Issuer with certain provisions of the Indenture and certain past defaults under the Indenture and their consequences. Any such consent or waiver by the Holder of this Note shall be conclusive and binding upon such Holder and upon
all future Holders of this Note and of any Note issued upon registration of transfer hereof or in exchange herefor or in lieu hereof, whether or not notation of such consent or waiver is made upon this Note or such other Note. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No reference herein to the Indenture and no provision of this Note or of the Indenture shall alter or impair the obligation of the Issuer,
which is absolute and unconditional, to pay the principal of and interest on this Note at the times, places and rate, and in the coin or currency, herein prescribed. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">13.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Defaults and Remedies.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Indenture provides that an Event of Default with respect to the Notes occurs when any of the following occurs: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) the Issuer defaults in the payment of the principal and premium, if any, of any of the Notes when it becomes due and payable at Maturity
or upon redemption; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) the Issuer defaults in the payment of interest (including Additional Tax Amounts, if any) on any of the Notes
when it becomes due and payable and such default continues for a period of 30 days after the date when due; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) the Guarantor fails to
perform its obligations under the Guarantees; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) except as permitted by the Indenture, the Guarantees is held in any final, <FONT
STYLE="white-space:nowrap">non-appealable</FONT> judicial proceeding to be unenforceable or invalid or shall cease for any reason to be in full force and effect or the Guarantor, or any person acting on behalf of the Guarantor, shall deny or
disaffirm its obligations under the Guarantees; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) either the Issuer or the Guarantor fails to perform or observe any other term,
covenant or agreement contained in the Notes or the Indenture and the default continues for a period of 60 days after written notice of such failure, requiring the Issuer or the Guarantor, as the case may be, to remedy the same, shall have been
given to the Issuer or the Guarantor, as the case may be, by the Trustee or to the Issuer or the Guarantor, as the case may be, and the Trustee by the Holders of at least 25% in aggregate principal amount
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of the Outstanding Notes (provided that such notice may not be given with respect to any action taken, and reported publicly or to holders of such series of the Notes, more than two years prior
to such notice; provided further that the trustee shall have no obligation to determine when or if any holders have been notified of any such action or to track when such <FONT STYLE="white-space:nowrap">two-year</FONT> period starts or concludes);
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) (i) the Issuer or the Guarantor fails to make by the end of the applicable grace period, if any, any payment of principal or interest
due in respect of any Indebtedness for borrowed money, the aggregate outstanding principal amount of which is an amount in excess of $250,000,000; or (ii)&nbsp;there is an acceleration of any Indebtedness for borrowed money in an amount in excess of
$250,000,000 because of a default with respect to such Indebtedness, without, in the case of either (i)&nbsp;or (ii) above, such Indebtedness having been discharged or such <FONT STYLE="white-space:nowrap">non-payment</FONT> or acceleration having
been cured, waived, rescinded or annulled for a period of 30 days after written notice to the Issuer by the Trustee or to the Issuer and the Trustee by the Holders of at least 25% in aggregate principal amount of the Outstanding Notes of such
series; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) the occurrence of certain events of bankruptcy, insolvency or reorganization of the Issuer or Guarantor as specified in
the Supplemental Indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If an Event of Default shall occur and be continuing, the principal of all the Notes may be declared due and
payable in the manner and with the effect provided in the Supplemental Indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any time period in this Supplemental Indenture, the
Base Indenture or the Notes to cure any actual or alleged default or event of default may be extended or stayed by a court of competent jurisdiction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the avoidance of doubt, failure to achieve one or more Sustainability Performance Targets shall not constitute a Default or an Event of
Default with respect to the Notes. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">14.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Authentication.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Note shall not be valid until the Trustee (or authenticating agent) executes the certificate of authentication on the other side of this
Note. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">15.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>ISIN Numbers and Common Codes.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Issuer has caused ISIN numbers and Common Codes to be printed on this Note and, therefore, the Trustee shall use ISIN numbers and Common
Codes in notices of redemption as a convenience to Holders. Any such notice may state that no representation is made as to the correctness of such numbers either as printed on the Notes or as contained in any notice of a redemption and that reliance
may be placed only on the other identification numbers printed on the Notes, and any such redemption shall not be affected by any defect in or omission of such numbers. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">16.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Governing Law.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Supplemental Indenture, the Base Indenture and this Note shall be governed by, and construed in accordance with, the laws of the State of
New York. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">17.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Successor Corporation.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event a successor corporation legal entity assumes all the obligations of the Issuer or the Guarantor under this Note, pursuant to the
terms hereof and of the Indenture, the Issuer or Guarantor, as the case may be, will be released from all such obligations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ASSIGNMENT FORM </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To assign this Note, fill in the form below and have your signature guaranteed: (I)&nbsp;or (we) assign and transfer this Note to: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="76%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">(Insert assignee&#146;s soc. sec. or tax I.D. no.)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">(Print or type assignee&#146;s name, address and zip code)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">and irrevocably appoint <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> to transfer this Note
on the books of the Issuer. The agent may substitute another to act for him. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="41%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="41%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Dated:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Your&nbsp;Name:&nbsp;&nbsp;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">(Print your name exactly as it appears on the face of this Note)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Your&nbsp;Signature:&nbsp;&nbsp;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">(Sign exactly as your name appears on the face of this Note)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Signature Guarantee<SUP STYLE="font-size:75%; vertical-align:top">*</SUP>:</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:75%; vertical-align:top">*</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Participant in a recognized Signature Guarantee Medallion Program (or other signature guarantor acceptable
to the Trustee).</I> </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SCHEDULE OF INCREASES OR DECREASES IN THE GLOBAL NOTE </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The initial outstanding principal amount of this Global Note is &#128;500,000,000. The following exchanges of a part of this Global Note for
an interest in another Global Note or for a Physical Note, or exchanges of a part of another Global Note or Physical Note for an interest in this Global Note, have been made: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="18%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="19%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="20%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="20%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="19%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Date of</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Exchange</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Amount of</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">decrease in</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Principal Amount</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">of this Global</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Note</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Amount of</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">increase in</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Principal Amount</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">of this Global</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Note</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Principal Amount</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">of this Global</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Note following</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">such decrease or</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">increase</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Signature of</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">authorized</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">signatory of</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Trustee</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-14 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.6
<SEQUENCE>3
<FILENAME>d475718dex46.htm
<DESCRIPTION>EX-4.6
<TEXT>
<HTML><HEAD>
<TITLE>EX-4.6</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 4.6 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:2.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:2.00pt solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">TEVA PHARMACEUTICAL FINANCE NETHERLANDS III B.V., </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">as Issuer, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">TEVA PHARMACEUTICAL
INDUSTRIES LIMITED, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">as Guarantor, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">THE BANK OF NEW YORK MELLON,
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">as Trustee </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">FOURTH
SUPPLEMENTAL SENIOR INDENTURE </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Dated as of March&nbsp;9, 2023 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">to the Senior Indenture dated as of March&nbsp;14, 2018 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Creating the
series of Securities (as defined herein) designated </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7.875% Sustainability-Linked Senior Notes due 2029 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8.125% Sustainability-Linked
Senior Notes due 2031 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:2.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:2.00pt solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="84%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD COLSPAN="3" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ARTICLE 1 DEFINITIONS AND INCORPORATION BY REFERENCE</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Definitions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Incorporation by Reference of Trust Indenture Act</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Rules of Construction</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ARTICLE 2 THE NOTES AND THE GUARANTEES</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>12</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Title and Terms</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Forms of Notes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Legends</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Form of Guarantee</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Book-Entry Provisions for the Global Notes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>[Reserved]</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Defaulted Interest</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Execution of Guarantees</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Add On Notes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>CUSIP and ISIN Numbers</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ARTICLE 3 ADDITIONAL COVENANTS</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>20</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Payment of Additional Tax Amounts</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Stamp Tax</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Corporate Existence</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Certificates of the Issuer and the Guarantor</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Guarantor To Be the Sole Equityholder of the Issuer</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Limitation on Liens</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Limitation on Sales and Leasebacks</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ARTICLE 4 REDEMPTION OF NOTES</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>23</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Optional Redemption</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Notice of Redemption</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Deposit of Redemption Price</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Tax Redemption</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ARTICLE 5 SATISFACTION AND DISCHARGE</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>24</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Satisfaction and Discharge</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ARTICLE 6 MISCELLANEOUS PROVISIONS</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>24</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Scope of Supplemental Indenture</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Provisions of Supplemental Indenture for the Sole Benefit of Parties and Holders of Notes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Successors and Assigns of Issuer and Guarantor Bound by Supplemental Indenture</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="83%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Notices and Demands on Issuer, Trustee and Holders of Notes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Officer&#146;s Certificates and Opinions of Counsel; Statements to be Contained Therein</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Payments Due on Saturdays, Sundays and Holidays</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Conflict of any Provisions of Supplemental Indenture with Trust Indenture Act of 1939</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>New York Law to Govern</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Counterparts</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Effect of Headings</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.11</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Submission to Jurisdiction</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.12</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Not Responsible for Recitals or Issuance of Securities</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.13</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Electronic Means</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ARTICLE 7 SUPPLEMENTAL INDENTURES</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>29</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Without Consent of Holders</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>With Consent of Each Affected Holder</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">EXHIBIT A - FORM OF 2029 NOTE</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">EXHIBIT B - FORM OF 2031 NOTE</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">FOURTH SUPPLEMENTAL SENIOR INDENTURE, dated as of March&nbsp;9, 2023, by and among Teva
Pharmaceutical Finance Netherlands III B.V., a private company with limited liability (<I>besloten vennootschap met beperkte aansprakelijkheid</I>), incorporated under Dutch law (the &#147;<U>Issuer</U>&#148;), Teva Pharmaceutical Industries
Limited, a corporation incorporated under the laws of Israel (the &#147;<U>Guarantor</U>&#148;) and The Bank of New York Mellon, a New York banking corporation, as trustee (the &#147;<U>Trustee</U>&#148;) </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>W I T N E S S E T H: </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Issuer has heretofore executed and delivered to the Trustee a Senior Indenture, dated as of March&nbsp;14, 2018 (the
&#147;<U>Base Indenture</U>&#148;), providing for the issuance from time to time of one or more series of its senior unsecured debentures, notes or other evidences of indebtedness (the &#147;<U>Securities</U>&#148;); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Issuer has heretofore executed and delivered to the Trustee a first supplemental senior indenture, dated as of March&nbsp;14,
2018, providing for the issuance of the 6.000% Senior Notes due 2024 and the 6.750% Senior Notes due 2028; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Issuer has
heretofore executed and delivered to the Trustee<STRIKE> </STRIKE>a second supplemental senior indenture, dated as of November&nbsp;25, 2019, providing for the issuance of the 7.125% Senior Notes due 2025; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Issuer has heretofore executed and delivered to the Trustee a third supplemental senior indenture, dated as of November&nbsp;9,
2021, providing for the issuance of the 4.750% Sustainability-Linked Senior Notes due 2027 and the 5.125% Sustainability-Linked Senior Notes due 2029; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, Section&nbsp;7.01(h) of the Base Indenture provides that the Issuer, the Guarantor and the Trustee may from time to time enter into
one or more indentures supplemental thereto to establish the form or terms of Securities of a new series; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Issuer, pursuant
to the foregoing authority, proposes in and by this fourth supplemental senior indenture (this &#147;<U>Supplemental Indenture</U>&#148; and, together with the Base Indenture, the &#147;<U>Indenture</U>&#148;) to amend and supplement the Base
Indenture insofar as it will apply only to the 7.875% Sustainability-Linked Senior Notes due 2029 (the &#147;<U>2029 </U><U>Notes</U>&#148;) and the 8.125% Sustainability-Linked Senior Notes due 2031 (the &#147;<U>2031 Notes</U>&#148;) issued
hereunder (and not to any other series of Securities). Unless the context otherwise suggests, the 2029 Notes and the 2031 Notes are collectively referred to as the &#147;<U>Notes</U>&#148;; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, all things necessary have been done to make the Notes, when executed by the Issuer and authenticated and delivered hereunder and duly
issued by the Issuer, the valid obligations of the Issuer, and to make this Supplemental Indenture a valid and legally binding agreement of the Issuer, in accordance with their and its terms; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, THIS SUPPLEMENTAL INDENTURE WITNESSETH: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For and in consideration of the premises and the purchases of the Notes by the holders thereof, the Issuer, the Guarantor and the Trustee
mutually covenant and agree for the equal and proportionate benefit of the respective Holders from time to time of the Notes as follows: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DEFINITIONS AND INCORPORATION BY REFERENCE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.1 <U>Definitions.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Capitalized terms used herein but not defined shall have the meanings assigned to them in the Base Indenture unless otherwise indicated. For
all purposes of this Supplemental Indenture and the Notes, the following terms are defined as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Add On Notes</U>&#148;
means any notes originally issued after the date hereof pursuant to Section&nbsp;2.9, including any replacement notes as specified in the relevant Add On Note Board Resolutions, Officer&#146;s Certificate or supplemental indenture issued therefor in
accordance with the Base Indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Additional Tax Amounts</U>&#148; has the meaning specified in Section&nbsp;3.1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Affiliate</U>&#148; means, with respect to a specified Person, another Person that directly, or indirectly through one or more
intermediaries, Controls or is Controlled by or is under common Control with the Person specified. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Agent Members</U>&#148; has
the meaning specified in Section&nbsp;2.5. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Assurance Letter</U>&#148; means one or more assurance letters from an External
Reviewer confirming whether one or more of the Sustainability Performance Targets have been met. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Authorized Agent</U>&#148; has
the meaning specified in Section<U>&nbsp;6.11</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Authorized Officers</U>&#148; has the meaning specified in Section&nbsp;6.13.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Business Day</U>&#148; means a day other than (i)&nbsp;a Saturday or Sunday, (ii)<U></U>&nbsp;a day on which banks in New York,
New York are authorized or obligated by law or executive order to remain closed or (iii)<U></U>&nbsp;a day on which the Corporate Trust Office is closed for business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Capital Stock</U>&#148; means: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in the case of a corporation, corporate stock; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in the case of an association or business entity, any and all shares, interests, participations, rights or
other equivalents (however designated) of corporate stock; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in the case of a partnership or limited liability company, partnership or membership interests (whether general
or limited); and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any other interest or participation that confers on a Person the right to receive a share of the profits and
losses of, or distributions of assets of, the issuing Person. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Certification Date</U>&#148; means June&nbsp;30,
2026. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Clearstream</U>&#148; means Clearstream Banking, S.A. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Comparable Treasury Issue</U>&#148; means the United States Treasury security selected by an Independent Investment Banker as having
a maturity comparable to the remaining term to the Par Call Date of the applicable series of Notes to be redeemed that would be utilized, at the time of selection and in accordance with customary financial practice, in pricing new issues of
corporate debt securities of comparable maturity to the remaining term to the Par Call Date of such series of Notes. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Comparable Treasury Price</U>&#148; means, with respect to any Redemption Date,
(1)&nbsp;the average of the Reference Treasury Dealer Quotations for such Redemption Date after excluding the highest and lowest of such Reference Treasury Dealer Quotations or (2)<U></U>&nbsp;if the Independent Investment Banker obtains fewer than
five such Reference Treasury Dealer Quotations, the average of all such quotations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Consolidated Net Worth</U>&#148; means the
stockholders&#146; equity of the Guarantor and its consolidated subsidiaries, as shown on the audited consolidated balance sheet of the Guarantor&#146;s latest annual report to stockholders, prepared in accordance with GAAP. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Control</U>&#148; means the possession, directly or indirectly, of the power to direct or cause the direction of the management or
policies of a Person, whether through the ability to exercise voting power, by contract or otherwise. &#147;<U>Controlling</U>&#148; and &#147;<U>Controlled</U>&#148; have meanings correlative thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Corporate Trust Office</U>&#148; means the office of the Trustee located in The City of New York at which at any particular time its
corporate trust business shall be administered (which at the date of this Supplemental Indenture is located at 240 Greenwich Street, 7th Floor East, New York, New York 10286, Attention: Corporate Trust) or such other address as the Trustee may
designate from time to time by notice to the Holders and the Issuer, or the principal corporate trust office of any successor Trustee (or such other address as such successor Trustee may designate from time to time by notice to the Holders and the
Issuer). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>corporation</U>&#148; means corporations, associations, limited liability companies, companies and business trusts or
any other similar entity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Custodian</U>&#148; means the Trustee, as custodian for the Depositary with respect to the Notes in
global form, or any successor entity thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Default</U>&#148; means an event which is, or after notice or lapse of time or
both would be, an Event of Default. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Defaulted Interest</U>&#148; has the meaning specified in Section&nbsp;2.7. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Electronic Means</U>&#148; has the meaning specified in Section&nbsp;6.13. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>&#147;</U><U>Depositary</U>&#148; means The Depository Trust Company, its nominees and their respective successors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Emission Reduction Target</U>&#148; means the Guarantor&#146;s target to reduce the Scope 1 and 2 greenhouse gas (GHG) emissions by
no less than 25% as of the Testing Date (measured on a calendar year basis and compared to the 2019 baseline); <I>provided</I>, <I>however</I>, that for purposes of determining if the Emission Reduction Target has been attained, the Guarantor and
its consolidated subsidiaries may calculate greenhouse gas emissions attributable to any single or related series of acquisitions or divestitures completed since the issue date of the Notes as contemplated by The Greenhouse Gas Protocol or other
generally accepted protocol or standard for calculating such emissions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Euroclear</U>&#148; means Euroclear Bank S.A./N.V. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Event of Default</U>&#148; with respect to the Notes of each series shall not have the meaning assigned to such term by
Section&nbsp;4.01 of the Base Indenture. An Event of Default with respect to the Notes of each series means each one of the following events which shall have occurred and be continuing (whatever the reason for such Event of Default and whether it
shall be voluntary or involuntary or be effected by operation of law or pursuant to any judgment, decree or order of any court or any order, rule or regulation of any administrative or governmental body): </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) the Issuer defaults in the payment of the principal and premium, if any, of any of the
Notes of such series when it becomes due and payable at Maturity or upon redemption; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) the Issuer defaults in the payment of interest
(including Additional Tax Amounts, if any) on any of the Notes of such series when it becomes due and payable and such default continues for a period of 30 days after the date when due; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) the Guarantor fails to perform its obligations under the Guarantees relating to the Notes of such series; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) except as permitted by the Indenture, the Guarantees with respect to such series of Notes is held in any final, <FONT
STYLE="white-space:nowrap">non-appealable</FONT> judicial proceeding to be unenforceable or invalid or shall cease for any reason to be in full force and effect or the Guarantor, or any Person acting on behalf of the Guarantor, shall deny or
disaffirm its obligations under the Guarantees; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) either the Issuer or the Guarantor fails to perform or observe any other term,
covenant or agreement contained in the relevant Notes of such series or this Supplemental Indenture or the Base Indenture and the default continues for a period of 60 days after written notice of such failure, requiring the Issuer or the Guarantor,
as the case may be, to remedy the same, shall have been given to the Issuer or the Guarantor, as the case may be, by the Trustee or to the Issuer or the Guarantor, as the case may be, and the Trustee by the Holders of at least 25% in aggregate
principal amount of the Outstanding Notes of such series (provided that such notice may not be given with respect to any action taken, and reported publicly or to holders of such series of the Notes, more than two years prior to such notice;
provided further that the trustee shall have no obligation to determine when or if any holders have been notified of any such action or to track when such <FONT STYLE="white-space:nowrap">two-year</FONT> period starts or concludes); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) (i) the Issuer or the Guarantor fails to make by the end of the applicable grace period, if any, any payment of principal or interest due
in respect of any Indebtedness for borrowed money, the aggregate outstanding principal amount of which is an amount in excess of $250,000,000; or (ii)&nbsp;there is an acceleration of any Indebtedness for borrowed money in an amount in excess of
$250,000,000 because of a default with respect to such Indebtedness, without, in the case of either (i)&nbsp;or (ii) above, such Indebtedness having been discharged or such <FONT STYLE="white-space:nowrap">non-payment</FONT> or acceleration having
been cured, waived, rescinded or annulled, for a period of 30 days after written notice to the Issuer by the Trustee or to the Issuer and the Trustee by the Holders of at least 25% in aggregate principal amount of the Outstanding Notes of such
series; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) the entry by a court having jurisdiction in the premises of (i)&nbsp;a decree or order for relief in respect of the Issuer or
the Guarantor in an involuntary case or proceeding under any applicable U.S. federal or state bankruptcy, insolvency, reorganization or other similar law or (ii)&nbsp;a decree or order adjudging the Issuer or the Guarantor as bankrupt or insolvent,
or approving as properly filed a petition seeking reorganization, arrangement, adjustment or composition of or in respect of the Issuer or the Guarantor under any applicable U.S. federal or state law, or appointing a custodian, receiver, liquidator,
assignee, trustee, sequestrator or other similar official of the Issuer or the Guarantor or of any substantial part of its property, or ordering the winding up or liquidation of its affairs, and the continuance of any such decree or order for relief
or any such other decree or order unstayed and in effect for a period of 60 consecutive days; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) the commencement by the Issuer or
the Guarantor of a voluntary case or proceeding under any applicable U.S. federal or state bankruptcy, insolvency, reorganization or other similar law or of any other case or proceeding to be adjudicated as bankrupt or insolvent, or the consent by
the Issuer to the entry of a decree or order for relief in respect of the Issuer or the Guarantor in an involuntary case or proceeding under any applicable U.S. federal or state bankruptcy, insolvency, reorganization or other
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
similar law or to the commencement of any bankruptcy or insolvency case or proceeding against the Issuer or the Guarantor, or the filing by the Issuer or the Guarantor of a petition or answer or
consent seeking reorganization or relief under any applicable U.S. federal or state law, or the consent by the Issuer or the Guarantor to the filing of such petition or to the appointment of or the taking possession by a custodian, receiver,
liquidator, assignee, trustee, sequestrator or other similar official of the Issuer or the Guarantor or of any substantial part of its property, or the making by the Issuer or the Guarantor of an assignment for the benefit of creditors, or the
admission by the Issuer or the Guarantor in writing of its inability to pay its debts generally as they become due, or the taking of corporate action by the Issuer or the Guarantor expressly in furtherance of any such action. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as otherwise provided herein, with respect to the Notes, the references in Section&nbsp;4.01 of the Base Indenture to &#147;clauses
4.01(a), 4.01(b), 4.01(c) or 4.01(f) above&#148; shall be construed as references to clauses (a), (b), (c), (d), (e) or (f)&nbsp;of this definition and references to Sections 4.01(d) and (e)&nbsp;in the Base Indenture shall be construed as
references to clauses (g)&nbsp;and (h) of this definition. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any time period in this Supplemental Indenture, the Base Indenture or the
Notes to cure any actual or alleged default or event of default may be extended or stayed by a court of competent jurisdiction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the
avoidance of doubt, failure to achieve one or more Sustainability Performance Targets shall not constitute a Default or an Event of Default with respect to the Notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Exchange Act</U>&#148; means the Securities Exchange Act of 1934, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>External Reviewer</U>&#148; means a qualified provider of third-party assurance or attestation services appointed by the Issuer, the
Guarantor or one of the Guarantor&#146;s other subsidiaries to review the Guarantor&#146;s performance in connection with achieving the Sustainability Performance Targets. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>GAAP</U>&#148; has the meaning given to &#147;generally accepted accounting principles&#148; in the Base Indenture; <I>provided</I>,
<I>however</I>, that any change in GAAP that would cause the Guarantor to record an existing item as a liability upon that entity&#146;s balance sheet, which item was not previously required by GAAP to be so recorded, shall not constitute an
incurrence of Indebtedness for purposes of this Supplemental Indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Global Note</U>&#148; has the meaning specified in
Section&nbsp;2.2(b). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>guarantee</U>&#148; means any obligation, contingent or otherwise, of any Person, directly or indirectly
guaranteeing any Indebtedness of any other Person and any obligation, direct or indirect, contingent or otherwise, of such Person: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to purchase or pay (or advance or supply funds for the purchase or payment of) such Indebtedness of such other
Person (whether arising by virtue of partnership arrangements, or by agreement to keep-well, to purchase assets, goods, securities or services, to <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">take-or-pay,</FONT></FONT> or
maintain financial statement conditions or otherwise); or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">entered into for purposes of assuring in any other manner the obligee of such Indebtedness of the payment
thereof or to protect such obligee against loss in respect thereof (in whole or in part); <I>provided</I>, <I>however</I>, that the term &#147;guarantee&#148; will not include endorsements for collection or deposit in the ordinary course of
business. The term &#147;guarantee&#148; used as a verb has a corresponding meaning. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Guarantees</U>&#148;
means the guarantees of the Guarantor in respect of the Notes in the form provided in Section&nbsp;2.4. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Guarantor</U>&#148; means Teva Pharmaceutical Industries Limited, a corporation
incorporated under the laws of Israel, until a successor Person shall have become such pursuant to the applicable provisions of the Indenture, and thereafter &#147;Guarantor&#148; shall mean such successor Person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Holder</U>,&#148; &#147;<U>Holder of Notes</U>&#148; or other similar terms means the registered holder of any Note. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Indebtedness</U>&#148; means, with respect to any Person any liability for borrowed money which, in accordance with GAAP, would be
reflected on the balance sheet of such Person as a liability on the date as of which Indebtedness is to be determined, other than accounts payable or any other indebtedness to trade creditors created or assumed by such Person in the ordinary course
of business in connection with the obtaining of materials or services. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Independent Investment Banker</U>&#148; means one of the
Reference Treasury Dealers appointed by the Issuer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Instructions</U>&#148; has the meaning specified in Section&nbsp;6.13. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Interest Payment Date</U>&#148; means each of March&nbsp;15 and September&nbsp;15 of each year, beginning September&nbsp;15, 2023;
provided, however, in each case, that if any such date is not a Business Day, the payment shall be made on the next succeeding Business Day with the same force and effect as if made on such Interest Payment Date and no interest shall accrue thereon
on account of such delay. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Interest Rate</U>&#148; means 7.875% per annum for the 2029 Notes and 8.125% per annum for the 2031
Notes; <I>provided</I> that, the interest rate on the Notes shall be subject to adjustment as described in Section&nbsp;2.1(c)(1). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Issuer</U>&#148; means Teva Pharmaceutical Finance Netherlands III B.V., a private company with limited liability (<I>besloten
vennootschap met beperkte aansprakelijkheid</I>), incorporated under Dutch law, until a successor Person shall have become such pursuant to the applicable provisions of the Indenture, and thereafter &#147;Issuer&#148; shall mean such successor
Person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Issuer Order</U>&#148; means a written order signed in the name of the Issuer by any Officer of the Issuer or a duly
authorized <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Attorney-in-Fact</FONT></FONT> of the Issuer, and delivered to the Trustee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Lien</U>&#148; means, with respect to any asset, any mortgage, lien, pledge, charge, security interest or encumbrance of any kind in
respect of such asset, whether or not filed, recorded or otherwise perfected under applicable law, including any conditional sale or other title retention agreement, any lease in the nature thereof, any option or other agreement to give a security
interest in and any filing of or agreement to give any financing statement under the Uniform Commercial Code (or equivalent statutes) of any jurisdiction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Maturity</U>&#148; means the date on which the principal of the Notes of a given series becomes due and payable as therein or herein
provided, whether at the Stated Maturity or by acceleration, call for redemption or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Note</U>&#148; or
&#147;<U>Notes</U>&#148; has the meaning specified to it in the sixth recital paragraph of this Supplemental Indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Officer</U>&#148; has the meaning given to &#147;Officer&#148; in the Base Indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Par Call Date</U>&#148; means (i)&nbsp;with respect to the 2029 Notes June&nbsp;15, 2029 (the date that is three months prior to the
Stated Maturity of such Notes) and (ii)&nbsp;with respect to the 2031 Notes June&nbsp;15, 2031<U> </U>(the date that is three months prior to the Stated Maturity of such Notes). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Paying Agent</U>&#148; means an office or agency where Notes may be presented for
payment. The term &#147;Paying Agent&#148; includes any additional paying agent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Permitted Liens</U>&#148; means: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Liens existing as of the date when the Issuer first issues such series of Notes pursuant to this Supplemental
Indenture; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Liens on property created, incurred or assumed prior to, at the time of or within one year after the date of
acquisition, completion of construction or completion of improvement of such property to secure all or part of the cost of acquiring, constructing or improving all or any part of such property; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">landlord&#146;s, warehousemen&#146;s, material men&#146;s, carriers&#146;, workmen&#146;s, repairmen&#146;s and
other like Liens arising in the ordinary course of business in respect of obligations which are not overdue or which are being contested in good faith in appropriate proceedings; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">deposits or Liens to secure the performance of bids, trade contracts, leases, statutory obligations, surety and
appeal bonds, performance bonds and other obligations of a like nature, in each case in the ordinary course of business; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Liens existing on any property of any Person at the time such Person became or becomes a subsidiary of the
Guarantor (provided that the Lien has not been created or assumed in contemplation of such Person becoming a subsidiary of the Guarantor); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Liens securing debt owing by a subsidiary to the Guarantor or to one or more of its subsidiaries;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">purchase money Liens upon or in any real property or equipment acquired by the Guarantor or any of its
subsidiaries in the ordinary course of business to secure the purchase price of such property or equipment, or Liens existing on such property or equipment at the time of its acquisition (other than any such Liens created in contemplation of such
acquisition that were not incurred to finance the acquisition of such property), provided, however, that no such Liens shall extend to or cover any properties of any character other than the real property or equipment being acquired;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Liens securing capital lease obligations in respect of property acquired; provided that no such Lien shall
extend to or cover any assets other than the assets subject to such capitalized leases; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Liens in favor of any governmental authority of any jurisdiction securing the obligation of the Guarantor or
any of its subsidiaries pursuant to any contract or payment owed to that entity pursuant to applicable laws, regulations or statutes; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(10)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Liens over any Receivable Assets subject to a Qualified Securitization Transaction; provided that the aggregate
fair market value of all Receivable Assets secured in accordance with this subclause (10)&nbsp;shall not exceed US $2,500,000,000 (or its equivalent in another currency or currencies) at any one time outstanding; or </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(11)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any extension, renewal, substitution or replacement (or successive extensions, renewals, substitutions or
replacements), as a whole or in part, of any Lien referred to in the foregoing clauses (1)&nbsp;to (<U>10</U>), inclusive, or the Indebtedness secured thereby; <U>provided</U>, <U>however</U>, that (i)&nbsp;the principal amount of Indebtedness
secured thereby and not otherwise authorized by said clauses (1)&nbsp;to (10), inclusive, shall not exceed the principal amount of Indebtedness so secured at the time of such extension, renewal, substitution or replacement; and (ii)&nbsp;any such
extension, renewal, substitution or replacement Lien shall be limited to the property covered by the Lien extended, renewed, substituted or replaced (other than improvements thereon or replacements thereof). </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Person</U>&#148; means any individual, corporation, partnership, joint venture, association, joint-stock company, trust,
unincorporated organization, limited liability company or government or political subdivision thereof or any other entity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Physical Notes</U>&#148; means Notes issued in definitive, fully registered form without interest coupons, substantially in the form
of Exhibits <FONT STYLE="white-space:nowrap">A-1</FONT> - <FONT STYLE="white-space:nowrap">A-6</FONT> hereto (&#147;Exhibit A&#148;) and Exhibits <FONT STYLE="white-space:nowrap">B-1</FONT> - <FONT STYLE="white-space:nowrap">B-6</FONT> hereto
(&#147;Exhibit B&#148;), as applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Product Volume Target</U>&#148; means the Guarantor&#146;s target to increase access to
medicine program product volume by 150% in the year ending December&nbsp;31, 2025 compared to the year ending December&nbsp;31, 2020 through four access to medicine programs, including donations and social business in
<FONT STYLE="white-space:nowrap">low-</FONT> and middle-income countries (LMICs) on the World Health Organization&#146;s essential medicines list (WHO EML) across six key TAs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Primary Treasury Dealer</U>&#148; has the meaning assigned to it in the definition of Reference Treasury Dealer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Qualified Securitization Transaction</U>&#148; means any transaction or series of transactions entered into by the Guarantor or any
of its subsidiaries pursuant to which the Guarantor or such subsidiary sells, conveys or otherwise transfers to a Securitization Entity, or grants a security interest in for the benefit of a Securitization Entity, any Receivable Assets (whether now
existing or arising or acquired in the future), or otherwise contributes to the capital of such Securitization Entity, in a transaction in which such Securitization Entity finances its acquisition of or interest in such Receivable Assets by selling
or borrowing against such Receivable Assets; provided that such transaction is non-recourse to the Guarantor and its subsidiaries (except for Standard Securitization Undertakings). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Receivable Assets</U>&#148; means ordinary course of business accounts receivable of the Guarantor or any of its subsidiaries, and
any assets related thereto, including, without limitation, all collateral securing such accounts receivable, all contracts and contract rights and all guarantees or other obligations in respect of such accounts receivable, proceeds of such accounts
receivable and other assets (including contract rights) which are customarily transferred or in respect of which security interests are customarily granted in connection with asset securitization transactions involving accounts receivable and/or
receivables discount without recourse schemes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Record Date</U>&#148; means either a Regular Record Date or a Special Record
Date, as the case may be. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Redemption Date</U>,&#148; when used with respect to any Note<U>s</U> of any series to be redeemed,
means the date fixed for such redemption. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Redemption Price</U>&#148; when used (a)&nbsp;with respect to any Notes of any series
to be redeemed pursuant to Section&nbsp;4.1 of this Supplemental Indenture, means an amount that is equal to the greater of (i) 100% of the principal amount of the Notes of such series to be redeemed or (ii)&nbsp;the sum of the present values of the
Remaining Scheduled Payments of the Notes of such series being redeemed discounted, on a semi-annual basis (assuming a <FONT STYLE="white-space:nowrap">360-day</FONT> year consisting of twelve <FONT STYLE="white-space:nowrap">30-day</FONT> months),
using a discount rate equal to the sum of the Treasury Rate plus 50 basis points, in the case of the 2029 Notes, and 50 basis points, in the case of the 2031 Notes, plus in each case accrued and unpaid interest thereon, if any, to, but
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
not including, the Redemption Date, provided that if the Redemption Date is on or after the applicable Par Call Date with respect to any series of Notes, the Redemption Price for such Notes will
be equal to 100% of the aggregate principal amount of such Notes being redeemed, plus accrued and unpaid interest thereon, if any, to, but not including, the Redemption Date; and (b)&nbsp;with respect to any Notes of such series to be redeemed
pursuant to Section&nbsp;4.4 of this Supplemental Indenture, means an amount that is equal to 100% of the principal amount thereof, plus accrued and unpaid interest thereon, if any, to, but not including, the Redemption Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Reference Treasury Dealer</U>&#148; means (i)<U></U>&nbsp;each of Citigroup Global Markets Inc., Goldman Sachs Bank Europe SE and
Mizuho Securities USA LLC and (ii)<U></U>&nbsp;a Primary Treasury Dealer selected by PNC Capital Markets LLC and MUFG Securities Americas Inc., or, in each case, their respective affiliates or successors, each of which is a primary U.S. Government
securities dealer in the United States. If any of the foregoing shall cease to be a Primary Treasury Dealer or is unable or unwilling to provide such services, the Issuer will substitute another nationally recognized investment banking firm that is
a Primary Treasury Dealer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Reference Treasury Dealer Quotations</U>&#148; means, with respect to each Reference Treasury Dealer
and any Redemption Date, the average, as determined by the Independent Investment Banker, of the bid and asked prices for the Comparable Treasury Issue (expressed in each case as a percentage of its principal amount) quoted in writing to the
Independent Investment Banker by such Reference Treasury Dealer at 3:30 p.m., New York City time, on the third Business Day preceding such Redemption Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Registrar</U>&#148; means the office or agency where Notes may be presented for registration of transfer or for exchange. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Regulatory Submissions Target</U>&#148; means the Guarantor&#146;s target to increase the cumulative number of new regulatory
submissions made by the Guarantor and its subsidiaries in <FONT STYLE="white-space:nowrap">low-</FONT> and middle-income countries (LMIC) as designated by the World Bank as of June 2020 and on the World Health Organization&#146;s essential medicines
list (WHO EML) as of September 2021 within the therapeutic areas of cardiovascular diseases, pediatric oncology, respiratory diseases, diabetes, mental health and pain/palliative care by 150% in the four-year period ending December&nbsp;31, 2025
compared to the four-year period ended December&nbsp;31, 2020. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Regular Record Date</U>&#148; means the close of business on the
preceding March&nbsp;1 and September<U></U>&nbsp;1, in each case whether or not a Business Day. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Remaining Scheduled
Payments</U>&#148; means, with respect to each Note to be redeemed, the remaining scheduled payments of principal of and interest on such Note as if redeemed on the applicable Par Call Date, determined at the interest rate to be applicable on such
redemption date. If the applicable Redemption Date is not an Interest Payment Date with respect to such Note, the amount of the next succeeding scheduled interest payment on such Note will be reduced by the amount of interest accrued on such Note to
such Redemption Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Sale-Leaseback Transaction</U>&#148; means the sale or transfer by the Guarantor or any subsidiary of any
property to a Person and the taking back by the Guarantor or any subsidiary, as the case may be, of a lease of such property. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Securities Act</U>&#148; means the Securities Act of 1933, as amended. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Securitization Entity</U>&#148; means a Person (which may include a special purpose
vehicle and/or a financial institution) to which the Guarantor or any subsidiary transfers Receivable Assets for purposes of a securitization financing, and with respect to which: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">no portion of the Indebtedness or any other obligations (contingent or otherwise) of such entity (i)&nbsp;is
guaranteed by the Guarantor or any subsidiary of the Guarantor (other than the Securitization Entity) (excluding guarantees of obligations (other than the principal of, and interest on, Indebtedness) pursuant to Standard Securitization
Undertakings), (ii) is recourse to or obligates the Guarantor or any subsidiary of the Guarantor (other than the Securitization Entity) in any way other than pursuant to Standard Securitization Undertakings or (iii)&nbsp;subjects any asset of the
Guarantor or any subsidiary of the Guarantor (other than the Securitization Entity), directly or indirectly, contingently or otherwise, to the satisfaction thereof, other than pursuant to Standard Securitization Undertakings and other than any
interest in the Receivable Assets (whether in the form of an equity interest in such assets or subordinated indebtedness payable primarily from such financed assets) retained or acquired by the Guarantor or any subsidiary of the Guarantor;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">neither the Guarantor nor any subsidiary of the Guarantor has any material contract, agreement, arrangement or
understanding other than on terms no less favorable to the Guarantor or such subsidiary than those that might be obtained at the time from Persons that are not Affiliates of the Guarantor, other than fees payable in the ordinary course of business
in connection with servicing receivables of such entity; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">neither the Guarantor nor any subsidiary of the Guarantor has any obligation to maintain or preserve such
entity&#146;s financial condition or cause such entity to achieve certain levels of operating results (it being understood that (i)&nbsp;obligations of the Guarantor or other subsidiaries to transfer Receivable Assets to the Securitization Entity,
(ii)&nbsp;obligations of the Guarantor or any other subsidiary to procure such transfers of Receivable Assets to the Securitization Entity, and (iii)&nbsp;Receivable Asset performance measures or credit enhancement measures shall not constitute an
obligation to preserve the Securitization Entity&#146;s financial condition or to cause it to achieve certain levels of operating results). </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Special Record Date</U>&#148; for the payment of any Defaulted Interest means a date fixed by the Trustee pursuant to
Section&nbsp;2.7. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Standard Securitization Undertakings</U>&#148; means representations, warranties, covenants and indemnities
reasonably customary (as determined by the Guarantor acting in good faith) in accounts receivable securitization transactions and/or receivables discount without recourse schemes in the applicable jurisdictions, including, to the extent applicable,
in a manner consistent with the delivery of a &#147;true sale&#148;/&#147;absolute transfer&#148; opinion with respect to any transfer by the Guarantor or any Subsidiary. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Stated Maturity</U>&#148; means the date specified in any Note as the fixed date for the payment of principal on such Note. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>subsidiary</U>&#148; means, with respect to any Person, a corporation more than 50% of the outstanding voting stock of which is
owned, directly or indirectly, by such Person or by one or more other subsidiaries, or by such Person and one or more other subsidiaries. For the purposes of this definition only, &#147;voting stock&#148; means stock which ordinarily has voting
power for the election of directors, whether at all times or only so long as no senior class of stock has such voting power by reason of any contingency. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Sustainability Performance Targets</U>&#148; means, collectively, the Product Volume Target, the Regulatory Submissions Target and
the Emissions Reduction Target; <I>provided</I>, <I>however</I>, that for purposes of determining if any Sustainability Performance Target has been achieved, the Guarantor and its consolidated subsidiaries may exclude the impact of (i)&nbsp;any
amendment to, or change in, any applicable laws, regulations, rules, guidelines, standards and policies applicable or relating to the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
business, operations or properties of the Guarantor and its consolidated subsidiaries following the issue date of the Notes, including with respect to the measurement or calculation of any of the
Sustainability Performance Targets or (ii)&nbsp;any <I>force majeure</I>, extraordinary or exceptional events or circumstances, including the occurrence of such events or circumstances with respect to any governmental,
<FONT STYLE="white-space:nowrap">non-governmental</FONT> or healthcare organization whose participation, involvement or functioning is necessary, appropriate or, as of the date of this offering, anticipated, for the achievement of the Sustainability
Performance Targets (including but not limited to <FONT STYLE="white-space:nowrap">geo-political</FONT> instability, poor governance practices or the failure of local infrastructure (including physical or social infrastructure or supranational,
national, state, provincial or local governance)). If a Sustainability Performance Target is not achieved as a result of the occurrence of any of the foregoing described in the proviso to the immediately preceding sentence, as determined by the
Guarantor in its reasonable judgment, such Sustainability Performance Target will be deemed to have been achieved for purposes of this Supplemental Indenture and no interest rate adjustment shall result from the failure to achieve such
Sustainability Performance Target. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Taxing Jurisdiction</U>&#148; means, with respect to the Notes, The Netherlands, Israel or
any jurisdiction where a successor to the Issuer or the Guarantor is incorporated or organized or considered to be a resident, if other than The Netherlands or Israel, respectively, or any jurisdiction through which payments will be made. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Testing Date</U>&#148; means December&nbsp;31, 2025. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>TIA</U>&#148; means the Trust Indenture Act of 1939, as amended, as in effect on the date of this Supplemental Indenture; provided,
however, that in the event the TIA is amended after such date, &#147;TIA&#148; means, to the extent such amendment is applicable to this Supplemental Indenture and the Base Indenture, the Trust Indenture Act of 1939, as so amended, or any successor
statute. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Treasury Rate</U>&#148; means, with respect to any Redemption Date, the rate per year equal to the semi-annual
equivalent yield to maturity (computed as of the second Business Day immediately preceding such Redemption Date) of the Comparable Treasury Issue, assuming a price for the Comparable Treasury Issue (expressed as a percentage of its principal amount)
equal to the Comparable Treasury Price for such Redemption Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Trustee</U>&#148; means The Bank of New York Mellon, a New York
banking corporation, until a successor Trustee shall have become such pursuant to the applicable provisions of this Supplemental Indenture, and thereafter &#147;Trustee&#148; shall mean such successor Trustee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Underwriting Agreement</U>&#148; means the Underwriting Agreement, dated March&nbsp;1, 2023, among the Issuer, Teva Pharmaceutical
Finance Netherlands <U>II</U> B.V., the Guarantor and the underwriters named in Schedule I thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>U.S. Dolla</U><U>r</U>&#148;
means the coin or currency of the United States of America as at the time of payment is legal tender for the payment of public and private debts. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.2 <U>Incorporation by Reference of Trust Indenture Act</U><U>.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Whenever the Indenture refers to a provision of the TIA, the provision is incorporated by reference in and made a part of this Supplemental
Indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following TIA terms used in the Indenture have the following meanings: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>indenture securities</U>&#148; means the Notes of each series and the Guarantees; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>obligor</U>&#148; on the Notes of each series means the Issuer and on the
Guarantees means the Guarantor and any other obligor on the indenture securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All other TIA terms used in this Supplemental Indenture
that are defined by the TIA, defined by TIA reference to another statute or defined by SEC rule have the meanings assigned to them by such definitions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.3 <U>Rules of Construction</U><U>.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For all purposes of this Supplemental Indenture, except as otherwise expressly provided or unless the context otherwise requires: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) the terms defined in this Article have the meanings assigned to them in this Article and include the plural as well as the
singular; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) all accounting terms not otherwise defined herein have the meanings assigned to them under GAAP; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) the words &#147;herein,&#148; &#147;hereof&#148; and &#147;hereunder&#148; and other words of similar import refer to this
Supplemental Indenture as a whole and not to any particular Article, Section or other subdivision. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 2 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE NOTES AND THE GUARANTEES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.1 <U>Title and Terms</U><U>.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The 2029 Notes and 2031 Notes shall be known and designated as the &#147;7.875% Sustainability-Linked Senior Notes due 2029&#148; and the
&#147;8.125% Sustainability-Linked Senior Notes due 2031&#148; of the Issuer, respectively. The aggregate principal amount that may be authenticated and delivered under this Supplemental Indenture of (i)&nbsp;the 2029 Notes is limited to
$600,000,000 and (ii)&nbsp;the 2031 Notes is limited to $500,000,000; except, in each case, for Add On Notes of the applicable series issued in accordance with Section&nbsp;2.9 and Notes of any series authenticated and delivered upon registration
of, transfer of, or in exchange for, or in lieu of, other Notes of the same series pursuant to Section&nbsp;2.5. The Notes of each series shall be issuable in minimum denominations of $200,000 principal amount and integral multiples of $1,000 in
excess of $200,000. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The 2029 Notes shall mature on September&nbsp;15, 2029 and the 2031 Notes shall mature on September&nbsp;15, 2031,
in each case unless earlier redeemed by the Issuer. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Interest on the Notes shall accrue from March&nbsp;9, 2023, applicable to Notes of
such series at the Interest Rate until the principal thereof is paid or made available for payment. Interest shall be payable semi-annually in arrears on each Interest Payment Date. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) From and including September&nbsp;15, 2026 (the &#147;<U><FONT STYLE="white-space:nowrap">Step-up</FONT> Date</U>&#148;)
the Interest Rate payable on the Notes shall increase by: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) 0.100% per annum unless the Guarantor has achieved the
Regulatory Submissions Target as of the Testing Date; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) 0.100% per annum unless the Guarantor has achieved the Product Volume
Target as of the Testing Date; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) 0.100% per annum unless the Guarantor has achieved the Emission Reduction Target
as of the Testing Date; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">in each case, as certified by the Issuer or the Guarantor to the Trustee in an Officer&#146;s certificate (which
shall include the Assurance Letter as an exhibit thereto) on or prior to the Certification Date (subject to any clerical or administrative errors (including any delays resulting therefrom)); <I>provided</I> that, for the avoidance of doubt: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">(A) the Interest Rate on the Notes shall not increase on the <FONT STYLE="white-space:nowrap">Step-up</FONT> Date if the Guarantor has
achieved the three Sustainability Performance Targets as of the Testing Date and certified to such on or prior to the Certification Date; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">(B) the increase in the Interest Rate on the Notes on the <FONT STYLE="white-space:nowrap">Step-up</FONT> Date shall not exceed a total of
0.100% if the Guarantor has achieved two of the three Sustainability Performance Targets as of the Testing Date and certified to such on or prior to the Certification Date; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">(C) the increase in the Interest Rate on the Notes on the <FONT STYLE="white-space:nowrap">Step-up</FONT> Date shall not exceed a total of
0.200% if the Guarantor has met one of the three Sustainability Performance Targets as of the Testing Date and certified to such on or prior to the Certification Date; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">(D) in no event shall the total increase in the Interest Rate on the Notes on the <FONT STYLE="white-space:nowrap">Step-up</FONT> Date exceed
0.300% (this being the consequence of the Guarantor failing to achieve any of the three Sustainability Performance Targets on the Testing Date and failing to certify to achievement on or prior to the Certification Date). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Interest on the Notes shall be computed on the basis of a <FONT STYLE="white-space:nowrap">360-day</FONT> year of twelve <FONT
STYLE="white-space:nowrap">30-day</FONT> months. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) A Holder of any Note at the close of business on a Regular Record Date shall be
entitled to receive interest on such Note on the corresponding Interest Payment Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Principal of and interest on Global Notes shall
be payable to the Depositary in immediately available funds. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Principal on Physical Notes shall be payable at the office or agency of
the Issuer maintained for such purpose, initially the Corporate Trust Office of the Trustee. Interest on Physical Notes will be payable by (i)&nbsp;U.S.&nbsp;Dollar check drawn on a bank in The City of New York delivered to the address of the Person
entitled thereto as such address shall appear in the register of the Notes, or (ii)&nbsp;upon written application to the Registrar not later than the relevant Record Date by a Holder of an aggregate principal amount of Notes in excess of $5,000,000,
wire transfer in immediately available funds, which application and written wire instructions shall remain in effect until the Holder notifies, in writing, the Registrar to the contrary. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) The Notes shall be redeemable at the option of the Issuer as provided in Article 4. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.2 <U>Forms of Notes</U><U>.</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Except as otherwise provided pursuant to this Section&nbsp;2.2, the Notes are issuable in fully registered form without coupons in
substantially the form of Exhibit A and Exhibit B hereto with such applicable legends as are provided for in Section&nbsp;2.3. The Notes are not issuable in bearer form. The terms and provisions contained in the form of Notes shall constitute, and
are hereby expressly made, a part of this Supplemental Indenture and to the extent applicable, the Issuer, the Guarantor and the Trustee, by their execution and delivery of this Supplemental Indenture, expressly agree to such terms and provisions
and to be bound thereby. Any of the Notes may have such letters, numbers or other marks of identification and such notations, legends and endorsements as the Officers executing the same may approve (execution thereof to be conclusive evidence of
such approval) and as are not inconsistent with the provisions of this Supplemental Indenture and the Base Indenture, or as may be required to comply with any law or with any rule or regulation made pursuant thereto or with any rule or regulation of
any securities exchange or automated quotation system on which the Notes of any series may be listed or designated for issuance, or to conform to usage. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Notes and the Guarantees are being (i)&nbsp;initially offered and sold by the Issuer to the underwriters thereof pursuant to the
Underwriting Agreement. The Notes shall be issued initially in the form of one or more permanent global Notes in fully registered form without interest coupons, substantially in the form of Exhibit A and Exhibit B hereto (the &#147;<U>Global
Notes</U>&#148;), each with the applicable legends as provided in Section&nbsp;2.3. Each Global Note shall be duly executed by the Issuer and authenticated and delivered by the Trustee, shall have endorsed thereon the applicable Guarantees executed
by the Guarantor and shall be registered in the name of the Depositary or its nominee and retained by the Trustee, as Custodian, at its Corporate Trust Office, for credit to the accounts of the Agent Members holding the Notes evidenced thereby. The
aggregate principal amount of each Global Note may from time to time be increased or decreased by adjustments made on the records of the Trustee, as Custodian, and of the Depositary or its nominee, as hereinafter provided. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) At such time as all beneficial interests in a Global Note have either been exchanged for Physical Notes, redeemed, repurchased or
cancelled, such Global Note shall be returned by the Depositary to the Trustee for cancellation or retained and cancelled by the Trustee at the written direction of the Issuer. At any time prior to such cancellation, if any beneficial interest in a
Global Note is exchanged for Physical Notes, redeemed, repurchased or cancelled, the principal amount of Notes of the relevant series represented by such Global Note shall be reduced and an adjustment shall be made on the books and records of the
Trustee with respect to such Global Note, by the Trustee, to reflect such reduction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.3 <U>Legends</U><U>.</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Each Global Note shall bear a legend on the face thereof substantially in the following form (each defined term in the legend being defined
as such for purposes of the legend only) (the &#147;<U>Global Notes Legend</U>&#148;): </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">THIS IS A GLOBAL NOTE WITHIN THE MEANING OF THE
INDENTURE REFERRED TO HEREINAFTER. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">UNLESS THIS NOTE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST
COMPANY, A NEW YORK CORPORATION (&#147;DTC&#148;), TO TEVA PHARMACEUTICAL FINANCE III, B.V. OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY NOTE ISSUED IN EXCHANGE FOR THIS NOTE IS REGISTERED IN THE NAME OF CEDE&nbsp;&amp;
CO. (&#147;CEDE&#148;) OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE
HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE, HAS AN INTEREST HEREIN. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">THIS
GLOBAL NOTE MAY NOT BE EXCHANGED, IN WHOLE OR IN PART, FOR A NOTE REGISTERED IN THE NAME OF ANY PERSON OTHER THAN THE DEPOSITORY TRUST COMPANY OR A NOMINEE THEREOF, EXCEPT IN THE LIMITED CIRCUMSTANCES SET FORTH IN THE SUPPLEMENTAL INDENTURE AND MAY
NOT BE TRANSFERRED, IN WHOLE OR IN PART, EXCEPT IN ACCORDANCE WITH THE RESTRICTIONS SET FORTH IN THE INDENTURE REFERRED TO ON THE REVERSE HEREOF. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Each Physical Note shall bear a legend on the face thereof substantially in the following form (the &#147;<U>Physical Notes
Legend</U>&#148;): </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">IN CONNECTION WITH ANY TRANSFER, THE HOLDER WILL DELIVER TO THE REGISTRAR AND TRANSFER AGENT SUCH CERTIFICATES AND
OTHER INFORMATION AS SUCH REGISTRAR AND TRANSFER AGENT MAY REASONABLY REQUIRE TO CONFIRM THAT THE TRANSFER COMPLIES WITH THE FOREGOING RESTRICTIONS. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.4 <U>Form </U><U>of </U><U>Guarantee</U><U>s.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A Guarantee substantially in the following form shall be endorsed on the reverse of each Note: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Teva Pharmaceutical Industries Limited (the &#147;<U>Guarantor</U>&#148;) hereby unconditionally and irrevocably guarantees to the Holder of
this Note (the &#147;<U>Guarantee</U>&#148;) the due and punctual payment of the principal of and interest (including Additional Tax Amounts, if any), on this Note, when and as the same shall become due and payable, whether at Maturity or upon
redemption or upon declaration of acceleration or otherwise, according to the terms of this Note and of the Indenture. The Guarantor agrees that in the case of default by the Issuer in the payment of any such principal or interest (including
Additional Tax Amounts, if any), the Guarantor shall duly and punctually pay the same. The Guarantor hereby agrees that its obligations hereunder shall be absolute and unconditional irrespective of any extension of the time for payment of this Note,
any modification of this Note, any invalidity, irregularity or unenforceability of this Note or the Indenture, any failure to enforce the same or any waiver, modification, consent or indulgence granted to the Issuer with respect thereto by the
Holder of this Note or the Trustee, or any other circumstances which may otherwise constitute a legal or equitable discharge of a surety or guarantor. The Guarantor hereby waives diligence, presentment, demand of payment, filing of claims with a
court in the event of merger or bankruptcy of the Issuer, any right to require a demand or proceeding first against the Issuer, protest or notice with respect to this Note or the indebtedness evidenced hereby and all demands whatsoever, and
covenants that this Guarantee will not be discharged as to this Note except by payment in full of the principal of and interest (including Additional Tax Amounts, if any) on this Note. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Guarantor shall be subrogated to all rights of the Holders against the Issuer in respect
of any amounts paid by the Guarantor pursuant to the provisions of the Guarantees or the Indenture; <I>provided</I>, <I>however</I>, that the Guarantor hereby waives any and all rights to which it may be entitled, by operation of law or otherwise,
upon making any payment hereunder (i)&nbsp;to be subrogated to the rights of a Holder against the Issuer with respect to such payment or otherwise to be reimbursed, indemnified or exonerated by the Issuer in respect thereof or (ii)&nbsp;to receive
any payment in the nature of contribution or for any other reason, from any other obligor with respect to such payment, in each case, until the principal of and interest (including Additional Tax Amounts, if any) on this Note shall have been paid in
full. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Guarantee shall not be valid or become obligatory for any purpose with respect to this Note until the certificate of
authentication on this Note shall have been signed by the Trustee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Guarantee shall be governed by and construed in accordance with
the laws of the State of New York. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, Teva Pharmaceutical Industries Limited has caused the Guarantee to be signed
manually or by facsimile by its duly authorized Officer. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="94%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">TEVA PHARMACEUTICAL INDUSTRIES LIMITED</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.5 <U>Book-Entry Provisions for the Global Notes</U><U>.</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Global Notes initially shall be registered in the name of the Depositary (or a nominee thereof) and be delivered to the Trustee as
Custodian for such Depositary. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Members of, or participants in, the Depositary (&#147;<U>Agent Members</U>&#148;) shall have no rights
under this Supplemental Indenture with respect to any Global Note held on their behalf by the Depositary, or the Trustee as its Custodian, or under such Global Note, and the Depositary may be treated by the Issuer, the Guarantor, the Trustee and any
agent of the Issuer or the Trustee as the absolute owner of such Global Note for all purposes whatsoever. Notwithstanding the foregoing, nothing contained herein shall prevent the Issuer, the Guarantor, the Trustee or any agent of the Issuer or the
Trustee from giving effect to any written certification, proxy or other authorization furnished by the Depositary or impair, as between the Depositary and the Agent Members, the operation of customary practices governing the exercise of the rights
of a Holder of any Note. With respect to any Global Note deposited on behalf of the subscribers for the Notes represented thereby with the Trustee as Custodian for the Depositary for credit to their respective accounts (or to such other accounts as
they may direct) at Euroclear or Clearstream, the provisions of the &#147;Operating Procedures of the Euroclear System&#148; and the &#147;Terms and Conditions Governing Use of Euroclear&#148; and the &#147;Management Regulations&#148; and
&#147;Instructions to Participants&#148; of Clearstream, respectively, shall be applicable to the Global Notes. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Holder of a Global
Note may grant proxies and otherwise authorize any Person, including DTC Participants and Persons that may hold interests through DTC Participants, to take any action that a Holder is entitled to take under this Supplemental Indenture, the Base
Indenture or the Notes of any series. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) A Global Note may not be transferred, in whole or in part, to any Person other than the
Depositary (or a nominee thereof), and no such transfer to any such other Person may be registered. Beneficial interests in a Global Note may be transferred in accordance with the rules and procedures of the Depositary. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Except as provided in Section&nbsp;2.5(f), owners of beneficial interests in Global Notes shall not be entitled to receive physical
delivery of Physical Notes. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) If at any time: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) the Depositary notifies the Issuer in writing that it is no longer willing or able to continue to act as Depositary for the
Global Notes of any series or the Depositary ceases to be a &#147;clearing agency&#148; registered under the Exchange Act and a successor depositary for the Global Notes of such series is not appointed by the Issuer within 90 days of such notice or
cessation; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) an Event of Default has occurred and is continuing and enforcement action is being taken in respect thereof
under their Indenture and the Registrar has received a request from the Depositary for the issuance of Physical Notes in exchange for such Global Note or Global Notes; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) the Issuer, at its option, notifies the Trustee in writing that it elects to exchange in whole, but not in part, the Global
Note for Physical Notes; such Global Note or Global Notes shall be deemed to be surrendered to the Trustee for cancellation and the Issuer shall execute, and the Trustee, upon receipt of an Officer&#146;s Certificate and Issuer Order for the
authentication and delivery of Notes, shall authenticate and deliver, in exchange for such Global Note or Global Notes, Physical Notes of the applicable series in an aggregate principal amount equal to the aggregate principal amount of such Global
Note or Global Notes. Such Physical Notes shall be registered in such names as the Depositary shall identify in writing as the beneficial owners of the Notes represented by such Global Note or Global Notes (or any nominee thereof). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Notwithstanding the foregoing, in connection with any transfer of beneficial interests
in a Global Note to the beneficial owners thereof pursuant to Section&nbsp;2.5(f), the Registrar shall reflect on its books and records the date and a decrease in the principal amount of such Global Note in an amount equal to the principal amount of
the beneficial interests in such Global Note to be transferred. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.6 <U>[Reserved]</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.7 <U>Defaulted Interest</U><U>.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the Issuer fails to make a payment of interest on any Note when due and payable (&#147;<U>Defaulted Interest</U>&#148;), it shall pay such
Defaulted Interest plus (to the extent lawful) any interest payable on the Defaulted Interest, in any lawful manner. It may elect to pay such Defaulted Interest, plus any such interest payable on it, to the Persons who are Holders of such Notes on
which the interest is due on a subsequent Special Record Date. The Issuer shall notify the Trustee in writing of the amount of Defaulted Interest proposed to be paid on each such Note. The Issuer shall fix any such Special Record Date and payment
date for such payment. At least 15 days before any such Special Record Date, the Issuer shall deliver to Holders affected thereby, with a copy to the Trustee, a notice that states the Special Record Date, the Interest Payment Date and amount of such
interest to be paid. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.8 <U>Execution of Guarantees</U><U>.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Guarantor hereby agrees to execute the Guarantees in substantially the form above recited to be endorsed on each Note. If the Issuer shall
execute Physical Notes in accordance with Section&nbsp;2.5, the Guarantor shall execute the Guarantees in substantially the form above recited to be endorsed on each such Note. The Guarantees shall be executed on behalf of the Guarantor by an
Officer of the Guarantor. The signature of any Officer on the Guarantees may be manual or facsimile. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In case any Officer of the Guarantor
who shall have signed the Guarantees endorsed on a Note shall cease to be such Officer before the Note so signed shall be authenticated and delivered by the Trustee, such Note nevertheless may be authenticated and delivered or disposed of as though
the person who signed such Guarantees had not ceased to be such Officer of the Guarantor; and any Guarantees endorsed on a Note may be signed on behalf of the Guarantor by such persons as, at the actual date of the execution of such Guarantee, shall
be the proper Officers of the Guarantor, although at the date of the execution and delivery of this Supplemental Indenture any such person was not such an Officer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.9 <U>Add On Notes</U><U>.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Issuer may, from time to time, subject to compliance with any other applicable provisions of this Supplemental Indenture and the Base
Indenture, without the consent of the Holders, create and issue pursuant to this Supplemental Indenture and the Base Indenture Add On Notes having terms identical to those of the Outstanding Notes of any series, except that Add On Notes: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) may have a different issue date from other Outstanding Notes; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) may have a different first Interest Payment Date after issuance than other Outstanding Notes of such series; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) may have a different amount of interest payable on the first Interest Payment Date after issuance than is payable on other Outstanding
Notes of such series; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) may have a different issue price; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) may have a different CUSIP or ISIN number if such Add On Notes are not fungible with the
Notes of such series then outstanding for United States federal income tax purposes; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) may have terms specified in Add On Note Board
Resolutions, an Officer&#146;s Certificate or a supplemental indenture for such Add On Notes making appropriate adjustments to this Article 2, Exhibit A and Exhibit B (and related definitions), as the case may be, applicable to such Add On Notes in
order to conform to and ensure compliance with the Securities Act (or other applicable securities laws) and any registration rights or similar agreement applicable to such Add On Notes, which are not adverse in any material respect to the Holder of
any Outstanding Notes of such series (other than such Add On Notes) and which shall not affect the rights, benefits, immunities or duties of the Trustee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In authenticating any Add On Notes, and accepting the additional responsibilities under the Indenture in relation to such Add On Notes, the
Trustee shall be entitled to receive, and shall be fully protected in relying upon: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) the Add On Note Board Resolutions, Officer&#146;s
Certificate or supplemental indenture relating thereto, setting forth the form and terms of the Add On Notes; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) an Officer&#146;s
Certificate complying with Section&nbsp;6.5; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) an Opinion of Counsel complying with Section&nbsp;6.5 stating, </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) that the forms of such Notes have been established by or pursuant to Add On Note Board Resolutions, an Officer&#146;s
Certificate or a supplemental indenture, as permitted by this Section&nbsp;2.9 and in conformity with the provisions of this Supplemental Indenture and the Base Indenture; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) that the terms of such Notes have been established by or pursuant to Add On Note Board Resolutions, an Officer&#146;s
Certificate or a supplemental indenture, as permitted by this Section&nbsp;2.9 and in conformity with the provisions of this Supplemental Indenture and the Base Indenture; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) that such Notes and the related Guarantees, when authenticated and delivered by the Trustee and issued by the Issuer and
the Guarantor in the manner provided for herein and in the Base Indenture and the Guarantees, respectively, subject to any customary conditions specified in such Opinion of Counsel, will constitute valid and legally binding obligations of the Issuer
and the Guarantor, respectively, entitled to the benefits provided in this Supplemental Indenture and the Base Indenture, enforceable in accordance with their respective terms, except to the extent that the enforcement of such obligations may be
subject to bankruptcy laws or insolvency laws or other similar laws, general principles of equity and such other qualifications as such counsel shall conclude are customary or do not materially affect the rights of the Holders of such Notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If such forms or terms have been so established by or pursuant to Add On Note Board Resolutions, an Officer&#146;s Certificate or a
supplemental indenture, the Trustee shall have the right to decline to authenticate and deliver any Notes: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) if the
Trustee, being advised by counsel, determines that such action may not lawfully be taken; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) if the Trustee in good faith
determines that such action would expose the Trustee to personal liability to Holders of any Outstanding Notes; or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) if the issue of such Add On Notes pursuant to this Supplemental
Indenture and the Base Indenture will affect the Trustee&#146;s own rights, duties, benefits and immunities under the Notes, this Supplemental Indenture and the Indenture or otherwise in a manner which is not reasonably acceptable to the Trustee.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding anything in this Section&nbsp;2.9, the Issuer may not issue Add On Notes if an Event of Default shall have occurred and
be continuing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.10 <U>CUSIP and </U><U>ISIN Numbers.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Issuer in issuing the Notes may use &#147;CUSIP&#148; numbers and &#147;ISIN&#148; Numbers (if then generally in use), and, if so, the
Trustee shall use &#147;CUSIP&#148; and &#147;ISIN&#148; numbers in notices of redemption and other notices to the Holders as a convenience to Holders; <I>provided</I><I> </I><I>that</I><I> </I>any such notice may state that no representation is
made as to the correctness of such numbers either as printed on the Notes of a given series or as contained in any notice of a redemption and that reliance may be placed only on the other identification numbers printed on the Notes of a given
series, and any such redemption shall not be affected by any defect in or omission of such numbers. The Issuer will promptly notify the Trustee of any change in the &#147;CUSIP&#148; or &#147;ISIN&#148; numbers. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 3 </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ADDITIONAL
COVENANTS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to the covenants set forth in Article 3 of the Base Indenture, the Notes shall be subject to the additional
covenants set forth in this Article 3. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.1 <U>Payment of Additional Tax Amounts</U><U>.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">With respect to the Notes, Section&nbsp;12.02 of the Base Indenture is not applicable. All payments of interest and principal by the Issuer
under the Notes of any series and by the Guarantor under the Guarantees shall be made without withholding or deduction for, or on account of, any present or future Taxes unless such withholding or deduction is required by law. In the event that the
Issuer or the Guarantor is required to withhold or deduct on account of any such Taxes from any payment made under or with respect to the Notes, the Issuer or the Guarantor, as the case may be, will (a)&nbsp;withhold or deduct such amounts,
(b)&nbsp;pay such additional Tax amounts so that the net amounts received by each Holder or beneficial owner of the relevant Notes, including those additional Tax amounts, will equal the amount such Holder or beneficial owner would have received if
such Taxes had not been required to be withheld or deducted (&#147;Additional Tax Amounts&#148;) and (c)&nbsp;pay the full amount withheld or deducted to the relevant tax or other authority in accordance with applicable law, except that no such
Additional Tax Amounts shall be payable in respect of any Note: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) to the extent that such Taxes are imposed or levied by
reason of such Holder (or the beneficial owner) having some present or former connection with the Taxing Jurisdiction other than the mere holding (or beneficial ownership) of such Note or receiving principal or interest payments on the Notes
(including but not limited to citizenship, nationality, residence, domicile, or the existence of a business, permanent establishment, a dependent agent, a place of business or a place of management present or deemed present in the Taxing
Jurisdiction); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) in respect of any Taxes that would not have been so withheld or deducted but for the failure by the
Holder or the beneficial owner of the Notes to make a declaration of <FONT STYLE="white-space:nowrap">non-residence,</FONT> or any other claim or filing for exemption to which it is entitled or otherwise comply with any reasonable certification,
identification, information, documentation or other reporting requirement concerning nationality, residence, identity or connection with the Taxing Jurisdiction if (a)&nbsp;compliance is required by applicable law, regulation, administrative
practice or treaty as a precondition to exemption from all or part of the Taxes, (b)&nbsp;the Holder (or beneficial owner) is able to comply with these requirements without undue hardship and (c)&nbsp;the Issuer has given the Holders (or beneficial
owners) at least 30 calendar days prior notice that they will be required to comply with such requirement; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) to the extent that such Taxes are imposed by reason of any estate,
inheritance, gift, sales, transfer or personal property taxes imposed with respect to the Notes, except as otherwise provided in the Indenture; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) to the extent that any such Taxes would not have been imposed but for the presentation of the Notes, where presentation is
required, for payment on a date more than 30 days after the date on which such payment became due and payable or the date on which payment thereof is duly provided for, whichever is later, except to the extent that the Holder would have been
entitled to Additional Tax Amounts had the Notes been presented for payment on any date during such <FONT STYLE="white-space:nowrap">30-day</FONT> period; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) in respect of any Taxes imposed under Sections 1471-1474 of the Internal Revenue Code of 1986, as amended, any applicable
U.S. Treasury Regulations promulgated thereunder, or any judicial or administrative interpretations of any of the foregoing; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6) any combination of items 1 through 5 above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of this Section&nbsp;3.1, &#147;Taxes&#148; means, with respect to payments on the Notes, all taxes, withholdings, duties,
assessments or governmental charges of whatever nature imposed or levied by or on behalf of any Taxing Jurisdiction or any political subdivision thereof or any authority or agency therein or thereof having power to tax. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.2 <U>Stamp Tax</U><U>.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Issuer and the Guarantor will pay any present or future stamp, court or documentary taxes or any other excise or property taxes, charges
or similar levies that arise from the execution, delivery, enforcement or registration of the Notes of any series or any other document or instrument in relation thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.3 <U>Corporate Existence</U><U>.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to Article 8 of the Base Indenture and subject to the ability of the Issuer or the Guarantor to convert (or similar action) to another
form of legal entity under the laws of the jurisdiction under which the Issuer or the Guarantor then exists, each of the Guarantor and the Issuer will do or cause to be done all things necessary to preserve and keep in full force and effect its
corporate existence, rights (charter and statutory) and franchises; provided, however, that the Issuer and the Guarantor shall not be required to preserve any such existence, right or franchise if the Issuer and the Guarantor determine that the
preservation thereof is no longer desirable in the conduct of the business of the Issuer or the Guarantor and that the loss thereof is not disadvantageous in any material respect to the Holders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.4 <U>Certificates of the Issuer and the Guarantor</U><U>.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Issuer will furnish to the Trustee within 120 days after the end of each fiscal year of the Issuer an Officer&#146;s Certificate of the
Issuer as to the signer&#146;s knowledge of the Issuer&#146;s and the Guarantor&#146;s compliance with all conditions and covenants under this Supplemental Indenture and the Base Indenture (such compliance to be determined without regard to any
period of grace or requirement of notice provided under this Supplemental Indenture or the Base Indenture). In the event the Issuer comes to have actual knowledge of an Event of Default or an event which, with notice or the lapse of time or both,
would constitute an Event of Default, regardless of the date, the Issuer shall deliver an Officer&#146;s Certificate to the Trustee specifying such Default and the nature and status thereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.5 <U>Guarantor To Be the Sole Equityholder of the Issuer</U><U>.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">So long as any Notes are outstanding, the Guarantor or its successor will directly or indirectly own all of the outstanding Capital Stock of
the Issuer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.6 <U>Limitation on Liens</U><U>.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Guarantor shall not, and shall not permit any subsidiary to, directly or indirectly, create, incur, or assume any Lien, other than a
Permitted Lien, upon any of its property (including any shares of Capital Stock or Indebtedness of any subsidiary) to secure any other Indebtedness incurred by the Guarantor or any subsidiary, without in any such case making effective provision
whereby all of the Notes outstanding (together with, if the Guarantor so determines, any other Indebtedness by the Guarantor or any subsidiary ranking equally with the Notes or the Guarantees) shall be secured equally and ratably with, or prior to,
such Indebtedness for so long as such other Indebtedness shall be so secured unless, after giving effect to such Lien, the aggregate amount of secured Indebtedness then outstanding (excluding Indebtedness secured solely by Permitted Liens) plus the
value (as defined in Section&nbsp;3.7) of all Sale-Leaseback Transactions (other than those described in clause (a)&nbsp;or clause (b)&nbsp;of Section&nbsp;3.7) then outstanding would not exceed the greater of (i) 10% of the Guarantor&#146;s
Consolidated Net Worth and (ii)&nbsp;US$2,000,000,000 (or its equivalent in another currency or currencies). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.7
<U>Limitation on Sales and Leasebacks</U><U>.</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Guarantor will not, and will not permit any subsidiary to, enter into any
Sale-Leaseback Transaction after the date of this Supplemental Indenture unless: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) the Sale-Leaseback Transaction: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) involves a lease for a period, including renewals, of not more than five years; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) occurs within one year after the date of acquisition, completion of construction or completion of improvement of such
property; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) is with the Guarantor or one of its subsidiaries; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) the Guarantor or any subsidiary, within one year after the Sale-Leaseback Transaction shall have occurred, applies or causes to be applied
an amount equal to the value of the property so sold and leased back at the time of entering into such arrangement to the prepayment, repayment, redemption, reduction or retirement of any Indebtedness of the Guarantor or any subsidiary that is not
subordinated to the Notes and that has a Stated Maturity of more than twelve months; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) the Guarantor or such subsidiary would be
entitled pursuant to Section&nbsp;3.6 to create, incur, issue or assume Indebtedness secured by a Lien on the property without equally and ratably securing the Notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As used in this Section&nbsp;3.7, the term &#147;value&#148; shall mean, with respect to a Sale-Leaseback Transaction, as of any particular
time an amount equal to the greater of (i)&nbsp;the net proceeds of sale of the property leased pursuant to such Sale-Leaseback Transaction, or (ii)&nbsp;the fair value of such property at the time of entering into such Sale-Leaseback Transaction as
determined by the Board of Directors of the Guarantor, in each case multiplied by a fraction of which the numerator is the number of full years of remaining term of the lease (without regard to renewal options) and the denominator is the full years
of the full term of the lease (without regard to renewal options). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 4 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REDEMPTION OF NOTES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.1 <U>Optional Redemption</U><U>.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Issuer may at its option redeem the Notes of any series, in whole or in part, at any time or from time to time, on any date prior to the
Stated Maturity, upon notice as set forth in Section&nbsp;4.2, at the Redemption Price. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.2 <U>Notice of
Redemption</U><U>.</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notice of redemption to the Holders of the Notes of any series to be redeemed shall be given by delivering notice
of such redemption, on at least 10 days&#146;, but not more than 60 days&#146;, prior notice delivered by electronic transmission, first-class mail, postage prepaid, at their respective addresses as they appear on the registration books of the
Registrar, with a copy of such notice delivered to the Trustee. The notice of redemption of the Notes of any series to be redeemed at the option of the Issuer shall be given by the Issuer or, at the Issuer&#146;s request, delivered to the Trustee at
least five Business Days before the date such notice is to be given to Holders (unless a shorter period shall be acceptable to the Trustee), by the Trustee in the name and at the expense of the Issuer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notice of any redemption of any series of Notes in connection with a corporate transaction (including an equity offering, an incurrence of
indebtedness or a change of control) may, at the Issuer&#146;s discretion, be given prior to the completion thereof and any such redemption or notice may, at the Issuer&#146;s discretion, be subject to one or more conditions precedent, including,
but not limited to, completion of the related transaction. If such redemption or purchase is so subject to satisfaction of one or more conditions precedent, such notice shall describe each such condition, and such notice may be rescinded or the
Redemption Date delayed in the event that any or all such conditions shall not have been satisfied by the Redemption Date. In addition, the Issuer may provide in such notice that payment of the Redemption Price and performance of its obligations
with respect to such redemption may be performed by another Person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If any Note of any series is to be redeemed in part only, the notice
of redemption that relates to such Note shall state the portion of the principal amount thereof to be redeemed, in which case a portion of the original Note of such series will be issued in the name of the holder thereof upon cancellation of the
original Note of such series. In the case of a Global Note of any series, an appropriate notation will be made on such Note of such series to decrease the principal amount thereof to an amount equal to the unredeemed portion thereof. Subject to the
terms of the redemption notice (including any conditions contained therein), Notes of any series called for redemption become due on the date fixed for redemption. On and after the Redemption Date, interest ceases to accrue on such Notes or portions
of them called for redemption, unless the redemption price is not paid on the Redemption Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.3 <U>Deposit of Redemption
Price</U><U>.</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On or prior to the Redemption Date, the Issuer shall deposit with the Trustee or with a Paying Agent an amount of money
sufficient to pay the Redemption Price in respect of all the Notes to be redeemed on that Redemption Date. If less than all of the Notes (or any series thereof) are to be redeemed, the Notes to be redeemed shall be selected by the Trustee on a
<I>pro rata </I>basis, by lot or by such method as the Trustee shall deem fair and appropriate and subject to the rules of the applicable depositary. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.4 <U>Tax Redemption</U><U>.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) If, as a result of any change in or amendment to the laws (or any regulations or rulings promulgated thereunder) of any Taxing
Jurisdiction or any political subdivision or taxing authority thereof or in any Taxing Jurisdiction affecting taxation or any change in official position regarding the application or interpretation of such laws, regulations or rulings, which change
or amendment becomes effective or, in the case of a change in official position, is announced on or after the date of this </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Supplemental Indenture, the Issuer or the Guarantor (or any of their respective successors), as the case may be, is or will be obligated to pay any Additional Tax Amounts with respect to the
Notes (or any series thereof), and if the Issuer or the Guarantor (or any of their respective successors), as the case may be, determines that such obligation cannot be avoided by the Issuer or the Guarantor (or any of their respective successors),
as the case may be, after taking reasonable measures available to it, then at the option of the Issuer or the Guarantor (or any of their respective successors), as the case may be, the Notes (or any series thereof) may be redeemed in whole, but not
in part, at any time, upon the giving not less than 10 days&#146; nor more than 60 days&#146; notice to the Trustee and the Holders of such Notes, at the Redemption Price; provided, however, that (1)&nbsp;no notice of such tax redemption may be
given earlier than 90 days prior to the earliest date on which the Issuer or the Guarantor (or their respective successors), as the case may be, would, but for such redemption, be obligated to pay such Additional Tax Amounts were a payment on such
Notes then due, and (2)&nbsp;at the time such notice is given, such obligation to pay such Additional Tax Amounts remains in effect. The notice of tax redemption shall be given by the Issuer or, at the Issuer&#146;s request delivered to the Trustee
at least five Business Days before the date such notice is to be given to Holders (unless a shorter period shall be acceptable to the Trustee), by the Trustee in the name and at the expense of the Issuer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Not less than five Business Days (unless a shorter period shall be acceptable to the Trustee) before any notice of tax redemption pursuant
to Section&nbsp;4.4(a) is given to the Trustee or the Holders of the Notes (or any series thereof), the Issuer or the Guarantor (or their respective successors), as the case may be, shall deliver to the Trustee (i)&nbsp;an Officer&#146;s Certificate
stating that the Issuer or the Guarantor (or their respective successors), as the case may be, is entitled to effect such redemption and setting forth a statement of facts showing that the conditions precedent to the right of the Issuer or the
Guarantor (or their respective successors), as the case may be, to so redeem have occurred or have been satisfied and (ii)&nbsp;an opinion of independent legal counsel of recognized standing to that effect based on the statement of facts. Such
notice, once given to the Trustee, shall be irrevocable. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 5 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SATISFACTION AND DISCHARGE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.1 <U>Satisfaction and Discharge</U><U>.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) With respect to the Notes, Section&nbsp;9.01 of the Base Indenture is not applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Issuer and the Guarantor may satisfy and discharge their obligations under this Supplemental Indenture with respect to any series of
Notes while such Notes remain outstanding, if (a)&nbsp;all Outstanding Notes of such series have become due and payable at their scheduled Maturity, or (b)&nbsp;all Outstanding Notes of such series have been called for redemption, and in either
case, the Issuer has deposited with the Trustee an amount sufficient to pay and discharge all Outstanding Notes of such series on the date of their scheduled Maturity or the scheduled Redemption Date, as the case may be. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 6 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MISCELLANEOUS PROVISIONS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.1 <U>Scope of Supplemental Indenture</U><U>.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The changes, modifications and supplements to the Base Indenture effected by this Supplemental Indenture shall only be applicable with
respect to, and govern the terms of, the Notes and shall not apply to any other Securities that may be issued by the Issuer under the Base Indenture. Other than such, changes, modifications and supplements, the Base Indenture is incorporated by
reference herein and affirmed in all respects. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.2 <U>Provisions of Supplemental Indenture for the Sole Benefit of Parties
and</U><U> </U><U>Holders of Notes</U><U>.</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Nothing in this Supplemental Indenture, the Base Indenture or in the Notes or the
Guarantees, expressed or implied, shall give or be construed to give to any person, firm or corporation, other than the parties hereto and their successors and the Holders of the Notes, any legal or equitable right, remedy or claim under this
Supplemental Indenture or under any covenant or provision herein contained, all such covenants and provisions being for the sole benefit of the parties hereto and their successors and of the Holders of the Notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.3 <U>Successors and Assigns of Issuer and Guarantor Bound by Supplemental</U><U> </U><U>Indenture</U><U>.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All the covenants, stipulations, promises and agreements in this Supplemental Indenture contained by or on behalf of the Issuer shall bind its
successors and assigns, whether so expressed or not. All the covenants, stipulations, promises and agreements in this Supplemental Indenture contained by or on behalf of the Guarantor shall bind its successors and assigns, whether so expressed or
not. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.4 <U>Notices and Demands on Issuer, Trustee and Holders of Notes</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any notice or demand which by any provision of this Supplemental Indenture is required or permitted to be given or delivered to or by the
Trustee or by the Holders of Notes to the Issuer or the Guarantor shall be in writing in the English language and may be given or served by being deposited postage prepaid, first-class mail (except as otherwise specifically provided herein)
addressed (until another address is filed with the Trustee) as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If to the Issuer: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Teva Pharmaceutical Finance Netherlands III B.V. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Piet Heinkade 107, 1019 GM </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Amsterdam, Netherlands </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Attention: Managing Director </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Fax: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">+972-39-062501</FONT></FONT> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">with a copy (which shall not constitute notice) to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Teva Pharmaceuticals USA, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">400 Interpace Parkway, Building A, </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Parsippany, NJ 07054 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Attention:
David M. Stark </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Fax: +1 (215) <FONT STYLE="white-space:nowrap">293-6499</FONT> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">with a copy (which shall not constitute notice)to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Kirkland&nbsp;&amp; Ellis LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">601 Lexington Avenue </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">New York,
NY 10022 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Attention: Ross M. Leff, P.C. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Christie W.S. Mok </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Fax: +1 (212) <FONT STYLE="white-space:nowrap">446-4900</FONT> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If to the Guarantor: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Teva
Pharmaceutical Industries Limited </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">124 Dvora Hanevi&#146;a Street </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Tel Aviv, 6944020, Israel </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Attention: Corporate Treasurer </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Facsimile:
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">+972-3-914-8678</FONT></FONT></FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">with copies (which shall not constitute notice) to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Teva Pharmaceuticals USA, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">400 Interpace Parkway, Building A, </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Parsippany, NJ 07054 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Attention:
David M. Stark </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Fax: +1 (215) <FONT STYLE="white-space:nowrap">293-6499</FONT> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Kirkland&nbsp;&amp; Ellis LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">601 Lexington Avenue </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">New York,
NY 10022 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Attention: Ross M. Leff, P.C. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Christie W.S. Mok </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Fax: +1 (212) <FONT STYLE="white-space:nowrap">446-4900</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any notice, direction, request or demand by the Issuer, the Guarantor or any Holder of Notes to or upon the Trustee shall be deemed to have
been sufficiently given or made, for all purposes, if delivered in person or mailed by first-class mail as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If to the Trustee:
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">The Bank of New York Mellon </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">240 Greenwich Street, Floor 7E </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">New York, NY 10286 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Attention:
Corporate Trust &#150; Global Finance Unit </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Fax: (212) <FONT STYLE="white-space:nowrap">815-2830</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Trustee also agrees to accept and act upon instructions or directions pursuant to the Indenture sent by unsecured <FONT
STYLE="white-space:nowrap">e-mail,</FONT> facsimile transmission or other similar unsecured electronic methods. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Issuer, the Guarantor
or the Trustee by written notice to each other may designate additional or different addresses for subsequent notices or communications. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any notice or communication to the Issuer or the Guarantor shall be deemed to have been given or made as of the date so delivered if
personally delivered or if delivered electronically, in pdf format or if telecopied; and seven calendar days after mailing if sent by registered or certified mail, postage prepaid (except that a notice of change of address shall not be deemed to
have been given until actually received by the addressee). Any notice or communication to the Trustee shall be deemed delivered upon receipt. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Where this Supplemental Indenture provides for notice to Holders, such notice shall be sufficiently given (unless otherwise herein expressly
provided) if in writing, in the English language, and delivered to each Holder entitled thereto, at his last address as it appears in the register of the Notes of the applicable series. In any case where notice to Holders is given by mail, personal
delivery, telecopy or electronic delivery, neither the failure to mail such notice, nor any defect in any notice so mailed or delivered, to any particular Holder shall affect the sufficiency of such notice with respect to other Holders. Where this
Supplemental Indenture provides for notice in any manner, such notice may be waived in writing by the person entitled to receive such notice, either before or after the event, and such waiver shall be the equivalent of such notice. Waivers of notice
by Holders shall be filed with the Trustee, but such filing shall not be a condition precedent to the validity of any action taken in reliance upon such waiver. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In case, by reason of the suspension of or irregularities in regular mail service, it shall be impracticable to mail notice to the Issuer, the
Guarantor or Holders of Notes when such notice is required to be given pursuant to any provision of this Supplemental Indenture, then any manner of giving such notice as shall be satisfactory to the Trustee shall be deemed to be a sufficient giving
of such notice. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding anything to the contrary contained herein, in the Base Indenture or in the
Notes, where this Supplemental Indenture, the Base Indenture or any Note provides for notice of any event (including any notice of redemption or purchase) to a Holder of a Global Note (whether by mail or otherwise), such notice shall be sufficiently
given if given to the Depositary electronically or by other method in accordance with the procedures of the Depositary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.5
<U>Officer</U><U>&#146;</U><U>s Certificates and Opinions of Counsel; Statements to be</U><U> </U><U>Contained Therein</U><U>.</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon
any application or demand by the Issuer or the Guarantor to the Trustee to take any action under any of the provisions of this Supplemental Indenture, the Issuer or the Guarantor, as the case may be, shall furnish to the Trustee an Officer&#146;s
Certificate or Guarantor&#146;s Officer&#146;s Certificate, as the case may be, stating that all conditions precedent provided for in this Supplemental Indenture relating to the proposed action have been complied with and an Opinion of Counsel
stating that in the opinion of such counsel all such conditions precedent have been complied with. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each certificate or opinion provided
for in this Supplemental Indenture and delivered to the Trustee with respect to compliance with a condition or covenant provided for in this Supplemental Indenture shall include (a)&nbsp;a statement that the person making such certificate or opinion
has read such covenant or condition, (b)&nbsp;a brief statement as to the nature and scope of the examination or investigation upon which the statements or opinions contained in such certificate or opinion are based, (c)&nbsp;a statement that, in
the opinion of such person, he has made such examination or investigation as is necessary to enable him to express an informed opinion as to whether or not such covenant or condition has been complied with and (d)&nbsp;a statement as to whether or
not, in the opinion of such person, such condition or covenant has been complied with. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any certificate, statement or opinion of an
Officer of the Issuer or the Guarantor may be based, insofar as it relates to legal matters, upon a certificate or opinion of or representations by counsel, unless such Officer knows that the certificate or opinion or representations with respect to
the matters upon which his certificate, statement or opinion may be based as aforesaid are erroneous, or in the exercise of reasonable care should know that the same are erroneous. Any certificate, statement or opinion of counsel may be based,
insofar as it relates to factual matters, information with respect to which is in the possession of the Issuer or the Guarantor, as the case may be, upon the certificate, statement or opinion of or representations by an Officer of Officers of the
Issuer or the Guarantor, as the case may be, unless such counsel knows that the certificate, statement or opinion or representations with respect to the matters upon which his certificate, statement or opinion may be based as aforesaid are
erroneous, or in the exercise of reasonable care should know that the same are erroneous. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any certificate, statement or opinion of an
Officer of the Issuer or the Guarantor or of counsel may be based, insofar as it relates to accounting matters, upon a certificate or opinion of or representations by an accountant or firm of accountants in the employ of the Issuer, unless such
Officer or counsel, as the case may be, knows that the certificate or opinion or representations with respect to the accounting matters upon which his certificate, statement or opinion may be based as aforesaid are erroneous, or in the exercise of
reasonable care should know that the same are erroneous. Any certificate or opinion of any independent firm of public accountants filed with the Trustee shall contain a statement that such firm is independent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Trustee shall be entitled to conclusively rely on an Officer&#146;s certificate from the Issuer or the Guarantor, shall have no duty to
inquire as to or investigate the accuracy of any such Officer&#146;s certificate (or related Assurance Letter), verify the attainment of the Sustainability Performance Targets, or make calculations, investigations or determinations with respect to
the attainment of the Sustainability Performance Targets. The Trustee and the Paying Agent shall have no liability to the Issuer, any Holder or any other Person in acting in good faith on any such Officer&#146;s certificate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.6 <U>Payments Due on Saturdays, Sundays and Holidays</U><U>.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the date of maturity of interest on or principal of the Notes of any series or the date fixed for redemption or repayment of any such Note
shall not be a Business Day, then payment of interest or principal need not be made on such date, but may be made on the next succeeding Business Day with the same force and effect as if made on the date of maturity or the date fixed for redemption,
and no interest shall accrue for the period after such date. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.7 <U>Conflict of any Provisions of Supplemental Indenture with Trust
Indentur</U><U>e</U><U> </U><U>Act</U><U> </U><U>of 1939.</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If and to the extent that any provision of this Supplemental Indenture
limits, qualifies or conflicts with another provision included in this Supplemental Indenture by operation of Sections 310 to 317, inclusive, of the TIA (an &#147;incorporated provision&#148;), such incorporated provision shall control. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.8 <U>New York Law to Govern</U><U>.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Supplemental Indenture, each 2029 Note and each 2031 Note shall be deemed to be a contract under the laws of the State of New York, and
for all purposes shall be construed in accordance with the laws of such State. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.9 <U>Counterparts</U><U>.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Supplemental Indenture may be executed in any number of counterparts, each of which shall be an original; but such
counterparts shall together constitute but one and the same instrument. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.10 <U>Effect of Headings</U><U>.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Article and Section headings herein and the Table of Contents are for convenience only and shall not affect the construction hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.11 <U>Submission to Jurisdiction</U><U>.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each of the Issuer, the Guarantor<STRIKE></STRIKE><U> </U><STRIKE></STRIKE>and the Trustee agrees that any legal suit, action or proceeding
arising out of or based upon this Supplemental Indenture may be instituted in any federal or state court sitting in the Borough of Manhattan in New York City, and, to the fullest extent permitted by law, waives any objection which it may now or
hereafter have to the laying of venue of any such proceeding, and irrevocably submits to the <FONT STYLE="white-space:nowrap">non-exclusive</FONT> jurisdiction of such court in any law suit, action or proceeding. Each of the Issuer and the
Guarantor, as long as any of the Notes remain Outstanding or the parties hereto have any obligation under this Supplemental Indenture, shall have an authorized agent (the &#147;<U>Authorized Agent</U>&#148;) in the United States upon whom process
may be served in any such legal action or proceeding. Service of process upon such agent and written notice of such service mailed or delivered to it shall to the extent permitted by law be deemed in every respect effective service of process upon
it in any such legal action or proceeding. The Issuer and the Guarantor each hereby appoints Teva Pharmaceuticals USA, Inc. (400 Interpace Parkway, Building A, Parsippany, NJ 07054) as its agent for such purposes, and covenants and agrees that
service of process in any legal action or proceeding may be made upon it at such office of such agent. The Issuer will provide written notice to the Trustee of any change in the Authorized Agent. In the event that any Authorized Agent resigns, is
removed or becomes incapable of so acting, the Issuer shall promptly appoint a successor Authorized Agent and shall notify the Trustee in writing of such change in Authorized Agent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.12 <U>Not Responsible for Recitals or Issuance of Securities</U><U>.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The recitals contained herein and in the Notes, except the Trustee&#146;s certificates of authentication, shall be taken as the statements of
the Issuer and the Guarantor, and the Trustee assumes no responsibility for their correctness. The Trustee makes no representations as to the validity or sufficiency of this Supplemental Indenture or of the Notes. The Trustee shall not be
accountable for the use or application by the Issuer of Notes or the proceeds thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.13 <U>Electronic Means.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Trustee shall have the right to accept and act upon instructions, including funds transfer instructions (&#147;Instructions&#148;) given
pursuant to the Indenture and delivered using Electronic Means (as defined below); provided, however, that the Company shall provide to the Trustee an incumbency certificate listing officers with the authority to provide such Instructions
(&#147;Authorized Officers&#148;) and containing specimen signatures of such Authorized Officers, which incumbency certificate shall be amended by the Company </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
whenever a person is to be added or deleted from the listing. If the Company elects to give the Trustee Instructions using Electronic Means and the Trustee in its discretion elects to act upon
such Instructions, their understanding of such Instructions shall be deemed controlling. The Company understands and agrees that the Trustee cannot determine the identity of the actual sender of such Instructions and that the Trustee shall
conclusively presume that directions that purport to have been sent by an Authorized Officer listed on the incumbency certificate provided to the Trustee have been sent by such Authorized Officer. The Company shall be responsible for ensuring that
only Authorized Officers transmit such Instructions to the Trustee and that the Company and all Authorized Officers are solely responsible to safeguard the use and confidentiality of applicable user and authorization codes, passwords and/or
authentication keys upon receipt by the Company. The Trustee shall not be liable for any losses, costs or expenses arising directly or indirectly from their reliance upon and compliance with such Instructions notwithstanding such directions conflict
or are inconsistent with a subsequent written instruction. The Company agrees: (i)&nbsp;to assume all risks arising out of the use of Electronic Means to submit Instructions to the Trustee, including without limitation the risk of the Trustee acting
on unauthorized Instructions, and the risk of interception and misuse by third parties; (ii)&nbsp;that it is fully informed of the protections and risks associated with the various methods of transmitting Instructions to the Trustee and that there
may be more secure methods of transmitting Instructions than the method(s) selected by the Company; (iii)&nbsp;that the security procedures (if any) to be followed in connection with its transmission of Instructions provide to it a commercially
reasonable degree of protection in light of its particular needs and circumstances; and (iv)&nbsp;to notify the Trustee immediately upon learning of any compromise or unauthorized use of the security procedures. &#147;Electronic Means&#148; shall
mean the following communications methods: <FONT STYLE="white-space:nowrap">e-mail,</FONT> facsimile transmission, secure electronic transmission containing applicable authorization codes, passwords and/or authentication keys issued by the Trustee,
or another method or system specified by the Trustee as available for use in connection with its services hereunder. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>ARTICLE 7</U>
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SUPPLEMENTAL INDENTURES </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.1 <U>Without Consent of Holders</U><U>.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Sections 7.01(d), (e), (f), (g), (h), (k), (l), (m), (n), (q) and (r)&nbsp;of the Base Indenture are not applicable with respect to the
Notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) In addition to the provisions set forth in Section&nbsp;7.01 of the Base Indenture as amended by Section&nbsp;7.1(a) above,
the Issuer, the Guarantor and the Trustee may amend, modify or supplement the Base Indenture, this Supplemental Indenture or the Notes of any series without the consent of any Holder for one or more of the following purposes: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) to cure any ambiguity, supply any omission or correct or supplement any provision contained herein, in the Base Indenture,
in any supplemental indenture or in the Notes of any series which may be defective or inconsistent with any other provision contained herein or in any supplemental indenture; <U>provided </U>that such amendment, modification or supplement shall not,
in the good faith opinion of the Issuer&#146;s managing and supervisory directors, adversely affect the interests of the Holders of the Notes in any material respect; <U>provided</U>, <U>further</U>, that any amendment made solely to conform the
provisions of this Supplemental Indenture to the description of the Notes contained in the Issuer&#146;s Prospectus Supplement dated <U>March </U>1,<U> 2023</U> will not be deemed to adversely affect the interests of the Holders of the Notes; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) to surrender any right or power conferred upon the Issuer or the Guarantor hereunder; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) to comply with the requirements of the Commission in order to effect or maintain the qualification of the Indenture under
the TIA; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) to authorize the issuance of Add On Notes of either series of Notes
pursuant to Section&nbsp;2.9; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) to add or modify any other provision of the Indenture which the Issuer or the
Guarantor, as the case may be, and the Trustee may deem necessary or desirable and which will not adversely affect the interests of the Holders of the Notes of such series in any material respect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.2 <U>With Consent of Each Affected Holder</U><U>.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to the provisions set forth in Section&nbsp;7.02 of the Base Indenture, the Issuer, the Guarantor and the Trustee may not amend,
modify or supplement the Base Indenture, this Supplemental Indenture or the Notes of any series for one or more of the following purposes without the consent of each Holder so affected: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) to modify the Issuer&#146;s obligation to maintain an office or agency in New York City pursuant to Section&nbsp;3.02 of the Base
Indenture; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) to modify the Guarantor&#146;s obligation to own, directly or indirectly, all of the outstanding Capital Stock or
membership interests, as applicable, of the Issuer pursuant to Section&nbsp;3.5 of this Supplemental Indenture; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) to modify any
provision of Article 4 relating to redemption of such series of Notes; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) to modify the Guarantees in a manner that would adversely
affect the interests of the Holders of such series of Notes; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) to reduce the percentage in aggregate principal amount of the Notes
such series of then Outstanding necessary (i)&nbsp;to modify, amend or supplement the Base Indenture or this Supplemental Indenture or (ii)&nbsp;to waive any past default or Event of Default pursuant to Section&nbsp;4.10 of the Base Indenture. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly executed as of the
day and year first above written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">TEVA PHARMACEUTICAL FINANCE NETHERLANDS III B.V.,</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">as Issuer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ David Vrhovec</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: David Vrhovec</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Authorized Representative</TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Stephen David Harper</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Stephen David Harper</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Authorized Representative</TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">TEVA PHARMACEUTICAL INDUSTRIES LIMITED,as Guarantor</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Amir Weiss</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Amir Weiss</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Senior Vice President and Chief Accounting Officer</TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Eli Kalif</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Eli Kalif</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Executive Vice President and Chief Financial Officer</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(<I>Signature Page
Supplemental Indenture (USD)</I>) </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">THE BANK OF NEW YORK MELLON, AS TRUSTEE</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Stacey B. Poindexter</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Stacey B. Poindexter</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Vice President</TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(<I>Signature Page
Supplemental Indenture (USD)</I>) </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">EXHIBIT A </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[FORM OF FACE OF 2029 GLOBAL NOTE] </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[Insert
Global Notes Legend or Physical Notes Legend, as applicable] </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="39%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="60%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">No.[&#149;]</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">U.S.$600,000,000 as revised by the Schedule of Increases or Decreases in the Global Note attached hereto</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CUSIP No. 88167A AS0 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ISIN: US88167AAS06 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>GLOBAL NOTE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TEVA PHARMACEUTICAL FINANCE NETHERLANDS III B.V. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>7.875% Sustainability-Linked Senior Notes due 2029 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Payment of Principal, Interest and Additional Tax Amounts, if any, Unconditionally </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Guaranteed By </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TEVA
PHARMACEUTICAL INDUSTRIES LIMITED </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Global Note is in respect of an issue of 7.875% Sustainability-Linked Senior Notes due 2029
(the &#147;<U>Notes</U>&#148;) of Teva Pharmaceutical Finance Netherlands III B.V., a private company with limited liability (<I>besloten vennootschap met beperkte aansprakelijkheid</I>), incorporated under Dutch law (the &#147;<U>Issuer</U>&#148;,
which term includes any successor corporation under the Senior Indenture hereinafter referred to), and issued pursuant to a base indenture (the &#147;<U>Base Indenture</U>&#148;), dated as of March&nbsp;14, 2018, by and among the Issuer, Teva
Pharmaceutical Industries Limited, as guarantor (the &#147;<U>Guarantor</U>&#148;), and The Bank of New York Mellon, a New York banking corporation, as trustee (the &#147;<U>Trustee</U>&#148;), as supplemented by a first supplemental senior
indenture, dated as of March&nbsp;14, 2018, by and among the Issuer, the Guarantor and the Trustee, a second supplemental senior indenture, dated as of November&nbsp;25, 2019, by and among the Issuer, the Guarantor and the Trustee, a third
supplemental senior indenture, dated as of November<U></U> 9, 2021, by and among the Issuer, the Guarantor and the Trustee and as further supplemented by a fourth supplemental senior indenture (the &#147;<U>Sup</U><U>plemental Indenture</U>&#148;
and, together with the Base Indenture, the &#147;<U>Indenture</U>&#148;), dated as of March<U></U> 9, 2023, by and among the Issuer, the Guarantor and the Trustee. Unless the context otherwise requires, the capitalized terms used herein shall have
the meanings specified in the Supplemental Indenture and the Base Indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Issuer, for value received, hereby promises to pay to
Cede<U></U> &amp; Co., or its registered assigns, the principal amount of SIX HUNDRED MILLION United States Dollars (U.S. $600,000,000) on September&nbsp;15, 2029, and to pay interest on such principal amount in Dollars at the rate of 7.875% per
annum, subject to the paragraph immediately below, computed on a basis of a 360 day year consisting of twelve 30 day months, from the date hereof until payment of such principal amount has been made or duly provided for, such interest to be paid
semi-annually in arrears on March&nbsp;15 and September&nbsp;15 of each year, commencing September&nbsp;15, 2023. The interest so payable on March&nbsp;15 and September&nbsp;15 (each an &#147;<U>Interest Payment Date</U>&#148;) will, subject to
certain exceptions provided in the Supplemental Indenture, be paid to the person in whose name this Note is registered at the close of business on the immediately preceding March&nbsp;1 and September&nbsp;1, respectively (whether or not a Business
Day). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">From and including September&nbsp;15, 2026 (the <FONT STYLE="white-space:nowrap">&#147;Step-up</FONT> Date&#148;) the Interest Rate payable on the
Notes shall increase by: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(i) 0.100% per annum unless the Guarantor has achieved the Regulatory Submissions Target as of the Testing Date;
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(ii) 0.100% per annum unless the Guarantor has achieved the Product Volume Target as of the Testing Date; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(iii) 0.100% per annum unless the Guarantor has achieved the Emission Reduction Target as of the Testing Date; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">in each case, as certified by the Issuer or the Guarantor to the Trustee in an Officer&#146;s certificate (which shall include the Assurance Letter as an
exhibit thereto) on or prior to the Certification Date (subject to any clerical or administrative errors (including any delays resulting therefrom)); <I>provided</I> that, for the avoidance of doubt: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(A) the Interest Rate on the Notes shall not increase on the
<FONT STYLE="white-space:nowrap">Step-up</FONT> Date if the Guarantor has achieved the three Sustainability Performance Targets as of the Testing Date and certified to such on or prior to the Certification Date; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(B) the increase in the Interest Rate on the Notes on the <FONT STYLE="white-space:nowrap">Step-up</FONT> Date shall not exceed a total of
0.100% if the Guarantor has achieved two of the three Sustainability Performance Targets as of the Testing Date and certified to such on or prior to the Certification Date; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(C) the increase in the Interest Rate on the Notes on the <FONT STYLE="white-space:nowrap">Step-up</FONT> Date shall not exceed a total of
0.200% if the Guarantor has met one of the three Sustainability Performance Targets as of the Testing Date and certified to such on or prior to the Certification Date; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(D) in no event shall the total increase in the Interest Rate on the Notes on the <FONT STYLE="white-space:nowrap">Step-up</FONT> Date exceed
0.300% (this being the consequence of the Guarantor failing to achieve any of the three Sustainability Performance Targets on the Testing Date and failing to certify to achievement on or prior to the Certification Date). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Reference is hereby made to the further provisions of this Note set forth on the reverse hereof, which further provisions shall for all
purposes have the same effect as if set forth at this place. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Note shall not be valid or become obligatory for any purpose until the
certificate of authentication hereon shall have been signed by the Trustee. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Issuer has caused this Note to be duly executed manually or by
facsimile by its duly authorized officers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">TEVA PHARMACEUTICAL FINANCE NETHERLANDS III B.V.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Trustee&#146;s Certificate of Authentication </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This is one of the 7.875% Sustainability-Linked Senior Notes due 2029 described in the within-named Indenture. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THE BANK OF NEW YORK MELLON,</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">as
Trustee</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center">Authorized Signatory</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Teva Pharmaceutical Industries Limited (the &#147;Guarantor&#148;) hereby unconditionally
and irrevocably guarantees to the Holder of this Note (the &#147;Guarantee&#148;) the due and punctual payment of the principal of and interest (including Additional Tax Amounts, if any), on this Note, when and as the same shall become due and
payable, whether at Maturity or upon redemption or upon declaration of acceleration or otherwise, according to the terms of this Note and of the Indenture. The Guarantor agrees that in the case of default by the Issuer in the payment of any such
principal or interest (including Additional Tax Amounts, if any), the Guarantor shall duly and punctually pay the same. The Guarantor hereby agrees that its obligations hereunder shall be absolute and unconditional irrespective of any extension of
the time for payment of this Note, any modification of this Note, any invalidity, irregularity or unenforceability of this Note or the Indenture, any failure to enforce the same or any waiver, modification, consent or indulgence granted to the
Issuer with respect thereto by the Holder of this Note or the Trustee, or any other circumstances which may otherwise constitute a legal or equitable discharge of a surety or guarantor. The Guarantor hereby waives diligence, presentment, demand of
payment, filing of claims with a court in the event of merger or bankruptcy of the Issuer, any right to require a demand or proceeding first against the Issuer, protest or notice with respect to this Note or the indebtedness evidenced hereby and all
demands whatsoever, and covenants that this Guarantee will not be discharged as to this Note except by payment in full of the principal of and interest (including Additional Tax Amounts, if any) on this Note. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Guarantor shall be subrogated to all rights of the Holders against the Issuer in respect of any amounts paid by the Guarantor pursuant to
the provisions of the Guarantees or the Indenture; provided, however, that the Guarantor hereby waives any and all rights to which it may be entitled, by operation of law or otherwise, upon making any payment hereunder (i)&nbsp;to be subrogated to
the rights of a Holder against the Issuer with respect to such payment or otherwise to be reimbursed, indemnified or exonerated by the Issuer in respect thereof or (ii)&nbsp;to receive any payment in the nature of contribution or for any other
reason, from any other obligor with respect to such payment, in each case, until the principal of and interest (including Additional Tax Amounts, if any) on this Note shall have been paid in full. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Guarantee shall not be valid or become obligatory for any purpose with respect to this Note until the certificate of authentication on
this Note shall have been signed by the Trustee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Guarantee shall be governed by and construed in accordance with the laws of the
State of New York. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, Teva Pharmaceutical Industries Limited has caused the Guarantee to be
signed manually or by facsimile by its duly authorized officers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">TEVA PHARMACEUTICAL INDUSTRIES LIMITED</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[FORM OF REVERSE OF NOTE] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TEVA PHARMACEUTICAL FINANCE NETHERLANDS III B.V. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>7.875% Sustainability-Linked Senior Note due 2029 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Payment of Principal, Interest and Additional Tax Amounts, if any, Unconditionally </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Guaranteed By </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TEVA
PHARMACEUTICAL INDUSTRIES LIMITED </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Capitalized terms used herein but not defined shall have the meanings assigned to them in the
Indenture referred to below unless otherwise indicated. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Principal and Interest.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Teva Pharmaceutical Finance Netherlands III B.V., a private company with limited liability <I>(besloten vennootschap met beperkte
aansprakelijkheid)</I>, incorporated under Dutch law (the &#147;Issuer&#148;), promises to pay interest on the principal amount of this Note at 7.875% per annum, subject to adjustment as described in the paragraph below, from March&nbsp;9, 2023
until the principal thereof is paid or made available for payment. Interest shall be payable semi-annually in arrears on each March&nbsp;15 and September&nbsp;15 of each year (each an &#147;<U>Interest Payment Date</U>&#148;), commencing
September&nbsp;15, 2023. If an Interest Payment Date falls on a day that is not a Business Day, interest will be payable on the next succeeding Business Day with the same force and effect as if made on such Interest Payment Date and no interest
shall accrue thereon on account of such delay. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interest on the Notes shall be computed on the basis of a
<FONT STYLE="white-space:nowrap">360-day</FONT> year of twelve <FONT STYLE="white-space:nowrap">30-day</FONT> months. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A Holder of any
Note at the close of business on a Regular Record Date shall be entitled to receive interest on such Note on the corresponding Interest Payment Date. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Interest Rate Adjustment Upon Failure to Achieve Sustainability Performance Targets</U>
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">From and including September&nbsp;15, 2026 (the <FONT STYLE="white-space:nowrap">&#147;Step-up</FONT> Date&#148;) the Interest Rate
payable on the Notes shall increase by: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">0.100% per annum unless the Guarantor has achieved the Regulatory Submissions Target as of the Testing Date;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">0.100% per annum unless the Guarantor has achieved the Product Volume Target as of the Testing Date; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">0.100% per annum unless the Guarantor has achieved the Emission Reduction Target as of the Testing Date;
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">in each case, as certified by the Issuer or the Guarantor to the Trustee in an Officer&#146;s certificate (which shall include the
Assurance Letter as an exhibit thereto) on or prior to the Certification Date (subject to any clerical or administrative errors (including any delays resulting therefrom)); <I>provided</I> that, for the avoidance of doubt: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(A)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Interest Rate on the Notes shall not increase on the <FONT STYLE="white-space:nowrap">Step-up</FONT> Date
if the Guarantor has achieved the three Sustainability Performance Targets as of the Testing Date and certified to such on or prior to the Certification Date; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(B)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the increase in the Interest Rate on the Notes on the <FONT STYLE="white-space:nowrap">Step-up</FONT> Date
shall not exceed a total of 0.100% if the Guarantor has achieved two of the three Sustainability Performance Targets as of the Testing Date and certified to such on or prior to the Certification Date; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(C)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the increase in the Interest Rate on the Notes on the <FONT STYLE="white-space:nowrap">Step-up</FONT> Date
shall not exceed a total of 0.200% if the Guarantor has met one of the three Sustainability Performance Targets as of the Testing Date and certified to such on or prior to the Certification Date; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(D)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in no event shall the total increase in the Interest Rate on the Notes on the
<FONT STYLE="white-space:nowrap">Step-up</FONT> Date exceed 0.300% (this being the consequence of the Guarantor failing to achieve any of the three Sustainability Performance Targets on the Testing Date and failing to certify to achievement on or
prior to the Certification Date). </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Method of Payment.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interest on any Note which is payable, and is punctually paid or duly provided for, on any Interest Payment Date shall be paid to the person
in whose name that Note (or one or more Predecessor Notes) is registered at the close of business on the relevant Regular Record Date for such interest. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Principal of and interest on Global Notes shall be payable to the Depositary in immediately available funds. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Principal of Physical Notes will be payable at the office or agency of the Issuer maintained for such purpose, initially the Corporate Trust
Office of the Trustee. Interest on Physical Notes will be payable by (i)&nbsp;U.S.&nbsp;Dollar check drawn on a bank in The City of New York delivered to the address of the Person entitled thereto as such address shall appear in the register of the
Notes, or (ii)&nbsp;upon written application to the Registrar not later than the relevant Record Date by a Holder of an aggregate principal amount of Notes in excess of $5,000,000, wire transfer in immediately available funds, which application and
written wire instructions shall remain in effect until the Holder notifies, in writing, the Registrar to the contrary. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Paying Agent and Registrar.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Initially, The Bank of New York Mellon, the Trustee under the Supplemental Indenture, will act as Paying Agent and Registrar. The Issuer may
change the Paying Agent or Registrar without notice to any Holder. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Supplemental Indentures and Indenture.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Issuer issued this Note under a Base Indenture (the &#147;<U>Base Indenture</U>&#148;), dated as of March&nbsp;14, 2018, by and among the
Issuer, the Guarantor and The Bank of New York Mellon, as trustee (the &#147;<U>Trustee</U>&#148;), as supplemented by a first supplemental senior indenture, dated as of March&nbsp;14, 2018, by and among the Issuer, the Guarantor and the Trustee, a
second supplemental senior indenture, dated as of November&nbsp;25, 2019, by and among the Issuer, the Guarantor <U>and</U> the Trustee, a third supplemental senior indenture, dated as of November<U></U>&nbsp;9, 2021, by and among the Issuer, the
Guarantor and the Trustee and as further supplemented by a <U>fourth</U> supplemental senior indenture (the &#147;<U>Supplem</U><U>ental Indenture</U>&#148; and, together with the Base Indenture, the &#147;<U>Indenture</U>&#148;), dated as of
March<U></U> 9, 2023, by and among the Issuer, the Guarantor and the Trustee. The terms of the Note include those stated in the Indenture, and those made part of the Indenture by reference to the Trust Indenture Act of 1939, as amended
(&#147;<U>TIA</U>&#148;). This Note is subject to all such terms, and Holders are referred to the Indenture and the TIA for a statement of all such terms. To the extent permitted by applicable law, in the event of any inconsistency between the terms
of this Note and the terms of the Indenture, the terms of the Indenture shall control. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Optional Redemption.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Issuer may at its option redeem this Note, in whole or in part, at any time or from time to time, on any date prior to the Stated
Maturity, upon notice as set forth in Section&nbsp;4.2 of the Supplemental Indenture, at a Redemption Price equal to the greater of (1) 100% of the principal amount of the Notes to be redeemed or (2)&nbsp;the sum of the present values of the
Remaining Scheduled Payments of the Notes being redeemed discounted, on a semi-annual basis (assuming a <FONT STYLE="white-space:nowrap">360-day</FONT> year consisting of twelve <FONT STYLE="white-space:nowrap">30-day</FONT> months), using a
discount rate equal to the sum of the Treasury Rate plus 50 basis points, plus accrued and unpaid interest </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
thereon, if any, to, but not including, the Redemption Date, provided that if the Issuer redeems the Notes on or after the applicable Par Call Date, the Redemption Price for such Notes will be
equal to 100% of the aggregate principal amount of the Notes being redeemed, plus accrued and unpaid interest thereon, if any, to, but not including, the Redemption Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On and after the Redemption Date, interest shall cease to accrue on Notes or portions of Notes called for redemption, unless the Issuer
defaults in the payment of the Redemption Price. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notice of redemption will be given by the Issuer to the Holders as provided in the
Supplemental Indenture. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">7.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Tax&nbsp;Redemption.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If, as a result of any change in or amendment to the laws (or any regulations or rulings promulgated thereunder) of any Taxing Jurisdiction or
any political subdivision or taxing authority thereof or in any Taxing Jurisdiction affecting taxation or any change in official position regarding the application or interpretation of such laws, regulations or rulings, which change or amendment
becomes effective or, in the case of a change in official position, is announced on or after the issuance of the Notes, the Issuer or the Guarantor (or any of their respective successors), as the case may be, is or will be obligated to pay any
Additional Tax Amount with respect to the Notes (of any series thereof), and if the Issuer or the Guarantor (or any of their respective successors), as the case may be, determines that such obligation cannot be avoided by the Issuer or the Guarantor
(or any of their respective successors), as the case may be, after taking reasonable measures available to it, then at the option of the Issuer or the Guarantor (or any of their respective successors), as the case may be, the Notes (of any series
thereof) may be redeemed in whole, but not in part, at any time, upon the giving not less than 10 days&#146; nor more than 60 days&#146; notice to the Trustee and the Holders of such Notes, at the Redemption Price; provided, however, that
(1)&nbsp;no notice of such tax redemption may be given earlier than 90 days prior to the earliest date on which the Issuer or the Guarantor (or their respective successors), as the case may be, would, but for such redemption, be obligated to pay
such Additional Tax Amounts were a payment on such Notes then due, and (2)&nbsp;at the time such notice is given, such obligation to pay such Additional Tax Amounts remains in effect. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">8.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Denominations; Transfer; Exchange.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes are issuable in registered form, without coupons, in minimum denominations of $200,000 principal amount and integral multiples of
$1,000 in excess of $200,000. A Holder may register the transfer or exchange of Notes in accordance with the Indenture. The Issuer or the Trustee may require a Holder, among other things, to furnish appropriate endorsements and transfer documents,
and the Issuer may require a Holder to pay any taxes or other governmental charges that may be imposed in connection with any exchange or registration of transfer of Notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Issuer shall not be required to exchange or register a transfer of (a)&nbsp;any Note for a period of 15 days next preceding the first
delivery of notice of redemption of Notes to be redeemed, (b)&nbsp;any Notes selected, called or being called for redemption except, in the case of any Note where notice has been given that such Note is to be redeemed in part, the portion thereof
not so to be redeemed or (c)&nbsp;any Notes between a record date and the next succeeding payment date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event of redemption of the
Notes in part only, in the case of a Global Note, the aggregate principal amount of such Global Notes may be increased or decreased by adjustments made on the records of the Depositary or, if necessary, a new Note or Notes for the unredeemed portion
thereof will be issued in the name of the Holder hereof. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">9.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Holders to be Treated as Owners.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The registered Holder of this Note shall be treated as its owner for all purposes. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">10.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Unclaimed Money.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any moneys deposited with or paid to the Trustee or any Paying Agent for the payment of the principal of or interest on any Note and not
applied but remaining unclaimed for two years after the date upon which such principal or interest shall have become due and payable, shall, upon the written request of the Issuer and unless otherwise required by mandatory provisions of applicable
escheat or abandoned or unclaimed property law, be repaid to the Issuer by the Trustee or such Paying Agent, and the Holder of such Note shall, unless otherwise required by mandatory provisions of applicable escheat or abandoned or unclaimed
property laws, thereafter look only to the Issuer for any payment which such Holder may be entitled to collect, and all liability of the Trustee or any Paying Agent with respect to such moneys shall thereupon cease. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">11.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Satisfaction and Discharge.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Issuer and the Guarantor may satisfy and discharge their obligations under the Indenture while the Notes remain outstanding, if
(a)&nbsp;all Outstanding Notes have become due and payable at their scheduled Maturity, or (b)&nbsp;all Outstanding Notes have been called for redemption, and in either case, the Issuer has deposited with the Trustee an amount sufficient to pay and
discharge all Outstanding Notes on the date of their scheduled Maturity or the scheduled Redemption Date, as the case may be. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">12.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Supplement; Waiver.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Without notice to or the consent of the Holders of the Notes, the Indenture and the Notes may be amended, supplemented or otherwise modified
by the Issuer, the Guarantor and the Trustee as provided in the Indenture. The Indenture permits, with certain exceptions as therein provided, the amendment thereof and the modification of the rights and obligations of the Issuer and the rights of
the Holders of the Notes under the Indenture at any time by the Issuer and the Trustee with the consent of the Holders of a majority in aggregate principal amount of the Outstanding Notes (or such lesser amount as shall have acted at a meeting
pursuant to the provisions of the Indenture). The Indenture also contains provisions permitting the Holders of specified percentages in principal amount of the Notes at the time Outstanding, on behalf of the Holders of all the Notes, to waive
compliance by the Issuer with certain provisions of the Indenture and certain past defaults under the Indenture and their consequences. Any such consent or waiver by the Holder of this Note shall be conclusive and binding upon such Holder and upon
all future Holders of this Note and of any Note issued upon registration of transfer hereof or in exchange herefor or in lieu hereof, whether or not notation of such consent or waiver is made upon this Note or such other Note. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No reference herein to the Indenture and no provision of this Note or of the Indenture shall alter or impair the obligation of the Issuer,
which is absolute and unconditional, to pay the principal of and interest on this Note at the times, places and rate, and in the coin or currency, herein prescribed. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">13.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Defaults and Remedies.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Indenture provides that an Event of Default with respect to the Notes occurs when any of the following occurs: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) the Issuer defaults in the payment of the principal and premium, if any, of any of the Notes when it becomes due and payable at Maturity
or upon redemption; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) the Issuer defaults in the payment of interest (including Additional Tax Amounts, if any) on any of the Notes
when it becomes due and payable and such default continues for a period of 30 days after the date when due; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) the Guarantor fails to
perform its obligations under the Guarantees; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) except as permitted by the Indenture, the Guarantees is held in any final, <FONT
STYLE="white-space:nowrap">non-appealable</FONT> judicial proceeding to be unenforceable or invalid or shall cease for any reason to be in full force and effect or the Guarantor, or any person acting on behalf of the Guarantor, shall deny or
disaffirm its obligations under the Guarantees; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) either the Issuer or the Guarantor fails to perform or observe any other term, covenant
or agreement contained in the Notes or the Indenture and the default continues for a period of 60 days after written notice of such failure, requiring the Issuer or the Guarantor, as the case may be, to remedy the same, shall have been given to the
Issuer or the Guarantor, as the case may be, by the Trustee or to the Issuer or the Guarantor, as the case may be, and the Trustee by the Holders of at least 25% in aggregate principal amount of the Outstanding Notes (provided that such notice may
not be given with respect to any action taken, and reported publicly or to holders of such series of the Notes, more than two years prior to such notice; provided further that the trustee shall have no obligation to determine when or if any holders
have been notified of any such action or to track when such <FONT STYLE="white-space:nowrap">two-year</FONT> period starts or concludes); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) (i) the Issuer or the Guarantor fails to make by the end of the applicable grace period, if any, any payment of principal or interest due
in respect of any Indebtedness for borrowed money, the aggregate outstanding principal amount of which is an amount in excess of $250,000,000; or (ii)&nbsp;there is an acceleration of any Indebtedness for borrowed money in an amount in excess of
$250,000,000 because of a default with respect to such Indebtedness, without, in the case of either (i)&nbsp;or (ii) above, such Indebtedness having been discharged or such <FONT STYLE="white-space:nowrap">non-payment</FONT> or acceleration having
been cured, waived, rescinded or annulled for a period of 30 days after written notice to the Issuer by the Trustee or to the Issuer and the Trustee by the Holders of at least 25% in aggregate principal amount of the Outstanding Notes of such
series; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) the occurrence of certain events of bankruptcy, insolvency or reorganization of the Issuer or Guarantor as specified in
the Supplemental Indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If an Event of Default shall occur and be continuing, the principal of all the Notes may be declared due and
payable in the manner and with the effect provided in the Supplemental Indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any time period in this Supplemental Indenture, the
Base Indenture or the Notes to cure any actual or alleged default or event of default may be extended or stayed by a court of competent jurisdiction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the avoidance of doubt, failure to achieve one or more Sustainability Performance Targets shall not constitute a Default or an Event of
Default with respect to the Notes. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">14.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Authentication.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Note shall not be valid until the Trustee (or authenticating agent) executes the certificate of authentication on the other side of this
Note. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">15.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>CUSIP</U><U> Numbers.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Issuer has caused CUSIP numbers to be printed on this Note and, therefore, the Trustee shall use CUSIP numbers in notices of redemption as
a convenience to Holders. Any such notice may state that no representation is made as to the correctness of such numbers either as printed on the Notes or as contained in any notice of a redemption and that reliance may be placed only on the other
identification numbers printed on the Notes, and any such redemption shall not be affected by any defect in or omission of such numbers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">16. <U>Governing
Law.</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Supplemental Indenture, the Base Indenture and this Note shall be governed by, and construed in accordance with, the laws of
the State of New York. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">17.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Successor Corporation.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event a successor corporation legal entity assumes all the obligations of the Issuer or the Guarantor under this Note, pursuant to the
terms hereof and of the Indenture, the Issuer or Guarantor, as the case may be, will be released from all such obligations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ASSIGNMENT FORM </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">To assign this Note, fill in the form below and have your signature guaranteed: (I)&nbsp;or (we) assign and transfer this Note to: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Insert
assignee&#146;s soc. sec. or tax I.D. no.)</P> <P STYLE="margin-top:0pt;margin-bottom:1pt;border-bottom:1px solid #000000" align="left">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">(Print or type assignee&#146;s name, address and zip code)</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">and irrevocably appoint <U></U>to transfer this Note on the books of the Issuer. The agent may substitute another to act for
him. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Dated:<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Your&nbsp;Name:&nbsp;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">(Print your name exactly as it appears on the face of this Note)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Your
Signature:&nbsp;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">(Sign exactly as your name appears on the face of this Note)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Signature Guarantee<SUP STYLE="font-size:75%; vertical-align:top">*</SUP>:</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:75%; vertical-align:top">*</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Participant in a recognized Signature Guarantee Medallion Program (or other signature guarantor acceptable
to the Trustee).</I> </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SCHEDULE OF INCREASES OR DECREASES IN THE GLOBAL NOTE </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The initial outstanding principal amount of this Global Note is $600,000,000. The following exchanges of a part of this Global Note for an
interest in another Global Note or for a Physical Note, or exchanges of a part of another Global Note or Physical Note for an interest in this Global Note, have been made: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="18%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="19%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="20%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="20%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="19%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Date of</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Exchange</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Amount of</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">decrease in</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Principal Amount</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">of this Global</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Note</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Amount of</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">increase in</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Principal Amount</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">of this Global</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Note</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Principal Amount</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">of this Global</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Note following</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">such decrease or</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">increase</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Signature of</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">authorized</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">signatory of</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Trustee</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[FORM OF FACE OF 2031 GLOBAL NOTE] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[Insert Global Notes Legend or Physical Notes Legend, as applicable] </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">No. [&#149;]</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">U.S. $500,000,000 as revised by the Schedule of Increases or Decreases in the Global Note attached hereto</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CUSIP No. 88167A AR2 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ISIN US88167AAR23 </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>GLOBAL NOTE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TEVA PHARMACEUTICAL FINANCE NETHERLANDS III B.V. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>8.125% Sustainability-Linked Senior Notes due 2031 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Payment of Principal, Interest and Additional Tax Amounts, if any, Unconditionally </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Guaranteed By </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TEVA
PHARMACEUTICAL INDUSTRIES LIMITED </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Global Note is in respect of an issue of 8.125% Sustainability-Linked Senior Notes due 2031
(the &#147;<U>Notes</U>&#148;) of Teva Pharmaceutical Finance Netherlands III B.V., a private company with limited liability (<I>besloten vennootschap met beperkte aansprakelijkheid</I>), incorporated under Dutch law (the &#147;<U>Issuer</U>&#148;,
which term includes any successor corporation under the Senior Indenture hereinafter referred to), and issued pursuant to a base indenture (the &#147;<U>Base Indenture</U>&#148;), dated as of March&nbsp;14, 2018, by and among the Issuer, Teva
Pharmaceutical Industries Limited, as guarantor (the &#147;<U>Guarantor</U>&#148;), and The Bank of New York Mellon, a New York banking corporation, as trustee (the &#147;<U>Trustee</U>&#148;), as supplemented by a first supplemental senior
indenture, dated as of March&nbsp;14, 2018, by and among the Issuer, the Guarantor and the Trustee, a second supplemental senior indenture, dated as of November&nbsp;25, 2019, by and among the Issuer, the Guarantor and the Trustee, a third
supplemental senior indenture, dated as of November<U></U>&nbsp;9, 2021, by and among the Issuer, the Guarantor and the Trustee and as further supplemented by a fourth supplemental senior indenture (the &#147;<U>Sup</U><U>plemental
Indenture</U>&#148; and, together with the Base Indenture, the &#147;<U>Indenture</U>&#148;), dated as of March&nbsp;9, 2023, by and among the Issuer, the Guarantor and the Trustee. Unless the context otherwise requires, the capitalized terms used
herein shall have the meanings specified in the Supplemental Indenture and the Base Indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Issuer, for value received, hereby
promises to pay to Cede<U></U>&nbsp;&amp; Co., or its registered assigns, the principal amount of FIVE HUNDRED MILLION United States Dollars (U.S. $500,000,000) on September&nbsp;15, 2031, and to pay interest on such principal amount in Dollars at
the rate of 8.125% per annum, subject to the paragraph immediately below, computed on a basis of a 360 day year consisting of twelve 30 day months, from the date hereof until payment of such principal amount has been made or duly provided for, such
interest to be paid semi-annually in arrears on March&nbsp;15 and September&nbsp;15 of each year, commencing September&nbsp;15, 2023. The interest so payable on March&nbsp;15 and September&nbsp;15 (each an &#147;<U>Interest Payment Date</U>&#148;)
will, subject to certain exceptions provided in the Supplemental Indenture, be paid to the person in whose name this Note is registered at the close of business on the immediately preceding March&nbsp;1 and September&nbsp;1, respectively (whether or
not a Business Day). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">From and including September&nbsp;15, 2026 (the &#147;<U><FONT STYLE="white-space:nowrap">Step-up</FONT> Date</U>&#148;) the
Interest Rate payable on the Notes shall increase by: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">0.100% per annum unless the Guarantor has achieved the Regulatory Submissions Target as of the Testing Date;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">0.100% per annum unless the Guarantor has achieved the Product Volume Target as of the Testing Date; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">0.100% per annum unless the Guarantor has achieved the Emission Reduction Target as of the Testing Date;
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">in each case, as certified by the Issuer or the Guarantor to the Trustee in an Officer&#146;s certificate
(which shall include the Assurance Letter as an exhibit thereto) on or prior to the Certification Date (subject to any clerical or administrative errors (including any delays resulting therefrom)); <I>provided</I> that, for the avoidance of doubt:
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(A)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Interest Rate on the Notes shall not increase on the <FONT STYLE="white-space:nowrap">Step-up</FONT> Date
if the Guarantor has achieved the three Sustainability Performance Targets as of the Testing Date and certified to such on or prior to the Certification Date; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(B)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the increase in the Interest Rate on the Notes on the <FONT STYLE="white-space:nowrap">Step-up</FONT> Date
shall not exceed a total of 0.100% if the Guarantor has achieved two of the three Sustainability Performance Targets as of the Testing Date and certified to such on or prior to the Certification Date; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(C)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the increase in the Interest Rate on the Notes on the <FONT STYLE="white-space:nowrap">Step-up</FONT> Date
shall not exceed a total of 0.200% if the Guarantor has met one of the three Sustainability Performance Targets as of the Testing Date and certified to such on or prior to the Certification Date; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(D)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in no event shall the total increase in the Interest Rate on the Notes on the
<FONT STYLE="white-space:nowrap">Step-up</FONT> Date exceed 0.300% (this being the consequence of the Guarantor failing to achieve any of the three Sustainability Performance Targets on the Testing Date and failing to certify to achievement on or
prior to the Certification Date). </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Reference is hereby made to the further provisions of this Note set forth on the
reverse hereof, which further provisions shall for all purposes have the same effect as if set forth at this place. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Note shall not
be valid or become obligatory for any purpose until the certificate of authentication hereon shall have been signed by the Trustee. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Issuer has caused this Note to be duly executed manually or by
facsimile by its duly authorized officers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">TEVA PHARMACEUTICAL FINANCE NETHERLANDS III B.V.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Trustee&#146;s Certificate of Authentication </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This is one of the 8.125% Sustainability-Linked Senior Notes due 2031 described in the within-named Indenture. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THE BANK OF NEW YORK MELLON,</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">as
Trustee</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center">Authorized Signatory</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Teva Pharmaceutical Industries Limited (the &#147;Guarantor&#148;) hereby unconditionally
and irrevocably guarantees to the Holder of this Note (the &#147;Guarantee&#148;) the due and punctual payment of the principal of and interest (including Additional Tax Amounts, if any), on this Note, when and as the same shall become due and
payable, whether at Maturity or upon redemption or upon declaration of acceleration or otherwise, according to the terms of this Note and of the Indenture. The Guarantor agrees that in the case of default by the Issuer in the payment of any such
principal or interest (including Additional Tax Amounts, if any), the Guarantor shall duly and punctually pay the same. The Guarantor hereby agrees that its obligations hereunder shall be absolute and unconditional irrespective of any extension of
the time for payment of this Note, any modification of this Note, any invalidity, irregularity or unenforceability of this Note or the Indenture, any failure to enforce the same or any waiver, modification, consent or indulgence granted to the
Issuer with respect thereto by the Holder of this Note or the Trustee, or any other circumstances which may otherwise constitute a legal or equitable discharge of a surety or guarantor. The Guarantor hereby waives diligence, presentment, demand of
payment, filing of claims with a court in the event of merger or bankruptcy of the Issuer, any right to require a demand or proceeding first against the Issuer, protest or notice with respect to this Note or the indebtedness evidenced hereby and all
demands whatsoever, and covenants that this Guarantee will not be discharged as to this Note except by payment in full of the principal of and interest (including Additional Tax Amounts, if any) on this Note. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Guarantor shall be subrogated to all rights of the Holders against the Issuer in respect of any amounts paid by the Guarantor pursuant to
the provisions of the Guarantees or the Indenture; provided, however, that the Guarantor hereby waives any and all rights to which it may be entitled, by operation of law or otherwise, upon making any payment hereunder (i)&nbsp;to be subrogated to
the rights of a Holder against the Issuer with respect to such payment or otherwise to be reimbursed, indemnified or exonerated by the Issuer in respect thereof or (ii)&nbsp;to receive any payment in the nature of contribution or for any other
reason, from any other obligor with respect to such payment, in each case, until the principal of and interest (including Additional Tax Amounts, if any) on this Note shall have been paid in full. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Guarantee shall not be valid or become obligatory for any purpose with respect to this Note until the certificate of authentication on
this Note shall have been signed by the Trustee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Guarantee shall be governed by and construed in accordance with the laws of the
State of New York. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, Teva Pharmaceutical Industries Limited has caused the Guarantee to be
signed manually or by facsimile by its duly authorized officers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">TEVA PHARMACEUTICAL INDUSTRIES LIMITED</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title:</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[FORM OF REVERSE OF NOTE] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TEVA PHARMACEUTICAL FINANCE NETHERLANDS III B.V. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>8.125% Sustainability-Linked Senior Note due 2031 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Payment of Principal, Interest and Additional Tax Amounts, if any, Unconditionally </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Guaranteed By </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TEVA
PHARMACEUTICAL INDUSTRIES LIMITED </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Capitalized terms used herein but not defined shall have the meanings assigned to them in the
Indenture referred to below unless otherwise indicated. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Principal and Interest.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Teva Pharmaceutical Finance Netherlands <U>III</U> B.V., a private company with limited liability <I>(besloten vennootschap met beperkte
aansprakelijkheid)</I>, incorporated under Dutch law (the &#147;Issuer&#148;), promises to pay interest on the principal amount of this Note at 8.125% per annum, subject to adjustment as described in the paragraph below, from March&nbsp;9, 2023
until the principal thereof is paid or made available for payment. Interest shall be payable semi-annually in arrears on each March&nbsp;15 and September&nbsp;15 of each year (each an &#147;<U>Interest Payment Date</U>&#148;), commencing
September&nbsp;15, 2023. If an Interest Payment Date falls on a day that is not a Business Day, interest will be payable on the next succeeding Business Day with the same force and effect as if made on such Interest Payment Date and no interest
shall accrue thereon on account of such delay. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interest on the Notes shall be computed on the basis of a
<FONT STYLE="white-space:nowrap">360-day</FONT> year of twelve <FONT STYLE="white-space:nowrap">30-day</FONT> months. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A Holder of any Note at the close
of business on a Regular Record Date shall be entitled to receive interest on such Note on the corresponding Interest Payment Date. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Interest Rate Adjustment Upon Failure to Achieve Sustainability Performance Targets.</U>
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">From and including September&nbsp;15, 2026 (the <FONT STYLE="white-space:nowrap">&#147;Step-up</FONT> Date&#148;) the
Interest Rate payable on the Notes shall increase by: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">0.100% per annum unless the Guarantor has achieved the Regulatory Submissions Target as of the Testing Date;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">0.100% per annum unless the Guarantor has achieved the Product Volume Target as of the Testing Date; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">0.100% per annum unless the Guarantor has achieved the Emission Reduction Target as of the Testing Date;
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">in each case, as certified by the Issuer or the Guarantor to the Trustee in an Officer&#146;s certificate (which shall include the
Assurance Letter as an exhibit thereto) on or prior to the Certification Date (subject to any clerical or administrative errors (including any delays resulting therefrom)); <I>provided</I> that, for the avoidance of doubt: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(A)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Interest Rate on the Notes shall not increase on the <FONT STYLE="white-space:nowrap">Step-up</FONT> Date
if the Guarantor has achieved the three Sustainability Performance Targets as of the Testing Date and certified to such on or prior to the Certification Date; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(B)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the increase in the Interest Rate on the Notes on the <FONT STYLE="white-space:nowrap">Step-up</FONT> Date
shall not exceed a total of 0.100% if the Guarantor has achieved two of the three Sustainability Performance Targets as of the Testing Date and certified to such on or prior to the Certification Date; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(C)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the increase in the Interest Rate on the Notes on the <FONT STYLE="white-space:nowrap">Step-up</FONT> Date
shall not exceed a total of 0.200%if the Guarantor has met one of the three Sustainability Performance Targets as of the Testing Date and certified to such on or prior to the Certification Date; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(D)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in no event shall the total increase in the Interest Rate on the Notes on the
<FONT STYLE="white-space:nowrap">Step-up</FONT> Date exceed 0.300% (this being the consequence of the Guarantor failing to achieve any of the three Sustainability Performance Targets on the Testing Date and failing to certify to achievement on or
prior to the Certification Date). </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Method of Payment.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interest on any Note which is payable, and is punctually paid or duly provided for, on any Interest Payment Date shall be paid to the person
in whose name that Note (or one or more Predecessor Notes) is registered at the close of business on the relevant Regular Record Date for such interest. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Principal of and interest on Global Notes shall be payable to the Depositary in immediately available funds. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Principal of Physical Notes will be payable at the office or agency of the Issuer maintained for such purpose, initially the Corporate Trust
Office of the Trustee. Interest on Physical Notes will be payable by (i)&nbsp;U.S.&nbsp;Dollar check drawn on a bank in The City of New York delivered to the address of the Person entitled thereto as such address shall appear in the register of the
Notes, or (ii)&nbsp;upon written application to the Registrar not later than the relevant Record Date by a Holder of an aggregate principal amount of Notes in excess of $5,000,000, wire transfer in immediately available funds, which application and
written wire instructions shall remain in effect until the Holder notifies, in writing, the Registrar to the contrary. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Paying Agent and Registrar.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Initially, The Bank of New York Mellon, the Trustee under the Supplemental Indenture, will act as Paying Agent and Registrar. The Issuer may
change the Paying Agent or Registrar without notice to any Holder. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Supplemental Indentures and Indenture.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Issuer issued this Note under a Base Indenture (the &#147;<U>Base Indenture</U>&#148;), dated as of March&nbsp;14, 2018, by and among the
Issuer, the Guarantor and The Bank of New York Mellon, as trustee (the &#147;<U>Trustee</U>&#148;), as supplemented by a first supplemental senior indenture, dated as of March&nbsp;14, 2018, by and among the Issuer, the Guarantor and the Trustee, a
second supplemental senior indenture, dated as of November&nbsp;25, 2019, by and among the Issuer, the Guarantor and the Trustee, a third supplemental senior indenture, dated as of November<U></U>&nbsp;9, 2021, by and among the Issuer, the Guarantor
and the Trustee and as further supplemented by a fourth supplemental senior indenture (the &#147;<U>Supplem</U><U>ental Indenture</U>&#148; and, together with the Base Indenture, the &#147;<U>Indenture</U>&#148;), dated as of March&nbsp;9, 2023, by
and among the Issuer, the Guarantor and the Trustee. The terms of the Note include those stated in the Indenture, and those made part of the Indenture by reference to the Trust Indenture Act of 1939, as amended (&#147;<U>TIA</U>&#148;). This Note is
subject to all such terms, and Holders are referred to the Indenture and the TIA for a statement of all such terms. To the extent permitted by applicable law, in the event of any inconsistency between the terms of this Note and the terms of the
Indenture, the terms of the Indenture shall control. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Optional Redemption.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Issuer may at its option redeem this Note, in whole or in part, at any time or from time to time, on any date prior to the Stated
Maturity, upon notice as set forth in Section&nbsp;4.2 of the Supplemental Indenture, at a Redemption Price equal to the greater of (1) 100% of the principal amount of the Notes to be redeemed or (2)&nbsp;the sum of the present values of the
Remaining Scheduled Payments of the Notes being redeemed discounted, on a semi-annual basis (assuming a <FONT STYLE="white-space:nowrap">360-day</FONT> year consisting of twelve <FONT STYLE="white-space:nowrap">30-day</FONT> months), using a
discount rate equal to the sum of the Treasury Rate plus 50 basis points, plus accrued and unpaid interest thereon, if any, to, but not including, the Redemption Date; <I>provided</I> that if the Issuer redeems the Notes on or after the applicable
Par Call Date, the Redemption Price for such Notes will be equal to 100% of the aggregate principal amount of the Notes being redeemed, plus accrued and unpaid interest thereon, if any, to, but not including, the Redemption Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On and after the Redemption Date, interest shall cease to accrue on Notes or portions of Notes called for redemption, unless the Issuer
defaults in the payment of the Redemption Price. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notice of redemption will be given by the Issuer to the Holders as provided in the
Supplemental Indenture. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">7.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Tax Redemption.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If, as a result of any change in or amendment to the laws (or any regulations or rulings promulgated thereunder) of any Taxing Jurisdiction or
any political subdivision or taxing authority thereof or in any Taxing Jurisdiction affecting taxation or any change in official position regarding the application or interpretation of such laws, regulations or rulings, which change or amendment
becomes effective or, in the case of a change in official position, is announced on or after the issuance of the Notes, the Issuer or the Guarantor (or any of their respective successors), as the case may be, is or will be obligated to pay any
Additional Tax Amount with respect to the Notes (of any series thereof), and if the Issuer or the Guarantor (or any of their respective successors), as the case may be, determines that such obligation cannot be avoided by the Issuer or the Guarantor
(or any of their respective successors), as the case may be, after taking reasonable measures available to it, then at the option of the Issuer or the Guarantor (or any of their respective successors), as the case may be, the Notes (of any series
thereof) may be redeemed in whole, but not in part, at any time, upon the giving not less than 10 days&#146; nor more than 60 days&#146; notice to the Trustee and the Holders of such Notes, at the Redemption Price; provided, however, that
(1)&nbsp;no notice of such tax redemption may be given earlier than 90 days prior to the earliest date on which the Issuer or the Guarantor (or their respective successors), as the case may be, would, but for such redemption, be obligated to pay
such Additional Tax Amounts were a payment on such Notes then due, and (2)&nbsp;at the time such notice is given, such obligation to pay such Additional Tax Amounts remains in effect. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">8.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Denominations; Transfer; Exchange.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes are issuable in registered form, without coupons, in minimum denominations of $200,000 principal amount and integral multiples of
$1,000 in excess of $200,000. A Holder may register the transfer or exchange of Notes in accordance with the Indenture. The Issuer or the Trustee may require a Holder, among other things, to furnish appropriate endorsements and transfer documents,
and the Issuer may require a Holder to pay any taxes or other governmental charges that may be imposed in connection with any exchange or registration of transfer of Notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Issuer shall not be required to exchange or register a transfer of (a)&nbsp;any Note for a period of 15 days next preceding the first
delivery of notice of redemption of Notes to be redeemed, (b)&nbsp;any Notes selected, called or being called for redemption except, in the case of any Note where notice has been given that such Note is to be redeemed in part, the portion thereof
not so to be redeemed or (c)&nbsp;any Notes between a record date and the next succeeding payment date. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event of redemption of the Notes in part only, in the case of a Global Note, the
aggregate principal amount of such Global Notes may be increased or decreased by adjustments made on the records of the Depositary or, if necessary, a new Note or Notes for the unredeemed portion thereof will be issued in the name of the Holder
hereof. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">9.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Holders to be Treated as Owners.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The registered Holder of this Note shall be treated as its owner for all purposes. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">10.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Unclaimed Money.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any moneys deposited with or paid to the Trustee or any Paying Agent for the payment of the principal of or interest on any Note and not
applied but remaining unclaimed for two years after the date upon which such principal or interest shall have become due and payable, shall, upon the written request of the Issuer and unless otherwise required by mandatory provisions of applicable
escheat or abandoned or unclaimed property law, be repaid to the Issuer by the Trustee or such Paying Agent, and the Holder of such Note shall, unless otherwise required by mandatory provisions of applicable escheat or abandoned or unclaimed
property laws, thereafter look only to the Issuer for any payment which such Holder may be entitled to collect, and all liability of the Trustee or any Paying Agent with respect to such moneys shall thereupon cease. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">11.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Satisfaction and Discharge.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Issuer and the Guarantor may satisfy and discharge their obligations under the Indenture while the Notes remain outstanding, if
(a)&nbsp;all Outstanding Notes have become due and payable at their scheduled Maturity, or (b)&nbsp;all Outstanding Notes have been called for redemption, and in either case, the Issuer has deposited with the Trustee an amount sufficient to pay and
discharge all Outstanding Notes on the date of their scheduled Maturity or the scheduled Redemption Date, as the case may be. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">12.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Supplement; Waiver.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Without notice to or the consent of the Holders of the Notes, the Indenture and the Notes may be amended, supplemented or otherwise modified
by the Issuer, the Guarantor and the Trustee as provided in the Indenture. The Indenture permits, with certain exceptions as therein provided, the amendment thereof and the modification of the rights and obligations of the Issuer and the rights of
the Holders of the Notes under the Indenture at any time by the Issuer and the Trustee with the consent of the Holders of a majority in aggregate principal amount of the Outstanding Notes (or such lesser amount as shall have acted at a meeting
pursuant to the provisions of the Indenture). The Indenture also contains provisions permitting the Holders of specified percentages in principal amount of the Notes at the time Outstanding, on behalf of the Holders of all the Notes, to waive
compliance by the Issuer with certain provisions of the Indenture and certain past defaults under the Indenture and their consequences. Any such consent or waiver by the Holder of this Note shall be conclusive and binding upon such Holder and upon
all future Holders of this Note and of any Note issued upon registration of transfer hereof or in exchange herefor or in lieu hereof, whether or not notation of such consent or waiver is made upon this Note or such other Note. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No reference herein to the Indenture and no provision of this Note or of the Indenture shall alter or impair the obligation of the Issuer,
which is absolute and unconditional, to pay the principal of and interest on this Note at the times, places and rate, and in the coin or currency, herein prescribed. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">13.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Defaults and Remedies.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Indenture provides that an Event of Default with respect to the Notes occurs when any of the following occurs: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) the Issuer defaults in the payment of the principal and premium, if any, of any of the Notes when it becomes due and payable at Maturity
or upon redemption; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) the Issuer defaults in the payment of interest (including Additional Tax Amounts, if
any) on any of the Notes when it becomes due and payable and such default continues for a period of 30 days after the date when due; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)
the Guarantor fails to perform its obligations under the Guarantees; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) except as permitted by the Indenture, the Guarantees is held in
any final, <FONT STYLE="white-space:nowrap">non-appealable</FONT> judicial proceeding to be unenforceable or invalid or shall cease for any reason to be in full force and effect or the Guarantor, or any person acting on behalf of the Guarantor,
shall deny or disaffirm its obligations under the Guarantees; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) either the Issuer or the Guarantor fails to perform or observe any
other term, covenant or agreement contained in the Notes or the Indenture and the default continues for a period of 60 days after written notice of such failure, requiring the Issuer or the Guarantor, as the case may be, to remedy the same, shall
have been given to the Issuer or the Guarantor, as the case may be, by the Trustee or to the Issuer or the Guarantor, as the case may be, and the Trustee by the Holders of at least 25% in aggregate principal amount of the Outstanding Notes (provided
that such notice may not be given with respect to any action taken, and reported publicly or to holders of such series of the Notes, more than two years prior to such notice; provided further that the trustee shall have no obligation to determine
when or if any holders have been notified of any such action or to track when such <FONT STYLE="white-space:nowrap">two-year</FONT> period starts or concludes); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) (i) the Issuer or the Guarantor fails to make by the end of the applicable grace period, if any, any payment of principal or interest due
in respect of any Indebtedness for borrowed money, the aggregate outstanding principal amount of which is an amount in excess of $250,000,000; or (ii)&nbsp;there is an acceleration of any Indebtedness for borrowed money in an amount in excess of
$250,000,000 because of a default with respect to such Indebtedness, without, in the case of either (i)&nbsp;or (ii) above, such Indebtedness having been discharged or such <FONT STYLE="white-space:nowrap">non-payment</FONT> or acceleration having
been cured, waived, rescinded or annulled for a period of 30 days after written notice to the Issuer by the Trustee or to the Issuer and the Trustee by the Holders of at least 25% in aggregate principal amount of the Outstanding Notes of such
series; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) the occurrence of certain events of bankruptcy, insolvency or reorganization of the Issuer or Guarantor as specified in
the Supplemental Indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If an Event of Default shall occur and be continuing, the principal of all the Notes may be declared due and
payable in the manner and with the effect provided in the Supplemental Indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any time period in this Supplemental Indenture, the
Base Indenture or the Notes to cure any actual or alleged default or event of default may be extended or stayed by a court of competent jurisdiction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the avoidance of doubt, failure to achieve one or more Sustainability Performance Targets shall not constitute a Default or an Event of
Default with respect to the Notes. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">14.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Authentication.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Note shall not be valid until the Trustee (or authenticating agent) executes the certificate of authentication on the other side of this
Note. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">15.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>CUSIP Numbers.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Issuer has caused CUSIP numbers to be printed on this Note and, therefore, the Trustee shall use CUSIP numbers in notices of redemption as
a convenience to Holders. Any such notice may state that no representation is made as to the correctness of such numbers either as printed on the Notes or as contained in any notice of a redemption and that reliance may be placed only on the other
identification numbers printed on the Notes, and any such redemption shall not be affected by any defect in or omission of such numbers. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">16.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Governing Law.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Supplemental Indenture, the Base Indenture and this Note shall be governed by, and construed in accordance with, the laws of the State of
New York. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">17.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Successor Corporation.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event a successor corporation legal entity assumes all the obligations of the Issuer or the Guarantor under this Note, pursuant to the
terms hereof and of the Indenture, the Issuer or Guarantor, as the case may be, will be released from all such obligations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ASSIGNMENT FORM </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To assign this Note, fill in the form below and have your signature guaranteed: (I)&nbsp;or (we) assign and transfer this Note to: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="20%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="79%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">(Insert assignee&#146;s soc. sec. or tax I.D. no.)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">(Print or type assignee&#146;s name, address and zip code)</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">and irrevocably appoint<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> <U></U>to transfer this
Note on the books of the Issuer. The agent may substitute another to act for him. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="37%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="43%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Dated:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Your</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(Print your name exactly as it appears on the face of this Note)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Your</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Signature:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(Sign exactly as your name appears on the face of this Note)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Signature Guarantee<SUP STYLE="font-size:75%; vertical-align:top">*</SUP>:</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Participant in a recognized Signature Guarantee Medallion Program (or other signature guarantor acceptable
to the Trustee).</I> </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SCHEDULE OF INCREASES OR DECREASES IN THE GLOBAL NOTE </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The initial outstanding principal amount of this Global Note is $500,000,000. The following exchanges of a part of this Global Note for an
interest in another Global Note or for a Physical Note, or exchanges of a part of another Global Note or Physical Note for an interest in this Global Note, have been made: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="18%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="19%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="20%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="20%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="19%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Date of</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Exchange</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Amount of</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">decrease in</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Principal Amount</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">of this Global</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Note</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Amount of</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">increase in</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Principal Amount</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">of this Global</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Note</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Principal Amount</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">of this Global</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Note following</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">such decrease or</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">increase</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Signature of</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">authorized</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">signatory of</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Trustee</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-15 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>4
<FILENAME>d475718dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-5.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 5.1 </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g475718dsp6a.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">March&nbsp;9, 2023 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Teva Pharmaceutical Industries Limited </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Teva Pharmaceutical
Finance Netherlands II B.V. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Teva Pharmaceutical Finance Netherlands III B.V. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c/o Teva Pharmaceutical Industries Limited </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">124 Dvorah
Hanevi&#146;a Street </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tel Aviv 6944020 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Israel </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Re: <U>Registration Statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT></U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are acting as Israeli counsel for Teva
Pharmaceutical Industries Limited, an Israeli corporation (the &#147;<U>Teva</U>&#148; or the &#147;<U>Company</U>&#148;), in connection with the execution and delivery by the Company of an underwriting agreement, dated March&nbsp;1, 2023 (the
&#147;<U>Underwriting Agreement</U>&#148;), among Teva Pharmaceutical Finance Netherlands II B.V. (the &#147;<U>Euro Issuer</U>&#148;) and Teva Pharmaceutical Finance Netherlands III B.V. (the &#147;<U>USD Issuer</U>&#148;), each a private company
with limited liability organized under the laws of The Netherlands, the Company and the several underwriters named in Schedule I thereto (the &#147;<U>Underwriters</U>&#148;), relating to the sale : (i) by the Euro Issuer of &#128;800,000,000
aggregate principal amount of the 7.375% Sustainability-Linked Senior Notes due 2029 (the &#147;<U>2029 Euro Notes</U>&#148;); and &#128;500,000,000 aggregate principal amount of the 7.875% Sustainability-Linked Senior Notes due 2031 (the
&#147;<U>2031 Euro Notes</U>&#148;, and together with the 2029 Euro Notes, the &#147;<U>Euro Notes</U>&#148;); and (ii)&nbsp;by the USD Issuer of $600,000,000 aggregate principal amount of the 7.875% Sustainability-Linked Senior Notes due 2029 (the
&#147;<U>2029 USD notes</U>&#148;); and $500,000,000 aggregate principal amount of the 8.125% Sustainability-Linked Senior Notes due 2031 (the &#147;<U>2031 USD Notes</U>&#148;, and together with the 2029 USD Notes, the &#147;<U>USD Notes</U>&#148;,
and collectively with the Euro Notes, the &#147;<U>Notes</U>&#148;). The Notes are being offered pursuant to Rule 415 under the Securities Act of 1933, as amended (the &#147;<U>Securities Act</U>&#148;), and have been registered under the
Company&#146;s Registration Statement on Form <FONT STYLE="white-space:nowrap">S-3ASR,</FONT> filed with the Securities and Exchange Commission on October&nbsp;27, 2021 (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-260519)</FONT> (the
&#147;<U>Registration Statement</U>&#148;). The Euro Notes are being issued under a senior indenture dated as of March&nbsp;14, 2018, as supplemented by a fourth supplemental indenture, dated March&nbsp;9, 2023, (such indenture, so supplemented, the
&#147;<U>Euro Notes Indenture</U>&#148;), among the Euro Issuer, the Company and The Bank of New York Mellon, as Trustee (the &#147;<U>Trustee</U>&#148;) and The Bank of New York Mellon, London branch, as paying agent. The USD Notes are being issued
under a senior indenture dated as of March&nbsp;14, 2018, as supplemented by a fourth supplemental indenture, dated March&nbsp;9, 2023, (such indenture, so supplemented, the &#147;<U>USD Notes Indenture</U>&#148;, and together with the Euro Notes
Indenture, the &#147;<U>Indentures</U>&#148;), among the USD Issuer, the Company and The Bank of New York Mellon, as Trustee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of the
opinions hereinafter expressed, we have examined the Company&#146;s Articles of Association and such corporate resolutions and records, as well as such other materials, as we have deemed necessary as a basis for the opinions expressed herein.
Insofar as the opinions expressed herein involve factual matters, we have relied (without independent factual investigation), to the extent we deemed proper or necessary, upon certificates of, and other communications with, officers and employees of
Teva and upon certificates of public officials. We have also considered such questions of Israeli law as we have deemed relevant and necessary as a basis for the opinions hereinafter expressed. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g475718dsp6.jpg" ALT="LOGO">
 </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g475718dsp6a.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In making our examination and in rendering the opinions set forth below, we have assumed, without any
investigation, the genuineness of all signatures on original documents of all persons, the legal competence and capacity of natural persons, the authenticity and completeness of all documents submitted to us as originals, the conformity to authentic
original documents of all documents submitted to us as certified, photostatic or facsimile copies and the authenticity of the originals of such copies and the legal capacity and due authenticity of all persons executing such documents, that the
documents examined by us have not been amended, supplemented or otherwise modified, or determined by a court of competent jurisdiction to be illegal or void, revoked, annulled, terminated or otherwise modified and that there are no agreements or
understandings among the parties, written or oral, and that there is no usage of trade or course of prior dealing among the parties that would, in either case, expand, modify, supplant or qualify or otherwise affect or be inconsistent with the terms
of the Underwriting Agreement, the Indentures and the Notes (the &#147;<U>Operative Documents</U>&#148;) or the respective rights or obligations of the parties thereunder. We have assumed, without any investigation, the same to have been properly
given and to be accurate, and we have assumed that all consents, minutes and protocols of meetings of the Company&#146;s board of directors and shareholders which have been provided to us are true, accurate and have been properly prepared in
accordance with the Company&#146;s incorporation documents and all applicable laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Insofar as this opinion relates to factual matters, information with
respect to which is in possession of the Company, we have relied (without independent investigation) upon and have assumed the truth and accuracy of the representations by the Company in the Underwriting Agreement (including the schedules thereto)
and representations or certificates of, or communications with, directors, officers, employees or representatives of the Company and certain public officials. We have not examined any records of any court, administrative tribunal or other similar
entity in connection with our opinion expressed herein. Except to the extent expressly set forth herein, we have not undertaken any independent investigation to determine the existence or absence of any fact, and no inference as to our knowledge of
the existence or absence of any fact should be drawn from our representation of the Company or the rendering of the opinion set forth below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The opinions
hereinafter expressed are qualified to the extent that the validity or enforceability of any of the agreements, documents or obligations referred to herein may be limited by, subject to or affected by applicable bankruptcy, insolvency,
reorganization, moratorium or other laws relating to or affecting the rights of creditors generally, or by statutory or decisional law concerning recourse by creditors to security in the absence of notice and hearing, or by general equitable
principles (regardless of whether enforcement is sought in equity or at law), including principles of commercial reasonableness or conceivability and an implied covenant of good faith and fair dealing, or by the discretionary powers of any court or
administrative body. We do not express any opinion herein as to the availability of any equitable or other specific remedy, including specific performance, upon breach of any of the agreements, documents or obligations referred to herein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with all of the opinions expressed below, we have assumed, without any investigation, that, at or prior to the time of the delivery of the
Notes, (i)&nbsp;the Company has received the consideration provided for pursuant to the relevant corporate action and, if applicable, the underwriting agreements; (ii)&nbsp;the Registration Statement (including any post-effective amendments) is
effective under the Securities Act, and such effectiveness shall not have been terminated or rescinded; and (iii)&nbsp;there shall not have occurred any change in law affecting the validity or enforceability of any such security. We have also
assumed due authorization, execution and delivery of the all documents, including the Operative Documents, by the parties thereto other than the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g475718dsp6.jpg" ALT="LOGO">
 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g475718dsp6a.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have also assumed, other than with respect to the Company, (i)&nbsp;the due organization, valid corporate
existence (or similar existence with respect to <FONT STYLE="white-space:nowrap">non-corporate</FONT> entities) and good standing of each of the parties to the Underwriting Agreement under the laws of its jurisdiction of establishment, and
(ii)&nbsp;that each of the parties to the Underwriting Agreement has all requisite power and authority (corporate, partnership or otherwise, as applicable) to execute, deliver and perform the Underwriting Agreement and the agreements, instruments
and documents executed by it in connection therewith, and, to the extent applicable, has taken all action (corporate, partnership or otherwise) and obtained all consents and approvals necessary for the execution, delivery and performance by such
party of the Underwriting Agreement and of the agreements, instruments and documents executed by it in connection therewith, and to effect the Indentures and the issuance of the Notes and the consummation of the transactions contemplated thereby.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our opinions expressed below are only with respect to the specific and express legal issues addressed, and do not and are not intended to address any
other legal issues. No other opinions may be implied from the specific and express opinions set forth below, nor may the taking of any actions on our part be inferred or implied unless specifically and expressly stated. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our opinions expressed below are based upon, and limited to, our consideration of only those statutes, rules and regulations of the State of Israel which, in
our experience, are normally applicable to guarantors of securities of the nature of the Notes. Whenever a statement herein is qualified by &#147;our knowledge&#148; or a similar phrase, it is intended to indicate that those attorneys in this firm
who have rendered substantive legal services in connection with the referenced documents do not have current actual knowledge of the inaccuracy of such statement. However, except as otherwise expressly indicated, we have not undertaken any
independent investigation to determine the accuracy of any such statement, and no inference that we have any knowledge of any matters pertaining to such statement should be drawn from our representation of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Further, the governing law of the Operative Documents is not the law of Israel and we therefore express no opinion in respect to matters governed by or
construed in accordance with the laws of any jurisdiction other than the laws of the State of Israel and as to any questions of law relating to interpretation of the Operative Documents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Based on and subject to the foregoing, we are of the opinion that Teva&#146;s guarantees for the Notes under the Indentures are have been duly
authorized&nbsp;and are binding obligations of Teva. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We do not purport to be expert on the laws of any jurisdiction other than the laws of the State of
Israel, and we express no opinion herein as to the effect of any other laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This opinion shall be governed by the laws of the State of Israel and
interpreted in accordance with the laws of the State of Israel, without regard to the choice of laws principles of the State of Israel, as to all matters, including matters of validity, construction, affect, enforceability, performance and remedies
and exclusive jurisdiction with respect thereto under all and any circumstances. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We hereby consent to the filing of this opinion as an exhibit to the
Company&#146;s Current Report on Form <FONT STYLE="white-space:nowrap">8-K,</FONT> which is incorporated into the Registration Statement and in accordance with the requirements of Item 601(b)(5) of Regulation
<FONT STYLE="white-space:nowrap">S-K</FONT> promulgated under the Securities Act. By giving our consent, we do not admit that we are in the category of persons whose consent is required under Section&nbsp;7 of the Securities Act or the rules and
regulations issued or promulgated thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This opinion is being delivered to you for your information in connection with the above matter and
addresses matters only as of the date hereof and we assume no obligation to update (including, without limitation, with respect to any action which may be required in the future to perfect or continue the perfection of any security interest) or to
supplement such opinions to reflect any fact or circumstance that hereafter may come to our attention or any change in law that hereafter may occur or become effective. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g475718dsp6.jpg" ALT="LOGO">
 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g475718dsp6a.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The opinions expressed herein represent the judgment of this law firm as to the legal matters addressed
herein but they are not guarantees or warranties as to how a court might rule on such matters and should not be construed as such. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">/s/ Agmon with Tulchinsky</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">Agmon with Tulchinsky</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g475718dsp6.jpg" ALT="LOGO">
 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.2
<SEQUENCE>5
<FILENAME>d475718dex52.htm
<DESCRIPTION>EX-5.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-5.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 5.2 </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g475718dsp10.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">601 Lexington Avenue</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">New York, NY 10022</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">United States</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Facsimile:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">+1 212 446 4800</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">+1 212 446 4900</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">www.kirkland.com</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">March&nbsp;9, 2023 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Teva Pharmaceutical Industries Limited </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">124 Dvora Hanevi&#146;a
Street </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tel Aviv, 6944020 Israel </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are issuing this opinion letter in our capacity as special counsel for and at the request of Teva Pharmaceutical Finance Netherlands II B.V.
(the &#147;Euro Issuer&#148;) and Teva Pharmaceutical Finance Netherlands III B.V. (the &#147;USD Issuer&#148;), each a Dutch private limited liability company (together, the &#147;Issuers&#148;), and Teva Pharmaceutical Industries Limited, an
Israeli corporation (the &#147;Guarantor&#148;), in connection with the issuance and sale by the Euro Issuer of &#128;800,000,000 aggregate principal amount of its 7.375% Sustainability-Linked Senior Notes due 2029 (the &#147;2029 Euro Notes&#148;)
and of &#128;500,000,000 aggregate principal amount of its 7.875% Sustainability-Linked Senior Notes due 2031 (the &#147;2031 Euro Notes&#148; and, together with the 2029 Euro Notes, the &#147;Euro Notes&#148;) and the issuance and sale by the USD
Issuer of $600,000,000 aggregate principal amount of its 7.875% Sustainability-Linked Senior Notes due 2029 (the &#147;2029 USD Notes&#148;) and $500,000,000 aggregate principal amount of its 8.125% Sustainability-Linked Senior Notes due 2031 (the
&#147;2031 USD Notes&#148; and, together with the 2029 USD Notes, the &#147;USD Notes&#148; and, together with the Euro Notes, the &#147;Notes&#148;) under the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), which are guaranteed
by the Guarantor (the &#147;Guarantee&#148;). The Notes are being issued pursuant to a registration statement on Form <FONT STYLE="white-space:nowrap">S-3ASR</FONT> (No. <FONT STYLE="white-space:nowrap">333-213290)</FONT> (the &#147;Registration
Statement&#148;) filed by the Issuers, the Guarantor and certain other finance subsidiaries of the Guarantor with the Securities and Exchange Commission (the &#147;Commission&#148;) on October&nbsp;27, 2021, including a base prospectus dated
October&nbsp;27, 2021 (the &#147;Base Prospectus&#148;), a preliminary prospectus supplement dated February&nbsp;27, 2023 (the &#147;Preliminary Prospectus Supplement&#148;) and a final prospectus supplement dated March&nbsp;1, 2023 (together with
the Base Prospectus and the Preliminary Prospectus Supplement, the &#147;Prospectus&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In that connection, we have examined
originals, or copies certified or otherwise identified to our satisfaction, of such documents, corporate records and other instruments as we have deemed necessary for the purposes of this opinion, including (i)&nbsp;the Registration Statement and
the exhibits thereto and the Prospectus, (ii)&nbsp;the indenture, dated as of March&nbsp;14, 2018 (the &#147;Euro Notes Base Indenture&#148;), by and among the Euro Issuer, the Guarantor and The Bank of New York Mellon, as trustee (in such capacity,
the &#147;Trustee&#148;), as supplemented by the Fourth </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Austin &nbsp;Bay Area &nbsp;Beijing &nbsp;Boston &nbsp;Brussels &nbsp;Dallas
&nbsp;Hong Kong &nbsp;Houston &nbsp;London &nbsp;Los Angeles &nbsp;Munich &nbsp;New York &nbsp;Paris &nbsp;Salt Lake City &nbsp;Shanghai &nbsp;Washington, D.C. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g475718dsp11.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Teva Pharmaceutical Industries Limited </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">March&nbsp;9, 2023 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 2
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Supplemental Indenture relating to the Euro Notes, dated as of March&nbsp;9, 2023 (the &#147;Euro Notes
Supplemental Indenture&#148; and, together with the Euro Notes Base Indenture, the &#147;Euro Notes Indenture&#148;), by and among the Euro Issuer, the Guarantor, the Trustee and The Bank of New York Mellon, London Branch, as paying agent,
(iii)&nbsp;the indenture, dated as of March&nbsp;14, 2018 (the &#147;USD Notes Base Indenture&#148;), by and among the USD Issuer, the Guarantor and the Trustee, as supplemented by the Fourth Supplemental Indenture relating to the USD Notes, dated
as of March&nbsp;9, 2023 (the &#147;USD Notes Supplemental Indenture&#148; and, together with the USD Notes Base Indenture, the &#147;USD Notes Indenture&#148;), by and among the USD Issuer, the Guarantor, and the Trustee, and (iv)&nbsp;copies of
the Notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of this opinion, we have assumed the authenticity of all documents submitted to us as originals, the conformity
to the originals of all documents submitted to us as copies and the authenticity of the originals of all documents submitted to us as copies. We have also assumed the genuineness of the signatures of persons signing all documents in connection with
which this opinion is rendered, the authority of such persons signing on behalf of the parties thereto, and the due authorization, execution and delivery of all documents by the parties thereto. As to any facts material to the opinions expressed
herein that we have not independently established or verified, we have relied upon statements and representations of officers and other representatives of the Issuers and the Guarantor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our opinion expressed below is subject to the qualifications that we express no opinion as to the applicability of, compliance with, or effect
of (i)&nbsp;any bankruptcy, insolvency, reorganization, fraudulent transfer, fraudulent conveyance, moratorium or other similar law affecting the enforcement of creditors&#146; rights generally, (ii)&nbsp;general principals of equity (regardless of
whether enforcement is considered in a proceeding in equity or at law), and (iii)&nbsp;public policy considerations that may limit the rights of parties to obtain certain remedies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based upon and subject to the foregoing qualifications, assumptions and limitations and the further limitations set forth below, we are of the
opinion that the Notes are binding obligations of the Issuers and the Guarantor, as applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We hereby consent to the filing of this
opinion as Exhibit 5.2 to the Guarantor&#146;s Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> in connection with the sale of the Notes and to its incorporation into the Registration Statement. We also consent to the reference to
our firm under the heading &#147;Legal Matters&#148; in the Prospectus with respect to the Notes constituting part of the Registration Statement. In giving this consent, we do not thereby admit that we are in the category of persons whose consent is
required under Section&nbsp;7 of the Securities Act or the rules and regulations of the Commission promulgated thereunder. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g475718dsp11.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Teva Pharmaceutical Industries Limited </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">March&nbsp;9, 2023 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 3
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our advice on every legal issue addressed in this letter is based exclusively on the internal
law of the State of New York and represents our opinion as to how that issue would be resolved were it to be considered by the highest court in the jurisdiction which enacted such law. The manner in which any particular issue relating to the
opinions would be treated in any actual court case would depend in part on facts and circumstances particular to the case and would also depend on how the court involved chose to exercise the wide discretionary authority generally available to it.
None of the opinions or other advice contained in this letter considers or covers any foreign or state securities (or &#147;blue sky&#148;) laws or regulations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This opinion is limited to the specific issues addressed herein, and no opinion may be inferred or implied beyond that expressly stated
herein. This opinion speaks only as of the date hereof and we assume no obligation to revise or supplement this opinion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have also
assumed that the execution and delivery of the Euro Notes Indenture, the USD Notes Indenture, the Notes and the Guarantee and the performance by the Issuers and the Guarantor of their obligations thereunder do not and will not violate, conflict with
or constitute a default under any agreement or instrument to which either of the Issuers or the Guarantor are bound. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This opinion is
furnished to you in connection with the filing of the Guarantor&#146;s Current Report on Form <FONT STYLE="white-space:nowrap">8-K,</FONT> which is incorporated into the Registration Statement and in accordance with the requirements of Item
601(b)(5) of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> promulgated under the Securities Act, and is not to be used, circulated, quoted or otherwise relied upon for any other purposes. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Sincerely,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">/s/ KIRKLAND&nbsp;&amp; ELLIS LLP</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">KIRKLAND&nbsp;&amp; ELLIS LLP</TD></TR>
</TABLE></DIV>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.3
<SEQUENCE>6
<FILENAME>d475718dex53.htm
<DESCRIPTION>EX-5.3
<TEXT>
<HTML><HEAD>
<TITLE>EX-5.3</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 5.3 </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="84%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="15%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Teva Pharmaceutical Finance Netherlands II B.V.</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Teva Pharmaceutical Finance Netherlands III B.V.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Jachthavenweg 121</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1081 KM Amsterdam</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">P.O. Box 75265</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1070 AG Amsterdam</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">the Netherlands</P></TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="84%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="15%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c/o Teva Pharmaceutical Industries Limited</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">124
Dvora Hanevi&#146;a Street</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tel Aviv, 6944020</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Israel</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">T +31 20 6789 123</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">F +31 20 6789
589</P></TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="93%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">9 March 2023</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Our ref.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">40.00.3172</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Subject</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Registration Statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> ASR re: Teva Pharmaceutical Finance Netherlands II B.V. and
Teva</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Pharmaceutical Finance Netherlands III B.V.</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Sirs, </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have acted as
Dutch legal advisers to Teva Pharmaceutical Finance Netherlands II B.V. (<B>TPFN II</B>) and Teva Pharmaceutical Finance Netherlands III B.V. (<B>TPFN III</B>), each a Dutch private limited liability company (each a <B>Dutch Company</B>), in
connection with the issuance by TPFN II of (i) &#128;800,000,000 7.375% Sustainability-Linked Senior Notes due 2029 and (ii) &#128;500,000,000 7.875% Sustainability-Linked Senior Notes due 2031 (the <B>Euro Notes</B>) and with the issuance by TPFN
III of (i) $600,000,000 7.875% Sustainability-Linked Senior Notes due 2029 and (ii) $500,000,000 8.125% Sustainability-Linked Senior Notes due 2031 (the <B>Dollar Notes</B> and together with the Euro Notes: the <B>Notes</B>), guaranteed by Teva, to
be issued pursuant to the Indentures (as defined in Schedule 2 (<I>Documents</I>)) and registered under the Registration Statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> ASR filed by Teva Pharmaceutical Industries Limited, an Israeli
corporation (<B>Teva</B>) and the Dutch Companies (the <B>Registration Statement</B>), with the Securities and Exchange Commission pursuant to the Securities Act of 1933 (the <B>Act</B>), on 27&nbsp;October 2021. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the purpose of this opinion, we have examined and relied only on the documents listed in Schedule 2 (<I>Documents</I>) and Schedule 3 (<I>Corporate
Documents</I>), which shall form part of this opinion. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The documents listed in Schedule 2 are referred to as the <B>Documents </B>and the documents listed in
Schedule 3 as the <B>Corporate Documents</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Unless otherwise defined in this opinion (including Schedule 1) or unless the context otherwise requires,
words and expressions defined in the Documents shall have the same meanings when used in this opinion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with such examination and in giving
this opinion, we have assumed: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the genuineness of the signatures to the Documents and the Corporate Documents, the authenticity and
completeness of the Documents and the Corporate Documents submitted to us as originals, the conformity to the original documents of the Documents and Corporate Documents submitted to us as copies and the authenticity and completeness of those
original documents; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the due incorporation and valid existence of, the corporate power and authority of and the due authorization
and execution of the Documents by, each of the parties thereto (other than the Dutch Companies) under any applicable law (other than Dutch law); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the due compliance with all matters of, and the validity, binding effect and enforceability of the Documents
under, any applicable law (other than Dutch law) and in any jurisdiction (other than the Netherlands) in which an obligation under the Documents falls to be performed; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the due authorization and due execution by each Dutch Company of the Documents submitted to and examined by us
in draft in the form of those drafts; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(v)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">that (1)&nbsp;no resolution for the dissolution (<I>ontbinding</I>) of any Dutch Company has been taken and no
application has been made for the (opening of) any Insolvency Proceeding in respect of any Dutch Company, (2)&nbsp;none of the Dutch Companies has been dissolved, (3)&nbsp;none of the Dutch Companies is subject to any Insolvency Proceeding and
(4)&nbsp;no order for the administration of assets of any Dutch Company has been made; the assumptions referred to under (2)&nbsp;and (3) as to Dutch Insolvency Proceedings are supported by the Extracts and the Corporate Enquiries, it being noted
that (i)&nbsp;this does not constitute conclusive evidence thereof and (ii)&nbsp;a Dutch <FONT STYLE="white-space:nowrap">Pre-insolvency</FONT> Proceeding (as defined under qualification (B)) may be in the form of a confidential proceeding which the
Extracts and the Corporate Enquiries will not reveal; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(vi)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">that no party to the Documents is controlled by or otherwise connected with a person, organisation or country
which is subject to United Nations, European Union or Dutch sanctions implemented or effective in the Netherlands under or pursuant to the Sanction Act 1977 (<I>Sanctiewet 1977</I>), the Economic Offences Act (<I>Wet economische delicten</I>), the
General Customs Act (<I>Algemene Douanewet</I>) or Regulations of the European Union; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(vii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">that no Dutch Company takes deposits or other repayable funds from the public within the meaning of the
European Regulation No.&nbsp;575/2013 on prudential requirements for credit institutions and investment firms and the Notes will not be offered in the Netherlands; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Page 2</I> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(viii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">that the execution of and performance under the Documents by a Dutch Company are not prohibited or affected by
contractual restrictions or obligations binding on that Dutch Company; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ix)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">that any foreign law which may apply with respect to any of the Documents or the transactions contemplated
thereby does not affect this opinion. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This opinion is only given with respect to Dutch law in force as at the date hereof and as
generally interpreted on the basis of <FONT STYLE="white-space:nowrap">case-law</FONT> published at the date hereof. We do not express any opinion on: (i)&nbsp;matters of fact or the completeness or accuracy of the representations or warranties made
pursuant to the Documents, (ii)&nbsp;matters of foreign law, international law (including the law of the European Union to the extent not directly applicable in the Netherlands), tax law (except for any specific tax opinions contained herein) and
anti-trust and competition law (including the law of the European Union in respect of antitrust and competition), and (iii)&nbsp;commercial, accounting or <FONT STYLE="white-space:nowrap">non-legal</FONT> matters or on the ability of the parties to
meet their financial or other obligations under the Documents. We do not assume any obligation to advise the Dutch Companies (or any other person entitled to rely on this Opinion Letter) of subsequent changes in Dutch law or in the interpretation
thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Based on and subject to the foregoing and subject to the qualifications set out below and matters of fact, documents or events not disclosed to
us, we express the following opinion: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Notes have been duly authorized, executed, authenticated, issued and delivered in accordance with the
relevant Indenture by the relevant Dutch Company, and, as a matter of Dutch law, constitute valid and binding obligations of the relevant Dutch Company. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The opinion expressed above is subject to the following qualifications: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(A)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Our opinions expressed herein are subject to and limited by (i)&nbsp;Dutch or foreign laws and regulations
applicable to Insolvency Proceedings, including laws and regulations of general application relating to or affecting the rights of creditors or secured creditors and (ii)&nbsp;the provisions of the Insolvency Regulation. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(B)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Dutch Bankruptcy Act (<I>Faillissementswet</I>) provides for a composition outside Insolvency Proceedings
(<B>Dutch</B> <B><FONT STYLE="white-space:nowrap">Pre-Insolvency</FONT> Proceedings</B>). Dutch <FONT STYLE="white-space:nowrap">Pre-Insolvency</FONT> Proceedings are proceedings to restructure debt of companies in financial distress. Rights and
claims against a Dutch Company and security granted by a Dutch Company can be compromised as a result of a composition plan adopted and confirmed in Dutch <FONT STYLE="white-space:nowrap">Pre-Insolvency</FONT> Proceedings. A composition plan adopted
and confirmed in Dutch <FONT STYLE="white-space:nowrap">Pre-Insolvency</FONT> Proceedings can extend to rights and claims against entities that are not incorporated under Dutch law and/or are residing outside the Netherlands on the basis that there
is a connection with the Netherlands. In Dutch <FONT STYLE="white-space:nowrap">Pre-Insolvency</FONT> Proceedings, the Court can order a cooling down period (<I>afkoelingsperiode</I>). During such cooling down period: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any recourse on the assets of the relevant debtor will require the authorisation of the court; this includes
action to (i)&nbsp;enforce security over the assets of the debtor and (ii)&nbsp;collect pledged claims and to notify the debtors of such pledged claims of the right of pledge; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Page 3</I> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the debtor can continue to exercise any authority it had prior to the commencement of the cooling-down period
to use, consume and dispose of assets (included secured assets) and to collect pledged claims, in each case in the ordinary course of business and subject to the requirement that the interests of parties affected thereby are sufficiently protected;
and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">filings for bankruptcy or suspension of payments of the debtor are suspended. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(C)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The term &#147;enforceable&#148; used in the opinion above means that the obligations assumed by the relevant
party under the relevant document are of a type which the Dutch courts generally enforce and does not mean that those obligations will be necessarily enforced in accordance with their terms under all circumstances. In particular, the availability in
the Dutch courts of remedies, such as injunction and specific performance is at the discretion of the Dutch courts. The enforcement in the Netherlands of the Documents is subject to the Dutch rules of civil procedure as applied by the Dutch courts.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(C)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Foreign currency amounts claimed in a Dutch Insolvency Proceeding will be converted into euro for enforcement
purposes at the rate prevailing at the commencement of such Dutch Insolvency Proceeding. In addition, foreign currency amounts may have to be converted into euro for enforcement purposes. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(D)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Under the Dutch rules on fraudulent preference, the validity of a transaction (such as the execution of an
agreement or the giving of guarantees or security) entered into by a Dutch Company may be contested. In particular if a transaction entered into by a Dutch Company is prejudicial to the interests of its creditors, the validity of such transaction
may in certain circumstances be contested by such creditors or the public receiver in an Insolvency Proceeding of that Dutch Company. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(E)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Pursuant to the Dutch Act on Financial Supervision (<I>Wet op het financieel toezicht</I>) persons, firms or
companies (regardless of where they are domiciled) may only provide intermediary services in The Netherlands in respect of the Notes if they are licensed by the Netherlands Authority for the Financial Markets (<I>Autoriteit Financi&euml;le
Markten</I>) or exempt from such license requirement. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We hereby consent to the filing of this opinion as an exhibit to the Current
Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> filed by Teva and incorporated by reference into the Registration Statement. By giving our consent, we do not admit that we are in the category of persons whose consent is required under
Section&nbsp;7 of the Act or the rules and regulations promulgated thereunder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Page 4</I> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This opinion is being delivered to you for your information in connection with the above matter and
addresses matters only as of the date hereof. This opinion is strictly limited to the matters stated herein and is not to be read as extending by implication to any other matters in connection with the Documents or the Corporate Documents or
otherwise. This opinion is given subject to and may only be relied upon by you on the express conditions that (i)&nbsp;Van Doorne N.V. is the party issuing this opinion, (ii)&nbsp;&nbsp;&nbsp;&nbsp;any liability of individual persons or legal
entities involved in the services provided by or on behalf of Van Doorne N.V. is expressly excluded (<I>uitgesloten</I>), (iii) in respect of Dutch legal concepts, which are expressed in this opinion in English terms, the original Dutch terms will
prevail, (iv)&nbsp;this opinion and the opinions given herein are governed by Dutch law, (v)&nbsp;all disputes arising from or in connection with this opinion must be submitted to the exclusive jurisdiction of, and will be exclusively decided by,
the competent court in Amsterdam, the Netherlands, without prejudice to the right of appeal and appeal to the Supreme Court, and (vi)&nbsp;the aggregate liability of Van Doorne N.V. (and the individual persons and legal entities involved in the
services provided by or on behalf of Van Doorne N.V) in respect of this opinion towards the Dutch Companies and any other person will be limited to the amount which can be claimed under the professional liability insurance(s) taken out by Van Doorne
N.V., increased by the amount which Van Doorne N.V. has to bear as their own risk pursuant to the terms of such insurance(s). </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Yours faithfully,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B><I>/s/ Van Doorne N.V.</I></B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><I>Van Doorne N.V.</I></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Page 5</I> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SCHEDULE 1 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DEFINITIONS AND INTERPRETATION </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>1</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>INTERPRETATION </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any reference in this opinion to a &#147;person&#148; includes any individual person, firm, partnership,
company, corporation, government agency or administrative body or any other legal entity. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any reference in this opinion made to the laws of the Netherlands or Dutch law or to the Netherlands in a
geographical sense, should be read as: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a reference to the laws as in effect in that part of the Kingdom of the Netherlands that is located in
Continental Europe (<I>Europese deel van Nederland</I>); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a reference to the geographical part of the Kingdom of the Netherlands that is located in Continental Europe.
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>2</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>DEFINITIONS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In this opinion: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Dutch
Insolvency Proceeding </B>means a bankruptcy (<I>faillissement</I>) or a (provisional) suspension of payment (<I>(voorlopige) surseance van betaling</I>); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Indentures </B>means the Euro Notes Indenture and the USD Notes Indenture; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Insolvency Proceeding</B> means a Dutch Insolvency Proceeding or any foreign insolvency proceeding howsoever named (including without
limitation any insolvency proceeding referred to in the Insolvency Regulation or in Annex A to the Insolvency Regulation); and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Insolvency Regulation</B> means the Regulation (EU) 2015/848 of the European Parliament and of the Council of 20&nbsp;May 2015 on insolvency
proceedings (recast). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Page 6</I> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SCHEDULE 2 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DOCUMENTS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A copy of the signed Registration Statement dated on 27&nbsp;October 2021; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a signed copy of the indenture relating to the Euro Notes dated as of 14&nbsp;March 2018, as supplemented by a
first supplemental indenture dated 14&nbsp;March 2018, a second supplemental indenture dated 25&nbsp;November 2019 and a third supplemental debenture dated 9&nbsp;November 2021 (the <B>Euro Notes Base Indenture</B>); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a signed copy of a fourth supplemental indenture relating to the Euro Notes, dated 9 March 2023 and made
between TPFN II B.V., Teva Pharmaceutical Industries Limited, The Bank of New York Mellon as trustee, and The Bank of New York Mellon, London branch, as principal paying agent (the <B>Euro Notes Supplemental Indenture</B> and together with the Euro
Notes Base Indenture, the <B>Euro Notes Indenture</B>); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a signed copy of the indenture relating to the Dollar Notes dated as of 14&nbsp;March 2018, as supplemented by
a first supplemental indenture dated 14&nbsp;March 2018, a second supplemental indenture dated 25&nbsp;November 2019 and a third supplemental indenture dated 9&nbsp;November 2021 (the <B>USD Notes Base Indenture</B>); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a signed copy of a fourth supplemental indenture relating to the Dollar Notes, dated 9 March 2023 and made
between TPFN III B.V., Teva Pharmaceutical Industries Limited and The Bank of New York Mellon as trustee (the <B>USD Notes Supplemental Indenture</B> and together with the USD Notes Base Indenture, the <B>USD Notes Indenture</B>).
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Page 7</I> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE 3 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CORPORATE DOCUMENTS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A copy of the deed of incorporation of (i)&nbsp;TPFN II B.V. dated 16&nbsp;October 2013 and TPFN III B.V. dated
21&nbsp;September 2015; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a copy of (i)&nbsp;the articles of association of TPFN II B.V. dated 14&nbsp;November 2013 and (ii)&nbsp;the
articles of association of TPFN III B.V. as included in its Deed of Incorporation; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">an extract in respect of each Dutch Company from the Commercial Register, each dated the date of this opinion
(the <B>Extracts</B>). </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Page 8</I> </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>teva-20230309.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 3/10/2023 2:47:28 AM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2022"
  xmlns:teva="http://www.tevapharm.com/20230309"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.tevapharm.com/20230309"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" namespace="http://xbrl.sec.gov/dei/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd" namespace="http://xbrl.sec.gov/naics/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="teva-20230309_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="teva-20230309_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.tevapharm.com//20230309/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>teva-20230309_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 3/10/2023 2:47:28 AM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:type="locator" xlink:label="dei_EntityAddressCountry" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCountry_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Country</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCountry_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Country</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>teva-20230309_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 3/10/2023 2:47:28 AM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.tevapharm.com//20230309/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="teva-20230309.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.tevapharm.com//20230309/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:type="locator" xlink:label="dei_EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCountry" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>g475718dsp10.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g475718dsp10.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M^T6TC;R&P K(V,@G'S G'I0!U- !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % '_
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>g475718dsp11.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g475718dsp11.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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MRP(D2&0OE@,C=CDH>] &GH7C73M=U:XTD6]W8ZE;H)6MKR,(Y3.-PP2",^]
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6>?+<*\ID484;BOW1Z 4 =G0 4 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>g475718dsp6.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g475718dsp6.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@#B/&WBZ?3M7TSPOH[-_;6J+(4:-59K=0C;7(8$8W@=>P:@!GPI\5WOBC
MPHQU>8/K%E,T-T"@1LYRI*@ #CCIU4T =U0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % $4LDJ, D!D&.H8"@!GGW'_/HW_?:T 'GW'_
M #Z-_P!]K0 >?<?\^C?]]K0 >?<?\^C?]]K0 >?<?\^C?]]K0 >?<?\ /HW_
M 'VM !Y]Q_SZ-_WVM !Y]Q_SZ-_WVM !Y]Q_SZ-_WVM !Y]Q_P ^C?\ ?:T
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M +[% !Y]Q_SZ-_WVM !Y]Q_SZ-_WVM !Y]Q_SZ-_WVM !Y]Q_P ^C?\ ?:T
M'GW'_/HW_?:T 'GW'_/HW_?:T 'GW'_/HW_?:T 'GW'_ #Z-_P!]K0 >?<?\
M^C?]]K0 >?<?\^C?]]K0 >?<?\^C?]]K0 >?<?\ /HW_ 'VM !Y]Q_SZ-_WV
MM !Y]Q_SZ-_WVM !Y]Q_SZ-_WVM !Y]Q_P ^C?\ ?:T 'GW'_/HW_?:T 'GW
M'_/HW_?:T 'GW'_/HW_?:T 'GW'_ #Z-_P!]K0 >?<?\^C?]]K0 >?<?\^C?
M]]K0 >?<?\^C?]]K0 >?<?\ /HW_ 'VM !Y]Q_SZ-_WVM !Y]Q_SZ-_WVM !
MY]Q_SZ-_WVM !Y]Q_P ^C?\ ?:T 'GW'_/HW_?:T 'GW'_/HW_?:T 'GW'_/
MHW_?:T 'GW'_ #Z-_P!]K0 >?<?\^C?]]K0 >?<?\^C?]]K0 >?<?\^C?]]K
M0 >?<?\ /HW_ 'VM !Y]Q_SZ-_WVM !Y]Q_SZ-_WVM !Y]Q_SZ-_WVM !Y]Q
M_P ^C?\ ?:T 'GW'_/HW_?:T 'GW'_/HW_?:T 'GW'_/HW_?:T 'GW'_ #Z-
M_P!]K0 ^*25VP\!C&.I8&@"6@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H YWQQ::WJ'A"_L/#ZP_;[I/)#3/M5$;AC]<9 ]S0 [P9X3LO
M!?AFVT>R&=@WS2'K+(?O,?Z>P% $/COPT_BGPR]C!L%RDBRPES@9'!Y^A- &
MYIOVH:9:B^ %V(E$V#D;\<X]LT 6J "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M:^E*2W\WDP #.6X'/H.1S[T %WXAT^U:U591<O<3)"JV[*Y7<VW<1G[H/4T
M7X;NVN"!#<12$J'&QP?EZ9X[<'\J )J "@ H * "@ H * "@ H * "@ H *
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M#0!V% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 >>ZAX1U:Y^(ZZS#%']D^TP3>:T_14C*L/+Q@L<\
M'MCWH B\)> KW2OMZZC%;M(8/)AFW!RSY?$F-HVG#=>3R: ,[2OAQJ<>C16=
M];P$->VC3Q"8%7BCW!SP!U#=.I[F@#H/&'AS6+_6-+N]$@MHWLXRL,YE,9@;
M<O4=&0J"-N.] &3JO@+5;N/5/LT<$<MV;TE]X!<231O&#^"'Z4 .O? VK7.E
MZ7#$D43&\E:[C,@.R"2578 @ $_(#@ #DXH M^%/#'B&P\=WFM:NMJ(I;5X0
MT!4!B90P^4 8X'?)SWYH ]!H * "@ H * "@ H * "@ H * "@#G_%OAN3Q/
MIBV27WV9"2) T0D5U(QTR/F!P0<\$4 <WJ/PT@U;5=1$CRPP2Z;!;)<$JQ>5
M6!+[<]A'&#G&<F@"NWPDDDWM+KP:1Y;J5F%IC)GC"'C?VQGWSVH T+3X96=K
MKRZI)=&X40HC0F$9+I'LR&)X!ZX]>^* $^'WA[Q!X>M+*UO-L-KY4LEQ$65V
M\TN @R,\!%'0XH JM\*3Y<VW79!)<Q3).3!E6+R"0$#=\N"%R.<X[4 7;GX>
MSW=E##-K*F9=0>^>9;4*VYB#\OS94C'7)'/(X% &E9>#_L6K1WBW^^*/4)[Y
M8C%R#*C*R[L]BV<X]O>@#*T[X;'38KKR]7!FEG@G23[, 0T4C."WS?.3NP3Q
MT_"@"67X>>9<:3*=5)_L^X><*T&0=UQYW'S?*?X2><C\J .XH * "@ H * "
M@ H * "@ H Y"Y^(%E:QZN7M9=VFW:6I4$9E9CU'T )_"@#6U;Q%;Z;;SE%,
MEQ"4S$P9,AI%0D$CD MVS0!6U'QCI=FZQ03QW$PN8X9(U8@J&D\LL./FP<CC
MN,4 ::ZS8,MLRSY2YQY3[&VL3P!NQ@$^AYH S[KQ(]CKSV%SI[Q6J1><;PS+
MMV<#.W[WWB%QUH L+XHT1C;@:C#FX_U8YY^;9SZ?-\O..>* *^E^++"^T^2Y
MG<6[QR,CQ\L1^],:D<<Y('3N<4 7H]>TR1X42Z!,V OR-P2Q4 \?*2RL,''(
M(H HZ9XMTV]M+!KF>.UNKQ5982V<%B0HSC'.TXSC.#B@"W9>)-(U&01VE\DK
M$J!@$9W!BN,CD$(Q!]J ,_Q!XQMM"@T^=;66]BO4>53"0"(T3S&;YL9^4$X]
MJ +W_"2Z0ML;B2[\J(1+-ND1D&PD ,,CD9(''K0 MCKUI>ZA-9*ZK*K?NER=
MTB>7&Y;&.!^\ YH AU+Q"--UFVT\V4LJ2JA>9&4"/<X1<@G)^8CI0!#>^*H+
M+2WNGC'GB:2)(=Q^8)/Y6[...<=>YQ0!>UK68M$@MI989)/M%S';J$'0NP7)
M/8<T := !0 4 % &+J.O266L1:=%8-.6A,[R>:J!%!QT/)_"@"+2/%VF:E:6
M!EN(K>\NK=)C;E\[-RE@"<8S@$^I )H L1^)-/N'LEM7:=;N;RE9$;"_NS("
M>.A &#W!STH DM?$&EWOD?9KH2+.=L;A&V,>> V,9X/&<\4 5)O$<MKKTFGS
MZ9)';1JKFZ\U2,,2JX0?,26&W &<T 3/XIT2-XD?48T:4HJ!@027+*HZ>J,/
M;!S0 L?B?1ID5X[Y60Q>:&VMC;M+=<==JDXZX&: '7.OV<&E0:I&WFV,DBJT
MP. BD[=_/49Q^>: ,S3O&]C=+(]VHLT\N*1%9B\A#H7Y4#Y<*N>_'I0!<UOQ
M/::1I5S=J#-+';M/%&0RK* N[ ;&,XY]: )-5\0V^D-I231LSZC<+ BJ?NY&
M2Q]AQ^= $>F>)[.]M;=YR+>::1T6,9;&)3&"2!@9(&,XY.* +UGK&GW]Q);V
MMP'EC!++M(X#%21D<C((R.XH JQ^)=-N9+);.4W*W4QA5XU) ^1GSTZ$+U_P
M- $/B7Q3;^&A;B6UFN7F623;%@;8XUW.QR1T';J: %T_Q3::EKT^EP12?NDW
M"4D8;Y4;[N=P&)%Y( /- &[0 4 <;>_$.RLKF^MGLIVFM;I+8*"/WF[=\X]A
ML;/TH Z!]?TN-"[7B!0-W0\_/LX]?FXQZT )#XATFXD1(;U)-Z!U*@E2"I8<
MXQG:"<=< T 1W'B?1K1 \U^B@@$?*QZH7'0?W03^% $MIK=EJ=M<RZ7,EZ\"
MY\M&P22N5'/0,,8/3G- &9H/C73]:L[664?8IKKF*&1@Q*EBJDD<#+ @ ]2*
M -+_ (2+2 J,;^(!@A!)QPZLR_3(5C^% $</BG1+A83%J,3><_EQCG+-@$ #
M&>C*?H<]* )FU>(>(DT9(V>;[,;F1QTC7<%4'W)S_P!\F@"FOB:$:]<:;/:R
M0QQ%@+EG78Q5%=LC.1@,.<8]Z '#Q9HDA1(;^-YI"RQQ'(9F4 D8(XX93]#F
M@"#2O&6EZAHMK?RS"%I8PTD8#.(SL#L,@=%!!)[=\4 6[GQ1HED\B7&H1QM'
MNW*0<C:P4]O5@/QH K6GBNVFF$4L+K^ZDF+Q!I5 24Q]0O7C/M0!H-KFFK9V
MUV;D>1<IOB<*3N7&=W3@8YR>* ':9JD>I_:_+C=/LUPT#;U(R5QR/;F@"]0
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M=SIF#R\!MWW<Y;&.I/- %CQ'X,;Q$UJSZI+:O:VSQ1F)/XVV_.<GI\OW?UH
M2S\'S6@1/[11XQ(K./LY!(6X,P .[@Y8@GT]* -'3- _LZ]6X^T^9MBDCQLQ
M]^4R9Z]LXH J:7X6GTYH';4(W,5R+C:EMY:']VR-A0V%)W9XXR.G)H O:OH4
M>N6%M;7XMY"CHTC&#.X#&X+DY3=C!Y/!(]Z *UIX8%IXADU070(:5Y0@BPWS
M(J[2V>5&W(&/Y4 =!0 4 <I=^![>[FN9VNB)Y7E96\OA=[(>1GDC:0#Q]\T
M'_"'S#SU_M&)HWC,2(]KN 4S&0ALMSUQD8(ZC!H -,\&M82QO/J/VLA &DDB
M/F%A$8\AMV!P?0GWYH K_P#""2R-"TVJHS1;0-MMM!"P-"/XS_>S^&* -'PQ
MX6_X1M[AOMGVCSH+:''E[,>5'LSU/7K[>] &1IOP[_LZ.RB_M3S(X!!Y@\C!
M<Q3-*N#N^7EL'KT[4 ,3X:(;J>2;5I)(9C-F,0XP&B,: '/\"LW;DGM0!J:%
MX.71KBTG-S')) I4E+?9O^14!/S$Y^7]<< 4 6KCPPDOB:'6X]1NHI%=6D@&
MTQN%1U Z9'WSW[GCG( *MYX-2]U*_N9+J-$NUE5MD&)0'A$9!?=R!C=C'7Z4
M 1:?X(%EJ4%ZUY$SQQ2QD1VVS=O5%!SN)R-G?.<]L4 5M/\  5QIVC1Z7'K"
M/#'!+ I>UY"RJ _\?]X;AZ9(YH L7_@2WU#7I-3DNR ]Q;S>5Y>0!$#E<YZ,
M=I/^Z* $;P3*+&2UBU,*)8)K>0F G*R2F0XPPQ]XK^O% &GJN@2:G86ML+B&
M P#AD@(V'& 4PP*$?4@]""* +5AILUA/<LEPC0W%P\[*T1W#<!P#N]1GITX]
MZ -*@ H * "@#F-1\(F^UF2_2^$ DE68XAS(KK&4&U\\#H<8ZK0!E0?#AXK4
MQMK!:4W$<K2"WP740^4ZG+')<$DG/4]* .OOM/6]N+"4N%-I.9A\N<DQNGX?
M?SGVH Y:/X?LI1GU-"RN')6VQN/D-%D_,<D[MQ/<T 36'@7[%H^KZ?\ VCO_
M +0L(;/?Y./+V0^7NQNYSUQQZ9H 9;> FM[>:$:FN)8Y8RJ6^U%#Q+&=J[N#
M\H8]<DF@#H-/T^[LKFXEDNX95N9C-*JP%3G8BJ%.XXQL.<YSGMCD J?\(XSO
MJ337@D-]>Q7#?NN%2/9B/KSPG7_:/% $NN>'X=<.9F3 M9[=0\0?:TFW#C)Z
MC;^O44 5+'PL]IXF&L/?B;"2($,6&P^S@MNZ#9P,=_S &V'A$65ND/VJ,[)8
M75EA(8K&Y8!B6.2<X[#OCF@"E!X B@U**[-ZDFTH65[?/*,[*5.[Y?O^A/'&
M,T 95]X+N-.71X+*66ZDBBMK23%OA"D=PLA?.[Y3UXYS0!IZ5X!DTR>P8ZJ)
MTLV#*K0'C#R,=OSX7/F '@_=% %S5O"$^J:G=78U3R4GC*>6L Y^[C<01NP5
M)'&?F(SB@#H[=;A587,L<C;OE,<90 8'!RQR<YYH FH * "@#'\1:#_;]@;0
MWTUJCJT<GE\AT88((/'T/:@"IHWA"WT75Y+Z*[ED7]]Y43 8C\UU=N>_*C'X
M]: *ESX%%WIJ64VK7!2)$BBPBX5$1U *]"<2$Y]57TH ETWP1;:;;V$*7DKB
MSNUNE)4?,5A$6#[8&: (-/\ A]9V%H;;[9++&7C<@J!G8\C8_'S"/PH R;+P
M+<ZQ%<MK/GV9#"*%2T;,8_L_DDG:2 >21SU'3M0!T$'@Z&.&\$E[))->0SQ2
MR%0,^8L:Y [8$2_F: +=]X=%]K45^]],L2-$_D#!7=&6((/5<[B#CJ* *R^$
M(18+;-=%V1+=49XP0/))VY7H<@X- %#_ (5S8^9.QO9BMQ;^3,-B L?*:/<#
MCCALX'<"@#0/AJZET.UT^;5I1):S!TD1!AD *A&7HP*GD>M &%)\.X[G49+:
M2:X33X=+AM(92X9GD5]V_'8@*@Z=\"@#7L?!4-FUT[7TLKW$PF<E /F\[S?Y
M\4 9VL^!@]D\-J&G,UU%M ")Y"><7=B>K?*S+ZXP,=: -'Q1X(M?%$TDL]W+
M SVOV8&,#Y1Y@?/Z8^A- $5QX$CNK6^@FU2Y?[1&T2.0-T:F7S.O\6",#/0<
M4 :&@>%K7P]?:A<V\TC_ &SRQL8#$:H#@#VRQ/XT ;U !0 4 96FZM/?:KJ=
ME):QQ?8)%C+K*6WED#CC:,<,/QH =J^MV^E6<\O$TT/E@PJX##S'V*3Z#.>?
M8^E &;9>*I+Q+:0:>NR::: JDVYPT0?=@;<,,I@'(^\.* )M/\2/>V6J2MI\
MBW.G\-;Q/O9V\L/L7@?-\P4C'6@";1-=.K6MT\UFUI-;2>4\;-GYMBM@' Z;
ML'C@@T 9,'CRVD\)R:\\,. L>RVAN \A=_NJV0-IY]^_I0!:G\6&/5H["&R2
M4/*EOYOGX7S'B:1>BG*X7[WOTH 6U\5B;5K/39+5([BX><,1."J+&Q3(R 26
M8$ 8Z GM0!5@\:R7-O=3Q::@6"S%\N^XQNBRX[*<-F/ITYZT =9&6:-2Z['(
M!*YS@^F: '4 % !0 4 % !0 4 % !0 4 9-QK$T'B6TTA;5&6XA>;S3*05"%
M01MV]?F&.?6@#3>:*.1(WD57?.Q2<%L>GK0!QEO\1([G3;R]33MBV]I]M"RS
MXW1;G7!PIP^4^[[]: -33/%#WVN-I=QILMG)Y+S*7;)*JX3)&!@$G*GN!0!*
MGB,GQ,-'DT^6,,KM',6&&"!<L1V4EL ]RIH DOO$EG9:E)8[D>:*T>ZD4. 0
MJ] !W)PQ^BT 9]UXOEM- OM3DTY-]D4\R$7!^8.BLNT[>3\X&,#GO0 D/C>V
M:PU6[EMBBZ>C,R+(&8D.Z!2,#:Q*<#N&% "WGC$68MC]B63?##-,4G!$8DD$
M8"D##88\].!0!LZ;?W%Y->PW%M'"]K*(B8Y2X8E%?NH[,* -"@ H * "@ H
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M@T 7Z "@ H * "@ H Q[?1KFUUR\U"&_417DZRRPF')(6((%#9XY4'./;WH
M;<>&--DGU.[@M;>*]U"W\B25H5<8YY*]\DC//.T9Z"@"&P\*P:7>Z:]G-Y=G
MIUI);P6Y3/S.REI"V>2=O3'<\T 0Z+X173;4B\:QO;Y)9)H;MK+:Z2.<LQRQ
M).?0CIB@";2?#*VUG%%K#6FJ3P3-/#.UF$9'9MS-RS<[N<C';TH J1^$[Y))
M;QM9674O-C:.>2U&T*@=5#(&&3B1N01VXXH 2#P4;;4;*>+4?]'MC%(8FARS
MR1PF)6W9X&#DC'4=: 'VGA&:U>Q_XF8>.%8OM&8/FF>-V<,#N^3+.<C!X]*
M*UOX%D@AN(?[5S&\<5O&!!@K DID*GYN6.XC=Q]* .RH * "@ H * "@ H *
M "@ H * ,?4=%GNM8@U.VO5MYX+66W3=#O +E2&ZCIMZ=\]: )KK0M.U"[L[
MR^LX+FZM>8Y'B!(/X^_(]#0!DS^"K6>UU&'?%%_:-Y'<7!B@"!T1PPCP#WQR
MW<L3CG% $Z^&?.UG4KK4GL[ZSO=H-O+9Y*A/N#<6(('S'[O5J (Y?!\-WKL=
M[>W"W-C CI!9/ NU ZJI4GNGR@A<<$]3Q0!3N?A]9S:M+<PW/V:SDVN;6*(+
MM=8FB7:PZ+M8_+CKW[4 6H/"<IL5@OK])W-W#<2,D&Q7$04*N-QQ]Q23GUXH
M BA\%O;I/Y>HC>&!MB8.(\3^=\XW?/\ -_N\>_- #)_!#S?91_:>,!!=?N/]
M;MG\X;?F^3YB?[W'TH W])TU]-BN1)<>?)<7$D[/LVXW'@8R>@ 'X4 :% !0
M 4 % !0 4 % !0!EZ=I,VGW=U(EV&AN;B2X>/RL'+!0!G/;:>W.>V* *5[X.
MTJXM-5BM[2UAEU-]T\K6ZN>V<#CG@D>C$MS0 K^&6BO;J\TZ\6TF:QCL;7]S
MN6V1222!D;LY'IC:.M !:^%TBTBW@F>V.I6MN;>VU"*U"R0K@@;=Q8\9]>>?
M6@!+3PE9BRD34E@OKR2224W!@"F-W !,8.=G0=#UYH K6OA.^L[.+RM6B^W0
M2H\<K6O[L!8C$ 4W]=I/.1SCC Q0!=M_#\ME;-':7_E3+90VD,IB#>7Y>[YB
M"><[N1QTH HW/A"XN+:",ZFBN?-%TPM^)%DE$K!!N^3D8&=W!H HO\.]UU/,
MNJE0K,]HI@SY3&=9SN^;YQN4#^'CWYH Z7P]HXT'1HM/\\SLK.[R%=NYF8L>
M.PR3Q0!J4 % !0 4 % !0 4 % !0 4 9=SI,TFM+J=O=B&1;?[.%:+<,;U8G
MJ.P(_'- $EUH6EWNI0:C<Z?;S7<"[8Y9(E9EY!&"1G((X],GUH R+/P9!:Z/
M%IYEB -\M[/Y-N(DD96#!0@.%'RH._W?>@":W\-RR:GJDVK7-KJ5G?E?]&DM
M/N!3\BY+$$#D].IS[4 /C\-(]]*]^]O=V/E-##:M;* B,RMM;DA@"@V\#'O0
M!2'@F));V..Z6*PGCF2*WB@"^49$5&Y!P0 HP,#'X"@"]::#<I+%<7M]'/.+
MPW<IC@V*[>3Y2@#<<8 !ZGD=J ,>/X?[K5EN=59KD3R21S0Q>6$6219&4J6.
M>5ZY';\0#1U#PQ<ZI+>-=:F&5T*6P6#!A_>+)\QS\^&11T' ]3F@#*'PZ#7:
M74NJL997WW92#:)/W_GC9R2GS<?Q<?G0!W- !0 4 % !0 4 % !0 4 8WB#1
M[O6([-+:\AMQ;SK.1-;F579?NY =>AY^H% '/O\ #R0WSW<>KA7CG:XM0;?(
MC=I5E;=\WSC* #I@'O0!>B\'2VZVT46I*( L7VE6@RTK1RM*I4[OE&]SD8/&
M![T 5X/A_#I^BZ=::9<PVMY:9+W/V;<)RT91BR[@<X;CGB@!VM^ DU6STVSA
MOQ!;65FUD0\ D9D.SD'(VL/+'.#UH AE^':3M/%+J;-9R&51&(L.(Y)!(Z[M
MW)+*N#C@9&#G( -FX\.S7MC##>7PFG2PFLWF,.-[2!/WF,\$;.GOVH K2^&=
M2_MB]U&VUB*"2X@C@C/V/>\2IR!DO@@G<2, \]1@&@#./@B]L+?S--U)6N$W
M7 22'_67($A4@Y^5-TARN#P.O6@#2U'PD^JZK'?W6HONCCA141,*-KEG)YYW
M X]O>@#%M_AM/ "#K,4@"VZ(6L\-&L(8*58/D/AOO=.N00<  N/X +7NJSIJ
M\D0OH)X5"18:+S9?,)W;N><C&!P: ([#X>O8QF--5"JSESY5MLVGS?,&WYCM
MQDCOV],$ U/"'A/_ (16&[C-XMR;AD;(A\O&U N3R<DXR3ZDT =)0 4 % !0
M 4 % &!X9UNYUI]4,XC1;2\EMD5(F'",0"6)P2<= .* *^M>,K&RCN8K"ZMI
M[NUGBBN0S9%NK.%9V ZA<\\\=R* *EAXIU74-*TJ\@MK9KB_CG*6F""WEJ^&
M#EL!681]1T?K0!-IGBV2YL+Q;@V8U)9I8+*'S1&+QD ^[N/3?E<\]* )-/\
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M/+PHPN/EW#')^]U)H 23P[:3:]%J\DUPTD1WI"9,Q*^PIN QG.TXQG'?&>:
M(;[PEIM_K<>J3><)%:-WB5\1R-'GRV88SE=QQ@CWS0!2M/ &DVEH]J)KJ6)F
MAXD=3A(GWI'T^[DGKS[T 3#P3IBS7,J37*M*7,>''[AFD$C%..N]5/.>GI0
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M)T*_U$C/V:!Y0/4A20* /&/!UU-#X6\96:F4>=I:WB[T*DL8B)&&>H)[CTH
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M&1')GD4 0^#?^1H\8_\ 7^O_ *!0!V= !0 4 % !0 4 % !0 4 % !0 4 %
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90 4 % !0 4 % !0 4 % !0 4 % !0!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>g475718dsp6a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g475718dsp6a.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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MQ':ZHGF@J, R#A_QZ$_[U &'\+?$S^%/'=C=%B+2X;[-<J.Z,0,_@<-^&.]
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M;?[-?EO)\J0LW,A;D8XXH A\<?#GQ&WCF/QOX.OH4U0!5D@G  .$V9!/!RN
M0<>H- %#1/AAXI\0^-[?Q9X\OH5FLWC:"UM\'.P[E&1PJ@\XY)R>E &Q\7O
M&M>-KOP_+I)M]M@TIE\Z0K]XQXQP<_=- %OXP^ M0\=:#80Z4T(O+6X+CSFV
MJ4*D-S@\Y"T :OPO\,ZAX1\#6NCZGY7VJ*21F\IMRX9B1SB@#"UCX1P:SKWB
M.ZFNR+74H ]JG_/M<L5+R >_E1\]2"10!JKX$EM?#WA/3+*6(-I.HQ7MT\K'
M,I"OYA& <L6?/./K0!6O_ FIW6F7ULD]J'N/$*ZHI9FP(@R':?E^]\IXZ>]
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M0S!=:\&,Q  EF))[?-%0!EZ%"WQ8^.4^N^5G1-*92I895E0XC7G^\V6QZ9H
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M:ULM/\,V[E%NA]IN<'[R@X1?IN!/_ 10!XGX.\.2^+?%FGZ)"VS[3)AWQ]Q
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,,+N^N.O6@"Q0!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140242736696288">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Mar. 09, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">TEVA PHARMACEUTICAL INDUSTRIES LTD<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000818686<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar.  09,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">L3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-16174<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">00-0000000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">124 Dvora Hanevi&#8217;a Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Tel Aviv<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">6944020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">972<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">3-914-8213<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">American Depositary Shares, each representing one Ordinary Share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">TEVA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>d475718d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="teva-20230309.xsd" xlink:type="simple"/>
    <context id="duration_2023-03-09_to_2023-03-09">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000818686</identifier>
        </entity>
        <period>
            <startDate>2023-03-09</startDate>
            <endDate>2023-03-09</endDate>
        </period>
    </context>
    <dei:EntityRegistrantName
      contextRef="duration_2023-03-09_to_2023-03-09"
      id="Hidden_dei_EntityRegistrantName">TEVA PHARMACEUTICAL INDUSTRIES LTD</dei:EntityRegistrantName>
    <dei:AmendmentFlag contextRef="duration_2023-03-09_to_2023-03-09">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2023-03-09_to_2023-03-09"
      id="Hidden_dei_EntityCentralIndexKey">0000818686</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2023-03-09_to_2023-03-09">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2023-03-09_to_2023-03-09">2023-03-09</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2023-03-09_to_2023-03-09">L3</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2023-03-09_to_2023-03-09">001-16174</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2023-03-09_to_2023-03-09">00-0000000</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2023-03-09_to_2023-03-09">124 Dvora Hanevi&#x2019;a Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2023-03-09_to_2023-03-09">Tel Aviv</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode contextRef="duration_2023-03-09_to_2023-03-09">6944020</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCountry contextRef="duration_2023-03-09_to_2023-03-09">IL</dei:EntityAddressCountry>
    <dei:CityAreaCode contextRef="duration_2023-03-09_to_2023-03-09">972</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2023-03-09_to_2023-03-09">3-914-8213</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2023-03-09_to_2023-03-09">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2023-03-09_to_2023-03-09">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2023-03-09_to_2023-03-09">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2023-03-09_to_2023-03-09">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2023-03-09_to_2023-03-09">American Depositary Shares, each representing one Ordinary Share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2023-03-09_to_2023-03-09">TEVA</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2023-03-09_to_2023-03-09">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2023-03-09_to_2023-03-09">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>16
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$
MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7<K_WUE[O)I#-ZG7TZSFN4
M?VFK :?MNYO/D_QSZ.2?IY/734+.<+PL"?'[(UMAAR=N.Q-R.AQG0GS/]O:1
MI24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG LR+7E$8D19_(
M+;KD$3BU20TR$S\(G8:8:E < J0),9:AAOBTQJP1X!-]M[X(R-^-B/>K;YH]
M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M
MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZ<TT#PE"\D^DJ1CVFS(Z=T)LWH
M,QK!1J\;=8=HTCQZ_@7YG#4*')$;'0)G&[-&(81IN_ >KR2.FJW"$2M"/F(9
M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+
MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T
M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M='@//GL?)=-[*CG_5U/\!%!+ P04    "  NBFE6EXJ[',     3 @  "P
M %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">, ?0(8@S9?$6!/D!5J(/V!(%BD6=
MOZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]$%)I6M6X 4BV)8]ISI%"KM0L'C6'
MTD!$VV-#L%HL/D N&6:WO606IW.D5XA<UYVE/=LO3T%O@*\Z3'%":4A+,P[P
MS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T
M>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0    ( "Z*:58<.&7J/P$
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M?P%02P$"% ,4    "  NBFE6!T%-8H$   "Q    $               @ $
M    9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( "Z*:5;9L[J+[P   "L"
M   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0
M   ( "Z*:5:97)PC$ 8  )PG   3              "  <T!  !X;"]T:&5M
M92]T:&5M93$N>&UL4$L! A0#%     @ +HII5NJJI/UH!   N!   !@
M         ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0
M   ( "Z*:5:?H!OPL0(  .(,   -              "  :P,  !X;"]S='EL
M97,N>&UL4$L! A0#%     @ +HII5I>*NQS     $P(   L
M ( !B \  %]R96QS+RYR96QS4$L! A0#%     @ +HII5APX9>H_ 0  / (
M  \              ( !<1   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    (
M "Z*:58D'INBK0   /@!   :              "  =T1  !X;"]?<F5L<R]W
M;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( "Z*:59ED'F2&0$  ,\#   3
M              "  <(2  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )
-  D /@(   P4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d475718d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tevapharm.com//20230309/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityRegistrantName -  d475718d8k.htm 7</Log>
  </Logs>
  <InputFiles>
    <File doctype="8-K" original="d475718d8k.htm">d475718d8k.htm</File>
    <File>d475718dex42.htm</File>
    <File>d475718dex46.htm</File>
    <File>d475718dex51.htm</File>
    <File>d475718dex52.htm</File>
    <File>d475718dex53.htm</File>
    <File>teva-20230309.xsd</File>
    <File>teva-20230309_lab.xml</File>
    <File>teva-20230309_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>22
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d475718d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 22
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d475718d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "teva-20230309_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "teva-20230309_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "teva-20230309.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "teva",
   "nsuri": "http://www.tevapharm.com/20230309",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d475718d8k.htm",
      "contextRef": "duration_2023-03-09_to_2023-03-09",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.tevapharm.com//20230309/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d475718d8k.htm",
      "contextRef": "duration_2023-03-09_to_2023-03-09",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230309/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230309/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230309/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230309/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230309/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230309/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country",
        "terseLabel": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230309/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230309/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230309/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230309/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230309/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230309/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230309/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230309/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230309/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230309/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230309/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230309/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230309/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230309/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230309/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230309/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>23
<FILENAME>0001193125-23-066281-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-23-066281-xbrl.zip
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M[P#9IX'E@Y_B!)XU(Q[H%&\T$R.H!YPAH(NJ$$W<2&1K ^@'V,R>A?=&C@5
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MV&V14425@B6$T'_88:^G2"TZT2Y/2H"WEXEC63/BO*!;XP5#8$ 3W7;0NWG
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MTQ_X8AEWZG#,MH#2/)MKX7*T5- &<R(&L\#&<;FC,5X9%E=HO*%=T U@E>F
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MW6<&<(&-PYLP1V JWQ3)>G$QG +H;N:K5'5,@%#!R+)IB'B!9* DQ4L0!+U
M2]+  F&0FXXD;X$"#0EDQMA"32@P&_<SYJ#(Q=PP]ZQ*M$48%9,=B&D[=F+Q
M/Y8E(8R2Y2\)!D,  58'"&[1'0"2"C!A=F$QI1?J\WB.ERA*H"9Y=.!11%_1
M$?+U$.R>S3QH.Z*FA;"FZYRBD\RB]+H26F8#YG2&I)1T#ON.43BD]A,/7%^?
MR0D!->&>/I.T$#4,H46,<KTO-+41>>&!-VHCAUA(HE-9$[_- F&ZV^Q")LI0
MZ#),J<%2ZZYY> H/@1,H%T<$2_+::QYR-2@WK@?]T.@7Q1&Q*Q^Z<U3U?:/1
M*-?/:J?:1;23/<KC<$<LH @3+IC9D.H4:+8-YO(GFL'@R+3B!>!0R*,US?@P
M7L30O>X[T3)(_5Q89JT4^HNH^<3>M<1,XE5FX!J+"@]+3 KM@EQ/_LR&''AW
MENJU(4DK@5L 3?Z#>0<S-4''%1LG"-@TL,9BV(6<&])CA#;^A<M3=!)3$O,(
M:1-/([GDN/84L@_E@-]H+ 3V,#83LSYC1VQ,":9"G1K,T[GI1BN&<\F.^57Y
ME<GKTI(E_57Y;%D61E,N3KP*B7Z(V(7#?-D2+Z+C%+T#1%HEW),)Y)VA9$2O
M;0QURHI:F#6FYTLTBB@@MUPXOIE*2)36J'=8A:"<T;,KR:GQ$_ZHM+:(-,G8
M%/?03<PA.C+-"C!QLU+'CP9^-/'C%#_.\.-<]-ZLM.87BP5:08UW LY15:AW
M(*VMDQ,'#X8D-:/3U0%(I463I,Q(3D(*MC\:X[A))MHD4Z_4&M_M'ID.>M[*
M)Z/D!C0!&(;/T=:\^\0IE>@A)R^$AU3BZ<4@GI:(\083QGQRS3ENQ@O=24KB
M VEWL]5F8TUNVM&;J$%;^BCU/OK2!.E(<)^3/,(S(4LI?2@B#"&ZX@&DN1*L
M91GV#.0D"7IKX<;"W2;J\\XP:(3 'Y=*CGL EZJW"Y"-[U:]Q9HLB@NDY8],
M^:XW_FU>6F&<I*')-]7U]S[%:C>\OL8Q5BC8ZB@K]<60% A_K7/HU(+SKN3-
MB\:>#YU:^\"H4&QRSNA>2SK6.,<'L_&N16=MTQ;;QH>6HS_M_ P<Q;';G%^T
M\#B3U<>?"'+&_),C)EG:A,>>XYV<01.W(5Q"00'RU/?\AKFLXLP];2R)/PA!
M_NN],"_/B:%DPO$0C(GON^UJ]>7EI>(QO3)VGJO7$,Q#1.-5Q9ODJ@;U:;6E
MM<Y:9U5@04V[:&CU4ZU5:]5/6_6J<7I::S6:!GMMGE8F_A1S71MN$B@E2[_7
MWP]=6G>/\@95XJ2XV$L$'U$)1DBD1FU1>NY:KNMM&@%JM<39\ZI&6JSLR<SC
M#=,3!;P-3>VQ2.6^$@=\9))+FMCCH%V(+8%TH13\.26NOA^!,YKGI^=:"^6E
M+N4E;[O*VC(4'2CPKB*TS[U(1\Z<Y\S&X3@S-[4GE*3,[$.,/:<3ZT?EDD/"
MYN%)F"X^.Y)P4Q*>?H<>F;8WC^Q;<<GJYT>7[ \C<F=[UYIGAW3)WD^&CLR5
M9:[SPS%7[I+E,HM\=E0/.11L'9Z"J=K+(P4WH^!I1=LW!4^51W3OFK9:&'T,
M+/"N;.]I)I2X26T'? <L(;UESZ;O/9EJ:#IU+^%.A13EBVA-8M&7DR-5,U3=
M>R;EM)ZAZB\F?T*[FJ1=U[),,)^W#Z08V<HC"7-)N/>4PVDC0\)?\<1YQ^'X
M5EMQXM]-X.N3(\6B=_\T#J<_.X[MJ?J/+?3G0CL)%N%(6T7;@VG1!&U7:-$E
M=*P?Z:CH>#!5FJ!CK$I+2I<N(5WC2#J9^'G?I&W'@:OD 69(Q$E15-21XG$9
MN*G*8@D:8=EUM.T"U_W);Y_ZM\1P] "3$_A^AGC]/*?*92>5)M]UU51]C:*I
M5'[W6ZB RA0\/<3GC'X6"<8%]4W?9]5B\UBUN,<#'M9[E5GOI[OKQZ_][ELW
M:&Q<./<PM_^)X_F[7-7XK?<"G-)\\AV/,3("$!Z=!I[8^F+B/ABQ'B!WFWDP
M>7FP&];K#=F$6J,PBR\JHE4#K,0/L&A8= >TFC@<#P3>:B/+1GC!TY3:><=6
M[JZX\(-Z5<CA*@R;V0)#*2D+:PS3(J=%[Z7<I.IPZ:LN6^>IJL-LF=J>7)6$
MW]186>>+;R8C#S]?][]<=[I?'WN=ZUO2N[OY.GCL][H#<MO[TGOLWB3K?[?T
M]Y#'ECE\XOZWY/$5KC[-VEM5*:[N>;/7%ZYXE<^&ZJ'J52% ,\DON!-L[^\M
MS,,&OFCNO3"=F.F!9RE>K/ANTWP%0R>"@U_Q@ 3P G$JME\BG8G)1LD=/:,1
MM.!YX4#T!JCOT34\7>(:?J@.'6,&5R#HM:[^'U!+ P04    "  NBFE6I4(C
MWL77   _C@4 $    &0T-S4W,3AD97@T,BYH=&WLO6MSV\B2)OR=$?P/B)XY
M&U($K-;%U[:/(RB)MCDK2UI2;D^_&_L!)(L2CD& !P E:W[]F[>Z 2 EV9(I
MNSD[VV.1!%"HRLK*RY-/OOEP]O'H[9L/W<[AVW;KS5GO[*C[MOO?3YYN[;[Y
MG?^"CW^7[X,W^R>'?P7[[P].CD[Z__SM\X?>6?>WMT&[!3\Z4&FI\K=O#GM_
M!H.SOXZZ__SM*AZ7%W^\W'H6I[\%41*?I__\+5&3\C>ZUZG^V33*S^/T29G-
M_MB>E:\#^7N8E64VY8\F65H^*>+_47_LV+\GT31.KO\XBZ>J"([55=#/IA$\
MJ7/4>W_\S]_R^/P"'O5F_VWWZT4\C,L WBIX\_O^VS>_G[YUGN_<?!=N7AE.
M;32_O?U?Z;"8O<:[P'N;VR1QJIY<*'SJ'[M;V[>XT^MAEH]5KC^!B^##H,B2
M>!S\QS;]C_NPH/E9>S<_:[?VK)W9U\4/<M_*N2_-SGVMSHC$Y;>W9]T_.\'I
MAT[_8^>@^^FL=] Y"M[UCCO'!]W@N'OVH=L_ZAP?#H)>+]C?^G,K#'[T *,B
MZ!7%7.7\Z&:Y_5%3TV[UC@\_#<[ZO>X@..I]A/UW^,/'!3/R?A[E45IF^8]?
M#Q")8+]S_+^#DW<@()^#OT[Z_SOXV#TZ.CE>P4RT6V?YO"B5^N&/3L<_7![]
MF6^WO*F'_QR>' ?[?=BZ'U8ADZ?1=9R>!YUS^*CZ^.]0\6_X$0M5_?-O4K\-
MJOXU'Y>[.__P'O^[//\'3N:[DT_]LP_MUN#3Z>E1]V/W^ R4\J![W#OI!Z!_
MX.]/_>Z/7N'#J%3C -8YFP0?HWQTP7/T*@QVMW?W?K@:*K.@O%#!0*5QE@>]
M= R?SW,5C)N'N?,4Q[GS<BV8WS/I![F*2MSD,/7M5J'R6-%$#]1HGL<E_K4!
M4S]6$YB'<7"A<A6GF_!W ;8G+<P/%MH76WLOGOTC&, 1$<5I-(R3N+Q^<A2G
M7V L(CO'60GW&,\5"O*K'V_?_/B#Y,76RX6S EJG/BU[._>X;Q:8T0]BLB_:
MFP]BL_\.KA=LRP.M%@+ZWS>SH"BO$^4OJYK65A4_FD7GZLD0=MF7)T,UR7+U
M1Y1<1=<%>FQO/O2#0>__@S?9^TW?DAS!/_[C%?W/;\'GWN'9AW_^MK.]_0^S
MZ =P7'3[C]9+U#();N)99_^HB\;-P0D,^?AL8)Q%=QF_1_+0Q::''(#1-#CM
M'/2.W__SM^W?Z._3SN&A_MN;R/V3_F&W3Y_+&/B3)S#[1YW30?</_8^EKUR=
MG]H4X +1$/MOY1^'9B![H/O?_'YV:+_Y4Z[F5[5#UC_T;_#R6V^P_-_PGSY_
MT-=SXXAPG!;Q&$3X,H,]<^NY>8F+)F.$B85E.B:1KXS7K*M]U^9?W/@[^Y3=
M)K$\A1=B0;SI279*[%+>V[20R%2?#V+_FSM)KG(-_*T1-&Y9^0CW.]D>J(1*
M];6$0:)%]<<3_>%=]C;.6J</#C/LM)W@L/NN=]P[ZYT<#X+.\2%8L <G_=.3
M?@<_"O;_"OK==]U^]_B@J[?[/:PI#D'_:.G2U:-5.]4KCD\^]SNGMWA"PVYP
MILU9O@_=WOL/9[ K_;UJ/W9%\L:?//WMX3;C0JG[+DG;NS=) \NSC+-4C/RM
MG=N)SS)YX-5^>X@V;(SW+KY%'!?(S&U_6)'*G;O=>BT(&#Z_)T'HI:,LGV5Y
MA+</AM=!7TW KTE'"CT?BCXY[F=G5#X"<=E>R\L=Y67OWN2E/T_8*3X U5'F
M<WK,+R$3-YUEGB'R* ^MQVTJ[088X3T^.>NRH81_O?_4Z7? &^H.'HEQM+:.
M?E8EMWN/UM%97"8JP-#5F<JGC\%"6IM(=Y6&^S.1WF4@ WCD4<SP$0C#[EH8
M[B@,]V?_'*ESE8X?@Q3LK:7@CE+P]%Y5 FH$ 2JH1Z$6GJX%XHX"\>S>!&(_
MR[X\Z:9E?AV<YMEE7&!D!<:24QKW?9(-H^31G!_/UH)R1T%Y?F^"\G_[JE#Y
MI1K_OT<@",_7@G!'07AQGQ'8:)X@:*"'N1A5/(;(VEH@[BH0+^]-(+I?U6A.
M4=C'9EBLI>*N4O'JWJ2B,QX')^FC,1W6HG#GJ-3V_>5J!KWCX'@^':J\H.C4
M03:=@KXXR,:/0CA>KF/PCSP&OQ<@"@B1"9TC&.F?W>/.\=ECB;V_7,?>?U(M
MMW>/L??3Z'J*$'LP@N#L(X@"N,YGT=>@,\WF:?EK*+J_FWS<7S1^4$;3&<K#
M(Y"#5VLYN*,<W%\@_D!@*RKH?HV+$A$K:XGX"27B_H+R!RHOXTD\BDI&J&#D
ME6LKR5BF0*PN+%R+RD\H*O<7KC=R$)QEP;[B6JLL 5WR[WE<7E]DR1BDQI.A
MU4O,[AKW=E>)N;^X_5$\C4L&2<+_'L7J,0!GUQ)Q9XFXOP"^+Q&#"'&1>,X<
MJ:A0PVCTY=<0D'5(YF%#,D^#?O>P^_&4RD6P]!T!DH\C(K.[1D/^K(KNZ3U&
M9$YF$H3IJ[&:SAX'X'MWC8B\JT3<7PSF."MC+A!9B\1/+1+W%XXY5+.LB$M?
M)H+3/'X,89FU9-Q9,NXO+(.A^U],3:QMXH>UB9\%@\Y9;_"N<T!6,58+'?8&
M!Q\Z_?>/I(IZ=W=M&O^DNNW9/9K& _#_BTE$=R?G_S N1A?P#H_AT/O^,I&U
MGGM8/?<\..W\U3M^'W3>=X_/UIIMK=F^2[,]OU\8AJ$[_"5TV=]-%.[/V^\F
M<.<\2^-1\%%%CR+OL1:'NXK#/0(O!H=]<.C.YTGT2!RZ;ZF$A/\@51I>%;R9
M+6"!JRU6X"["RX7$?P],)A<'0O?6_C59^7 A_Z8\=KL/QV.WIFQCH_M%\+$W
M0$GJ''=//@V"T_[)G[T!\K<]$@/\Z=H _TF/V1?W&5H893-*L0SFLUFB$!,=
M)9:*ZQ$<N^MZ\[M*Q_W9Y$Z1^4(1,>7GA&S;5ZF:<(+F-,J)S!H#5A\(ZO:8
MZ$W6<G5GN;H_XWXP'XU446128-8ID-J<I,-!TEKTY'XVA[^'UVLE]>L(T_UE
M_A@FP))TJ.!9XP*A<KK?C;0V"?W6&FNE](O(T?VAM4\F$Y"C_'_]Q\[3YZ^+
MP,/YH[B<S.)4'X4'H)$*E;P.!B5\CPJI",HL&"HDK,1^ &H<G''GAD<@5>MR
MZKM*U?TANJ70L @.YXH1O'!DC:/K(H33+,5_:%T4XQ^/0%I>K*7ECM)R?VAO
MT!Z3)!Z1_1RE'LO38@/\*BXOFCB4\9*=5WNOUC+U$\K4_3&^X#/^RO(OP5%T
MA8?4^^Q2Y8_A6%H+Q5V%XOX(7]" *54^ Q]]?>;\C*)PCX0OW<E$\6GQ045C
M\)'6$O%32L0]1H7GPVE<H-V!!\9_S?.X&,>/A(-_+1EWEXQ[K<D(^JJ8@44:
M#Q,._O;5* :+%$S4G*(ND;3UL T-'X'4K%FC'GO&]&7@M6HU/5H?2\)T31SU
MLVK E_>8,/T,SG8V+ZDQC1!(21SYEU!R?S?!N+^3$07#E8IN-+H(.F1:*YUK
M> 0B\OU\,.MS\ '.P>Y_?^CM]\Z"3O D>'?2_X@U^M1)&0OUO_7PNU_1Z3QY
MS/6-CWA-][TUW=MY1&NZ_TUK"C_^F7&MOSJP]4XSZ8KYTW_<4<+?G7SJGWWP
M[?9!][AWTK?F>QB,J6E]1"F,CU$^NN!5?Q6BAML+$=B!*;!HFJ7GP9FZC-JM
MTXLHGT8C-2_C490$[^*4G,IC55ZH/*$4?Z\7[&_]N14&43#+XTNDZ!METQEF
M32@ADB!Q#CPWB:4W>[#QIO=VJ(HD*U4:7*HTS;(2Z^AFP525P5#-5/X%[A)%
M:3'+HR\JB?_UY4+%XS>_]]YNAD%L>EC"7><I4G<=SDLXY)/H*MA !!2FCE^\
M?O/IK>;R^O06/WKY&J[&]PHJK]5+Q_.BS!$D=<2C#=NM*'!;938\%)\$CQ2X
M3!ZII/)TAW[.'0#\9#]*OQ#<0:<$/JHDR5*<0_/1$'Z#. EG%"$N7LDXBLJS
M!%WA/(D;FBU[V%&6CN'5]F&0HPN\=[LU8VQ&1-@,_PE^B9!YS%:P6&OL/GV8
MWNJ?@UYP%AP'W6  _Z\+__[P1V-[=5=K[#[$QOO\H=OO=@:ARSYX 8N$D(,R
M0R44*"+ZQXT'ZS$&8;Z$[\88S\-K9-T,9:$/C@D&*HTQFJ/3B0LW\<Y3$-G=
M[9V7E57;CPKE(K0<09QA3A/#S 8Y&.N@T23/ID$)+TO#Q/\+3\M2A9&E*;Y4
MH6BWP*=Q6<!?-$J$8HSF^')C->0'%F&09D30F <9ZHQ P3.1O9,OAH$-X7U2
M5125@;M!*S/HU\$OM\*3."_*H' SRC*=<7W1VZW:J@>XZ$L74W@-][9VGVW_
M0TL4 :V"\5RA[M\U@WNZ]6Q[P8^>O5ZRTQ]^[MNM!YA\D%?0@;>=?0:H72ID
MY.?YWWU&\__J-O/_'$S7Y5/[2\EU>1'GMYY9DFM_:MDJV;F=9+\@R8;Q1&"@
ML)7QY"A.O\#-F^;[A2/O>R^>W>'2O>U5+E4EG;"]LW&QJ2?!5_0R:W"?\B(J
MG34.?6)<,Q%Z-:?1=8/VIZ,7%J[,8*6<8\ L9>&O=,E2A-<KF-EA$A<7])@)
M==*#95329-.J>8+:!"F\-A\NJU4W9KIF\QREK6RW1.YQ:YQG9"7-RXL,!G]-
M0CK+"KA=S,008$K#!L"6</,<;."EVP //OBI/?D6@*OU*8@/@#%FYV2$LY%=
MEP!^"VL)-Y@ N#P1/(<WN!VCN1OH7#/(."VR292C&HQ+>&B2!!%<< UF ?Q'
MYN;%';?3[JO*J<^A%@8!^Y8LW_[EW7;K3NWVZ/57;X_Z!&Z ,DN6?;NU@4\$
MPX5F"!P9-EVLT6.E%NS?3VF"Y@L^"$X3E$#^_54,ZU',S\]A"Q2\'/;US#O9
M(051CG=(L/X:5"W,:JXF*A>5&Q7^@E;>@J1BA:HI2G#7(V8!MC#6%$3Y-9PG
MEPK\.?#RQJ@UX"VFX,[1>]#PP^#J KXTYPSM&H_%&[<8#(S0O]5SR*P7?SY/
MKMLM64KO1CSUE^"=CX,,5-$Y^5(5SO"0%\2,$#;D I1?)+?"WR?J'%[\.AC"
M_+'?E"NE^UFX-T>U, )/;DSGEMZR,0\=36A2B"LX6XY//H?8F[W??7>",8*S
M#[W!@OQ?\+EW=MP=#+IGY&W]X(&^D\,*9G*44<A2/'.9Z5FNIG'A;"Q0W",P
M:"PY/&\R$8T+J3F@DRJ;A+<_(MNMZ;R<T[*/P&))(ZEBH+4W-HKZ-_R$/J>C
M(2=.S1)W@ZG+PI_!R3GC[6ZJ(!I]+SO^" \5\-^OBC]T^.RGB_SMK -_]Q8+
MT5G[G6\.@'SG  Z[[WK'U&1J0-1MO>.#D_[I2;]#9&[[?P6@6D"]'!]T5Q.B
M\8SFG2V8IT_8C3-.J=E0L85GZ(]79P?1#+$Z\.NQ&,/S0LXTT'##>4GFQQC'
M"1\7%WB^TG&*FF"JHI2.VH@*]HQ/-D7MV. ,S-E"L58)'E=TI&X%H%?;+;P[
MZ$LV84G=+#G_1!W*"<XF,2HD/ #Y5="0T4.OZ:L?.,G&6/+;*FJ;"30Y$MR0
MA:>C5#$,@'2[6!+1I)10+_JJ 9\6QBG >:_V@J0 =3)G>R!%(VZ61".V"E*M
MPE'KQY-8C?6*Y2I1EWA'9ZC!?A:!#]U71990JU"8[L7%4>A6>7Z&=3#D7>BL
MFY#K 4M>-T<J8K,LLOOPZ]78"LRX0!=B#LM.\.>SVJQLZ\=O;_LFL%Y)#,OC
M#)ZD+N1I%P. +'SG+4[!$J!X?\JN!__-SOPXSN&*!+Q.]B+E3_@RS^;G%VZ<
M%@QBU--3-8XC]%U"*HO+,\8(PAZ7/Q.VF?DSMJE'NMDD_<#*B(S$#'654D*A
MIH\4-*H(!WCKMY*.W:UGJWP!V)<Y;<$C599NHHIEQ NY1^;'"?U8+,4H#;I?
MX4_8*^U67UW&ZHI6+YW$^11?'EPL$B'W7F)1^HXT+BW&9^@99\AJ"7Z)=>&F
MJESE5'&L!8_+2@;J+LN-X.S'\1*BQ[]-ISW?VEVE3MN?%S%E; ZCZYK(XI$W
MCC L!)(7CRY(D:A\%(,NQY0F.VAHI8/E JX_^&CI.<8=\R\H;V@Z9#,0-SRG
MAOI!, $F>PF7MUN<N@1_N?=6(IUC4HZ8(@[I6M><F>G:SRQU39=(HBGN^^AW
MP2*^(3K[WKNP&PBO^:0[![<.7CB -87IP>A$7T7)$YRUX'V>P=T&L$TEH-;]
M"NXI?$373F S#J[!E9P&&V?(<7R&(2A\:_1HT_-5+JV8I<&@S$9?JFM;,^#L
M,YY;9W.A[^GYFHAS(=*O^R7O<EC!JNQA578QU^W3Z"AR$(-_!HOP40;Q)!<_
M_4<3XD>^? ;NI(>,DG^SF[BQL^E>XW[W?7#-.RS\ZZ R*#%&1V@'4CC> Q\8
M! 3,$X@'1ZLL&DECD5S)74O(=TC([D\@(2G:)1EH=X[%.3H;P[:8&L$#@>)C
MX&."'TN8 +)*.2R.E8_Q*)Y%XN 0( [-TW9+  /_GL>744+Z>^,BNU*7\.%8
MH>.+:I<28+>4S+7JNA_!W/L)!),$*P4+ZR*>H5S686B"4@NKOYRR0X%_&3D-
M-K09#<8GG--@:]M[;MKDRUKF'DKFGCY"F;.I02TH*#^>1F.7'=TQ8C@"=6E]
M><7*#GU_<.$5)@$B5I$VJ9%-,#M$-F\"1B79L^3XCV-$+ [G)I<%>A@-:)W+
MP)@/>A'\M*V;I?,'&IDF:(43=-@0' G^:YXJB=]L$[!M]_D*_;:#1$4Y3+>*
MIK61.M\1TA+F/ P&6YV56O$<NY$F35%>]]+NA LM@YWGV\'_F6,4X,]X5((+
M&X&'D"M5FA]W#Y[^&3P]ZH3!IQ1U8KOUOV$FQMF4,*L23!J; 9&+AC[4"*</
MY?MW^,"92Y)QW%^%IJAS]@UB2U8I#K#CB"8(SY-C5;9;G[.\O*A-,FY#LD<D
MV<A!6S)HX/B1+>[G&7&SC]S;%_,AZ%,=O</(,9A J79DH_F8#C7ODF&44 BG
MN( %JCU&1XX3Y-/"S&6*B<I<88X2-9$[8,2U*%!G'(*H1(S;K?>=SNEJEP%#
MDXW3/B-=69#;8@*D7K@T-#HVPX 9O#E_@[\:1?.",RW\F4TSMULP!CCL.,</
MNAYF?63 2SIJJVT%'9&EI1*K R%17S$> D^XS-#?YQ$0_![Q(WG$@S#9FJV@
M^LH)7.7C@>H_46,OM'3I9(U@&7.%=.Z<3K*[:37:RO$Q:VOI?$?B;UP-^&N1
M14<[Q?R3X5C:*2'P?*%U"TUQNU7 C1+00NRQK%*B8:?%97 0%1<@2VF4^/!G
M)\(6<49$VPT&\:)A?*@N73RFA(JO]9F0Y=?D8@WFPQ%<D8&&P1H'DXY GPI'
M,:-1P,Q2EZ,"(VD1T@UPC@![ VS]M"B$W34*X=X%& 2B41_CV'.,*UJXI[%.
M\ _;8"+8Z'[:#%YMO_I]=WOGZ1:NS8IVXZ$:WFXSCC+1*7J7Q"F\97[SKD0L
M4Y3G] G6LH/O! J*SIN"\*:>=510/!E4&,>0Z<PI['SJHJ1JYKYC,&D;-C'=
MN+G)54$ \%#95[ [/8@G!)DW4>U)%"=!-H(?%INK/$ .U22:)V7#V@3J$@?*
MP?NX8*.2,OJI]+0%)SZ:<<B L59Y  .\"*ZR>0+KIT)*L%T*I$^>] A>%E:F
M)S[G-Z60=K=>K/(MZDV&?KXT6%=3,_75F#>M9$T;-6#- "_IM^S\P_5L;W(;
M@!TR6G8#W+GI18;&Z#G,RL;[#^\W R6/12ACNY5F@:"/04YWG_U#RE1(ZX!L
MX 2B@QULP$@*JLVB&,0( ZICT"W7J&"&41&SH41FDU/D@<4M^+4"DU-M>ODV
M3K7!!Q*3Y;])AU3S;V.%((28EC/FP2V</%I_2CA')1/X-N QVZVECA(I,7C%
M$9XIJCJ-=@+A"11"(9-&H-Y@*)XGI ?(1L8[&]AW- +7K8@EY((QF$N<8RZ
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MTD[(5.\X<NH5Z#;I>U.DKHO/:F,A[6F5.^]P(M+$)A9:5;EZ:7DW0N<NOF)
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MF<P2IJD%[6?91#ZB7)_]G,3,?B7G%]\18^@"_8JG6#G#I\^-[K)M[Z!;'TB
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M-S+;Z/>FJ331KG;+"W?-4[/2>D(-Z&O@HZT]EGAGZ44>*L '9U=;_JN2*R[
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MZH(MX:^'63ETO.!U8G1YJ#]$6NB"R8B!;TW;2Z/N2T,6XDSUS8?)N'X>D5#
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MUVYRR.[<-KPS<YF@$FU-N52M$45-&#$48 7%_MT+&2U!B,BX=;47I5)D3X%
M7IILP5UQ;SFM?:ZPP;/18JVO)&("^,@Y??SX.4?S**\ELN_)?ZV*6MKB1<,&
MW3"HWF0;H+3-W-]F)+54=QHR(>J0@'8H#A(-"$A/56!><T<9"JM QK+1R4DS
M%G'.QA'.SX"Q9%FJ* A4XG:7 *K'+&3*)8M2J]*UKHW"JMJCH#S5IF(P'D$_
MZ-Q2E0!VT(&H,L0U$6T;O[W9&,W6PI_B*!Q3T0C+FW00RG'0?>,M&RQ"<==0
MH9H1QTZHZ+TI"HJBUS&B-\M:R,?KEF/18:2W'$:Z= ?<SC A3".UZA5-K>)'
ML"1)Z]D[4CJ SW,IS0X3*F5#>IOA8.314'5I4NW0(,I"*X/*U]/XLVI!$-3P
M2UJ7@>0$(S30D1FM)!H^K[1Q[++$/<YP'X%;O:A)E*DRU#S*$CYI&N2L+OS"
MV36@<CSL0PH74&4F;U?+%+!74C%U-\H"Y-EJ0TE5"(5]T8ZBR51:;WS3+UH0
MFB$O207\WL!:<245UV28UB5NX;=3=WQM.<NE/U19-%V0-:(UQ+0-Q)3QU+=F
MZ!W%UX3KU0>3J4#P.8E%.F,ECC\29U;?IKJW EE71K4CLHL*L;CD$[# ^)X@
MU+F"0&!'-,9=%WN,<GB(BF?*+RBK&/7KJXN[E95;QY=S@N?QG  /@?%QMN=)
M& !FRR"$M[YW?N.G S\("T8"^!3%E&<_)<W2IP-[?.Q]W/@V]O(<Y:0^:GSG
M49A[GV'GOV,(<VOS;0O^V-KW?O\R]Z&T!R!%:=<?M)R5F?LPL"@!E>P[[XL?
M^]<HR@KW>>Z#^>3_F"+[.?$#_V__[?:KG?U7FV^V7V]N2994)4L?<"0>=2AM
M_$N!(#2>JD7_QY<"9N27XMAFWM?+=@MNFV#^IW1W<Y,YZG%7T4G\?H<IJX]%
M1"SC'HQK[HK#3[-HR 'ST__T-M]NOMX=H]^?^:@B<A7<8]Z7#21+2+_/>R1T
M3O_?EK>VO?5Z??*!W=[?>?5F=W_?/H(O,EJ\NXH6+T8K+D(I_CU*O^.=S)+V
M[_Y@^-X[ZH,)ZYV<G,]= ;W9W/).0D1(RL$S:(.Y7(2Z\P=TTC_ D-F4VOH%
MV0\7R&,-*NDD[/7 _]HXF/_-(7OUS'\>W*18U1YZ?VQ<;GA?DN^+,918 6]/
MH8!W=]^\VMW?W%R4#60<$^TICO..GLW&:39*O@DXTP5F1N&C)P+..^>K= LN
ME</;)/6]SWX<WD:,S( D2&D(OLJ\!>LJ[(-RB6Y;WIO]W=W-[4TP ;/4AY\N
M4+$<J"P)^-X,DK0(UT1J+,'X>KR',J4+\VI_:_?5WINW>ZX/LU!7!JYL/"XK
M5V;ERJQ<F9516C5*Y[R!V@9N-APC>"'2O+*!?P8;^+DS/RW31];2 ',F&^14
MH[1*"1;IBN.\C).6P32Z@E<LP9-5BQ&IT%K &]TV38V4TK\W:1FL^.6:<69H
M427C4<_*+B'D(_<%TS<H:P)SJ>1IIDN1/),C4F[;FK\?,AJY8^Y':'MWT_L=
M_(SXCKH8R.5H>9_Z"6S@VZ.Y#Z<4SMC>>[-(N\3V.D!4L,?K]>9[Q=^@LEI?
MXRA?B,TRI=K;VWK]:GMO9PE<?UL)+>S4$1_;>,"<N4< WFQZ_U6@[OT68=8M
M6ICS+\MP=+#[S=L]:<][(? HP97Q=Y"2;C(0K.ZYGGV5!(6;M7SZ+U4'X6+,
MG-U=;WOSK;?_!O[[>F><7GP>XX7C]8AE,74:T[YEYU\ZY. -]+-$-W1-AC$B
M4TPW^B/'VR@P(H4N@1"=3,C]-*V[5,O%=5CX2S^UWF!U\TK#\ )J$*_&V:>V
M 0J+HX /3/L1 ;%(_Z^/I)D,7Q-JTBZN+>U&/2J'SBTF2FY;5* *"LDTXZI7
MNYOZ!?>DO%YE&9^EV,X1D*D+V6J<) 79+8Z1<,KG"ALR2VRGJ"=.$:$AF)]C
MI;?M/)ECC1^D5NMAM^<1TUPNG\[Q0QA^[;X7G.1;QLX,XR[H"(*99W8!U#%4
M>M?3.HK96M6[!58G['JUA+"ZEH[Y^0QP-MP FK)1E<@YZ"UU/B6OEM3743\K
M 4.XK6;JC(?K&]X4^S;1P[4&8^'%#8D>AB!J%J V_R @D'$UG5*@R(K.:$PI
MPZQC:R1>RHK/KA#332&DE-!+5:]=#+F.8F+J-5NC"C9;)? ]I<DE%A%JL$>N
MIZ?66YQJ']'QE;# 68ER(1+.U)N4;%;H?4DP3&^01:I'O0+8:G%':UI9*H/8
M#O(E,B[G$ E!: [8FLQ'BJJGK9O5?"!F\%E&[H#'%,RY18$,:S-:2%=!@^J&
MA,0MI$9JJQ(5$+'K<5NZ@<. GLAB\MXR_1'W+Z@]#BHTRF6L8+Y991TV/"-T
M(SLPZJ1.)@!R&^,M7\/X>>?3^;4J?>4H2Q0HM- _%?J"LV2RM +0G]BD1]+Y
MK;E&Z5V65J;/_+.(;E'YY:45@3G3QTF$8N'A[MQKT=!/J:_L9;8,>EZ/U:BC
MX7R#-5^%FH?Q1%T%KX4P @Q$DOO?"?JIA$1E36T!V@A17PE1N:-@>M21RXH,
M,;:D!ATOGY29L:2%CB9"_Y:#P,Y1"X^VJ0 ?#%.<?J!8&>BC;A.Z94/:4/Q)
M6BT\)X"%$H&&+G^W*]YM<WV6>GH:A2WT^'GAJ;'?ZUL"I.EVD_2^?#/56! D
M/186-3_=<,0K\5U ?YN#=09KP UOFE<Y1C+W>ZOAA*\3?5>,[WIKB9:NK#XB
M24WHGM/$M'5*2DX9<PF7^$9K66D30YY,/JIO1=)=;M8UU0HC]X?VR? V79_^
M)HYZAF$!V< 9^@9;:@[P;^!VAOZ@9/Y) X8#D83Z. B2M&M ZW(&-U.@7KFB
M:5UPF\YK;-,1G$)I'N.J%OD'W$,6[PAW\IPQ!P:=]P.FO'B/">'<-!MWPE*'
MVH$6QBN6QH7VB'YE:,'[,M^@D]0!>1_A;Y24!_X3[@S[#C$]D@;7SFJ]?2@]
MX#A"F5Z1QF@!5I#NQO#(X OTP^7WS<;HSX]XO\U%(_"C57X7W<[34PIGM&5-
M5-263D-.4@()DN6UR @2;L$5$$<BD%<":LFG.T91=Q:7"W-:*?Z6.G)S,Y$1
M+Y__43Y"@SYP=U/-:8;59J3BD9Q998NUC,9IFUCD $I/\"S[S1+,5T)H46!8
MM#@:(E$,U@%S\O$VU:\!PA\A/HS;>TSJ7 ^Y9=%@>!WP6'K6.WW=0L> S6SB
M*E@(,FM_^ 1EH_E*;\,L5VA39#8:LKC,:$@S2)M?6Z/#U$\'L7.(,PC&'(Q8
MH=8(V59MY\T&_$[#0M%OQD[!)]\L#K'_U&>S*62 R)MH0/]B%Y7QU164IQHP
M+5\)[:J\%Y;TX+A&'.JU;LV$ZYX_:@' @Y;&>_=@.R);/X#Y'VP,J02VUK78
MH5)[9D:Y3V3,$C]0!"B*LZ2'J'[DX9.ZY7@[@P4,_#RG$ 9C\(Z22/8WTA!%
M (\T:\K.O2+"TMSJM.9JI-_CY,X"SA[U[.J#ZSAJ9:3V62/G>?+RV0M"^)3H
MV&883\.#%J9@X(5)D;4L^SC\@5"IF=BI&BLU('CG&R1OI,F9N65$Y&<_CN-E
M4VVNNHVFW+D>1^N:#;UY?"!]@ZYIK9V R^NHSI"0FXWG-:,)HHM9III9O="X
MPJRQLZ<;3HD(V98[M8ZCY6[42!\C@E,\_W$2B @T#Q3!%YMM>;/*MBS9%>-F
M$RGG,)O:\ADJ#VVYQ]XZ?JR>)J8%8^STK)]J?1?"!9_<NU.JOZ[(0)#KK$[U
MD5I!&-@GN<^JRS%OO3+;S=9LC+[:*I)T[W!FJMT9%AWPP9U-&H'BH,DMT&#V
M*MZ!1('AJ72OZ3<M*.=>QIX80;VEXU%V"-XA\$CQ#PI8E%UY>[$U*O(H$U %
M"LA_C1.O6S"Q41138%;,:<<%4+"V09'Z@8Z3V\>C;B1K).M]0DIKPV!2<A9/
M0A3G]98'7J8"@ <)AYU4M*?XDTM8,_B1WXF(^.(\3,F&P0=<P1Z%.8OM .,M
M@=\/#"R/X[ADY.4ISI5QY^T!(Z@29$S<7K7FR)?!SRT%U>TZX=3"PCL7\IY8
M<33 WZZ3I(OY+9B-A+'8PQF])0L/,[X1LCYV?P\+XE&_1*<:$^$M6/28,^*,
M_1/A/Q:+975L%0F 9&@49T5\067@'*/6&U_.B-I$H*EY7"_Z4>'/E/M!,;5;
M!PV?UFR4LEHVY;;D0JSOF@':HT.*!O4$<O]54JM+5PGFT13MA?R6(A^PB(Q
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MOK1XZ61A88YCMG+#(P%ZL8'FMZM \X-YC]TPL5(*;L:FG^!QS^P*&?::TW"
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M)=0Z3XJ]/$4B:C3XLO=RL9>I\WL*\.4I8T.K/%'=\=E9SCS1ES"_20AG0+*
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M,7TD%B(K):[SR+74N9'<EK?6*;T=H]!]V K\I80IB&\!WU@;MA >F:J1;HI
M\:*386%-#/$G\/UNK$B5,2N%FK7Q0]$/CJ0H@[?9P!7/DKKP=%"9EDIDH8='
M)9I=W\I?E2&BU*W<K</8F4-5E)N6<W>2HBE:B7!N,^[?U[A)5K5C:XJ0*VV$
M4R&I3JJ4YG.A;JC^@0E%C523:9"LG.IB<8UU;-^IF*2X;$QEM_ #+!^(8>J*
M'HE?K HIBUAOJ^R^MIVU4R75)37UFJ*C^/.K -*,1LW^<AHURB?A4W]%.2VJ
M23B[BY$+8IE,&LMXJ2-GTS7LN9D%I21Q)GP/P.^%TB9[R;D)<$A_[N3$7T$A
M;&TNIT;X&A,A()R?+TD<WB^-!F@3"26,J-)J0$B>IFU%V?42:W)*QM1-.(YR
MU>;_M/MO&),REVPTWMC@-Z4Z%U_H=:.7W"64#\^L:"G92!1J$L04ZKZHY1UU
M"+)L?E;3_$,?L4)7V*F ,+%H,=/0G5 <9W9+0,G:N ;; [D1&9++I=0S.>MF
M(\R"&U"MM+(='XL=V8@Q4T>G*$SS>RZ((CO2WAH9C,OSY:D D%-Q6(J:.4$S
M/??'3<B;.!]L#C03XL@V''O:T7Z2?"=3L30YS9TF(F;MM>7;EA L@Z2/?D)+
M$PT:#&#5?#U&JFNY[^2LZ,;0-"11H>3J*B8UL[9>4FCL2_#BLYXO*2D0GD/%
M4;HTBOO*U4)N^!C/0D9SX&)70X'+066;^=BTJIBZ1SA=_=!*#; ^]I(B1R)>
MKDR)P+DU@0$X#6?FM_*U,9I6XO,PEDQ76YFB,W2/.],\.HQ'%2IPV,P+(PKT
M,%Z7I4]N_,J%YR87E,^9%92]DXPJQY% @YD5K1^?7!]=82D<-545-3._J91Q
M5 /]*R]Q5C6SI(BZIHKDO?<'\6XOC7KYH])!)I*JF<!=%N*:5'6E.-R)UTB5
M>LMM,'#(<YF"'.T%)T5;UQ_CG-UJN4XY8JV'QI7G&4?L"=' CU2XD+2C+[EK
MC&+IQ"&%J4RAA<1ZU#BJG.Z:5Y@HNRW=6[4FK0\K&OFZ):[5VG;=KYO4+B^1
MUG>C=].'C?J3*S<P#3"Q#K*J M>4!8KF) Y"\AF9;8?[0<XM[/"^,,P)B]^B
MHQ8_HLQ&K>>\7MY0OY\E5+!/Z4+KF])CH*+2=M98=R;#9S <X%]+V')LR:>=
MYSRS+T;8]4X(,^S5K:K B:ASDC ==K.!6/9@G6*>Q=TZ1S#'K(2&#J+/^5EN
M"O-J984E(DIM-)%LPT-_D#9-2T;*0]3^Q=@@$7PKZ!<9LU*#PQ"Q0)"-;!OK
MY#@-,5**7^P5-"9'T.WN#3M4+Y%4>N+(E(M3:J03'(1+F:3R8W V"_D@EOMP
MXQ'\"@/V\'^W6*BZ&I$$D\535,-5,L_YI04QRI\F5M>0:*_:EITX,2+E+GN2
MCNJ&\?LY+U0T ">4Y<I*YCLJK848%X*OX7>RI%_(CA8V^U1+65:5H('#'>ZL
MLW7Z,BRW]@-I,DW9:(JU[@\2KHP+BA07!*Q+K<\5.\K*H)K5H%I2Z)E#I?*X
MB1[!*<+EBK9;I@>;$Y)O!H?C2*729!9CJNN2 *0Y0ZT5V^A.O:3?3^ZH280^
M4 73??8Y@D=HWUX3BL.'#@45',A!A'Q&JB="]+YS[=*<H]Q359@U?J5RKIH-
MC#H-I7&*G:KW<T^4@B,[Y8IH36<A+(^G\5M7H51[B5#G3E@CZH,F7A^6-#28
MHKB0I*:=V-_A@K96.>!Z)\5?"UC/8+WD " F&>;:P')D)#-.4-7&.#3A8+:
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MO$F#ZCIS:W16/ZT"\: )D+\D*V9M*?B ;BVV[J#@2QYO ;;#9)3-AA$%?*-
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MOSU0=;W(9-(*^>NAMAL:O6@_,Y4X(JDRAK)%X#4"QLYM)1)>BS.D%0>C3Q!
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MJ.X4OY_S0D4#\.E9KJQDOJ/26LV&QKL833'?4I95)0;C\.DZZVR=O@S+G_U
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M1U$<83F8,()8Q$YG1L1Y*6>2EF6]VBK1(P<PDN#H*"B4' NR2]!R<J_HJON
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M?!(\4E""61#&I:=;!$!Z -S@!7ZU'R3?"0*CTD1?PSA.$WRN_J@/O\'6T-9
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MK^GP ITH<.## 99VX(XBW) X$@,L\5.V''WC>]E4Z8$+VD;\!,J9B_>6!8)
M\BZ(<%O\M'XZO%G_>2LZ=E?1WT=2)&O!NET$-V2ISQ5.?,)](TQ&43F]7&H$
MZGH*#D9$,N<KV>,?-QMZ1]NI!RK!BY#7!$XC*9VDFP4W=,;!V?Q5)3B0O6$"
M,IWI\._S%^NN]6\[02J+VVRL&4A^/;1<3=DZF3IZRKS[S1@5U<+O96Q*V84<
M0 \\T#Y1.L3;[FYYW.O#+3.@)\!MEU 0N#98+]E.HR"**3<W87PP&=MV(:6A
MFY&+T CG"!^F M*9,[F,UQNN8YH"S" TJ"9H8A9VZ:E;16V]3_F$K,O>88SM
M,HPY6IUPNC$&>_?3R7$/](Y2-)=1$6[DDV 0_I:DUUDP^>5CDB8;P602!C%*
MT(=?\8J/> 1%DJU,!V$XE.G$9&@2)K 6@Y $CL\[+G#-Y-2%KW(N1^0B%#I5
M^6(8W6@:4S!BP-(:"M5[YBZ]CE0(Q@%3IC $^%<_A(>,*L%]7QX.DWA#_O\P
MRH,1(M%O)31+4"8AB$,DP7*M4\KS4-T"A#"&U4>,AXYHH2GF8R17JD)Q\G1!
M,.H ;@!5KOBIU3$TA-G!7!EAJ<Y+1487ZYW7CMZYSG 3)#J2(T/!MZ:MD&'*
M*%-YO1F3!&\NX08";:$[A2$?!EF'0]Y?>3 .?=LN)*_M BRB1"F*6;?WZNXN
MVU8%9M/L7G<I<V'(7:U&<' (@IN1%^0NX^Z^@(5%?'FS81W!=):H37$R+<BU
MPFFK7>(UY16S TQ?R0K@P-#\A\W*<U.7WY5.ZT7P/4SX'3B+AO[=%';:@%-.
M\.M+\R(EM645\E%A"(4$BNN4?/P<S0N^@S6X]_C*,O 1DEQPDE4P&3*#U@HG
MJ;7O*<\EGKT<<ZB\V$Q1PS2"@4^D>)6)W5^J]Y:USH+!=[X1?<FZ=HZFA9?;
MN"%?DG6L[ E8JHQ"U+AIT%8(\V702*V-UK%0XG;*B*@*1%:1S*,*L+F V0GE
M%8U5R#DH;289 4XMY!M8'U@]IH5.5J!C4W%1F4.:9>DU+-$8_,$;R9RKW>&E
MUB:HVR@JG$S(8_XT2NB SDD^_[;S:LO?VJ+__U[J,PR&@;-: :6&09MFCL.U
M8*1\1M<]M-FPGXI6'J5C*<,ZG.$OD^S93V1(!KR^[Y6@K'+<Z'(8>2DOZ,.Y
MX5?O)  LX=&(D(@PN^!BE=M)/-H6LMQ*Z/$TL*=,8;SH&<3-!N,/0/,,4?GG
M Q3G(1L#R11SN_X"2[9THKA*>9'2?H ZKA6RN=JXV5@6Z]#:Q;ILW2*[(32>
MA!1DP?]E]5?1WHUBN8#16P55Y0C%B$.148A.D+V%';W"57-&L?".L",G++.9
M;7\JQI4;6\^<;W8WO5&(G!PJIHA<%T'R/9M.B@$&Z#'L"B<9_CL+T^PB2*+_
MU54&;D90 C)FJU=?,!AB>&:!18)GO1H#ZS8>0^$3W!O&C^<8!=6(I2/,8K39
ML1@6);L@/Q$.RY!(+MU1@Q;-X"D,Q?!I/()"HB-D3(D*T48\M;-6H33F.\PO
MS!-;Z)-)&B5DF@<F1^DK%'*&25LPX,"S%"N-0HAHFZG<9@X&7DBQ*9KATGI0
M_AS=D 5#3S-S3O=QMQ7DNP19H1@@>98++EVFE51+>"T,.E-!]_-X90(),SV"
M<P\A04H[B'&K^."T>3![+_"JJ]_Q.Y9_/4U@X#<2I\13@3VC&OL9,PFJGA U
M'QU/SZY#+M=E,L9C!+61!+HT2M5]3B?9"]GD*D)%W]6,A#U6VNZ*!&K6IE8"
M.1!R?0R*6_,@9PQK6SG,[Z,UO1>E-*7\]R<,&>^M0L;WFTBX>6D3B6@[2D V
MEA$G>[,,:J4TN$#<;#%/W/4F0U8+-$IOYI\((_LD)>V;7XM.4MNT_GSUS%Z\
MQXGHJH&Y0U3DCOP^RD.VQRR_D%-63:[<"+QOAE JO*<8<C6G<+-A'</>2SF%
M*;G(+W&+Q4QDW#0+"@1E<9J!0ATB0"-7]P9S8ZC2]@ON#YH4W099AHA"^A9J
M%5P8^A ]H]RSDMH4T+F1:#SZK7YI<9R*4HD>+!A+^&."&,#XAH.E%.6H6!I\
MJR4DF]LZ@&THG71,ABFDJB4!5JB'PX^"@\\K8*#9R6.\#V>Z!S$ZQ7FS@3]>
M"]9]C_[15_\8$ R4_CD2WU:RX#I?BQL49)^/=&LX\ RYNT<WIIO"#>$_0_Q/
M2+>&VXK_++#7H>;TDEB8?4-YOYQ'-&1*4;B3E!74LF;5#K39F#'2"^6KX(T5
M.Z\SK.='4+1 4@F*)X8KO>?,H+)?-PEJ%^L"K0$'FBG\.&7="],47A"=.P='
M</^HK+WZC$.ML*^*4,42Q-"V'%\IJPH16NRXO\\_=9^T^L+*5[7UA^FT#X:F
M!,8I$#NXC$+,YUOL.K>@U3$(#Q*NJ)BB:M(8!SHI[X#26"K@Y<?@$AUA;"U?
MBV*SF)[MW^*+;;_;W:.0/+$1*S*I9;T'LRAYBD2IAM(&23TY("WJ-I-]G@TW
M\(2]L5B:< T+K'$))(R0746H-,2.J&6I;3;<<]P@;"I00#$.; 0;I5IP[/57
M3"PY9!;51&I+2*Y8DI4_OEB&E[E66/HS!^>J\TE\00T #FN)IAPRD8AA'.9R
MM]K3H ICA#>OPS$2,HB%'&Z$ _6L.E93V>-8H& C@@M**.L?$2,PHR(<T\ZP
MD/:$O:"[,6!<K:Q3<>6KH#K>X#K(2<M,4##2:4ZDTIC,8_'CX9&+G:M18'"W
M7CTEF! @&)>HPTJ(_98<DDO$$GYF'#YJS5L"I4O(NIW-'3!(EO@&%RI=7@/2
MO[%2;;Y$R"XD**E-10T+4N5B]05JS89^DJ*R=-;;B=PH@ !1RKNC,&5MZM[S
M1T:F-=]OQ5#U9V>H0K].>+HI& %6(E9C!<,K=882I>D-^&#8S$MYG*5KQ"=?
MKTF>*8&28)G(J:9_@8,S%]?W*LJ**:DUFT#&BO*S3XOFJ@9UP/"_A^%DXSJ,
M8X(ZZ($Q?8?O7:3I,/<=[H!,VP)TR<+\W>*4=O ]W$@S3/+YDN$SB;YF \D(
M\"RWV \H6J)@*4,#3M<[<5U'LU<4.'\E/C"*<=*Q!Y)9/M')MB7;)+%4/]PF
M$?@4J?W0 (C*.[$P^$P*S1.7,EM 6)& QP1O5KF/"D@B58X=DE>7KF'(Z#)5
M"#C:N+<N.*$ $8+GQ4A4AYT&ZXL%Q-!10EBD6<Z:@&LEI%4'1PF'7)NDK$<P
MI&"W98P2I\1_LV$8(7OSGTU4X&3[P9#[9)T$7#6=3U+.DXFE\J*(@ R0K\JQ
MC7.B7S.O>#4U"1=5.\GA603=Z1!7M0)O[^<E3GFURH,\D2"F51=^?G=-K[ZY
M)KD]B[MK^AYZE#&2?NG"7L66;0,>*4S-60:KY*2$W")9SYT^-29.)REP6&0"
MV_![._Z^CK/B:Y?+V&T.L>7X[ZK-^?E'7T9;^DI#JJT5K&1$N-F T2]9>*'H
M$2[U7?"@PCLM\W7M<_!VW#W:G[JQW/\:$!NY^K7MA="U]W7I-86MA?=+N%LJ
M-"V6XU4./,@E5)O Q:(<8W .^$@1>&F )VPDBP!:8BZYKI,0-(:BW+-NQ<!.
M.'1U/@G_1;N/8#WY=,P!#'O,]2=OLP&CU4P$-7$O-EP*8>R"'X_A.1E8R8ZI
MOD2'?R[;43UEO-3[S.0ZFAF%7.IK8I*%TS0_4PV[]0("G3T5C[26"I%+)]VF
MK:](HW<Q-&D:8<*GJO82\<H^["P8-\U!Y9?<(MM"9ON>&+RD&^@FF/ 7TS>R
MX5*XIR..$@:>3>GNV_:ZR8:-<5^*0DBPV1T=+(P@L"\WNPM!_]5B$^PG.-)W
M$W^A9@8][L5GD,D\$M FV53X@_"(3K6"T;IL&,;!,HE%].N<U0F"M$R<A(RJ
M'>O@1JE)H#0]K/O=[K8DYBH^#ZVS,(>J45#Z6Q:.;Z_7-)_V_Z5.'X-D##![
MF0^RJ%]K<V.2=VU[?:E;KM0_?8Z5]P2]X9N-QVT.OV0#DB=SD?6H8FC+W%<,
MVCC)AK5).H4]9U"?E,N+<9 $II^>0:/C>DLGCBJZ)I#6DE9_B8>'[%HP)QD8
M<# 9&Y^"05$.VU5;4\[JN+S,[7<4A172I'I[EL*A7'DR3K/B IQ41"5CX=(D
M#H?X%]<U^(:HUB9A!B-F.NX[$)SO4<+I&2MNP+ <?I;N>T,,18SK]G6.RXEV
M4FJ4C6,!FYE]1/O2[>BE8Z8820W8D!4[-RIB]$.$&\U$BOG58ZK)U*+(B!K5
M@)),X8D+EG4BS1?"*"WS([V=<((BDWDQ.+:T]O)$D^"B+:7#P,:G/4\B"K8<
M()@PHVCQ03IDDC3#W4^73N$,65?+485K+$<F5:UZ+11A*$>@:>5B%3^5*KX#
M22-+L=S,8F_I(1K1LO&_;#M,9QHXXDBTS$.GHKY_XQ3C^$C"$@L86;.LVN*Z
M1-5;RIOB<3"K(_$<RQVDT41*\^@'Z8L!=:I!PML+4)&7MTHA+T?$Y*BX/0#!
M:MHW"U^PS/=QF*DK^T:7&=6ACRQ;U7"\BS\B+;YIS[';@9.$B/LQ#.O2JBXE
M9[6R,T2=T]T%L!?-'XONI%T>R^[V!VKR>?[Q#D.J[E5G1#]OQ/GU*N+\^%OH
MALA%2JWI-'FBHB#%,YG@]]=4O<K2*MA(1!R'%)(9$;4O^\"59)']**U1N&)9
MB(:T<3+AG^(CE\FS>*I9-M!@K$1 J\W$5VGE/QG,@];=8-L,WZ!AN[&<KE&4
MH5'+C1AJ>59<O[=D)#0;-FIO!6'XBT$86-;21)>YJ-0!N7%,0F<E$=2)7VDK
M I^BE8%V?1(RYV6)I0ES^A:]HZ_H'*5J5<H&-$+ _38:HX^@:[4XG*-&C(P"
M(2/MXYA!3IE.C ]2[J1 C\ZH08UY%/I^F=R<MAI?KVC'*X]:=?W["S97P^AG
MG&9#P0\CUT,6$H<HB*/^4.7!//O#09"!*E:])##!F'VWO\=^#5%F/F'F58YF
MQ-'WD$T C;N;B99Q4G96A,>FD!(*_"RD  ^R*:)SCOM6?]$G["KQIN9"T8^(
M/*S@  <"XR9( @ Z@+DC5"EDOMH6?\'^;P+AHKPOBZG1PQ0KLHH@4$(C1'9*
MGCKEQAE(D(]!/H1\4H0,N:HMF45^ERPL;GA;,..;UT\3O)-]>_J(?%[>.K;8
M4VR*]A*'$-T4WRVVU,HJ>EK9?O4"9;MD@0NV1!L<3D6 8PG9" ND0B)B?QT-
M#4P%DJ$9-:B^$L49WA0'0O$RYC=#OJ$JLH-A&L)U+093:2#IF/E.*L\WH,+U
ME: _K:"_?K&"SDD2$!#JW,?4U%1H:HF+1/F<BCOXS*[DE#ITN\KN/3-NK(3J
MJ83JS0L4*EW6P:@[EC&JQE,,,$2Q&EL*E;-E$P92#$S)747DA&V8FD YY9RW
ML(U+]HD:)?:S#*M>I3TFWQ@Y]J$P^X*R>TR<3,;Y]=9LI)\"%_$#E(*?I=4=
M+UJJ)4.QZK7+CO4( N$@I(-U1?E%UWVO!@=%]TU2>V ,<N":=-KZZ*1?"=F(
MW$VU<>"R3K3QPLQ&-3+P=.;2LP.B!&"E/)Y8>;Q]@<JC="(-@@EE.AD,8!OV
MKJ>KY4D+C^=:4[8LLR@W&S-D6363=L56/K7 7W0_&2 A7=B96=E13RNU[UZL
MU&+5(+RN1M([/2L$$67<!X>Q4@N\K@S32K]\!DI;N*JQ56G*83>HU(6?UPH4
MI0OCW>L<, _%J%1SCEQ11TV+E90_>6)JZ\6*N5:49T361;+2JFC'P/MOS?^A
M2$V$K:P'LIPS'U1939.F-73AR&*)+_$]++RK()[J_L(UCR;3KK;W+26]8&A,
M/^3AW/*R&.8&Y#.&B\^[WM]V_%=;AM 8D5RXT2PT%YFPPL'(_ YDQLB_(\)?
M,+4%>D=L AI"W7FUPC\A/.+-GQP>L=)$VR\Q1XZ[B\PW[AH-&R^\QNXAQ.*'
M#"R:%1'<)R%YE,ZUB,Q&=*>^/-?7Y^X-N FK=8M\G?F7*G74FB6$S$LB/1,W
MS)3DAA<I6;2* TVWET^]M0_G'[>W$.JQ+O!9'*%FYG,*QY2>(QQE'U.2YU8Q
MPSD6<)^; NYS5<"]9C'!U_)^VP]!FF_G*5)64E@H8 OAC:5E032L?S50MLX[
M573N;0:$A#MJ2"77FAOOW4T4WI< <LH%%Y?@#C)EW D$):D*" F6F9QZRF!T
MB6C018K<31Y$1$+J01S?E><,G6B!E0G/53U/:5#J\]'ZK(+W)2$G*1Q=2\2#
M9#<@P5.<;JN6V+?917SO7UB$YUWIN@S3:EF^V\B+=/!=5:4(6:C?;$P3IY+$
MI2:?U:.9#G5CPI,1G<+W5" #2X4CSCD&H[D93(5F:#5J7M)T7][D--8RU)BG
M7?5@RJ=L-"GJ1=RCV/#HQJX0)I"[]&@PI0:#%*-Z2FDR=RJ3@"H6 JHG;?^X
MC/IH0RTN]-C85D4=&[?Y]6OU:VX%[:WQR\L#O1:_,,-A;S^*_3N-8K\\BF:C
M-(Q]&0:?'=J_6B;&,$NQ)ZSW>QI/Q^$]F^K"ELHH*A/0D>KAFX]#[,&5D.J[
MR )BH: G7?&30 %NO]KZNQ(1P@F%S-%Q"!:]J=+<W294]*M*O]R%EVPA1CF=
M7ES"7$PS,SBO/+;<KE09IHGXN-2/+J52#@M5 5MXD2#$Z?6&D@2\R3@:#N-P
M S7/&'/><*QQ)Z.CKYV#?%T5%WY+LWCH?0F#&#R5$TLSJ1F' 81,2ZS>( ==
M!=MO[=N7$Z_]]0CD>Y AZ4L>_?"^AS=>K[54OL'3+!H'U'7:*:.>4P%@]VDU
MM0X61RUHD9GEV<M\U=NXN+4'7F&^E\)YU6/*?)%[#L'0C'0(J=BYH2!3O^-<
M*Y6*.L.7AS$:P(,TN0IO7((K'M4(2^')LR^];)O..C)7+_#^N55XY=EU5S4<
MV#-O5A]@T%QDL.O06E/)&$-.AO]4&21U$DW18%CWW7>BZ!@VIV8R4 (+2K19
MF94SAH8! &<%(U4D-?LJE8_)*[D@U?/$3!/=I?KN?5XCZCVDR2UL*OKZZ\HA
M%FZ$;(\>X07)!A;[4<ZLDNJE[AYE"5N3QI"XIEW5%;OTZN=8*,>\XOE22Y\K
MDU)E@IB3.-1<')FY34U@UIL1E_4%OV12"ZKQ><$6@W40Z4Y8;):J[CG8HC*-
M\2)D\-?!8B%6KXQ.72$P*X\;STLP.(LN+N4S_)7-,Y75 *C</,OL)PH>,*_\
M"CUH/6T&I"53836;+8UPW4(F4H< D Y89:V+!)KLCD^V85GYY)6[D*+2:5:7
MVQ='IDD(190=O4P-3!@Q7",:\(Z_<N! ?913*S)R;-7RZMV6#R[!:ULF9<H9
M\^G6$W!P_[4 U JF 3+/^C'7>W>Q4)&(H/&+9@._J6L<N=07U)6AZB45DQ)5
M4Q"#7%TA-A5PGG\D;:&;&82*/KH?4LTI]NOT;>8V@KN/HA_L-_%F,,6I+V,>
M3A'T8*VVF8>U8$;5H)J0W)V)9L.="L?T*'5*V%Y0I^J;&C") ZFZPQ#)Q-7)
M=$$0B4S:NGD8&=6$B3,ZVM7V%"T-/"TU3(3?CLU]J=R,DQ"J( <Y@\9"A=2%
M;3R<8C<TH6/)YSZ:D0[ZT4H]$ E40N;3.-I !A-T0X(\PNX."/=C&-]"7V3W
M]=;&,+A1[@@Y35CVH,PE&-EU&%^%M[B3<R,N_%S'D$K.0]&*C0A3G&6RID^;
M[&<$'8^GN?=J2UZ,J)7R2N='MV"6:1UN=XTJ;/7Y00[>EXEPN&'9-)E@U%);
M7A)-,ZT_\60&^_#G[1KU]D^>G'G*KE&&S93,,A2MTCGBEPSK:%3W*]1>TLY)
M%T1927:GG+SV$"J5\U6&0JK<G#2L;I"0%3N4FAUI:\GY'4"MV[AJ2C;4??:0
MMW@Z)2C?O\WQ,UN+-QMSSI^]AY\_<P\;34_RE/.T7#]J1A"FC@@!?D\?T^0K
M)K<#,*DOLG0Z\:2YP%?*[N>P"(--W_N<QD-XI->%G^?$VN>UIYA&\;IM=J.^
M1O\[O4SM/BGGW99W='2@<SK.<P-O1C@*?6EFL0&_^O3X '8A._]J0.J67\\_
M?;8?UQJ#W,%A(B-.:UCCPBA3HDL\,B,DF@D*X3-7Y%"PE=6LF,[.*%0T7.K9
M]EFG'R0EQT,8\AO(Z7>>4/Z""!C C^B,E"/J)AXY2S6@D*TTBIPY-^A7Y2"T
MBGERFJ!"D1:3HO7T)E3L[*8FF>B@339+PR4XQAIP<F&07B24/HP,32,VX,.G
MC*)LK/8>>,ZSQKE46WK&3O#^>YJRWWX+]E):_YFWPIC!4 )AI9.'M#C(!E%#
M$?6<8A'5%)7SB#!])1[]B/53D'_G\EZ,4*DPW0'%WDD&],AHA3'X0RW?V(&V
MS*N<&[^B 0)#,SWT7$6Y[OT;)HDO5EWL%+/)W'%K%M/9TP\RL_O;[I8WV1S#
M[L2E^R/-OJ/>X?9>O@J\4R,BEX1Q@B[[4$=67I3BQ5Q<%E05+0$&[TJ8(;D]
MTP->!57P'OA]*+VGEOS.B#S$HL#NM"]]$?.'9JO(7YB."=,(NCF98@8)IR"!
M(63ZD51>H)])Q)N5 'QM7!1$^G%31>M"+0FF;V!1T'+>B$Y(9HA &A].@%&0
M[?[9)6R]Z::7Z/Z:1Q4?LJW*_7DG@2*:$'<DQMGXYX,@&T;I59 /*&X$?J*4
M>D[@.0&\WP#&.$CC](+Z]>:3*..U-K^$W_5#,GG%4+OD]V!&L2CY%30*GJNX
MC@,J8';3BY@ W"#?5UKZS4TU8I-5-]=8=SU\6Y]V7.I95(G-U6Z/09R6(MLL
M)<C IA2?S;3K$NTZ9M5VJ8ZVQ!_H<N,N=6HJ 9IF0T5H;GD^HQHMQ_NDDD7=
M/-?1GXD5_7'H\KA%NB)I3(R7)=R^)@R5S/41??NL%RR4RUHKQIVY7IZ&$6E]
MH WI0.N,RL^J\5YI09,9?,/E&=.O)3:*$X4K,R";:=-OH''J]@R1/<G3/QT8
M%6ANKB]7/I=S.2(39A_H2Y'++M@J&T>HY_K!X/O<=#&%TH0X4Q_3LVKCW )?
M2@_;/"F!W7N,5+<T,\9!++YG75S?EQ+[4&)P3G'9,LT'VV5;W&S3]-C<K?;8
M_!EC?^]6L;^GDB@GL5_#J6SZIJ%7C]M$M44*F-<3"R"Y512R8L.O=-80?F$:
MCT6)QIVNSP%RE/:]P6I4(025)E7E-*>FN^6 >UF[TPA6%'1_>@JZ)/4F:697
MH+G=R6RDJPT66)O1JW+=(+49#:/AZ!C?T1"$V37?<X@K''BTK=6=;;I.@!5!
M&KB]M9P7*-W+-N'\L@WG.[.R[F8^ZR$QS8:#B?$I8(E&EHV^2?6DAOF338<4
MXH,.MRM=;_$*#JI'DJ9J-:7^*S=UM#4\)X_V#K.:L=HM4_D[JVFJ2D["G?*1
M(*!TW/XA,V&@+:JLWR4=YU#^3$";W;N-3#<J.2L!Z QENX22^XQ;XEB:M4,5
MX39'DQ'P,LK2,5\O2+2AW&@=*=@#<B=L[-P]=N*J8/\OR""9"$3(%9;D%IN<
M.C5BCP-%G:< 8+[3"L#TE*5R+"+?5\64]H;#?4P]SN#PBJG'-M9BTRZH(Z\I
MPU]%UZ2YD%V/$82&3B>WNRH5'M%N8CLOY]\K9KV6E>PIO;&C7T9X^JAMNIB]
M!'5)!:G&R1=.T1JLF7O4<EIUM2__:K25#]^7%@T!ED^HQLCH0F N(;L*5=$<
M"9J**!O_1;?^H/)HJKVV;4",1PPNHQ"CMWB,PKUC^"-FHVQ"'1Y(M/-I3$A1
M11 C*@"I*=W:QA+Q7V7/2T=$.US/S?,XJ%(]G16W?2T.O-DP<+%%3S;FLLNI
MA:A99"0RH&SRW*C>X4Z#4=EO-:#RY0YAXIA29IR.YJ:!L":7^!6I6?VUJ=4D
MSER5S&TV7-'0XC!S> MD ^[!XA$5=Y2*%U;BZ()ARY%XW9!=-V$GN3@,1P&\
M"YPP.L2J(@D6E%3L,6ED9)NGS4:IU]B;908V;V$J5T(F62C92<7[>4VG?D'@
M>2R>3;BJ)&$K=YQ0S [CV0$<P"#D-QK;?8- R9ITN)6U8^)GA]QV7=%&E+'<
M\U#@$K&Y$\Q;G?16Q-WF@<F=4@#9\%0I7%B7^&0,!*J9N  [0WFLU$Y1 RR.
M DLOA ); &(DF>?^5_XTZ.=IC/M::1_5K682)=K0*.&P%H:ANUK)+34"[+8D
MF=WDR&F3J8!F*M;-VX]W8G4#6P$"*^6PS+<V!\Q=NN>6NC@SHR,9JJ\,X,VB
M,?&NTH*[8F'%M05A@L/AFIK9SO+-2XUH4Y(BAT>R<DK[\BNGZ2XEN>==M>E]
M4NMEA3P)_F>7%B8X*)X]^YT<2>&WY%<4(QU]:K24^)IF8Y)>AYF6D% WNQ_)
M1!#>R^IOA2=K08N(VP8&@1P'<<H-'Y"M+$R0:W\0!SF;]#0$?"+-@@R5G]HG
M0L6<'Z>8GRC^,5CN!@2E# >XJJL_M4P01G'4I&"QSHEQ<[$T5:VM5E;0R#D0
M$<8+XL_:^ILSS"!RA2;]IM(+U,</-'U&1]%GE /GZH"ADV0D.F_!R]+B$8FO
M&#B21JX"2E"CIW$T)/7EF*N83. X)EM;T7@2<.9JS2*S:#8H?27-[&CW,)P'
M-B)75LZC^8(_IC%NNHMIA.=((@3==*[S*8Q$",ATY&29,ZYK,V"NGS9WMKVU
M2I[=&SBO(A:^LM:%.<ZE"+VKX(] +7"U*XD]H1"EKXBILK$K^NN:GHECH^@\
M!D$\F!IV58.:!8MZH>9RRX7P6E <W+=Y'/PKA,>P^@!%F@4ZL,/0NG B/:?"
M*\:*P%BB;# =XRX;N.]!Y^Y R,4LQIOZ*VM/>)N'T+\%DP%6 ]O7Z$:KF2"P
M"&QELZ@@(1)2Z0:POF@-<=DJETGJZ1Y-$U*]I#/AC L1!LVH JNO!(;)2BV/
MU*F=CL#FE-RD/ =UJ#IS1:LJRXR<46<9J1MO91VM"E0%P+=X?!9.UD68;FA>
M&#53F+F5A_J@+#61##UX@C%. MK*P,$%B:=,H!VG TK\CK* >]3@Y]8()XK4
M!2.8J62)G1]3:!,>H;#6L.#ZG]S#5.I6V ^'G_,SS0#7UQE$?HL33:&#Y#QC
M_"^[YMIF=&2W%IGN],WFK!NV8T[5MHW&8\(,@D5@0W11Y\%MZ_'/=L()[AJ1
M6R?>(OI<PPL.+W/%_L(750@DP6C!P*2]M'6:5XR$.94F7KE/.R&WK';B''J1
MJ:1HLRTI5I"$0W +WV")(8%>\ /7ZY^6G[O8,[%T>N_2:43N>YT\"\)84Z$Z
M1*J,?+:;@LO-3(]J]^B)<J]$#J4T&_]!WO50]9*FJ@D89C0DZ0'3SPKIEP:*
M5_-0?:L:)&:BC,K %6L-.QD:1J@$#Q'(RS3E>R&7CM:"2^L!M4L=;J=5Z^Y3
M^,S:A@;V]<Z&?=&_$> Z&A&Q0%(]C.KWM2'; +WKLJF+;J.#F\?2:5')#S]2
MR@-)'PU)2_/+P*_<G>)&A3@CK*W]R#')ZQK^E700WLIMKNO?:J) .^NYTCD%
MW?5>6(*7J73LBN/;!4)JBVQ(+X/=*L133GVSJ=%N-BQ^V)LHC(><,I%>N&N(
M+"=:/V/9Y"&&P-WZDQD'70UT=5W=9F:-CN]9!>,372,Z]QJ[KN>VI3STZF92
MZNY=JE!].2A<":97-$6/-D5"<2U=0?0U! ^$XF3J(_!UI%[-X2R$68EBYPA2
M07L^U,5RH%H/1LLZ#3J=X#!;0B:M-*=T578S3#HI$M$>_&1Y.WX^OJ-*?Y=&
MN$R531D"50W64@" 6BU>_U/?&TJ\UY0PT$F$B-YQ*KX4VP%@5817@7=Z&8"5
M-*#2%=S%GZ1IAGV*P] Z'6( V=_\?;,N9(.?3-60,'V7!-*7214=>!U>FB)=
MHK131>DAT@CAV\ '5C&9S5\R2#G+:\BM1S+K5ITI?BB5L*0J7%)6%2 '<8W#
M"]0.>%1DM0'T:3_&NJ&$R@^O4-TBCFD9#'9.&FU[<X>6/K&CXOT;J_(0!E]S
M2LK<;I+$//LK?+L,$[0Y-&:3QT6,Q$+>IE6*)N?HM'S+[1)*,,<HI@"S>N^(
M@^]4$Q=8S59G=Q9^?J'OD8.I0D9H:3$V:)H;+]-,#VGDPKE$J EK^FT_WX:-
M] !-[7>M/M2\"%2O)+P(2C-]UF!7 P7Z*8.RVZN@[&-+&.$X4KNH6%R=6HDR
M B?.M"DTU>&6T/F=>TZ6,..4]^( 3XV@/[_.:&'W9QI>G;Z8:7EABDGP?Y16
MM+ :J%BMS_"V1HV2UR%92W:7\-"U?MYM'U FQJ@GI90<PE3X8JR3HR:Q^0(.
MT%T\0,^F@DD\L#I\+_>0Q+0P&L*WC-7Y$K(GYTT!R3WQE,A3$Q8@(LH@Z"F;
M40F.TKHD"PE;/?],>3WCC>4CU!;TQ@^:@;7M=;;72,B5S"DY;V$4_W9R5[Z$
M(3HF/SF)I\A8"3-W#>Z30"J:#20/PY+E]W,V^?-,Q,XZB8)@?RCA(B!B>^74
M#*$-'R6WF1CR![S/K=:I.767NN*[O.+7*>9P^0#@MU%4B.:S="0?X<#-Q_1*
MUC>LN_B&F):*X,E!ABGI-"M8T:D(% :HZT-0IIN&:C$AT1C.)5%=NPB7K^B<
M'"BGHN&?=U[L[#V!/?)A_V/KK-<Y.&I[X"G\NO_Q/GKL@0/H?6E[QR>]=M=K
M'1]Z^-?G\]99"ZP0^.B^8WJ\(V!G<QN/@%Y4R/KV<&\]JO)_=^>-$*Q3?,=P
M"]+(#&V@:>?Q/4FOV=>QZ#<$%<;;XLWFVS>O_E[*'VT<1<EWH@0G! _?=#CE
M1UK[AS0AW^?MYO;.7>ZSNZW,M9$3U+#3#)OTFG.HWKC,@=EAL)L+PK('_([T
MRH0@#(>BRN8%DFWX2>'.+48 =#:UV?C;:ZNWEMN$A2_4J^!<Z/W-ZLGU7L[C
M,N\6!A=:PZ%WDACSM11.$T/6=+THMPHKB>\[&F,-Z^G\"<->MS;##G*T^Q;'
MSL@7YF)%LX-C5Y_%43CU3#&:\RHY=A27$<SDN=O9?,5K7VO$:^G&25#%)XAD
M&D_'\ X)M@HW0/:_[<A:5:1'U4)>X/D^GL9%-!%#[V_;= 4V3<"%RIT;S5/3
MLP["A^WW?F6_2Q@T8-E-#,6)&*ZO?/ZU\J KNF'!I;O;C- U]"AB%H9!!JN;
M&:X/Q=5%V_?YIV:P;B#GCN/'K\ED&IQ]MH*J[W10U<DT*6D3K@VU3PJ)M<AC
MB "6(^2%4U];2!<=9'=%JD3$=5*$Z2H LP*?0>EU#AQNFAMJ>5:U5%9:AIO1
M!!DX^1F1W="*U!*9S/66;F.AO7L,F_P33K6QH8FWIE8X7WMKYA1"9IY%,)5N
M$4XVIA,%4''3N.L,DW072<UGC6!H,JW^S6\/M. ?/FW1NK>U2;2<$PI))-.Q
M[8:5ZIH45J-@^N:Y\%&M=NWD]_N?-X"VLPJ@/9D0WEL*2_#F9F.!].D0[C*W
MW ->5V&Q*U#L9F/NAKN;BU#VG>_T?JY9":/"0C2N#W$.["J82!*X*M]+F1+O
MA-@9-2>AW P-1Z&(@1-3J54=.&G!$S*R2X_"HJ!^&<0)(#W%))NX+M32<(R:
MIQ_H!V@6KS6[,2_6!\24N2/X7S!$ZX]-56R+F65IYJ B\0(P;F%G"QY-8*G@
MX<-QM;Y>P="39V'A,K'<-I",V3"=]HL'!\"V=^\LLZWU&D.DYFP3 F8^W^3[
M^YRNB@[<V0H@X_9>*"ZSL Q2K<4:U^\,[NNB95.QK]U*)-XO80GVUR7:+[.K
M\W SE^0A\U]I-!K ;'!WIV9#E%?=&EGJZCI5T_X76ZF#E[12.S-7:HS\,DGX
M(A;I$8*\]UBH0ZI<35*!%?),TES0!#[3 O*RX5KMXEJM4:R(:_4E$Y*'_YXJ
MT(2[C@AIEI(A!6FV0.*W7E(9?F4]K=OSTMJ\ XII<O'ZSN]>]C3>^7"^=]X/
M/0TKE*^Y.0J5_-ZK14RY+TRS<<?.,,\?P@C7O9;W)8V'3.)LBG<Y[E!+>5O?
MS4K-JO!9Q*P"N+K;HEAUF$5EWN$F&'E-N3)V3GSA >GLNT_-:!V1E[,9:*4!
M@R53U#%$^?VR%P[#29I'!18O81V%A5"U(C/39/CPA/W=W_#"></$<UL>5T-#
M(A05NG0\9RRS7E&=V V\)%>,,>=(^APSW%4P4@(%.Y%;J[9'@JJT]W%ID K@
MK\;8M\CQ$+''_R+8'E9QAH/OWC +KA,69 2@XKI@A),H[FW$JHE(*V#I<)A)
M/)8\3ZJDMN5=^BBK(F/U>PD'3B:H).0H4=VA2P5X3E4<!<(1%%E@F0Q'"Q5I
M"%ZC6>VYZBHH;,ZW+(S#*XQOVYL46]$[VWU!+QO))5"D746B7ZE$@M]L7$>9
M83Y8(."^:DAHO0B19,H+TKTB W+(=1$/"I153F#"G_(F\/9H<W!#*\&U^J49
M4BU*B2-+\2K\E&&HW548ZK$4X.6ZE>C1ZH[3"X[&FSA<GH+>R@UT!>1.03CV
ME@T<VF'D[:<4<1AJ#]\V:?PT5D:P[K5K,$!Z^EP$/R9*2R_D6^8;(L7LY-MH
MR@UQ6)_RH3/6##*#%+4H]R"GECI!8IT_BBY2M[SWK%[WWKZTI!>VN*E17E3X
M'\+I-R1O"(>D7V;$><C2*^S:.45%=F>_1A\.!X9XC_FG#*1A8+>N8D#]%1BT
MD7D#6X8-VY3JG8L@77B5_HV%N\+TD#\/@5PN=9I%I^.DT*NP1>LD]R4 &&$9
M=SB8ZC/ YMM9 "53PR>.0^UEUDT6]__AJL,^G&AR0/=!^;>,BV2ZO! LB>X6
M4\P0SA-N;V*U]H6M\9UV%54P&B>'VM[CI4FJ69BT@"34^B+-\I"+$@4#(8'-
M7,V%N'N4I,;Q4%GW%545J;E263Y^*5CG00R&.88=4?;8090$(E\=Q.O2H,@(
M75+'>'3K2IF996\IJ40!1 A6CZ8?W2Q8,&X.#!,?!]?X8_TW@32)_D)Q:'#J
MTF@%V88++L)79XB!IJ77  $<W!09KM#=^[=J,>7E-S -8R]-+'+P.KB"O!4V
M=F&@HH5HH?V.&YF*J86.+4UH8\(_IWFPH _0D^;M#43'VIFAZ"".,1@R:6V;
M$U6  #-R,+)*@7M1!4[1CA+-4C66,#97JHTVZTY>#2Q1XR@I.9NP:!)B" -E
M^,)VQ!8>"-J%DY/!]]QCH?3(!2>#FT9FE[#9T$>NY(>E4YW>;/6GB&U-5$^/
M-M[!\CG-K VG\8WHD$J*A?;^'*R-2XOGVR5VHK)$:U;;JEBRI!X.#G!=DR?+
MLM)K(M.,I5Y*$UNN,FZI E&DR$G *D>S+)>'##-W@.QUX'9@>6%!5]8[EIQ4
M$<I&Y=0IVCH918O8U[^&K/@O0?B58F8!4YK6.DUZ*.;S':FPO'JH49B7 &N^
M<"SX?_LF:"QJ1OV!GINF-Y".6JGR] 8*1#IO8A!RNF"BZ1J&M7(5I!+))>BO
MP;K7DOILFAH\P4B*DA"6DID[5'=ZHO.S9Y<%F!E<B61"'02LKMT8@F_U)<I"
MT%_P4Y[_9F. 6CV.\2L:2NT&!-&<9I9H6O-;RFB2^/$M P7%U8)-\7/UO#)A
MI7@BREEF4K2*4[*)<T84@SAE.BA+0[>?JQJGUDTGS6:S8;]IE-]S CUK_HK+
M>3$&>0T=M9"#5U-;\HS,6P/N;<2%,E4J$.& T*'>-/V>BUZQ=T^SH2:\MC.3
M]6B_HH@HW#E"]C7=M)XC&<]?BU,^/M A/.*39OF>X*R#+,BH$1*.4BW3*!B$
MVK*8<4ZKDD,ZL==(T:IZ _0*U _EQFSRR \(,\&D_A7NF= ,)<;V%S4'O8@N
M3ZQUW#\4U'7W1%;O2Z?KP?^VO,]')_NM(T*U>]\Z\/DQX=J_MEO'G>//WLDG
M_+/9Z!P?MH][YV=M[ZS]J7UVUC[T>B?>E_99NW/<^M1KG_W$ ;*]58#LL>3J
M_/BHW>UZ)%XD4O!_3\_:71S_H;?_A]<Z]EKGO2\G9S )AR!+\F6KU_F]+<+F
M';9/3[J=WLG9'U[O[+S;:S8.3KZ>MH[_\$%>C]O?O#].SO[+.S@Y.STY@PM/
MCKTUWFB'O0-M0(-T]MJ_M[S3+ZVSKZV#]GFO<P!R_@G$]?@ QM7I^$0PX)V<
M>9T>[(3/, SO$_QUUO[<Z?;DSCBDL]9Q%V3>]]K_<_"E=?RYC=><MO[X"E?X
M5 D"8U.OVSV']X)-I'^+MW3F@^_?/N/?44E)ZRN]_$'[L,T[X#^#\>0]OO>F
M>C?ZCE^.AGSL=<\/OG@G</T9WZ#5Y;O_]WF[>\O9A@GSUM0+R!OA3;ZV#MLX
M@_A0?!K\TWH:_*C3^^.>SUOWZ6%F4D^/VH<\I7SW\RZH&U0L\'N<N]];1^?F
MZV^=;AN?Q(.B8;?/NK!0,)1O9R?'GS^='\'DM+I?<;RM+LVO->,GWX[A&7Q[
MG][/][ZTL)X'KL*?='NBU>Z36WVX4@8[RE+(7ULD5]Y^6\O3H8]K_^W+R5%;
MY."T=09BB%/5XJMF"Y@U7SS9/;AG[9[S9,MY<MNOG>-V&W_)$P>C:9_VU.V/
M.E\[* $'G;.#\Z_='NZPKM=MTW[J?5$_ZYZ?PF*CC+5PC=2!@O('+PI>,+^I
M$HVSF>]JGMXZ #5P2#L:#R]9;=B]G0/<OC6#J#_(3H[ETM]A=MHB'P_&J#^\
MBK OYH]C/S^N >38*:Z=WFR\ %,%UNW@Y/BX30O*J^PJ$%PX$)%#$.=OG:,C
M$.4C4#>D'\SF/VN=<<V>7";ZGK3:0?NLU_D$QX,4]C4;O#DZQR Y7_D< !5!
MOYU[-]RN9^T6;*_6_M$?I!H[9ZQ(3XX_=<Z^XG[KT:CTE;C/CCKP8"V_\-#V
MYQ,TOFQ)7GZ6:$]EB3QQ"4#"Y%\ZM"-_YTNJ-&^9(-.MA%^[>CIVI4,D5Z%T
M!-(]B9= 35)#FH01=/ ?R=D]DH*]DJ^A8FG6ME79G&FB&X'0M!!&)8.W30?4
MUL'JU">1")W\1\@&^/6D@&H?:!-[,9X1BR<IQ8),M$A:9O$0N=Y]&2YCP:%;
M0S5>KQ?\\%H4!\A50 +,B51JXMG)OKX,$Y7!T-D1M<[$ :9'Q0@0AR5>]2X@
M;H$)@C6L'L[R&0;9XB S/,:#01B'F8[/6,WON-S18NCFM)-*F#!RRL39+ *?
MGAL4Q2BX-+X221Y(_]\A=S,IA7$5L:O;^41Z!>M)S^HFO-E8..-NQ)8GEX+*
M]F(C4T-PH]>@_$HBD,Z;85#5:NRCB^#-/M7=,_!)CC"3&*MJ7/7"E'NTN9>X
MF9@I;'.6PN=TT#@=FCR=\SW=,TJNP,$:$M4P/I.0;4IDDC A3FH%G716.BW1
M1/']+(Y9N=C(K3 ]7@<1\5K:(_,9YLE4SZ!?IO$%Y?,N:"OJ[*O(@QN<DER$
M8NXU^)[*6'6L*K5[*I4HL'7;79.IM_L7"259FG&'1<H%8..62X22,GH26<)Y
M!B^4@,R0%YH*;/P"8L)LQ!+O$T:Z<"S[21;8]T8,2(6/8-=&8Z'L#IH-[!13
MH@F%'XU#&!65FB#6*YM."L/(IG+6E$^D?G44PJ/,)78/DH=3&%SU7!]%&?9)
MOP@0J>3<!7Y4$$:- 4F#:@BQLAQ.STF36%![";4>;D4:!RY,4.0I4Z)26M^T
M]J']1K<W!R8AXS#AV[?6A_6H/10A9^G?&-8Y3J$]IE9WE/I/'%IZM0HM/2+#
M7/G,Z9.5EZ47@6@\@O_AQM0Q6=9M><T&1+&5O89\ =RF@\60*Z(KJ<DR;V@9
M N&D.,O*_K:=3XHY6H^&*)M<7E.W*8\TMX2"EU+"0?>$(+9[!E(8 Z79((-F
M3'W"A :&][0Y>PW31%J=<+*5]81KJ&C-;->F1_0I; U*L"I9&(W[V,IKZ*LF
M9%0F0AT=TB341(FU*ZI=8 <?:_#E?-);"HQSRXI=@U"?47^J3+J1<_PQL;W/
MZ=@JR=J\-RUS:-15YC^2UG39;\$H)J%&6!LJZ^501%K>F:Y!@K4F@XJ.7+;0
MQ0C$.G$U\Y)KF7-$FJFT*SX)XV/P#-R!:LXD":V4FZI[&9,%$\5-(R2[C]E?
MYGBKY59AB#UV&]+=.0HA5%>(]>=_KPY%<(XQ1_!-Q1)OZ>1B 1IUK2PADT1?
M\,(U&_ 8=CY2ZM,U"@9$E$50=G0PV$\!B4@S:CD@H+K*5%BOM3.Y6X=>.CWE
M>"7E^(O5M+?<2[?<:U>UQ\4CVFK)^ZB]?C_B6<]]>S_*/^S6N]S>4W^A6NKR
MRQHK0OW0O?[=GOJ<^H.:)ZE7F-$?V+OC*Y0&1UV"839@:H_1 OI8E_SI'!^>
M8T2MW54A:S-0=Y#6TZR'?6EW/G_IP:N_=E_=^MR,8<>>AN>:@H_[-_; 2DM7
MTW!Y5K_D^>;<-G[4!VT39N:C'Q[UDO+^8XO^YZX<J9SWNN-_W6:T:&1S.UHV
MMG]*E^'URF5XFOCU*XQ?[Z?I]XTV6'?8)D&;[XHZP89I+!WWTBL-R(*YWAT@
MN89VE,9'BG7,4.]^6*U<TRBRO-G0F$!3G6=NO!1^,06V%&(WW08M(6B?7WEW
M':EVL)IVM-HR Y-4/!IPCA8R\=7U-7%PA=B:A',*$9JW\)A1%?7GE\)MU VG
M<-"8%%P<JH8U#JQ,8;6M-Q9/L(!M7_&22N%;WWTPTT8C.M6*T[OT*]8@"0^K
M0K+8AS;3#?/L61B5"8!-9&H3?X&SJ!O="IB:>Y7YZ")<<LL/5<@BI+"\9)/,
M-/BYQ?N)-S'[[0R>C[R[B^@*'RZ%A++ "E,YL,O6*9[WX\94?B@;DYV.T31+
MHORR%O.9$HEK$'$GOGY87*,G4OJ16F5'A/GE'!_?-.8V?>_8;5"3&_X(LT&4
M:RVAI-UVX*W2[DWOVP(A'_(H.7LF,JX(%*=][C67&27+RLP&:A8JS*'P[I:(
MN=JG-"D5=':469R<!JJ]9L%:97745ZCAX!/>,XR27<=,4'N:I8.8JO0S[P#_
MD>-V&I=:-VCGBG7,"2\%S/0IAH"'H"/T+\P=NU1%XE*3J@8RNB[I0.4V<N^S
M7K]S7C9]J]I[? T2$'"*;)R9-K/FIXH%M6/7SL+TG%IZU/"=.N_N]E4S:9E2
M#RSWX%H*T6+/SEUJM#>76M!:4Z*$-JWJWF!"4-H_].R.W28.@[@I>[;H<OZ9
MQ-:I/@P+80SH7'6<*U_,+<:"[_RP0+6G0XY[]0:(I[9($NC'"P\GEE2LNK):
M@WC.)G2*EIY_F89()E$N<I"8D"H2SS@ **357"J)![[O]E.W^P*2&E]H^_C"
M@"TE ZHF7>YJJ0IY@"Y44Q;7IK=_J]H"?1CK%ZICPB5-3-S]4I18TAYED^M9
MK='0KL>=4W;T:@WGE0P!&OBLXHLJ%89:]CHN$-6$M=FPRSY=J-+S"R]8S]BU
MU91//)AE[5$H34LGI*(Z*(7)57F=Y-VYL:P7I\D%A>IC3IG"MA&5S@WNI]()
ME<2@= S3IG/6U:V(K![> RQ4RG673SZ3Z%2C9 11A<@Q9+DY2NV%*)%<JXF]
M$LEPM1JL#2NC\\J#LVES56/=R22-DFIB 7<HS-J[+6^(M'SJ8DG;4MT/]E;&
MK?#0%@L/%P)LL9!X;970/A2 ",9/I3DP5[U$N5I63OX,%?Z + <YAPRQ%)PY
M24V&Q7A):'Q5JWX-HP8.0+;TD+JZ_GN*Z0W=;+<J4+I,MKK?RVS>5:<#/K-7
M_#U^L/0-*ETA-)! 0"\3]B"<S6J16I9W:X@U0[1S]!2H$]+73;7-.:EE7ZR?
M:D'6^X739U6/ZI;,E W$GG7#NM!!I71-283L*;ZA5((:+U8C3H35'>1E(@"F
M,K/G@97GP<OEQB>9U?JNDOTILP=(09I0[EB5K_8O_3N+FU^6U]GD^,D"6AVG
MW^?\JE%K5++6I6%M@JU8AA/GL\))K.,"E&'Q]:TM*A2JS&IP8TNI_-8Z^XU!
M4.__U17JE>5O35SWLAGW$X-#WJPBO8_(3+8@C@0""J==(D6PFA;":A)1:ZU2
M8P'7GI>=6)5OA3F8URF"#&3W7%2L55P)BF<NZ/9JO2E>-%1Z*="5WAKJ.5\=
M2%TNZYH:O5)S.2>09YGPE7OS@6!Y.4NO8GV- ?__>P9:)@.3X_\M!Y)>&M,;
M').89*#Y%%'=<ANT=9Q * )2<^ZG_9T[CFJHK$UGJ*D?"7%= E5;,??ZE]5U
M>I$JN$:P, H5NN[E*["O&1P!+J-0'%R/ID17<V,&5NJB4+V5SYO@1BZ'EP2E
MD&UZ'8[9D&F%+Z^&4WL+&HX.$]0]/"ITYW@5%P+[C$A4%"1-;5#%!]ML&$X9
M4UO/+8B(?!"#J<3K6GA=,,%Q2UI<?0R8=8PKLB=O9EF3RB+1ZJ)NWK,4(_;*
MW.-.(8)@TH.O>?(H^F'FIV:P2E90L,"M#PK+JM(]1UJPQJ#B"F_[%?M=?*S-
MO;%?-3'%AL-7T&A BN>;R+,TJ _@B)B4.1A\BAV1HT?V=\[]F E0,_/Y=92D
MK+@=Y8RGB_S23/#2]>9;U%%MS2$%8S6XQN4J*@L652TA2)4S489BTFE5R^06
M])$O"TY8U?>J5 JD:W\V/5='"GVK>F#5-UW0Z.I5?1'%T[Q ::-:-S;U3XH-
MJ)+!,4,DS%FS(4Y8Y7N^.;-<"8P2-ZK^>5)^*XF+,F"+4)8*J[4$7%K"!37.
MB$LOB/HYM3/%J@6E^UKV] <VR)#B7=IOAB51#Q*UIGPC+T_5K4V"Y2Z43)HN
MF5J3PW?4)^06G><P;A;EK/!Q^5#+8<J"+<$)Q\%I$F1X9 .:5[\,N*7D@"F(
M:EZU/*?O5<9YP0S*X.6Y\X64#Q$Y=(/<5U0X =>@#04$*:E0H^3<M_$MBF;)
M^&'K%<W!5WXR/";FV5+/JW_0'=@+K9HMF?J PY3,UY>XV,5E6K7O\,2P>P$N
M_YC0W-(W?I4WBSC<5(,6HAN,C*HVB&XK6',_ND,K\>9K0CG\4M=N.54*/B:S
ME:5 W'8U3*=W(5ET^S."TC(-=SER,U >8&KP "?30CO1-9%\W9Z9K"'[ ?=*
M@#P8)J69.,$GCHB&,"ED\MBNQ,7G]:R\V;UZ?3P8OE0[8JX3FV$X$K>:#H93
MDG/&&Y42&TMXP<&,%S26[RQG[:Y30*T+]1TJ$R*TBK4S\LQ9[CDR.LE A?_$
M3>[>KH*8CYAEKQ64@_-NYQ2-LTZW<RP4PUCR0U+M:'A%V3N:)A<1[@L%+:C?
M"_@-;!Q+AZ 3?IZ0,]%E/W<4PLG$K6VP-*<(?F@8WWV;XSTX[ZYGB8\RS$=R
M<1C2JIOY\/;3(!MBVTE"*#+)\OPT$B%%<ON(C?19J@,4SI2KVCED3X:]3+K*
MXMU4Q[9B>]_Q9S+$KG&T-R;#G CG&/ZU[JN4"KDH; J7N\%6!X:57H30+_$+
M<Z(7*ZXKE@_%- P9,N;5UPR>T<Y<Z=]@?=&Z-N+M)LRZ+C#3K>H#1>:[:/"Z
M]8/(<S!D.@X)W2$K<X:!%Z<0S.&J($=NP>$(+V= 0Y4Q\%OQ. Q$)1 DJ,9-
M^A(AIS*\\7B:\+R@*S7E?Y5ZDSQ_=#>QG3Y5Z.E.-RW@ ,TZE3H)3*DA]]K)
M(^(TP%<R& QC:1(R(-;M1FJ6M+#1M1;S2@7PX[LDP$S/3-7R%+/C)]W@0#%'
M?!]&H@<;G?CN%4WC.8K&U3+-1DG-S% R/(>JX6.1@J<2%H6H9MFB'/E)AC:;
MB&OJ/[^1TU^O:E;WG9G5'=^D&A![O?EJ.8?)@(<] 5W+08 #,%+S,%XT6HH"
M4UYQZ9 2PGQ)R&&D>GA8B053VPI&-6A<C4(O5;0O$.<%JSOGX*3C"]G7$34O
MX:IJRXYW4O2LCBID3WFT9@,/[NGX**@LO4QZWZZ6J;1,C]#5\9% 6D%AKXX:
MKS+/3+12,4[=.D!K@CLUW/L<:37A3$GN<Y+2;1DC93"R'#6QGVH/API^O]2E
M6)>.#$SM@6-<<RRWHBU]YHZQ2'^XHA]'0.0_<'[W(S;$;((GIP!'NJ^X,55W
MO X&7F,3"A>2?)]6))JUB5OKU&"SW<(2VL F$.:DI?4NM]&4:J_;;\^&/'49
M4JM@40YQX3Y* .SN*VJ;ISYBJU49U?BI[UV$";EI@N.(V? DPB6N';( [8C[
MT'5+N>X^-Y"C3_<$XN[8:(,;R4"[-B5+6!GA6$Y?-HK+["N.JEN&"3S2K-UC
MAB*3!K9H'])'5KL5KQ+7N5[MVKK!RB[IV<3'(^5<E##\>@9&40,R\H=R=#Z*
M31*Y]/B^P(C!DXND/<5 *8]AB,N![4(MO2OX8U41PFB-F"LI$(K\(G#6D>/;
MH>JX2%-J@HO\&_/>ZSJ=QD/L3H6!=_L>"#VA; \("?CFPB-G81=47K4:RQ:
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M)))%%?S *_XYS:)\&$G+SL+F-D&*^E WFEVKD=?\,IJL.T%7[AN*DHO7U+>
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M%%DL!VER)K1Z= R'U,O)?J1Y$+4CUA_=ZT$_<1!T9Q4$??0:SSU=5WE71?K
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M>[,%J.I$\*2-BK.M7O*_I65OGOUF">8KP:)\M0%S-#Z.^!#"2\S;U+@&&%1
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M'=YNR6ERBT&\Y:P%N:=H^*H89 D"Y#<#85]%F%<1YE4:?"7[*]G_567_>92
MO%F9PO<,]7ER\/O!R2FA?1YJA,^'+/_X!7#;5K!M*]BV1X%MVYL*WM,O"PH[
M!>$P0M_4"@ 5-I8/X];H1,U(HH06Q[L--\9@+ZK!W\0RD5,=XU#!??+9&G_R
M?F%T+8^SZIA6'5=;R:N;GZX#[_]XD^Y^?9LK+Q?N!\>#D[^SWM_:L&]Q^U<3
M+;<* KEW5[G?]2IC^O#]X[$!UDD"K3PV" ?)->&49?&X0=:'@PO\T/NX-ALN
ML-VJX042#OK-\0(YEJ_QP*K@4S:2DQLWM\G;=?*^L.";O#IZDQ_\"?<670M^
M7J^>-,!. N9$(7\+:D= R=JMID"^RD%$DD."BY"Z(_U+/XHIS6HENC?,3:3#
MO0J=9AK\$B43OLV)P70+?"0;MJG=FHC;U"-0S,:'>4,8?LXP6 %5'F!-05Y!
M'X*/8N)>/8"2GOTJ4(^7('H;845R%M?^MHE^4XZ>4_:X)DX[*.-@"1I8\WCQ
M.TFJQ])N\<;X@T%6AK*["<V'"<DT^A9A@SQ^TJ!7.1HV8D0_=(#(\-<&BJP]
M&SMBY_7F"]@TU51-0F2 RF9_W?DV YH]_@)UK5(*T'0,]S05;\L7.*4,_HO9
M%1L-P$JU>E9FL08UQP4"4A644A4,&I$@M8UBM[(4YK04MI?34G"1#+KFHOF.
M.??/IJJH*Z "LS$$4!VW6\UFQC-':M/5@$W*;1I2FYGHZU_V\#2$Q>27KZ:>
MK+5H??F.UN/#XDT];"OYNHM\/2,!FQN5<"5<#RU<STBZY@:%7(2=L'B8R':K
M&2?2>TXPD<V5*K^HAG@W34-,=QS6NDNH'V: H$W$?[P5+EJ[]03P'Z>'5%<'
MX X'X-.2'H#'0054 ;U&6$?OR<%O-MSU3[*<X>TS+V=8J9V]E=J9HG:>%ICL
MZG9^L&.ROX3'Y%ZQ?&^0=YH,YNL]72Q?ZO&^ 9AOXXW^'$[%=,'?6<Z$SK>P
MN$@)"T#2=4M3]6$G?E&<*>,H;:&YIV$4F!#1!0#@LH0&,BAY5'-FW*I0J)(<
M(>F?RW+D%X)&@5V>"?5*C\ ,\XX1ND'('DDKK,])A)2%<7B)+;A-.5H,HCB$
M5@MH>3R>V-,),W"XW&LE'[*F^^$XS:/"SZCLPV9^LHI(RB3(%SV["@5]M6Q#
MMI(;NRAXAN@ E<9]&"$LD$]E>7K[I/$32T*B(B*I)9VI:HDX9MAN'<FCAV[C
MIGTT9HRQ?VV:G9%ICO_&I'#>X"(<_/""S+]*%)%;\@/W!#LU]P1*0C-M!F&,
MB!"Z>M#S@R CR>7A'3,?F"D?$, 'XM?$PASYN!2<C,=8;A$IJ><#HMLZ:38=
MM].9^KJOLJC 8BWX?JQN%QG/"3TD\YG[*_8+HE?U:^?*G">BD+3+)V +SV$L
MQ*+54(/%:RSL:3SSO[Y2O'T=6'Q,?L.MG ^Y<7N*;"L<>'L>E#]1$Z2'1=0*
M.R@L?/@L1(FB07#ICZG2DID@L -8OSGU9>/CX/;N5%9(EHR:PN$@KNHSYKS.
M7R[G=0X7&K74GU/Q'RAGO>-+=*^+RNM,Y_BU4R<65?($;D+2>SX7PDU9!'JE
M5LS7[=8 ],,Y5TD[7TLSZ[!@[5W*)=:HCB5MPJ=M=7+F/#FOEO/D- M6+A71
M"B)K60Z1)<;"!FYC1A!:286(]P$9P17>4Q-9\=0C_H TW9,(JF\TH1LS9".)
M["/3=,/JP,=(#MVQ>,36?9N1".6Q7?P]@[&[W;H#93>\CEF[:1)S,G?C9X6]
M>R)SM_<@Q-WMUK=[9>[&DV$A\X7"FJO3_N@?Y@6]7X>>+ RW0#Y")=]C/]/X
MAN;$P\@R369D%R-8G^DR--36NYUW=,3 NX7?@1FZ9@YCKVNM"0[<HOBU2PG@
M!B9#GV;%8]385)7.(G>@>FUZ7<;&X8EK%$'GP3  _C[A[!7HH8_08F;I8FL:
MK>S8O^K4@-882T]XJ<E9ZX?%%6+D%&H[VJT:4F)1W:J*$#7_3NQU,K'3>&4G
MS&DGO%Y..^%H++V4)QJC<QFM H1-4^B6#"2*@:EPY%G DAS3BD,&<R0ETL$O
MX2$AR$J,+1,]._X#3RW\5P?1 G&23<B7H)@"U),,9RI(;&(UX_VMV<HB9+@G
MMY:E^N7&MCH_DRQ\')BUZ-CN"D\-_XT0KS( <-U]"2*L;:U[E.JNX0/:'54J
M<J_0V7"%&(YM;5O!JV'+33DRSR'@1T3W*D.#0G5"3CG5D \NPJ#$^(<$%W/W
M51S3UZ]"S$,<#R+"40C&:HN29I8U'[9T1+57-^A):6AI$74G>)1WZ6Z!&Q'#
ME>=H^:B1>Q2P<O;!6J\S3)Z4V;4PD\=E[KW:E(F-TX@:D>FGW( 4",:JP+I)
MF.OI GJ]>^9I_X?#["<81NQ%,XWJ1=K1G<ZZ(%$%MK1>P,!>Q\3]N2'/B<CR
MX<O=S!V:'<-"H@R6&7$,!V@/[W%^;N5EK(1T7->)P;9;^E#8FFAZA'&2HKC!
M*;G#>BT@T'XD@-EZS6M;&+FMHP/*PE+FD5H5X7.R>1EHDJQ0(*7\PP%\12+N
M!DR[8]<ELS @;BUA6><-\-5-F_WX#7Z'?'_">"Q8<!7G/X_ M*T4(CO@Z50H
MH4^#ZO=OOF17-NJ<-NJ;Y;11S_R?O!%+:*/VANQG2O6X<LHD#ANQ(D8GE ZA
MB#(A?JX):BJCG\MYA^-=QH1M@3WU92PHOAKJ=UV] -8$]>G_!<LT#Z*!H. B
M"<$UJ(\X8E@!<&>#B!&/J9Z?OR0HCL6UZ-BA6,R3GNM38H9J)OR?&J*_,DU,
M[45(3X"Y4#;0SWW![3=7D/HR*4,P/@N->TP7#BY,9\**J R3O-->UW:+06ES
MR2$1>GVFW64%\^]/&V\'W7\P5.'F&G#_M7.%8EC2M\I5)*%GJ:E:OX3:8/Y&
ME"E(7!P=M<5C5CWG4* >)N-#TV (IIC5HH#M<K !$1:H,[H1":<!?5==P6N*
MPB D@%#9_'4I.A@^W&2"$$,*6!? ]@O7L&F6 OAP(BC#I+1FMJ*T6W<:CNPJ
M(VHS4#391B.R[3%(KG.;L'Y10=N<Z/SXV) :/-!Z3=HR940.UQ6.N':\E/-K
MFTAU%UA<6'(N02_ ]"FUS#:$GX!AAZ@/.7?SP.^D"H1^][KR.Y4[J@9+[;M:
MG6LY+;*"51MD(M Z[/.6^*U)JEZIG@FZR+8@9$'8@  W,8Y4NOP=#]QU[OD3
M8(T%4O?&RF76ELZ_EU=I&0>\*]JNMDVXAM/=;M&GFH&NO*N0B!*T79?8MCH)
M:E!*2%5[_;+P%/B@3\M:@I:A!>O4CJ3HF6D#X<Q];E+W#\18]XP-KK?+:7#M
MATD*ZIJOX%TXW5P"LNL=_.0;=&G,KS.M*3$D3Y<TJFTB&= U:E@:VM%9[T&*
M.I"K2; Y<%2.X(*R)DQE,-M<!%-W:E6)V'D&/QMAPR!X'IQ0^>L6?<6MIY$'
M;7@:V 0U@RX0HF.I2FR(-T'9-U9Y3A-J?(7GR%5:2A_SJQ2W"K^_([D=)D1
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M/T_C4G:TM)FR.LJRJ@4-JJ 8#G.+.GU4]^X/I,,T8Z,IT;I_D'(IW*#,<$'
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MW?M^VCL6"$COL$0 RR5+EIA:+;+Q X^&["4\5@D\HHFA>>NMM+'4E6*4R\5
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M\SBMI;[!N4 UJ0;K@><#YX*J_4&+(*XC%H"(@SFYQJX6K5,9(XWE6:D^@Z-
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MJR8\Q?F^O-ZSWUX=8L?J-L)*F??/,G3T=L[TS]M9D:.F<-'6NSO&F[8W%_T
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M@M=0G_IF[;%-I76YHO%(5PBT+Q[J1F3XEK12CD:MXA7<),U%V3D-**A]P=R
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MT^?\TWE\WHXD915DUJ&-72'ZRTO._GDX+XAQ(1R-*NOB.ZM!HM,3E)_)I\#
M)%7D6\BV,5(7+"6156S:T-30@$]P'K'7L1JS@]>7%]U\9#5"UEG32.5B+XIO
M%0?RZ:QM'G6N#];IN09;O8BK7UZSN;FY5J]MUG<W7N0+"V&N/8ZHD#N6,F4/
MT"KTLVAPN;-24@VY9" 4.1>+C3D'+L?KM =0*KE)HS#/_+K<Z)YEB-;IYV#$
MHZ%@)_%X##664FQQ-V,2WU\&2=Q#J3"HK/[*P+(:)=\@3/MD#LYZ7%.,Q%01
MDQ3.#E%AZ84K_?V.:=U5OJZH'" FJ/I$7,U\PCJ=3$)K6+,'>RUZ"E+/YO;8
M]/>X\B@56R%D,TI^^'.CW_#!+3V,6LNW\Z-M>8EV+\F6)\0O\N-'YQW=5+\&
MD3T+&[4B\ -(4U1:!+9@(SX53'S&HHA,'2LY),W!@^%^ < 3J)#GRH&$SG#/
MN.^MA%(D,6+O(W()56G$B!YP1QW>K%,DCGX<I*00T,P@ :$J?.Y;==J(0'>6
M*/L@I:>,M[Z -OL,/ NM2=D$STBS2!N36&=14R ]WZ57Y0MK85K@QS'+PY@X
ML)86=O"LB;H2E(QR4V?6JX"B3](:(U6BXIR*&W9\U]HBWZKML#(4M,G0>%<K
MHY('#K*)<>-Q;&#L'.19E%NZQE&C&]H\FXVQMR(,21W@"8K5R,;@/K(VR?!O
MQ8IN^>K:IXKP]:.FR'&O86JDI>_<4I1;RB/P!NZM5H_YC!VAI\\NA?Q(YG97
ML:8YJ;N 3 #UVETV>1ARC;IMKLY)O6_B?.5YG'I+VW'4]RY0$Y%Q0Y&1>IM&
M5!;M1:YT>WF%?)X]U^%APMK\!LF:H+>[2>E[Q*6[?,_UR(YW*ZQ9/:EFG=-Z
ML_4.;;P[K3'#:^KV)RB,LU#,*UV,[^B<;GGSCYY [(@]'M[RF:;)_<'Y->NT
M_@?K;:YD),UIT=YON^:_TIF",\G)Z47W]/HKCY(>.DQZUC%,[1'',#]QZ/#
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M9(?2C%+(34W;*@8#[(-F=E T@&3T'NJ;2B=),*,>4<?A5$3T68E8#7F4N]E
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MKHJ%:A:9Y' L;Q7S"]X[:'<W6!F (!8!0QQ)DBAV$>Z94YRP?6X O=]A2C$
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M%UG7%-@M2J3E,LI( R*4UJ\#2P)\G#MSS*H5&>1[^>S9<\HW?J8=_\2:DAZ
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M0.A/G[$U<3BS5ZY8G$NW-!ODK+*7DD^W*,TV^3)<!8DQ&QO\*^HU\Y1TX;)
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MQ"I_>TJ-45Z]6OE@0_A]&O5P+P-'HAHVMV"/'>.&.4:%7C6XR^P9(QTC_X2
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M%'=<Z2WS/R.R733]SPEZSW]02P,$%     @ +HII5I/T5T2O!   9BH  !4
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M-_NT'Y;\#5!+ 0(4 Q0    ( "Z*:58'1ZVA>QH  !&Q   .
M  "  0    !D-#<U-S$X9#AK+FAT;5!+ 0(4 Q0    ( "Z*:5:E0B/>Q=<
M #^.!0 0              "  :<:  !D-#<U-S$X9&5X-#(N:'1M4$L! A0#
M%     @ +HII5EU>,\2!U   @6T% !               ( !FO(  &0T-S4W
M,3AD97@T-BYH=&U02P$"% ,4    "  NBFE6J'D_<IP3  #U20  $
M        @ %)QP$ 9#0W-3<Q.&1E>#4Q+FAT;5!+ 0(4 Q0    ( "Z*:5:L
M*-MAJ@X  )@Z   0              "  1/; 0!D-#<U-S$X9&5X-3(N:'1M
M4$L! A0#%     @ +HII5LR77B34&@  _J(  !               ( !Z^D!
M &0T-S4W,3AD97@U,RYH=&U02P$"% ,4    "  NBFE69O@%%#\#  !/"P
M$0              @ 'M! ( =&5V82TR,#(S,#,P.2YX<V102P$"% ,4
M"  NBFE6\M'[:50&  !Z0P  %0              @ %;" ( =&5V82TR,#(S
M,#,P.5]L86(N>&UL4$L! A0#%     @ +HII5I/T5T2O!   9BH  !4
M         ( !X@X" '1E=F$M,C R,S S,#E?<')E+GAM;%!+!08     "0 )
+ #<"  #$$P(    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
